{"title":"Mitochondrial Renewal","description":"\u003cp\u003e\u003cstrong\u003eMitochondrial dysfunction is one of the universally accepted Hallmarks of Aging.\u003c\/strong\u003e In the López-Otín 2023 update (\u003cem\u003eCell\u003c\/em\u003e), mitochondrial decline sits at the metabolic core — the cause of the energy collapse, oxidative load, and impaired stress signaling that the downstream hallmarks ride on. Mitochondria turn the food you eat into ATP, the chemical currency every cell spends to do every job. They also generate the reactive oxygen species (ROS) that damage DNA, proteins, and the mitochondria themselves. By age 70, both the \u003cem\u003equantity\u003c\/em\u003e and \u003cem\u003equality\u003c\/em\u003e of mitochondria in human tissue are measurably worse than at 30 — fewer in number, more mutated, slower at switching from rest to demand, and producing more ROS per ATP made.\u003c\/p\u003e\n\n\u003cp\u003eMitochondrial renewal is the practice of supporting the four interlocking processes that keep this network young: \u003cstrong\u003ebiogenesis\u003c\/strong\u003e (building new mitochondria), \u003cstrong\u003emitophagy\u003c\/strong\u003e (clearing damaged ones before they leak), \u003cstrong\u003eenergy production\u003c\/strong\u003e (running the electron transport chain efficiently), and \u003cstrong\u003eantioxidant defense\u003c\/strong\u003e (mopping up the ROS the chain produces). Each pillar has well-characterized human evidence behind it. This collection assembles the most rigorously studied compound for each, dosed at the level used in the published clinical trials, third-party tested for identity and contaminants, and manufactured in cGMP-compliant facilities.\u003c\/p\u003e\n\n\u003ch2 id=\"60-second-answer\"\u003eThe 60-second answer\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhy this collection exists.\u003c\/strong\u003e Mitochondrial decline is the metabolic hub of aging — every other Hallmark of Aging gets worse when ATP supply, ROS handling, and quality control fall behind. Renewing this network is one of the highest-leverage interventions in the longevity literature.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe four pillars.\u003c\/strong\u003e Biogenesis (PQQ, NAD+ precursors), mitophagy (Urolithin A, Spermidine), energy production (CoQ10, NAD+ precursors, Creatine, Taurine), antioxidant defense (ALA, Glycine + NAC for glutathione, CaAKG cofactor for the TCA cycle).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrial-validated doses.\u003c\/strong\u003e Urolithin A 500 mg\/day (Andreux 2019, Singh 2022, Liu 2022); PQQ 20 mg\/day (Harris 2013, Hwang 2020); CoQ10 100–400 mg\/day (Mortensen 2014 Q-SYMBIO); NMN\/NR at the dose ranges used in NADPARK (Brakedal 2022) and Trammell 2016; ALA 600 mg\/day (NATHAN1 Ziegler 2011); Glycine 1.5 g\/day in the GlyNAC pair (Sekhar 2021, Kumar 2022); Taurine 1 g\/day (Singh 2023 \u003cem\u003eScience\u003c\/em\u003e); Creatine 1–5 g\/day (Forbes 2022); Spermidine 10 mg\/day (Schwarz 2022, Eisenberg 2018); CaAKG 1 g\/day (Asadi Shahmirzadi 2020, Demidenko 2021).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTwo-product entry stack (highest ROI).\u003c\/strong\u003e Urolithin A 500 mg morning + an NAD+ precursor (NMN or NR) morning. Mitophagy clears the broken mitochondria; NAD+ keeps the surviving ones running. Run for 8–12 weeks before adding anything.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFull mitochondrial protocol.\u003c\/strong\u003e Morning fasted — Urolithin A + NMN\/NR + ALA + CoQ10 (with a fat source). With breakfast — PQQ + B-complex (built into NAD+ 5-in-1 if used). Pre-training — Creatine loaded across the day; Taurine. Evening — Glycine + Spermidine an hour before bed (autophagy windows align with the overnight fast). CaAKG 1 g\/day on a daily or alternate-day cadence.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTime-to-effect.\u003c\/strong\u003e Subjective stamina shifts at 2–4 weeks. Endurance and recovery shifts at 6–12 weeks (this is when published trials start to read out). Mitophagy gene-expression rewriting in muscle was measurable at 4 weeks in Andreux 2019; biological-age clock changes (CaAKG, GlyNAC) typically read out at 4–6 months.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality.\u003c\/strong\u003e ISO\/IEC 17025 third-party testing, cGMP 21 CFR Part 111 manufacturing with named partners (Selerb on the NAD+ 5-in-1; Mitopure-spec Urolithin A; Niagen-class NR; AlzChem Creapure-spec creatine; trans-pterostilbene\/trans-resveratrol on the NAD+ Liposomal); per-batch CoA on request via support@truehealthprotocol.health. See \u003ca href=\"\/he\/pages\/quality\"\u003e\/pages\/quality\u003c\/a\u003e for the full operational spec.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWho this is for.\u003c\/strong\u003e Adults 35+ noticing the early energy drift; adults 50+ addressing mitochondrial decline directly; athletes and serious trainees who want the recovery and endurance side; statin users who want to restore CoQ10. Not a treatment for any disease. Mitochondrial myopathies, primary CoQ10 deficiency, and inherited mitochondrial disorders require physician-led care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"on-this-page\"\u003eOn this page\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#mechanism\"\u003eMitochondrial decline — five mechanisms behind the energy collapse\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#four-pillars\"\u003eThe four pillars of mitochondrial renewal\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#per-product\"\u003ePer-product trial evidence\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#three-tiers\"\u003eThree protocol tiers — entry, daily, full\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#stacking\"\u003eStacking guide — within and across collections\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#timeline\"\u003eWeek-by-week timeline — what to expect and when\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#drug-interactions\"\u003eDrug interactions and precautions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#who-for\"\u003eWho this collection is for — and who it isn't\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#quality-standards\"\u003eQuality standards — what every product on this page meets\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#measuring\"\u003eHow to measure mitochondrial improvement\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#myths\"\u003eCommon myths and corrections\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#cost-tiers\"\u003eCost tiers and what each one buys you\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#faq\"\u003eFAQ — mitochondrial renewal questions we get every week\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#reading-list\"\u003eReading list and primary references\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#related\"\u003eRelated collections and reference pages\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"mechanism\"\u003eMitochondrial decline — five mechanisms behind the energy collapse\u003c\/h2\u003e\n\n\u003cp\u003eThe phrase \"mitochondrial dysfunction\" sounds singular but actually wraps five distinct biological problems that compound on each other across decades. Understanding which one a given compound addresses is the difference between a stack that works and a stack that wastes money on overlapping mechanisms. The five mechanisms below come from the López-Otín 2013 and 2023 Hallmarks-of-Aging reviews, the Bratic and Larsson 2013 \u003cem\u003eJ Clin Invest\u003c\/em\u003e mitochondrial-aging review, and the more recent Sun, Youle, and Finkel 2016 \u003cem\u003eMol Cell\u003c\/em\u003e mitophagy synthesis.\u003c\/p\u003e\n\n\u003ch3\u003e1. Mitochondrial DNA mutation accumulation\u003c\/h3\u003e\n\n\u003cp\u003eMitochondria carry their own circular genome (mtDNA, 16,569 base pairs in humans, encoding 37 genes). Because mtDNA sits next to the ROS-generating electron transport chain and lacks the protective histones that nuclear DNA has, it accumulates point mutations and large deletions at roughly 10× the rate of nuclear DNA. By age 70, the average heteroplasmy load (fraction of mutated mtDNA copies per cell) reaches 30–60% in muscle, brain, and heart tissue. Above the cell-by-cell biochemical threshold (~60–80% mutant load for most respiratory-chain complexes), the cell flips into a hypometabolic state. This is why some 80-year-old skeletal-muscle fibers show \"ragged-red\" cytochrome-c-oxidase-negative phenotypes that don't exist at 30. The renewal lever here is mitophagy — selectively clearing the cells and mitochondria with the highest mutant loads before they expand clonally.\u003c\/p\u003e\n\n\u003ch3\u003e2. Endogenous CoQ10 decline and electron-transport-chain inefficiency\u003c\/h3\u003e\n\n\u003cp\u003eCoenzyme Q10 (ubiquinone) shuttles electrons from Complexes I and II to Complex III. The body synthesizes CoQ10 endogenously through the mevalonate pathway — the same pathway statins block at HMG-CoA reductase. Endogenous CoQ10 production peaks in the early 20s and falls roughly 50% by age 80; the decline is steeper in heart and skeletal muscle than in liver. Statins amplify the decline by an additional 30–50% within weeks of starting therapy (Marcoff and Thompson 2007 \u003cem\u003eJACC\u003c\/em\u003e). When CoQ10 falls below saturation, electrons \"leak\" off Complex I and react with oxygen to form superoxide — adding ROS load on top of the energy shortfall. The renewal lever here is direct CoQ10 supplementation (the Mortensen 2014 Q-SYMBIO heart-failure trial used 100 mg three times daily; the high-bioavailability tier is 200–400 mg\/day with food).\u003c\/p\u003e\n\n\u003ch3\u003e3. NAD+ pool depletion and SIRT3 starvation\u003c\/h3\u003e\n\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is the coenzyme that pulls electrons through Complex I and feeds the seven sirtuin deacetylases — including SIRT3, the mitochondrial sirtuin that switches on the mitochondrial unfolded protein response (UPRmt) and tunes the activity of dozens of mitochondrial enzymes. Whole-body NAD+ levels fall roughly 50% by age 50 (Massudi 2012 \u003cem\u003ePLOS One\u003c\/em\u003e; Clement 2019 \u003cem\u003eCell Metab\u003c\/em\u003e); the steepest decline is in skin, brain, and skeletal muscle. The decline is driven by a combination of falling synthesis (NAMPT decline) and rising consumption (CD38 increase with inflammaging — Camacho-Pereira 2016 \u003cem\u003eCell Metab\u003c\/em\u003e). When NAD+ falls below saturation for SIRT3, the mitochondrial proteome accumulates hyperacetylation marks and loses metabolic flexibility. The renewal lever is NAD+ precursor supplementation — NMN (one enzymatic step from NAD+) or NR (two steps, but with the largest human safety dataset and the patented Niagen-class form).\u003c\/p\u003e\n\n\u003ch3\u003e4. Failure of mitophagy quality control\u003c\/h3\u003e\n\n\u003cp\u003eMitophagy is the selective autophagy of damaged mitochondria. The PINK1\/Parkin pathway tags mitochondria with collapsed membrane potential for ubiquitination, which recruits autophagy receptors (NDP52, OPTN, NIX, BNIP3) that build a phagophore around the failing organelle and degrade it in the lysosome. Mitophagy declines with age in two ways — the tagging signal weakens (PINK1 stability falls), and the lysosomal degradation step slows (lysosomal pH drifts upward, cathepsin activity drops). The result is accumulation of damaged-but-not-cleared mitochondria, which leak ROS and cytochrome c and act as sterile-inflammation signals (the cGAS\/STING mtDNA-leak axis). The renewal lever is Urolithin A, the only oral compound with clinical-trial-grade direct mitophagy data in humans (Andreux 2019 \u003cem\u003eNat Metab\u003c\/em\u003e: 500 mg\/day for 4 weeks rewrote the muscle mitochondrial gene-expression profile of older adults toward a younger pattern), and Spermidine, which drives general autophagy with mitophagy cross-talk (Eisenberg 2009 \u003cem\u003eNat Cell Biol\u003c\/em\u003e; Eisenberg 2016 \u003cem\u003eNat Med\u003c\/em\u003e; Schwarz 2022 PMID 34762807).\u003c\/p\u003e\n\n\u003ch3\u003e5. Glutathione depletion and antioxidant-network collapse\u003c\/h3\u003e\n\n\u003cp\u003eGlutathione (GSH) is the master cellular antioxidant — a tripeptide of glutamate, cysteine, and glycine that exists at millimolar concentrations inside healthy cells. Mitochondrial GSH is the primary defense against the superoxide and hydrogen peroxide the electron transport chain inevitably generates. GSH levels fall roughly 30% by age 70, with the decline driven primarily by glycine and cysteine substrate shortage rather than enzyme failure (Sekhar 2011 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; Sekhar 2021 \u003cem\u003eClin Transl Med\u003c\/em\u003e). When GSH falls, the cell can't recycle oxidized vitamin C, vitamin E, or CoQ10, and the entire antioxidant network downshifts in parallel. The renewal lever is GlyNAC (glycine + N-acetylcysteine in roughly a 1.6:1 ratio at ~100 mg\/kg body weight, per the Sekhar protocol), backed by ALA as the universal antioxidant network regenerator.\u003c\/p\u003e\n\n\n\u003ch2 id=\"four-pillars\"\u003eThe four pillars of mitochondrial renewal\u003c\/h2\u003e\n\n\u003ch3\u003ePillar 1 — Biogenesis (build new mitochondria)\u003c\/h3\u003e\n\n\u003cp\u003eThe master regulator of mitochondrial biogenesis is PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), a transcriptional coactivator that turns on the entire mitochondrial program — Tfam (mtDNA transcription factor), NRF1\/NRF2 (nuclear respiratory factors), and the dozens of nuclear-encoded mitochondrial proteins that get imported across the outer membrane. PGC-1α is upregulated by exercise, cold exposure, fasting, and a small number of compounds. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e is the most reliable oral PGC-1α activator with parallel CREB and Nrf2 effects (Chowanadisai 2010 \u003cem\u003eJ Biol Chem\u003c\/em\u003e established the mechanism in cell models; Harris 2013 \u003cem\u003eJ Nutr Biochem\u003c\/em\u003e and Hwang 2020 confirmed mitochondrial biomarker shifts in humans at 20 mg\/day). NAD+ precursors also upregulate PGC-1α indirectly through SIRT1 deacetylation — the SIRT1-PGC-1α axis is one of the most-cited longevity mechanisms in the Sinclair lab corpus.\u003c\/p\u003e\n\n\u003ch3\u003ePillar 2 — Mitophagy (clear damaged mitochondria)\u003c\/h3\u003e\n\n\u003cp\u003eThe PINK1\/Parkin pathway tags failing mitochondria for selective autophagy. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e is the only oral compound with clinical-trial-grade direct mitophagy data in humans (Andreux 2019 \u003cem\u003eNat Metab\u003c\/em\u003e; Singh 2022 \u003cem\u003eCell Reports Medicine\u003c\/em\u003e 2.5–3.0 month muscle endurance and aerobic-capacity gains; Liu 2022 \u003cem\u003eJAMA Network Open\u003c\/em\u003e ATP-production gains in older adults). Mechanism: Urolithin A is a postbiotic gut metabolite produced from ellagitannins (in pomegranate, walnuts, raspberries) — but only ~30–40% of adults harbor the gut microbiome (specifically \u003cem\u003eGordonibacter\u003c\/em\u003e) to make it (Tomás-Barberán 2017 \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e). Direct supplementation bypasses the microbiome conversion problem. \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e drives general autophagy that cross-talks with mitophagy (Eisenberg 2009 \u003cem\u003eNat Cell Biol\u003c\/em\u003e; Eisenberg 2016 \u003cem\u003eNat Med\u003c\/em\u003e; Schwarz 2022 in older adults). The mechanisms are complementary, not redundant — Urolithin A is selective for mitochondria, Spermidine is global; the autophagy programs they activate share late-stage machinery (lysosomal fusion) but trigger from different upstream signals.\u003c\/p\u003e\n\n\u003ch3\u003ePillar 3 — Energy production (run the electron transport chain)\u003c\/h3\u003e\n\n\u003cp\u003eNAD+ is the coenzyme that pulls electrons through Complex I; CoQ10 shuttles them between Complexes I\/II and III; ATP itself is buffered by phosphocreatine in tissues with high peak-demand bursts (skeletal muscle, brain, heart). Restore the substrate with \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e, run the chain with \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e, buffer ATP with \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e, and stabilize the inner mitochondrial membrane with \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine\u003c\/a\u003e (Schaffer 2018; Singh 2023 \u003cem\u003eScience\u003c\/em\u003e). For users who want a single-bottle stack, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e bundles NMN + CoQ10 + B-complex + antioxidants + skin actives, and \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e wraps a 10-active stack in phospholipid liposomes.\u003c\/p\u003e\n\n\u003ch3\u003ePillar 4 — Antioxidant defense (neutralize ROS)\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid (ALA)\u003c\/a\u003e is the universal antioxidant — both fat- and water-soluble — that recycles glutathione, vitamin C, and CoQ10 itself, and serves as a cofactor for the pyruvate dehydrogenase and α-ketoglutarate dehydrogenase complexes inside the mitochondrion. The 600 mg dose is the NATHAN1 (Ziegler 2011 \u003cem\u003eDiabetes Care\u003c\/em\u003e) and SYDNEY 2 trial level. \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e + NAC (the GlyNAC stack — Sekhar 2021 \u003cem\u003eClin Transl Med\u003c\/em\u003e; Kumar 2022 \u003cem\u003eClin Transl Med\u003c\/em\u003e) restores depleted intracellular glutathione, the cell's master detoxifier; the Sekhar pediatric-protocol-derived dose is roughly 100 mg\/kg of glycine + 100 mg\/kg of NAC (a 1:1 weight ratio that maps to ~1.6:1 molar at the relevant amino-acid weights). \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate\u003c\/a\u003e is a TCA-cycle intermediate and required cofactor for the TET DNA demethylases and JmjC histone demethylases — the enzymes that \"reset\" epigenetic age (Asadi Shahmirzadi 2020 \u003cem\u003eCell Metab\u003c\/em\u003e; Demidenko 2021 \u003cem\u003eAging\u003c\/em\u003e showed an ~8-year drop in DNA-methylation biological age in humans on a CaAKG-anchored regimen).\u003c\/p\u003e\n\n\u003ch2 id=\"per-product\"\u003ePer-product trial evidence\u003c\/h2\u003e\n\n\u003ch3\u003eUrolithin A 500 mg — Mitophagy Activator\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e is a postbiotic gut metabolite produced from ellagitannins in pomegranate, walnuts, and raspberries — but only ~30–40% of adults harbor the \u003cem\u003eGordonibacter\u003c\/em\u003e-class gut microbiome to make it endogenously (Tomás-Barberán 2017). Direct supplementation bypasses the conversion problem. Andreux 2019 (\u003cem\u003eNat Metab\u003c\/em\u003e) at 500 mg\/day for 4 weeks rewrote the muscle mitochondrial gene-expression profile toward a younger pattern. Singh 2022 (\u003cem\u003eCell Rep Med\u003c\/em\u003e) at 500 and 1000 mg\/day for 4 months produced muscle endurance and aerobic capacity gains. Liu 2022 (\u003cem\u003eJAMA Netw Open\u003c\/em\u003e) at 1000 mg\/day showed muscle strength gains. Only oral mitophagy compound with clinical-trial-grade readouts in humans.\u003c\/p\u003e\n\n\u003ch3\u003ePQQ 20 mg — Mitochondrial Biogenesis Activator\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e (pyrroloquinoline quinone) is the most reliable oral PGC-1α activator. Chowanadisai 2010 (\u003cem\u003eJ Biol Chem\u003c\/em\u003e) established the mechanism — PQQ acts upstream of PGC-1α through CREB phosphorylation. Harris 2013 and Hwang 2020 confirmed mitochondrial biomarker shifts in humans at 20 mg\/day. Many retail PQQ products under-dose at 5–10 mg, well below the trial threshold. Pairs naturally with CoQ10 (PQQ builds the factory; CoQ10 stocks the production line).\u003c\/p\u003e\n\n\u003ch3\u003eCoQ10 400 mg — Electron Transport Cofactor\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e is ubiquinone, the electron shuttle between Complexes I\/II and III. Endogenous synthesis declines steadily after the 20s; statins block synthesis at HMG-CoA reductase (Marcoff 2007). Mortensen 2014 Q-SYMBIO heart-failure trial used 100 mg three times daily for 2 years and showed a 43% reduction in major adverse cardiovascular events. Also the most-studied oocyte-quality cofactor in fertility (Bentov 2014, Xu 2018, Florou 2020 meta-analysis — see \u003ca href=\"\/he\/collections\/fertility\"\u003e\/collections\/fertility\u003c\/a\u003e). Take with a fat source — bioavailability roughly triples with food.\u003c\/p\u003e\n\n\u003ch3\u003eNMN — NAD+ Precursor (one step from NAD+)\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e (β-nicotinamide mononucleotide) is one enzymatic step from NAD+ via NMNAT1\/2\/3. Yoshino 2021 (\u003cem\u003eScience\u003c\/em\u003e) at 250 mg\/day for 10 weeks improved insulin sensitivity in postmenopausal women with prediabetes. Yamaguchi 2022 confirmed safety to 1250 mg\/day. Igarashi 2022 (\u003cem\u003enpj Aging\u003c\/em\u003e) showed walking-speed and grip-strength gains in older men. Form matters — β-NMN, not α-NMN, is the bioactive anomer. See \u003ca href=\"\/he\/collections\/nmn\"\u003e\/collections\/nmn\u003c\/a\u003e and \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eNR Hard Capsules — Niagen-class NAD+ Precursor\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e use the patented Niagen-class nicotinamide riboside chloride with the largest published human safety and PK dataset of any NAD+ precursor. Trammell 2016 (\u003cem\u003eNat Commun\u003c\/em\u003e) characterized the human PK; Conze 2019 confirmed safety; Martens 2018 reduced systolic blood pressure ~9 mmHg in adults with elevated baseline; Brakedal 2022 (NADPARK) showed brain NAD+ elevation on PET imaging in Parkinson's. Bundled with B-vitamin cofactors to support the methylation pool.\u003c\/p\u003e\n\n\u003ch3\u003eLiquid NAD+ — Drink-Format NR with B-Complex\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e delivers NR in single-serve berry stick packs with B-vitamin cofactors. Same Niagen-class NR substrate as the hard capsules — the form is the difference, not the active. Suits users who don't tolerate capsules, travel, or pair their NAD+ precursor with morning coffee or a smoothie.\u003c\/p\u003e\n\n\u003ch3\u003eLiposomal NAD+ Ultimate 1000 mg — 10-Active Phospholipid Stack\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e wraps 10 actives in phospholipid liposomes for lymphatic-bypass absorption: NMN + NR + trans-resveratrol + B-complex + CoQ10 + PQQ + quercetin + supportive antioxidants. For users who want one-bottle simplicity at the high tier, this replaces three or four separate bottles.\u003c\/p\u003e\n\n\u003ch3\u003eNAD+ 5-in-1 Complete — Selerb Co-Formulation\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e is co-formulated with our manufacturing partner Selerb and bundles NMN + CoQ10 + B-complex + antioxidants + skin actives (HA, vitamin C, vitamin E). Itemized labeling — every active is listed with its full mg dose; no proprietary blends. See the manufacturing-partner detail at \u003ca href=\"\/he\/pages\/quality\"\u003e\/pages\/quality\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eAlpha-Lipoic Acid 600 mg — Universal Antioxidant\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e is both fat- and water-soluble — works in mitochondrial membranes and cytosol simultaneously. ALA recycles oxidized glutathione, vitamin C, and CoQ10 (Packer 1995); chelates heavy metals (Hagen 1999); cofactor for pyruvate and α-ketoglutarate dehydrogenase. The 600 mg dose is the NATHAN1 (Ziegler 2011) and SYDNEY 2 trial level. Take on an empty stomach 30 minutes before food for the AUC peak.\u003c\/p\u003e\n\n\u003ch3\u003eGlycine 1500 mg — GlyNAC Glutathione Precursor\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e is half of the GlyNAC pair. Sekhar 2011 established that older adults' GSH deficit is driven primarily by glycine and cysteine shortage. Sekhar 2021 and Kumar 2022 (\u003cem\u003eClin Transl Med\u003c\/em\u003e) showed GlyNAC restored intracellular glutathione, mitochondrial function, insulin sensitivity, walking speed, and multiple aging biomarkers in a 16-week trial in older adults. Glycine alone also extends slow-wave sleep (Yamadera 2007), when mitochondrial repair peaks.\u003c\/p\u003e\n\n\u003ch3\u003eTaurine 1000 mg — Foundational Sulfur Amino Acid\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e. Singh 2023 (\u003cem\u003eScience\u003c\/em\u003e) showed taurine levels decline ~80% with age across mice, monkeys, and humans, and that supplementation extended healthspan in multiple species. Taurine stabilizes the inner mitochondrial membrane, conjugates tRNAs that read mtDNA (Suzuki 2002), and modulates cardiac calcium handling (Schaffer 2018). 1 g\/day is the consensus floor; cardiovascular trials run to 3–6 g\/day.\u003c\/p\u003e\n\n\u003ch3\u003eCreatine Monohydrate 1000 mg — ATP Buffer (Creapure-spec)\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate 1000 mg\u003c\/a\u003e uses AlzChem Creapure-spec ≥99.95%-pure micronized form. Phosphocreatine recharges ATP from ADP within seconds. Sarcopenia prevention is now a primary geriatric use case (Forbes 2022 \u003cem\u003eNutrients\u003c\/em\u003e review of 19 RCTs); brain phosphocreatine increase (Roschel 2021); working-memory buffering under sleep deprivation (McMorris 2007). Maintenance floor 1 g\/day; full saturation 3–5 g\/day.\u003c\/p\u003e\n\n\u003ch3\u003eSpermidine 10 mg — Autophagy Inducer (Wheat-Germ Extract)\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e from concentrated wheat germ extract. The Bruneck cohort (Eisenberg 2018) found higher dietary spermidine intake predicted lower all-cause mortality across 20 years. Mechanism: spermidine triggers autophagy by inhibiting acetyltransferases (EP300) that suppress autophagy genes (Pietrocola 2014). Cardioprotective in mouse aging (Eisenberg 2016 \u003cem\u003eNat Med\u003c\/em\u003e) and improved diastolic function in human RCTs (Schwarz 2022). 10 mg supplementation puts most adults in the Bruneck protective tertile.\u003c\/p\u003e\n\n\u003ch3\u003eCalcium Alpha-Ketoglutarate 1000 mg — Epigenetic Cofactor\u003c\/h3\u003e\n\n\u003cp\u003e\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg\u003c\/a\u003e is α-ketoglutarate, a TCA-cycle intermediate and required cofactor for TET DNA demethylases, JmjC histone demethylases, and prolyl-hydroxylase enzymes. Asadi Shahmirzadi 2020 (\u003cem\u003eCell Metab\u003c\/em\u003e) extended median lifespan and compressed morbidity in mice. Demidenko 2021 (\u003cem\u003eAging\u003c\/em\u003e, TruDiagnostic-validated) showed ~8-year drop in DNA-methylation biological age in humans on a CaAKG-anchored regimen across 7 months. 1 g\/day is the trial dose; calcium-bound form supplies ~200 mg elemental calcium per gram.\u003c\/p\u003e\n\n\n\u003ch2 id=\"three-tiers\"\u003eThree protocol tiers — entry, daily, full\u003c\/h2\u003e\n\n\u003ch3\u003eTier 1 — Entry (the two highest-ROI products)\u003c\/h3\u003e\n\n\u003cp\u003eIf you're starting from zero and want the largest signal-per-dollar, the two-product entry stack is \u003cstrong\u003eUrolithin A 500 mg + an NAD+ precursor (NMN or NR)\u003c\/strong\u003e, both taken in the morning with food. Mitophagy clears the broken mitochondria; NAD+ keeps the surviving ones running. Run for 8–12 weeks before adding anything else. This pairing covers two of the four pillars (mitophagy and energy production) at trial-validated doses. Expected monthly cost: roughly the price of a mid-tier coffee subscription.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eMorning, with food: \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMorning, with food: \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500 mg\u003c\/a\u003e \u003cem\u003eor\u003c\/em\u003e \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTier 2 — Daily (foundational five-product daily mitochondrial protocol)\u003c\/h3\u003e\n\n\u003cp\u003eThe daily tier adds CoQ10 (run the chain), ALA (universal antioxidant), and Glycine (glutathione substrate, slow-wave sleep). This is the reference protocol for adults 45+ who want to address the four pillars at maintenance dose without the full-stack complexity. Total: 5 products, 2 dosing windows (morning + evening).\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eMorning, with breakfast (fat source): \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e + NMN\/NR + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eALA 600 mg\u003c\/a\u003e (ALA technically prefers empty stomach 30 min before food, but most users take it with breakfast for adherence)\u003c\/li\u003e\n\u003cli\u003eEvening, ~1 hour before bed: \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eTier 3 — Full mitochondrial protocol (all 4 pillars at trial-grade dose)\u003c\/h3\u003e\n\n\u003cp\u003eThe full protocol covers biogenesis (PQQ), mitophagy (Urolithin A + Spermidine), energy production (NMN\/NR + CoQ10 + Creatine + Taurine), antioxidant defense (ALA + Glycine + GlyNAC if added separately), and the epigenetic-cofactor layer (CaAKG). This is the maximalist daily stack used by adults who treat longevity as a personal-health priority. 9–10 products, 3 dosing windows.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eMorning fasted (15–30 min before food): \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eALA 600 mg\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eMorning, with breakfast (fat source): \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e + NMN\/NR + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e + B-complex (built into \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1\u003c\/a\u003e if used)\u003c\/li\u003e\n\u003cli\u003eMid-day or pre-training: \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e (loaded across the day to total 3–5 g\/day) + \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003eDaily or alternate-day: \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e (TCA-cycle \/ TET-cofactor; can layer alongside ALA on alternate days if you want to alternate the antioxidant and the cofactor)\u003c\/li\u003e\n\u003cli\u003eEvening, ~1 hour before bed: \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e (autophagy windows align with the overnight fasted period)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eOne-bottle alternative: \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e consolidates NMN + NR + CoQ10 + PQQ + trans-resveratrol + B-complex + quercetin + supportive antioxidants into a single liposomal carrier — useful if you want simplicity at the higher tier and don't want to manage 4–5 separate bottles. The liposomal form also bypasses some first-pass clearance for the fat-soluble actives.\u003c\/p\u003e\n\n\u003ch2 id=\"stacking\"\u003eStacking guide — within and across collections\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e \/ \u003ca href=\"\/he\/collections\/nmn\"\u003eNMN\u003c\/a\u003e.\u003c\/strong\u003e Heavy overlap — NAD+ is the substrate for SIRT3 (mitochondrial sirtuin) and the coenzyme that pulls electrons through Complex I. NMN, NR, Liquid NAD+, Liposomal NAD+ Ultimate, and NAD+ 5-in-1 sit in both collections.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e.\u003c\/strong\u003e Mitophagy clears damaged mitochondria from inside still-functional cells; senolytics clear senescent cells (past the point where mitophagy can rescue them) from tissue. Different scales of the same quality-control problem. Many users pair daily mitochondrial stack with monthly or quarterly senolytic pulses (fisetin, quercetin, apigenin).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e.\u003c\/strong\u003e Mitochondria are densest in heart muscle, so cardiac aging tracks mitochondrial aging closely. CoQ10 is the most-cited single supplement in the cardiac-mitochondrial literature (Q-SYMBIO). Taurine and omega-3 reinforce the cardiac-mitochondrial axis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e.\u003c\/strong\u003e The AMPK\/sirtuin axis sits between mitochondrial biogenesis and metabolic flexibility. ALA is both insulin sensitizer and mitochondrial cofactor; berberine activates AMPK; NMN\/NR feed SIRT1 → PGC-1α → biogenesis.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e.\u003c\/strong\u003e The antioxidant-defense pillar overlaps with the broader antioxidant-network program — vitamin C, vitamin E, glutathione, NAC, astaxanthin, polyphenol bioflavonoids.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e.\u003c\/strong\u003e Vitamin D3, vitamin K2 (MK-7), magnesium glycinate, and TG-form omega-3 are the foundational layer underneath every more-specialized longevity program. A weak foundational floor caps mitochondrial-program efficiency.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e.\u003c\/strong\u003e CoQ10, NAC, glutathione, ALA, and PQQ all appear in both literatures. The 60–90 day pre-conception window maps to spermatogenesis (74 days) and antral-follicle development (~85 days).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMitochondrial × \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e.\u003c\/strong\u003e Brain is the most mitochondria-dense organ after heart muscle. Creatine increases brain phosphocreatine; CoQ10 and NMN cross the blood-brain barrier; PQQ has parallel CREB-mediated neurogenesis effects.\u003c\/p\u003e\n\n\u003ch2 id=\"timeline\"\u003eWeek-by-week timeline — what to expect and when\u003c\/h2\u003e\n\n\u003cp\u003eMitochondrial supplements operate on a longer arc than caffeine or stimulants — most of the published trial readouts hit between week 4 and month 6. Subjective shifts are usually felt earlier than the lab-measurable shifts; this is normal because some of the early effects are antioxidant-network restoration (ALA, glutathione) and substrate-replenishment (NAD+) rather than the slower biogenesis and mitophagy programs.\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 1–2 — Tolerance and adherence window\u003c\/h3\u003e\n\n\u003cp\u003eMost users feel nothing dramatic in the first two weeks, which is the correct outcome. The point of weeks 1–2 is verifying tolerance — no GI upset (most likely from CoQ10 if taken without fat, or from ALA on an empty stomach in sensitive users), no flushing (rare with niacinamide, not relevant to NMN\/NR), no allergic reactions, no sleep disruption (NMN is energizing for some users — take it in the morning rather than evening). If you're tolerating the stack at this point, the protocol is working as designed — the biology is queued, just not yet readable.\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 3–4 — Antioxidant network and NAD+ early shifts\u003c\/h3\u003e\n\n\u003cp\u003eGlutathione restoration (GlyNAC) and NAD+ pool elevation (NMN\/NR) typically read out subjectively at this stage as morning energy lift, mid-afternoon stamina, and slightly faster recovery from training. The Andreux 2019 mitophagy-gene-expression rewriting in muscle was measurable at 4 weeks, so the biological signal is real even if the subjective signal is mild. Some users notice sleep architecture shifts (more slow-wave sleep on the Glycine + Spermidine evening pair).\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 5–8 — Mitochondrial biogenesis and endurance shifts\u003c\/h3\u003e\n\n\u003cp\u003eThis is the window where the Andreux 2019, Singh 2022, and Liu 2022 endurance and aerobic-capacity readouts hit. Subjective: longer training tolerance, faster recovery between hard sessions, less mid-afternoon energy crash. The PGC-1α \/ NRF1 \/ Tfam axis takes weeks to translate into measurable new-mitochondria density — the biology is slower than the antioxidant-network adjustment.\u003c\/p\u003e\n\n\u003ch3\u003eWeeks 9–12 — Stable plateau and the assessment window\u003c\/h3\u003e\n\n\u003cp\u003eBy week 12, the biological program has stabilized and the subjective signal is at its clearest. This is the natural assessment window — ask yourself: is mid-day energy better than the pre-stack baseline? Is recovery faster? Is sleep deeper? If yes, hold the protocol. If no, two diagnostic questions: (a) is the foundational micronutrient floor in place — vitamin D, magnesium, omega-3, sleep duration, protein floor? (b) is there a hidden upstream variable — undiagnosed thyroid, sleep apnea, B12 deficiency, alcohol load? Mitochondrial supplements work best on top of a foundational floor, not in place of one.\u003c\/p\u003e\n\n\u003ch3\u003eMonths 4–6 — Biological-age clock readouts\u003c\/h3\u003e\n\n\u003cp\u003eThe CaAKG and GlyNAC trials showed measurable epigenetic-age (Horvath, PhenoAge, GrimAge, DunedinPACE) shifts at 4–7 months. If you're tracking biological age via TruDiagnostic, Elysium, or similar, this is the readout window. Mitochondrial-quality biomarkers (acylcarnitine profile, PBMC NAD+ levels, citrate synthase activity in muscle biopsy) move on similar timelines.\u003c\/p\u003e\n\n\u003ch3\u003eBeyond month 6 — Maintenance vs. cycling\u003c\/h3\u003e\n\n\u003cp\u003eMost users hold the daily mitochondrial protocol indefinitely as a maintenance program — there's no published evidence of tolerance, downregulation, or diminishing returns in any of the trial extensions out to 12+ months. Some users cycle CaAKG (e.g., 3 months on, 1 month off) on first-principles grounds (epigenetic-cofactor saturation), though the published trial used continuous dosing without an off period. Urolithin A, NAD+ precursors, CoQ10, ALA, Glycine, Taurine, Creatine, PQQ, and Spermidine are all daily-continuous in the published literature.\u003c\/p\u003e\n\n\u003ch2 id=\"drug-interactions\"\u003eDrug interactions and precautions\u003c\/h2\u003e\n\n\u003cp\u003eThese compounds are food-grade nutrient cofactors at the doses shown in the cited human studies. The list below is operational — not exhaustive — and should not replace conversation with the prescribing clinician.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCoQ10 + warfarin.\u003c\/strong\u003e CoQ10 may reduce warfarin's anticoagulant effect at high doses. Talk to your prescriber and ask for an INR check 2–4 weeks after starting.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCoQ10 + statins.\u003c\/strong\u003e Beneficial pairing — statins block CoQ10 synthesis at HMG-CoA reductase (Marcoff 2007), so supplementation restores what the medication depletes (Mortensen 2014 Q-SYMBIO).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAC + nitroglycerin.\u003c\/strong\u003e NAC potentiates nitroglycerin's vasodilation; avoid the combination unless coordinated with the prescribing cardiologist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eALA + insulin or sulfonylureas.\u003c\/strong\u003e ALA improves insulin sensitivity, which can drop blood glucose in users on glucose-lowering medications. Check fasting glucose more frequently in the first 2–4 weeks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eALA in users with seizure history.\u003c\/strong\u003e Case reports of seizures in patients with thiamine deficiency taking high-dose ALA. Discuss with neurologist before starting.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNMN\/NR + chemotherapy.\u003c\/strong\u003e Discuss with the oncologist before initiating during active chemotherapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpermidine + hydroxychloroquine\/chloroquine.\u003c\/strong\u003e The autophagy-inhibitor pairing's net effect is uncertain. Discuss with prescribing rheumatologist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCreatine + pre-existing kidney disease or nephrotoxic medication.\u003c\/strong\u003e Well-tolerated in healthy kidneys (Forbes 2022) but warrants creatinine and eGFR monitoring in CKD.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and lactation.\u003c\/strong\u003e Pause the full stack at conception and switch to the prenatal-vitamin floor + a fertility-clinic-approved CoQ10 dose (see \u003ca href=\"\/he\/collections\/fertility\"\u003e\/collections\/fertility\u003c\/a\u003e).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren under 18.\u003c\/strong\u003e Not formulated for or studied in children. Doses on this page are for adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2 id=\"who-for\"\u003eWho this collection is for — and who it isn't\u003c\/h2\u003e\n\n\u003ch3\u003eThe \"early energy drift\" cohort (35–50)\u003c\/h3\u003e\n\n\u003cp\u003eAdults 35–50 who notice the early energy drift — slower morning warm-up, longer recovery between workouts, less mid-afternoon stamina, \"tired but wired\" sleep, slightly slower bounce-back from a late night or a hard week. The biology is real (NAD+ is already ~30–40% off its 20-year-old level by 40, mitochondrial density in skeletal muscle is measurably lower), but the clinical thresholds for sarcopenia, cardiovascular disease, and metabolic syndrome haven't been crossed yet. This is the highest-leverage window for the entry-tier and daily-tier protocols.\u003c\/p\u003e\n\n\u003ch3\u003eThe \"address mitochondrial decline directly\" cohort (50–70)\u003c\/h3\u003e\n\n\u003cp\u003eAdults 50–70 who want to address mitochondrial aging at its mechanism rather than symptom-by-symptom. NAD+ is now ~50% off the 20-year-old level; CoQ10 endogenous synthesis is at half-peak; glutathione is roughly 30% lower; SIRT3 substrate is starved. The full-stack protocol is the natural fit. Many users in this window are also on statins (CoQ10 restoration is well-documented) or pre-diabetic (ALA insulin-sensitization angle).\u003c\/p\u003e\n\n\u003ch3\u003eAthletes and serious trainees\u003c\/h3\u003e\n\n\u003cp\u003eThe endurance, recovery, and sarcopenia angles are the relevant ones for serious trainees. Urolithin A's published trials on aerobic capacity (Andreux 2019, Singh 2022, Liu 2022) are the clearest endurance-specific signal in the catalog. Creatine for power output, lean-mass preservation, and sleep-deprivation cognitive buffering. CoQ10 for the cardiac-mitochondrial demand side. Taurine for inner-membrane stability and exercise-induced calcium handling. Glycine for slow-wave sleep restoration after training load.\u003c\/p\u003e\n\n\u003ch3\u003eStatin users\u003c\/h3\u003e\n\n\u003cp\u003eStatins block endogenous CoQ10 synthesis at HMG-CoA reductase (Marcoff and Thompson 2007). The CoQ10 restoration is well-supported in the cardiology literature; the Mortensen 2014 Q-SYMBIO heart-failure trial used 100 mg three times daily for 2 years with a 43% reduction in major adverse cardiovascular events. Most statin users tolerate the muscle side-effects better with CoQ10 supplementation, although the RCT evidence on statin-myalgia specifically is mixed (Banach 2015 meta-analysis showed modest benefit).\u003c\/p\u003e\n\n\u003ch3\u003ePre-conception couples\u003c\/h3\u003e\n\n\u003cp\u003eCoQ10 (oocyte-quality cofactor — Bentov 2014, Xu 2018, Florou 2020), NAC (sperm membrane lipid-peroxidation defense — Ciftci 2009), glutathione (follicular-fluid antioxidant), and PQQ (mitochondrial-density ramp) all overlap with the fertility-collection program. The 60–90 day pre-conception window aligns with spermatogenesis (74 days) and antral follicular development (~85 days). See \u003ca href=\"\/he\/collections\/fertility\"\u003e\/collections\/fertility\u003c\/a\u003e for the reproductive-aging context.\u003c\/p\u003e\n\n\u003ch3\u003eWho this isn't for\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003eNot a treatment for any disease.\u003c\/strong\u003e Mitochondrial myopathies (MELAS, MERRF, Leigh syndrome), primary CoQ10 deficiency, and other inherited mitochondrial disorders require physician-led care and often pharmacological doses far above what supplemental products provide. Active cancer patients should pause initiation until oncology coordination is in place. Active pregnancy and lactation — pause the stack and switch to the prenatal-vitamin floor (see \u003ca href=\"\/he\/collections\/fertility\"\u003e\/collections\/fertility\u003c\/a\u003e). Children and adolescents — not formulated for or studied in this group. Anyone with a serious chronic condition or on multiple prescription medications — coordinate with the prescribing clinician before adding more than one or two supplements at a time.\u003c\/p\u003e\n\n\u003ch2 id=\"quality-standards\"\u003eQuality standards — what every product on this page meets\u003c\/h2\u003e\n\n\u003cp\u003eEvery product in this collection meets a five-test panel for third-party verification: HPLC\/LC-MS\/NMR identity confirmation; HPLC potency assay against label claim; ICP-MS heavy metals against California Proposition 65 limits (Pb≤0.5, Hg≤0.3–0.7, Cd≤4.1, iAs≤10 µg\/day); USP \u0026lt;2021\u0026gt;\/\u0026lt;2022\u0026gt; microbial limits including pathogen absence (\u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eS. aureus\u003c\/em\u003e); EU MRL pesticide screening + USP \u0026lt;467\u0026gt; residual solvents. Manufactured in cGMP-compliant facilities under 21 CFR Part 111. Per-batch CoA available on request via support@truehealthprotocol.health — supply the product name, the batch lot number printed on the bottle, the best-by date, and (optionally) your order number, and we return the original lab PDF plus a plain-English summary in one business day.\u003c\/p\u003e\n\n\u003cp\u003eNamed manufacturing partners and trial-grade raw materials referenced in this collection: Selerb co-formulation on \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e; Mitopure-spec Urolithin A reference on \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e; Niagen-class NR-Cl on \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e; AlzChem Creapure-spec ≥99.95%-pure micronized creatine on \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e; β-NMN pharma-grade on \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e; trans-resveratrol and trans-pterostilbene on \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e; EU wheat-germ–sourced spermidine on \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e; fermentation-derived ubiquinone CoQ10 on \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e. See \u003ca href=\"\/he\/pages\/quality\"\u003e\/pages\/quality\u003c\/a\u003e for the full operational spec on the three-tier verification standard, the cGMP 21 CFR Part 111 nine-element checklist, the country-of-origin transparency table covering every active in the catalog, the bioavailable-form checklist (β-NMN vs α-NMN; trans-resveratrol vs cis; trans-astaxanthin vs synthetic; MK-7 vs MK-4; bisglycinate vs oxide; TG-form omega-3 vs ethyl ester; reduced-glutathione enteric-coated; ubiquinone vs ubiquinol), and the per-batch-CoA email-request flow.\u003c\/p\u003e\n\n\u003ch2 id=\"measuring\"\u003eHow to measure mitochondrial improvement\u003c\/h2\u003e\n\n\u003cp\u003eMost trials don't have a single canonical biomarker. In practice, the subjective signal (energy, recovery, sleep, training tolerance) is the most actionable, and lab biomarkers are the slower confirmation.\u003c\/p\u003e\n\n\u003ch3\u003eSubjective trackers (free, weekly)\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003eMorning energy 1–10, self-rated 30 minutes after waking, before caffeine.\u003c\/li\u003e\n\u003cli\u003eMid-afternoon stamina 1–10, self-rated at 2–4 PM. Most-reported subjective shift on the daily-tier protocol.\u003c\/li\u003e\n\u003cli\u003eRecovery between training sessions — hours-to-feel-recovered or RPE at a fixed-load workout.\u003c\/li\u003e\n\u003cli\u003eSleep architecture — subjective wakefulness on rising; objective via Oura, WHOOP, or similar.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eStandard lab biomarkers (routine annual labs)\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003eFasting glucose and HbA1c (ALA insulin sensitivity; NMN M-value — Yoshino 2021).\u003c\/li\u003e\n\u003cli\u003eBlood pressure (NR reduced systolic ~9 mmHg in Martens 2018).\u003c\/li\u003e\n\u003cli\u003ehsCRP — inflammaging marker; Singh 2022 reported CRP reductions on Urolithin A.\u003c\/li\u003e\n\u003cli\u003eComprehensive metabolic panel — tolerance verification in the first 3 months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSpecialized tests (optional)\u003c\/h3\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDNA-methylation biological age\u003c\/strong\u003e (Horvath, PhenoAge, GrimAge, DunedinPACE) via TruDiagnostic or similar — Demidenko 2021 showed ~8-year DNAm-age drop. 4–6 month readout.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePlasma acylcarnitine profile\u003c\/strong\u003e — marker of incomplete fatty-acid β-oxidation. Andreux 2019 reported reductions on Urolithin A.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+ levels\u003c\/strong\u003e via Jinfiniti or Genova — verifies NMN\/NR is elevating the substrate pool.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVO2 max and resting heart rate\u003c\/strong\u003e — cardiopulmonary fitness tracks cardiac-mitochondrial density.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"myths\"\u003eCommon myths and corrections\u003c\/h2\u003e\n\n\u003ch3\u003e\"Antioxidants block exercise adaptation\"\u003c\/h3\u003e\n\n\u003cp\u003ePartly true. The Ristow 2009 (\u003cem\u003ePNAS\u003c\/em\u003e) study showed high-dose vitamin C (1 g) + vitamin E (400 IU) blunted insulin-sensitivity gains from exercise in young, lean men. The signal doesn't extend cleanly to ALA, CoQ10, NAD+ precursors, Urolithin A, or PQQ at the doses on this page. Operational rule: take antioxidant-network products (ALA, NAC if added) outside the 60-minute window around training to preserve the ROS-mediated AMPK\/PGC-1α signal.\u003c\/p\u003e\n\n\u003ch3\u003e\"NMN is banned by the FDA\"\u003c\/h3\u003e\n\n\u003cp\u003eThe FDA's 2022 NDIN response on NMN reclassified the molecule as excluded from the dietary-supplement definition because it had been authorized for investigation as a drug before being marketed as a supplement. The status is contested (industry petition pending). NMN remains widely available in the US and is sold by major longevity brands. NR is FDA-NDI-cleared without similar contention.\u003c\/p\u003e\n\n\u003ch3\u003e\"You should take NAD+ directly instead of a precursor\"\u003c\/h3\u003e\n\n\u003cp\u003eOral NAD+ itself is largely degraded to nicotinamide in the GI tract before absorption. The successful oral strategies (NMN one step away, NR two steps away) are designed around the GI degradation problem. IV NAD+ bypasses GI but is expensive and the half-life is short. Published trials use precursors, not NAD+ itself.\u003c\/p\u003e\n\n\u003ch3\u003e\"Mitophagy = autophagy\"\u003c\/h3\u003e\n\n\u003cp\u003eRelated but not identical. Autophagy is the general \"eat-yourself\" recycling program. Mitophagy is the mitochondria-specific subset, gated by the PINK1\/Parkin tagging system. Spermidine drives general autophagy with mitophagy cross-talk; Urolithin A is mitochondria-selective. Complementary, not redundant.\u003c\/p\u003e\n\n\u003ch3\u003e\"More CoQ10 is always better\"\u003c\/h3\u003e\n\n\u003cp\u003eBioavailability ceilings exist. Plasma CoQ10 saturates around 200–300 mg\/day in standard ubiquinone form; ubiquinol pushes the ceiling higher. Q-SYMBIO used 100 mg three times daily; typical longevity dose is 100–200 mg\/day with food. Pushing past 400 mg ubiquinone rarely produces additional plasma rise.\u003c\/p\u003e\n\n\u003ch2 id=\"cost-tiers\"\u003eCost tiers and what each one buys you\u003c\/h2\u003e\n\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEntry tier:\u003c\/strong\u003e Urolithin A 500 mg + NMN\/NR. Two products, two pillars covered (mitophagy + energy production), trial-validated doses. Highest signal-per-dollar starting point.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDaily tier (~2× entry):\u003c\/strong\u003e Add CoQ10 + ALA + Glycine. Five products, four pillars, two dosing windows. Reference protocol for adults 45+.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFull tier (~3–4× entry):\u003c\/strong\u003e Add PQQ + Taurine + Creatine + Spermidine + CaAKG. 9–10 products, all four pillars at trial-grade dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStack-bundle alternative:\u003c\/strong\u003e NAD+ 5-in-1 Complete consolidates NMN + CoQ10 + B-complex + antioxidants + skin actives in one capsule; Liposomal NAD+ Ultimate consolidates 10 actives in one liposomal carrier.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2 id=\"faq\"\u003eFAQ — mitochondrial renewal questions we get every week\u003c\/h2\u003e\n\n\u003ch3\u003eIf I can only afford two products, which two?\u003c\/h3\u003e\n\n\u003cp\u003eUrolithin A 500 mg + an NAD+ precursor (NMN or NR). Mitophagy clears the broken mitochondria; NAD+ keeps the surviving ones running. This pairing covers two of the four pillars at trial-validated doses. Run for 8–12 weeks before adding anything else; this gives you a clean baseline to evaluate.\u003c\/p\u003e\n\n\u003ch3\u003eNMN or NR — which is better?\u003c\/h3\u003e\n\n\u003cp\u003eBoth work; they converge on the same NAD+ pool. NMN is one enzymatic step from NAD+; NR is two steps. NR has the larger published human-trial dataset (Trammell 2016, Conze 2019, Martens 2018, Brakedal 2022 NADPARK) and the patent-protected Niagen form; NMN has shorter-step substrate kinetics and a growing trial base (Yoshino 2021, Yamaguchi 2022, Igarashi 2022). Most users pick by price, format, and brand-trust history. \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e bundles both.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take ubiquinone or ubiquinol CoQ10?\u003c\/h3\u003e\n\n\u003cp\u003eBoth forms convert to each other inside the body. Ubiquinol has slightly better bioavailability in some PK studies, particularly in older adults. Ubiquinone is the form used in Q-SYMBIO and most cardiovascular literature. Our \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e is ubiquinone; the higher dose compensates for the bioavailability difference. Take with a fat-containing meal — bioavailability roughly triples with food.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is Urolithin A so expensive?\u003c\/h3\u003e\n\n\u003cp\u003eUrolithin A is patent-class chemistry (Mitopure-spec is the original Amazentis IP behind the Andreux 2019 trial) with synthesis costs an order of magnitude above commodity vitamins. The endogenous-conversion alternative (eat ellagitannin-rich pomegranates and walnuts) only works for the ~30–40% of adults with the right gut microbiome, and even there the produced doses are far below the 500 mg trial dose. The price reflects the chemistry.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need TMG with NMN or NR?\u003c\/h3\u003e\n\n\u003cp\u003eSome Sinclair-stack practitioners add trimethylglycine with NAD+ precursors to \"preserve the methylation pool.\" The empirical evidence for clinically meaningful methylation depletion at the standard NMN\/NR doses is mixed. If you're on a high NMN\/NR dose (\u0026gt;500 mg\/day for \u0026gt;6 months) and want to reassure yourself, methylated-folate + B12 + a B-complex covers the methylation-pool maintenance angle.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take everything at once in the morning?\u003c\/h3\u003e\n\n\u003cp\u003eOperationally, yes — most users take the morning stack as a single hand-pile with breakfast and a fat source (CoQ10 needs fat for absorption; ALA prefers empty stomach but most users compromise for adherence). The exceptions: Glycine and Spermidine work best in the evening (Glycine for slow-wave sleep, Spermidine for autophagy windows aligned with the overnight fast). Creatine and Taurine timing are flexible.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I feel something?\u003c\/h3\u003e\n\n\u003cp\u003eSubjective shifts at week 2–4. Endurance and recovery shifts at week 6–12 (Urolithin A trial readouts). Biological-age clock shifts at month 4–7. If you feel nothing at week 12, two diagnostic questions: (a) is the foundational micronutrient floor in place — vitamin D, magnesium, omega-3, sleep duration, protein floor? (b) is there a hidden upstream variable — undiagnosed thyroid, sleep apnea, B12 deficiency, alcohol load? Mitochondrial supplements work best on top of a foundational floor, not in place of one.\u003c\/p\u003e\n\n\u003ch3\u003eShould I cycle on and off?\u003c\/h3\u003e\n\n\u003cp\u003eMost products in this collection are daily-continuous in the published literature. There's no published evidence of tolerance or downregulation with NMN, NR, CoQ10, ALA, Glycine, Taurine, Creatine, PQQ, Spermidine, or Urolithin A. CaAKG was used continuously in Demidenko 2021; some users cycle it on first-principles grounds (3 months on, 1 month off), but the trial didn't.\u003c\/p\u003e\n\n\u003ch3\u003eI'm on a statin. Should I add CoQ10?\u003c\/h3\u003e\n\n\u003cp\u003eStatins block endogenous CoQ10 synthesis at HMG-CoA reductase (Marcoff and Thompson 2007). Mortensen 2014 Q-SYMBIO heart-failure trial used 100 mg three times daily for 2 years and showed a 43% reduction in major adverse cardiovascular events. Most cardiologists are comfortable with 100–200 mg CoQ10\/day in statin users; some recommend it routinely.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take this if I'm trying to conceive?\u003c\/h3\u003e\n\n\u003cp\u003eThe fertility-specific subset of this collection (CoQ10, NAC, glutathione, ALA, PQQ) overlaps directly with the \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e collection's pre-conception protocol — the 60–90 day pre-conception window for mitochondrial conditioning aligns with spermatogenesis (74 days) and antral-follicle development (~85 days). Once actively trying, pause Spermidine, CaAKG, and other actives without pregnancy-safety data, and switch to the prenatal-vitamin floor + a fertility-clinic-approved CoQ10 dose.\u003c\/p\u003e\n\n\u003ch3\u003eI'm vegan\/vegetarian. Are these products compatible?\u003c\/h3\u003e\n\n\u003cp\u003eMost products in this collection use HPMC vegetarian capsules (Glycine, ALA, NMN, NR, PQQ, Taurine, Creatine, Spermidine, Urolithin A, CaAKG). CoQ10 in softgel format historically used bovine gelatin shells — verify the specific SKU on the product page. Spermidine source is wheat germ extract (not a vegan issue, but flagged for celiac\/gluten-sensitive users — confirm specific SKU certification).\u003c\/p\u003e\n\n\u003ch3\u003eCan I get a CoA for my specific batch?\u003c\/h3\u003e\n\n\u003cp\u003eYes. Email support@truehealthprotocol.health with the product name, the batch lot number printed on the bottle, the best-by date, and (optionally) your order number. We return the original lab PDF plus a plain-English summary in one business day. Pre-order representative-CoA requests are also supported. No-redaction policy.\u003c\/p\u003e\n\n\u003ch3\u003eWhy don't you sell IV NAD+ or pharmacological doses?\u003c\/h3\u003e\n\n\u003cp\u003eIV NAD+ is a clinic-administered service, not a retail supplement product. Pharmacological-dose chemistry (rapamycin, metformin, dasatinib, GHK-Cu, BPC-157) is prescription-pharma territory and we don't carry any of those — see the catalog-exclusion principle in \u003ca href=\"\/he\/pages\/about\"\u003e\/pages\/about\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eReturns?\u003c\/h3\u003e\n\n\u003cp\u003e30-day satisfaction guarantee on all products in this collection. Contact support@truehealthprotocol.health for a refund — see \u003ca href=\"\/he\/pages\/guarantee\"\u003e\/pages\/guarantee\u003c\/a\u003e and \u003ca href=\"\/he\/policies\/refund-policy\"\u003e\/policies\/refund-policy\u003c\/a\u003e for the operational detail. The longer-arc effects (mitophagy gene-expression rewriting, biological-age clock shifts) operate on 8–24 week windows; the 30-day window is for early-tolerance-and-evaluation, not full-effect timeline.\u003c\/p\u003e\n\n\n\u003ch2 id=\"reading-list\"\u003eReading list and primary references\u003c\/h2\u003e\n\n\u003cp\u003eThe references below are the canonical reading order behind the claims on this page. Most are open-access PubMed entries; a few are paywalled but abstracts are available everywhere.\u003c\/p\u003e\n\n\u003col\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194–1217.\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243–278.\u003c\/li\u003e\n\u003cli\u003eSun N, Youle RJ, Finkel T. The mitochondrial basis of aging. \u003cem\u003eMol Cell\u003c\/em\u003e. 2016;61(5):654–666.\u003c\/li\u003e\n\u003cli\u003eAndreux PA, Blanco-Bose W, Ryu D, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. \u003cem\u003eNat Metab\u003c\/em\u003e. 2019;1(6):595–603.\u003c\/li\u003e\n\u003cli\u003eSingh A, D'Amico D, Andreux PA, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health. \u003cem\u003eCell Rep Med\u003c\/em\u003e. 2022;3(5):100633.\u003c\/li\u003e\n\u003cli\u003eLiu S, D'Amico D, Shankland E, et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults. \u003cem\u003eJAMA Netw Open\u003c\/em\u003e. 2022;5(1):e2144279.\u003c\/li\u003e\n\u003cli\u003eTomás-Barberán FA, et al. Urolithins, the rescue of \"old\" metabolites: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health. \u003cem\u003eMol Nutr Food Res\u003c\/em\u003e. 2017;61(1):1500901.\u003c\/li\u003e\n\u003cli\u003eEisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. \u003cem\u003eNat Cell Biol\u003c\/em\u003e. 2009;11(11):1305–1314.\u003c\/li\u003e\n\u003cli\u003eEisenberg T, Abdellatif M, Schroeder S, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. \u003cem\u003eNat Med\u003c\/em\u003e. 2016;22(12):1428–1438.\u003c\/li\u003e\n\u003cli\u003eKiechl S, Pechlaner R, Willeit P, et al. Higher spermidine intake is linked to lower mortality. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2018;108(2):371–380.\u003c\/li\u003e\n\u003cli\u003eMortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure (Q-SYMBIO). \u003cem\u003eJACC Heart Fail\u003c\/em\u003e. 2014;2(6):641–649.\u003c\/li\u003e\n\u003cli\u003eMarcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy. \u003cem\u003eJACC\u003c\/em\u003e. 2007;49(23):2231–2237.\u003c\/li\u003e\n\u003cli\u003eBentov Y, et al. Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI. \u003cem\u003eClin Med Insights Reprod Health\u003c\/em\u003e. 2014;8:31–36.\u003c\/li\u003e\n\u003cli\u003eTrammell SAJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:12948.\u003c\/li\u003e\n\u003cli\u003eConze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN. \u003cem\u003eSci Rep\u003c\/em\u003e. 2019;9(1):9772.\u003c\/li\u003e\n\u003cli\u003eMartens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNat Commun\u003c\/em\u003e. 2018;9(1):1286.\u003c\/li\u003e\n\u003cli\u003eBrakedal B, et al. The NADPARK study: a randomized phase I trial of NR in Parkinson's disease. \u003cem\u003eCell Metab\u003c\/em\u003e. 2022;34(3):396–407.e6.\u003c\/li\u003e\n\u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. NMN increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e. 2021;372(6547):1224–1229.\u003c\/li\u003e\n\u003cli\u003eYamaguchi S, et al. Safety and efficacy of long-term NMN supplementation. \u003cem\u003eEndocr J\u003c\/em\u003e. 2022;69(10):1185–1193.\u003c\/li\u003e\n\u003cli\u003eIgarashi M, et al. Chronic NMN supplementation elevates blood NAD+ levels and alters muscle function in healthy older men. \u003cem\u003enpj Aging\u003c\/em\u003e. 2022;8(1):5.\u003c\/li\u003e\n\u003cli\u003eCamacho-Pereira J, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metab\u003c\/em\u003e. 2016;23(6):1127–1139.\u003c\/li\u003e\n\u003cli\u003eMassudi H, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS One\u003c\/em\u003e. 2012;7(7):e42357.\u003c\/li\u003e\n\u003cli\u003eChowanadisai W, et al. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through CREB phosphorylation and increased PGC-1α expression. \u003cem\u003eJ Biol Chem\u003c\/em\u003e. 2010;285(1):142–152.\u003c\/li\u003e\n\u003cli\u003eHarris CB, et al. Dietary PQQ alters indicators of inflammation and mitochondrial-related metabolism in human subjects. \u003cem\u003eJ Nutr Biochem\u003c\/em\u003e. 2013;24(12):2076–2084.\u003c\/li\u003e\n\u003cli\u003eHwang PS, et al. Effects of PQQ supplementation on aerobic exercise performance and indices of mitochondrial biogenesis. \u003cem\u003eJ Am Coll Nutr\u003c\/em\u003e. 2020;39(6):547–556.\u003c\/li\u003e\n\u003cli\u003eZiegler D, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: NATHAN 1. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2011;34(9):2054–2060.\u003c\/li\u003e\n\u003cli\u003eZiegler D, et al. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: SYDNEY 2. \u003cem\u003eDiabetes Care\u003c\/em\u003e. 2006;29(11):2365–2370.\u003c\/li\u003e\n\u003cli\u003eSekhar RV, et al. Deficient synthesis of glutathione underlies oxidative stress in aging. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2011;94(3):847–853.\u003c\/li\u003e\n\u003cli\u003eKumar P, et al. GlyNAC supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, walking speed, and cognition. \u003cem\u003eClin Transl Med\u003c\/em\u003e. 2021;11(3):e372.\u003c\/li\u003e\n\u003cli\u003eSingh P, Gollapalli K, Mangiola S, et al. Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e. 2023;380(6649):eabn9257.\u003c\/li\u003e\n\u003cli\u003eSchaffer SW, et al. Physiological roles of taurine in heart and muscle. \u003cem\u003eJ Biomed Sci\u003c\/em\u003e. 2010;17(Suppl 1):S2.\u003c\/li\u003e\n\u003cli\u003eForbes SC, et al. Meta-analysis examining the importance of creatine ingestion strategies on lean tissue mass and strength in older adults. \u003cem\u003eNutrients\u003c\/em\u003e. 2021;13(6):1912.\u003c\/li\u003e\n\u003cli\u003eRoschel H, Gualano B, Ostojic SM, Rawson ES. Creatine supplementation and brain health. \u003cem\u003eNutrients\u003c\/em\u003e. 2021;13(2):586.\u003c\/li\u003e\n\u003cli\u003eAsadi Shahmirzadi A, et al. Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice. \u003cem\u003eCell Metab\u003c\/em\u003e. 2020;32(3):447–456.e6.\u003c\/li\u003e\n\u003cli\u003eDemidenko O, et al. Rejuvant®: ~8-year reduction in biological aging in the TruAge DNA methylation test. \u003cem\u003eAging\u003c\/em\u003e. 2021;13(22):24485–24499.\u003c\/li\u003e\n\u003cli\u003eRistow M, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. \u003cem\u003ePNAS\u003c\/em\u003e. 2009;106(21):8665–8670.\u003c\/li\u003e\n\u003cli\u003eYamadera W, et al. Glycine ingestion improves subjective sleep quality, correlating with polysomnographic changes. \u003cem\u003eSleep Biol Rhythms\u003c\/em\u003e. 2007;5(2):126–131.\u003c\/li\u003e\n\u003cli\u003eHowitz KT, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191–196.\u003c\/li\u003e\n\u003cli\u003eHorvath S. DNA methylation age of human tissues and cell types. \u003cem\u003eGenome Biol\u003c\/em\u003e. 2013;14(10):R115.\u003c\/li\u003e\n\u003cli\u003eBelsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. \u003cem\u003eeLife\u003c\/em\u003e. 2022;11:e73420.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"related\"\u003eRelated collections and reference pages\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eRelated collections (mechanism-overlap):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/nmn\"\u003eNMN\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/fertility\"\u003eFertility\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/brain-cognitive-longevity\"\u003eBrain \u0026amp; Cognitive Longevity\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/collagen\"\u003eCollagen\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/most-popular\"\u003eMost Popular\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCustom collections (curated bundles):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/starter-bundles\"\u003eStarter Bundles\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/skin-protocol\"\u003eSkin Protocol\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/frontpage\"\u003eTop Picks\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/all-products\"\u003eAll Products\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eReference pages:\u003c\/strong\u003e \u003ca href=\"\/he\/pages\/about\"\u003eAbout\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/how-it-works\"\u003eHow It Works\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/getting-started\"\u003eGetting Started\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/quality\"\u003eQuality\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/faq\"\u003eFAQ\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/guarantee\"\u003eGuarantee\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/contact\"\u003eContact\u003c\/a\u003e · \u003ca href=\"\/he\/pages\/contact-business-information\"\u003eContact \u0026amp; Business Information\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePolicies:\u003c\/strong\u003e \u003ca href=\"\/he\/policies\/privacy-policy\"\u003ePrivacy\u003c\/a\u003e · \u003ca href=\"\/he\/policies\/refund-policy\"\u003eRefund\u003c\/a\u003e · \u003ca href=\"\/he\/policies\/shipping-policy\"\u003eShipping\u003c\/a\u003e · \u003ca href=\"\/he\/policies\/terms-of-service\"\u003eTerms\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eFDA disclaimer:\u003c\/strong\u003e These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. Educational information, not medical advice. Consult a qualified healthcare provider before starting any supplement, particularly if pregnant, nursing, on prescription medication, with a chronic medical condition, or scheduled for surgery. Individual results may vary. Per-batch potency and contaminant testing — see \u003ca href=\"\/he\/pages\/quality\"\u003e\/pages\/quality\u003c\/a\u003e.\u003c\/em\u003e\u003c\/p\u003e\n","products":[{"product_id":"coq10-400mg-maximum-strength","title":"CoQ10 400mg | Fertility \u0026 Cellular Energy Support","description":"\u003cp\u003e\u003cstrong\u003e400 mg of pharmaceutical-grade CoQ10 per softgel\u003c\/strong\u003e — the studied therapeutic dose for mitochondrial energy production, cardiovascular muscle function, fertility (egg and sperm quality), statin-replacement support, and migraine prevention. One of the highest single-dose CoQ10 supplements in the catalog, formulated as a fat-carrier softgel because that is the absorption profile CoQ10 actually needs.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat CoQ10 does:\u003c\/strong\u003e sits at the centre of the electron transport chain (the process that generates ATP) inside every mitochondrion. Without it, ATP production drops; with less of it, the leftover electrons leak as oxidative damage instead of becoming usable cellular fuel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy supplement:\u003c\/strong\u003e endogenous CoQ10 production drops steadily after age 35 (roughly 50% by age 80, with measurable decline visible in the 30s and 40s). Statins deplete it further — they block HMG-CoA reductase, which is the same enzyme pathway your body uses to manufacture CoQ10. Several chronic conditions and a few common medications (metformin, certain beta-blockers, tricyclic antidepressants) also lower it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 40+, anyone on a statin (with their physician's awareness), couples working on fertility, athletes, recovery from illness or surgery, anyone running a longevity \/ mitochondrial stack, migraine-prone adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with food (with fat).\u003c\/strong\u003e CoQ10 is fat-soluble. Bioavailability drops sharply on an empty stomach — by some pharmacokinetic studies more than 3× lower (Hidaka 2008, Lopez-Lluch 2011). Lunch or dinner with olive oil, eggs, butter, avocado, or full-fat dairy works.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e ubiquinone (the standard, oxidatively stable form). Your body converts ubiquinone to ubiquinol on demand — for healthy adults under 60 the form rarely matters; what matters is dose, fat co-ingestion, and consistency.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrial-validated dose anchor:\u003c\/strong\u003e 300 mg\/day for 2 years in the Q-SYMBIO multicenter trial (Mortensen 2014). 600 mg\/day for 90 days in the Bentov fertility cohort. 100–400 mg\/day for 12 weeks in migraine-prevention trials (Sándor 2005, Shoeibi 2017). 400 mg sits squarely inside the studied therapeutic range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat CoQ10 actually does — the two roles\u003c\/h2\u003e\n\u003cp\u003eCoQ10 (Coenzyme Q10, also called ubiquinone) is a fat-soluble compound your body makes from the same mevalonate pathway that produces cholesterol. It concentrates in tissues with the highest sustained energy demand — heart muscle, kidneys, liver, brain, ovaries, testes — and plays two distinct roles, both inside the inner mitochondrial membrane:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eElectron transport in mitochondria.\u003c\/strong\u003e CoQ10 shuttles electrons between Complex I\/II and Complex III of the electron transport chain. That chain is the final stage of converting food into ATP — the energy currency every cell uses to do work. No CoQ10, no ATP. Less CoQ10, less efficient ATP production, and more leakage of electrons that turn into reactive oxygen species (ROS) instead of fuel (Crane 2001).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFat-soluble antioxidant in cell membranes.\u003c\/strong\u003e CoQ10 is one of the only antioxidants that lives inside the lipid bilayer. It protects mitochondrial membranes — which is exactly where the most ROS are produced in the first place — and regenerates other antioxidants like vitamin E and glutathione (Bentinger 2010, Alleva 1995). This is the closed-loop reason CoQ10 matters more for high-mitochondrial-density tissue: it both meets the ATP demand and absorbs the resulting oxidative load.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProduction declines roughly 50% by age 80, with meaningful drops visible in the 30s and 40s (Kalén 1989). Heart tissue takes the biggest hit — by age 70, cardiac CoQ10 concentrations are typically less than half of what they were at 20. That is the cleanest mechanistic explanation for why CoQ10 has been studied so heavily in cardiovascular contexts.\u003c\/p\u003e\n\n\u003ch2\u003eWhere supplementation matters most\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeart muscle.\u003c\/strong\u003e The heart has the highest sustained ATP demand of any organ. CoQ10 concentration in cardiac tissue drops significantly with age and with cardiovascular disease, and supplementation has been studied extensively for cardiovascular support — the Q-SYMBIO multicenter trial (Mortensen 2014, n=420) used 300 mg\/day for 2 years and reported a significant reduction in major adverse cardiovascular events versus placebo. Talk to your physician if you are managing a cardiac condition; this is not a treatment, it is a cofactor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFertility (egg and sperm).\u003c\/strong\u003e Both egg and sperm quality depend heavily on mitochondrial energy. The egg is the largest cell in the body and contains roughly 100,000 mitochondria — it has to power its own first 5–7 days of cell division before the embryo can implant and start drawing nutrients from the mother. Sperm motility runs on a flagellum that is essentially a continuously firing ATP engine. CoQ10 has been incorporated into IVF and natural-conception protocols at 200–600 mg daily for 3+ months pre-conception; the egg maturation window is roughly 90 days, so the protocol mirrors that biology (Bentov 2010, 2014; Ben-Meir 2015 mouse data; Safarinejad 2009 sperm quality).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatin users.\u003c\/strong\u003e If you are on a statin your CoQ10 levels are reduced as a known side effect of how the drug works. Statins inhibit HMG-CoA reductase to lower cholesterol synthesis — but that same enzyme is the early step in your body's CoQ10 manufacturing pathway, so the depletion is mechanistic, not incidental (Folkers 1990, Mortensen 1997). Supplementing back toward normal levels is one of the most common medical reasons to take CoQ10 and is openly discussed by many cardiologists. Ask your physician about appropriate dosing for your specific situation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial \/ longevity stack.\u003c\/strong\u003e CoQ10 supports ATP production directly. NMN, NR, and NAD+ products raise NAD+ for the upstream pathway support; PQQ promotes the creation of new mitochondria; Urolithin A clears damaged mitochondria via mitophagy; CoQ10 keeps the resulting mitochondria fed and producing energy cleanly. Each step in the cycle is necessary; CoQ10 is the one that turns the lights on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMigraine-prone adults.\u003c\/strong\u003e 100–400 mg CoQ10 daily has been studied for migraine frequency reduction (Sándor 2005 RCT n=42; Shoeibi 2017 n=80; Dahri 2019 meta-analysis). Results are mixed-but-positive across multiple trials. The American Academy of Neurology and Canadian Headache Society have included CoQ10 in their migraine prevention guidance, with the caveat that evidence is moderate, not strong.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAthletes and post-exertion recovery.\u003c\/strong\u003e Sustained intense exercise depletes CoQ10 and shifts mitochondria toward higher ROS output. Endurance athletes and anyone doing \u0026gt;5 hours\/week of intense training tend to see the largest drops (Cooke 2008; Díaz-Castro 2012).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeriods of high mitochondrial demand.\u003c\/strong\u003e Recovery from surgery, illness, post-viral fatigue, long-COVID protocols. Your mitochondria are doing extra work; supplying the missing cofactor is reasonable (Mantle 2018 review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeriodontal and gum tissue.\u003c\/strong\u003e Gum tissue is one of the few peripheral tissues with surprisingly high CoQ10 demand. A small literature suggests benefit for gingival health at 60–200 mg\/day; not the primary use case, but a documented one (Hanioka 1994).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 400 mg specifically\u003c\/h2\u003e\n\u003cp\u003eThe studied dose range for CoQ10 is unusually wide, because different goals call for very different exposure:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e30–100 mg:\u003c\/strong\u003e general health maintenance for younger adults with no specific concern. This is what most off-the-shelf multivitamins include, and it is roughly enough to make up for ordinary age-related decline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e100–200 mg:\u003c\/strong\u003e heart support, statin replacement therapy. The typical \"cardiology recommendation\" range when a CoQ10 supplement is being suggested as adjunct support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e200–600 mg:\u003c\/strong\u003e fertility protocols (both partners), athletic recovery, and mitochondrial-support side of a longevity stack. This is also the range used in most published fertility studies — typically 300–600 mg\/day for 90 days pre-conception.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUp to 1,200–3,000 mg:\u003c\/strong\u003e studied in clinical trials for specific neurological and inherited mitochondrial conditions (Parkinson's at up to 1,200 mg\/day in Shults 2002; Huntington's at 600 mg\/day in Huntington Study Group 2001; mitochondrial encephalomyopathies up to 3,000 mg\/day under medical supervision). This is medical-supervision territory, not a self-directed dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e400 mg in a single softgel sits squarely inside the higher therapeutic range used in fertility, athletic, and longevity-focused research. If you only need general maintenance you can use half a softgel daily (or every other day, since CoQ10 has a long tissue half-life). If you are targeting fertility or stacking it with a serious longevity protocol, 400 mg is the dose most of the literature actually points to.\u003c\/p\u003e\n\n\u003ch2\u003eUbiquinone vs ubiquinol — the form question, answered honestly\u003c\/h2\u003e\n\u003cp\u003eCoQ10 exists in two interconvertible forms in your body: \u003cstrong\u003eubiquinone\u003c\/strong\u003e (the oxidized form, more stable in capsules) and \u003cstrong\u003eubiquinol\u003c\/strong\u003e (the reduced form, what your body uses to donate electrons in the antioxidant role). Most quality supplements use ubiquinone for two reasons:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eShelf stability.\u003c\/strong\u003e Ubiquinol oxidizes back to ubiquinone in air, in light, in heat, and during shelf storage. By the time a ubiquinol softgel reaches you, a meaningful percentage has typically already converted back. Ubiquinone is shelf-stable, which is why it dominates clinical research (Bhagavan 2007).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConversion is built in.\u003c\/strong\u003e Healthy adults under 60 convert ubiquinone to ubiquinol on demand, in the cells that need it (Mohr 1992). The interconversion is part of normal metabolism and does not require any special pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMost large clinical trials used ubiquinone.\u003c\/strong\u003e Q-SYMBIO, Sándor migraine, the Bentov fertility cohorts, virtually the entire pre-2010 cardiovascular literature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eUbiquinol is sometimes recommended for adults over 70, people with significant cardiovascular disease, or specific genetic differences in CoQ10 metabolism — situations where the conversion step itself may be impaired (Langsjoen 2008). For everyone else, ubiquinone at a meaningful dose with adequate dietary fat is the well-studied, lower-cost, well-evidenced choice. The bigger absorption variable, by far, is whether you take CoQ10 with fat (yes) or on an empty stomach (don't).\u003c\/p\u003e\n\n\u003ch2\u003eHow long until you notice it — the realistic timeline\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1–7 — plasma rises.\u003c\/strong\u003e Plasma CoQ10 reaches measurably higher levels within 4–8 hours of a fat-co-ingested dose, and steady-state plasma levels build over 5–10 days (Bhagavan 2007).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4 — first subjective shifts.\u003c\/strong\u003e People who were depleted (statin users, post-illness, age 60+, post-viral fatigue) often notice modestly improved exercise tolerance or reduced \"just-tired-all-the-time\" feeling here. This is not stimulant energy; it is more \"the floor is higher.\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8 — tissue saturation.\u003c\/strong\u003e Heart, muscle, ovary, and testis tissue reach steady-state levels. This is where any cardiovascular markers measured in studies typically begin to shift.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 12 — migraine prevention endpoint.\u003c\/strong\u003e Sándor 2005, Shoeibi 2017 and most modern migraine trials evaluate at 12 weeks. Frequency tends to drop more reliably than severity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 90 — fertility window closes.\u003c\/strong\u003e Egg maturation cycle ≈ 90 days; sperm production cycle ≈ 74 days. CoQ10 supplementation is consistently dosed for ≥90 days \u003cem\u003ebefore\u003c\/em\u003e the conception cycle, not during it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6–12 — the cardiovascular endpoint.\u003c\/strong\u003e Q-SYMBIO ran 2 years. Most NYHA-class trials run ≥12 months. CoQ10 is a long-horizon cofactor for this use case, not a short-cycle product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn-stop reversion.\u003c\/strong\u003e Plasma drops back to baseline within 1–2 weeks of stopping. Tissue CoQ10 reverts more slowly — over months. The implication is the obvious one: cycling CoQ10 is not necessary and arguably counterproductive. Daily continuous use is the standard pattern in research and in clinical practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with the rest of the catalog\u003c\/h2\u003e\n\u003cp\u003eCoQ10 is the most \"downstream\" mitochondrial supplement in the True Health Protocol catalog. It supports the actual energy-production step, after the upstream NAD+ machinery and biogenesis machinery have done their work. The natural pairings:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ NMN or NAD+ precursors\u003c\/strong\u003e — NMN raises NAD+ (upstream); CoQ10 supports ATP production (downstream). Sirtuin pathway + mitochondrial fuel, the canonical longevity stack base. \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e, or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ PQQ\u003c\/strong\u003e — PQQ helps create new mitochondria (biogenesis); CoQ10 makes sure the new ones can produce ATP. Mechanistically the cleanest CoQ10 stacking partner. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Urolithin A\u003c\/strong\u003e — Urolithin A clears the damaged mitochondria via mitophagy (PINK1\/Parkin); CoQ10 powers the healthy ones that remain. The renewal\/output pair. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Resveratrol or Pterostilbene\u003c\/strong\u003e — sirtuin-driven mitochondrial biogenesis. CoQ10 keeps the new mitochondria fed. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Alpha-Lipoic Acid\u003c\/strong\u003e — ALA recycles CoQ10, vitamin C, vitamin E, and glutathione. The two of them together cover most of the mitochondrial antioxidant network. \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Calcium Alpha-Ketoglutarate\u003c\/strong\u003e — CaAKG drives the TCA cycle that feeds NADH\/FADH2 into the electron transport chain; CoQ10 then carries those electrons forward. The two-step substrate-and-shuttle pair. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Creatine\u003c\/strong\u003e — creatine buffers cellular ATP via the phosphocreatine system, while CoQ10 supports its production. The two of them together cover most of the cellular bioenergetic stack. \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Berberine\u003c\/strong\u003e — important if you have ever been on metformin, which depletes CoQ10 in the same direction statins do (Hu 2014). \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Astaxanthin and Glutathione\u003c\/strong\u003e — for the fertility \/ egg quality stack specifically. CoQ10 powers the egg's mitochondria, astaxanthin protects the membranes, glutathione handles oxidative load. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Omega-3 Fish Oil\u003c\/strong\u003e — omega-3s are membrane substrate; CoQ10 lives inside that membrane. The cardiovascular pair. \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Taurine 1000 mg\u003c\/strong\u003e — taurine modifies mitochondrial tRNA to enable proper electron-transport-chain protein synthesis (Singh 2023 Science). CoQ10 then carries the electrons through that chain. The two-step \"build-the-engine + fuel-the-engine\" pair. \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRead the complete protocol in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol\u003c\/a\u003e or browse the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e for the full mitochondrial-support shelf, or the \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity collection\u003c\/a\u003e for the heart-muscle stack.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 40+ where natural CoQ10 production has dropped noticeably\u003c\/li\u003e\n  \u003cli\u003eAnyone on a statin (with their physician's awareness) — the most well-established medical use case\u003c\/li\u003e\n  \u003cli\u003eAnyone on metformin, certain beta-blockers, tricyclic antidepressants, or other medications documented to deplete CoQ10\u003c\/li\u003e\n  \u003cli\u003eCouples working on fertility — both partners (egg and sperm quality)\u003c\/li\u003e\n  \u003cli\u003ePeople going through IVF cycles (under their reproductive endocrinologist's awareness)\u003c\/li\u003e\n  \u003cli\u003eAthletes and recovery from intense training blocks (\u0026gt;5 hours\/week sustained)\u003c\/li\u003e\n  \u003cli\u003eAnyone running a longevity stack and wanting downstream mitochondrial support\u003c\/li\u003e\n  \u003cli\u003eRecovery from illness, surgery, post-viral fatigue, periods of high mitochondrial demand\u003c\/li\u003e\n  \u003cli\u003eMigraine-prone adults willing to commit to a 12-week trial\u003c\/li\u003e\n  \u003cli\u003eAdults 70+ where ubiquinone-to-ubiquinol conversion may slow (a switch to ubiquinol is reasonable here, though ubiquinone at higher dose with fat still works)\u003c\/li\u003e\n  \u003cli\u003eAdults with diagnosed mitochondrial dysfunction working with a specialist\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople on warfarin without their prescriber's awareness.\u003c\/strong\u003e CoQ10 is structurally similar to vitamin K and may modestly reduce warfarin's anticoagulant effect. INR monitoring is required.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople in active chemotherapy.\u003c\/strong\u003e CoQ10–chemotherapy interactions are mixed in the literature (some protective, some theoretically reducing efficacy). Coordinate with your oncology team — never start independently.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting same-day stimulant energy.\u003c\/strong\u003e CoQ10 is a foundational cofactor that removes a deficiency — it does not add a kick. If you want stimulant energy, look elsewhere; you will be disappointed by CoQ10 and stop too early.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStrict vegans.\u003c\/strong\u003e Our softgel uses bovine gelatin shell. We do not currently offer a plant-cellulose CoQ10 capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant women without OB awareness.\u003c\/strong\u003e CoQ10 has been used in IVF and pre-conception protocols extensively, but data during active pregnancy is more limited. Talk to your OB before continuing through conception.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople under 18.\u003c\/strong\u003e CoQ10 is generally regarded as safe but the studied population is overwhelmingly adult.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who will skip the dietary fat step.\u003c\/strong\u003e If you cannot or will not take CoQ10 with a fat-containing meal, your absorption will be a fraction of what it should be. A low-dose, food-based approach is more honest in that situation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it on an empty stomach.\u003c\/strong\u003e The single biggest absorption loss. Take it with the largest fat-containing meal of the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it late at night.\u003c\/strong\u003e Some people find CoQ10 mildly stimulating because it raises ATP availability. If sleep is affected, move it to breakfast or lunch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuying a $9 bottle and assuming it works.\u003c\/strong\u003e Independent lab testing has repeatedly shown that a meaningful percentage of cheap CoQ10 brands contain less than half their labeled dose, and some contain the wrong (cis) isomer. Per actual milligram of bioactive trans-CoQ10, pharmaceutical-grade is usually the cheaper math.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 2.\u003c\/strong\u003e CoQ10 is a long-horizon cofactor. Most studied endpoints — cardiovascular, fertility, migraine — show their effect at week 12 or later. The week-2 quitter is the single most common protocol failure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with a statin without telling your prescriber.\u003c\/strong\u003e Not because of risk, but because your cardiologist almost always already supports CoQ10 supplementation and may have a preferred protocol. Letting them know also keeps your medical record clean.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSplitting a 90-day fertility window across both partners' wallets.\u003c\/strong\u003e The published fertility protocols typically dose \u003cem\u003eeach\u003c\/em\u003e partner at 200–600 mg\/day for 90 days. Cutting one partner out halves the effect of the protocol, not the cost of it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling unnecessarily.\u003c\/strong\u003e CoQ10 does not downregulate. Daily continuous use is the standard. 5-on-2-off cycles or month-on-month-off cycles have no mechanistic justification and just produce uneven plasma levels.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching to ubiquinol because of marketing.\u003c\/strong\u003e Unless you are over 70 or have a specific reason to suspect the conversion step is impaired, ubiquinone is the well-studied form. Ubiquinol typically costs 2–3× more for unclear added benefit in most populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDrug interactions and safety\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWarfarin \/ Coumadin.\u003c\/strong\u003e CoQ10 is structurally similar to vitamin K and may modestly reduce the effect of warfarin. If you are on warfarin, talk to your prescriber before starting CoQ10, and your INR may need to be checked again at 4–6 weeks. Not a hard contraindication; just something your physician should know about.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives.\u003c\/strong\u003e CoQ10 may have a mild blood-pressure-lowering effect of its own. If you are on an antihypertensive, monitor BP for the first 6–8 weeks; doses occasionally need adjustment downward, which is a reason to coordinate with your prescriber rather than do it alone (Rosenfeldt 2007 meta-analysis).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChemotherapy.\u003c\/strong\u003e Some CoQ10–chemotherapy interactions are theoretical, some are protective. Always coordinate with your oncology team.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medication (insulin, sulfonylureas).\u003c\/strong\u003e CoQ10 may have a modest blood-sugar-lowering effect. Worth knowing if you are on insulin or a sulfonylurea so you can adjust monitoring.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy.\u003c\/strong\u003e CoQ10 has been used in IVF and pre-conception protocols extensively, but data during active pregnancy is more limited. Talk to your OB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGeneral safety profile.\u003c\/strong\u003e CoQ10 has an excellent safety record. Trials have run up to 1,200 mg\/day for 16 months in Parkinson's (Shults 2002) and up to 3,000 mg\/day under medical supervision in mitochondrial encephalomyopathies, with mild GI discomfort and insomnia (when taken late) being the most reported issues. The 400 mg daily dose in this product is well within the range studied for years in fertility, cardiovascular, and migraine contexts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 forever, or do I need to cycle it?\u003c\/strong\u003e CoQ10 does not downregulate the way some compounds do; long-term daily use is the standard pattern in research and in clinical practice. No cycling required.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMy urine turned bright yellow — is that bad?\u003c\/strong\u003e No, that is normal and means you are absorbing it. CoQ10 is a yellow pigment; the fat-soluble surplus passes through and tints the urine.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 if I am vegan?\u003c\/strong\u003e Our softgel uses bovine gelatin, so it is not strictly vegan. We may add a vegan capsule format in the future; for now, vegan-strict customers should look for plant-cellulose CoQ10 capsules elsewhere.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take CoQ10 in the morning or evening?\u003c\/strong\u003e Morning or midday with a fat-containing meal is best. Some people find it slightly stimulating and do not sleep well if they take it after 4 pm — which makes sense, given the energy mechanism. Others have no issue with evening dosing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan my partner and I both take it for fertility?\u003c\/strong\u003e Yes — that is the standard protocol. Both egg quality and sperm quality benefit from CoQ10 for the same mitochondrial-energy reasons. The recommended dose for each partner is identical: 200–400 mg daily for 90+ days pre-conception.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs 400 mg too much?\u003c\/strong\u003e No. CoQ10 has an excellent safety profile, with clinical trials running up to 1,200–3,000 mg daily in specific contexts under medical supervision. 400 mg is a therapeutic dose in the studied range — not a megadose.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I split the softgel?\u003c\/strong\u003e Softgels are designed to be swallowed whole, but if you only want 200 mg daily you can pierce the softgel with a clean pin and squeeze half the contents onto food (it has a slightly oily, neutral taste). Most people find it easier to just take one whole softgel every other day, which works because of CoQ10's long tissue half-life.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy is CoQ10 so expensive in general?\u003c\/strong\u003e Pharmaceutical-grade CoQ10 is produced via fermentation, which is a slow, capital-intensive process. The cheap CoQ10 you see on Amazon is often diluted, mislabeled, or uses a synthetic isomer with much lower bioactivity. We test every batch for the trans-isomer (the bioactive form) and publish quality summaries — see the \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing page\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 interact with statins or replace them?\u003c\/strong\u003e CoQ10 is a cofactor that statins deplete; it does not replace a statin. If you are on a statin, your physician likely already supports CoQ10 supplementation — many cardiologists recommend it routinely. Always coordinate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUbiquinone or ubiquinol — which one should I buy?\u003c\/strong\u003e For healthy adults under 60, ubiquinone (this product) at a meaningful dose with adequate dietary fat is the well-studied, lower-cost, well-evidenced choice. Ubiquinol is reasonable for adults 70+, advanced cardiovascular disease, or specific genetic differences in CoQ10 metabolism — situations where the conversion step itself may be impaired. The bigger absorption variable, by far, is whether you take CoQ10 with fat.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 help with long COVID or post-viral fatigue?\u003c\/strong\u003e Open question. There is plausible mechanism (mitochondrial dysfunction is a documented feature of long COVID) and a small handful of pilot studies, but no large RCTs yet. Many post-viral fatigue clinicians include CoQ10 in their stacks; the evidence is not yet at the level of the cardiovascular or fertility data.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs CoQ10 the same as Q10 or coenzyme Q?\u003c\/strong\u003e Yes — all three names refer to the same molecule. \"Q\" comes from the historical name \"ubiquinone\" (because it is ubiquitous in tissues). The 10 refers to its 10-unit isoprenoid side chain.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take CoQ10 with my morning coffee or NAD+ stack?\u003c\/strong\u003e Yes. CoQ10 does not interact meaningfully with caffeine, NMN, NR, resveratrol, or the rest of the NAD+ stack. Just make sure the CoQ10 is taken with a fat-containing meal — a coffee-only breakfast does not count.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes CoQ10 help with thyroid energy issues?\u003c\/strong\u003e A small literature suggests CoQ10 levels are lower in hypothyroid patients (Mancini 1989), and supplementation has been included in some functional-medicine protocols. Talk to your endocrinologist; this is more \"supportive cofactor\" than treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow does this product compare to the CoQ10 I see in the NAD+ 5-in-1 formula?\u003c\/strong\u003e The 5-in-1 includes a smaller CoQ10 dose alongside NMN, B-complex, and antioxidants for an all-in-one daily. This standalone 400 mg softgel is what you reach for when you want a higher therapeutic dose specifically — fertility cycles, statin replacement, athletic recovery, migraine prevention, or stacking on top of your core NAD+ protocol.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy bovine gelatin softgel and not vegan capsule?\u003c\/strong\u003e CoQ10 is fat-soluble; bioavailability is dramatically higher when delivered in a fat-carrier softgel rather than a dry powder capsule. Hard-shell vegan CoQ10 capsules exist but typically need 2–3× the dose to match the same plasma exposure.\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 1 softgel daily with a meal containing some fat — eggs, avocado, full-fat yogurt, butter on toast, olive oil, full-fat dairy. Lunch or dinner usually works better than breakfast for higher fat content. \u003cstrong\u003eCoQ10 absorption drops dramatically on an empty stomach\u003c\/strong\u003e (Hidaka 2008; Lopez-Lluch 2011). Daily consistency matters more than dose timing. For fertility protocols, take consistently for 90+ days before the conception cycle. For migraine prevention, evaluate at 12 weeks. For statin support, take on the same daily schedule as the statin.\u003c\/p\u003e\n\n\u003ch2\u003ePer-softgel ingredient panel\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e400 mg pharmaceutical-grade CoQ10 (ubiquinone, \u0026gt;98% trans-isomer, fermentation-derived)\u003c\/li\u003e\n  \u003cli\u003eCarrier oil base (medium-chain triglycerides) for fat-soluble absorption\u003c\/li\u003e\n  \u003cli\u003eBovine gelatin softgel shell, glycerin, purified water, natural mixed tocopherols (oxidation protection)\u003c\/li\u003e\n  \u003cli\u003eNo magnesium stearate, titanium dioxide, silicon dioxide, GMOs, gluten, soy, dairy, or artificial colors and flavors\u003c\/li\u003e\n  \u003cli\u003eUV-protective amber HDPE bottle, induction-sealed, 60-softgel count\u003c\/li\u003e\n  \u003cli\u003e60 softgels per bottle = 60-day supply at 1 softgel\/day, or 30-day supply at 2 softgels\/day for fertility\/longevity protocols\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and QC\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-certified, FDA-registered facility, manufactured in the USA.\u003c\/strong\u003e ISO 9001 quality system.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification\u003c\/strong\u003e for ≥98% trans-isomer purity (the bioactive form). Cis-isomer content reported on the COA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch heavy metals testing\u003c\/strong\u003e per USP \u0026lt;2232\u0026gt; (lead, arsenic, cadmium, mercury) to specification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch microbial limits testing\u003c\/strong\u003e per USP \u0026lt;2021\/2022\u0026gt; (total aerobic, yeast\/mold, E. coli, Salmonella, S. aureus).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch residual solvents\u003c\/strong\u003e per USP \u0026lt;467\u0026gt; — meaningful given fermentation-derived CoQ10 production.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch pesticide screening\u003c\/strong\u003e per USP \u0026lt;561\u0026gt; on the carrier oil.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOxidation protection\u003c\/strong\u003e via mixed tocopherols in the softgel matrix and amber HDPE bottle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e24-month shelf life\u003c\/strong\u003e from manufacture date (printed on bottom of bottle).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCOA available on request.\u003c\/strong\u003e See the \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing page\u003c\/a\u003e and \u003ca href=\"\/he\/pages\/ingredient-sourcing\"\u003eIngredient Sourcing page\u003c\/a\u003e for detail on every active in the catalog.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStorage and quality\u003c\/h2\u003e\n\u003cp\u003eStore in a cool, dry place away from direct sunlight. CoQ10 in softgel form is stable at room temperature; refrigeration is not required but does not hurt. Avoid leaving the bottle in a hot car or near a stove. Best-by date is printed on the bottom of the bottle — typically 24 months from manufacture.\u003c\/p\u003e\n\n\u003ch2\u003eWhy not Amazon\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC for trans-isomer purity.\u003c\/strong\u003e Independent lab audits of CoQ10 marketplaces have repeatedly found products with less than half their labeled dose, or with the wrong (cis) isomer that has much lower bioactivity. Trans-isomer purity is reported on every batch we ship.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePharmaceutical-grade fermentation-derived CoQ10.\u003c\/strong\u003e Not synthetic, not blended with cheaper isomers, not \"CoQ10 complex\" with undeclared filler.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCatalog architecture.\u003c\/strong\u003e CoQ10 is one cofactor in a larger mitochondrial story (NAD+ upstream → biogenesis via PQQ → mitophagy via Urolithin A → fueling via CoQ10). The catalog is built so each piece has a defensible reason to be there.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on the science\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/coq10-and-statins-the-cofactor-your-statin-depletes-and-why-it-matters\"\u003eCoQ10 and Statins — the cofactor your statin depletes and why it matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — a practical 2026 protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols — supplement stacks by goal\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science — how the catalog is built\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity collection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/collections\/fertility\"\u003eFertility collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eMortensen SA et al. \u003cem\u003eThe effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO.\u003c\/em\u003e JACC Heart Fail. 2014;2(6):641–649.\u003c\/li\u003e\n  \u003cli\u003eSándor PS et al. \u003cem\u003eEfficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.\u003c\/em\u003e Neurology. 2005;64(4):713–715.\u003c\/li\u003e\n  \u003cli\u003eShoeibi A et al. \u003cem\u003eEffectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial.\u003c\/em\u003e Acta Neurol Belg. 2017;117(1):103–109.\u003c\/li\u003e\n  \u003cli\u003eBentov Y et al. \u003cem\u003eCoenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF–ICSI treatment.\u003c\/em\u003e Clin Med Insights Reprod Health. 2014;8:31–36.\u003c\/li\u003e\n  \u003cli\u003eBentov Y, Casper RF. \u003cem\u003eThe aging oocyte — can mitochondrial function be improved?\u003c\/em\u003e Fertil Steril. 2013;99(1):18–22.\u003c\/li\u003e\n  \u003cli\u003eBen-Meir A et al. \u003cem\u003eCoenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.\u003c\/em\u003e Aging Cell. 2015;14(5):887–895.\u003c\/li\u003e\n  \u003cli\u003eSafarinejad MR. \u003cem\u003eEfficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men.\u003c\/em\u003e J Urol. 2009;182(1):237–248.\u003c\/li\u003e\n  \u003cli\u003eFolkers K et al. \u003cem\u003eLovastatin decreases coenzyme Q levels in humans.\u003c\/em\u003e Proc Natl Acad Sci USA. 1990;87(22):8931–8934.\u003c\/li\u003e\n  \u003cli\u003eMortensen SA et al. \u003cem\u003eDose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.\u003c\/em\u003e Mol Aspects Med. 1997;18(Suppl):S137–144.\u003c\/li\u003e\n  \u003cli\u003eRosenfeldt FL et al. \u003cem\u003eCoenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials.\u003c\/em\u003e J Hum Hypertens. 2007;21(4):297–306.\u003c\/li\u003e\n  \u003cli\u003eShults CW et al. \u003cem\u003eEffects of coenzyme Q10 in early Parkinson disease.\u003c\/em\u003e Arch Neurol. 2002;59(10):1541–1550.\u003c\/li\u003e\n  \u003cli\u003eBhagavan HN, Chopra RK. \u003cem\u003ePlasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.\u003c\/em\u003e Mitochondrion. 2007;7(Suppl):S78–88.\u003c\/li\u003e\n  \u003cli\u003eLopez-Lluch G et al. \u003cem\u003eBioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.\u003c\/em\u003e Nutrition. 2019;57:133–140.\u003c\/li\u003e\n  \u003cli\u003eHidaka T et al. \u003cem\u003eSafety assessment of coenzyme Q10.\u003c\/em\u003e Biofactors. 2008;32(1–4):199–208.\u003c\/li\u003e\n  \u003cli\u003eBentinger M et al. \u003cem\u003eCoenzyme Q — biosynthesis and functions.\u003c\/em\u003e Biochem Biophys Res Commun. 2010;396(1):74–79.\u003c\/li\u003e\n  \u003cli\u003eCrane FL. \u003cem\u003eBiochemical functions of coenzyme Q10.\u003c\/em\u003e J Am Coll Nutr. 2001;20(6):591–598.\u003c\/li\u003e\n  \u003cli\u003eKalén A, Appelkvist EL, Dallner G. \u003cem\u003eAge-related changes in the lipid compositions of rat and human tissues.\u003c\/em\u003e Lipids. 1989;24(7):579–584.\u003c\/li\u003e\n  \u003cli\u003eMancini A et al. \u003cem\u003ePlasma coenzyme Q10 in thyroid disease.\u003c\/em\u003e Acta Endocrinol (Copenh). 1989;121(4):504–508.\u003c\/li\u003e\n  \u003cli\u003eHu PJ et al. \u003cem\u003eEffects of metformin on coenzyme Q10 levels.\u003c\/em\u003e Cardiovasc Drugs Ther. 2014.\u003c\/li\u003e\n  \u003cli\u003eMantle D, Hargreaves I. \u003cem\u003eCoenzyme Q10 and degenerative disorders affecting longevity: an overview.\u003c\/em\u003e Antioxidants. 2018;8(2):44.\u003c\/li\u003e\n  \u003cli\u003eGarrido-Maraver J et al. \u003cem\u003eCoenzyme Q10 therapy.\u003c\/em\u003e Mol Syndromol. 2014;5(3–4):187–197.\u003c\/li\u003e\n  \u003cli\u003eSingh P et al. \u003cem\u003eTaurine deficiency as a driver of aging.\u003c\/em\u003e Science. 2023;380(6649):eabn9257. (Stack relevance.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eCitations are provided as scientific context — not as a claim that this product treats, prevents, or cures any disease. References are to mechanism and efficacy data; consult your physician for clinical decisions.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication (including statins, blood thinners, antihypertensives, or diabetes medication) or have a medical condition.\u003c\/em\u003e\n\n\u003cdiv class=\"th-trust-strip\" style=\"display:flex;flex-wrap:wrap;gap:16px;align-items:center;justify-content:center;padding:14px 18px;margin:16px 0;background:#faf7f2;border-radius:8px;font-size:0.9em;color:#555;\"\u003e\n  \u003cdiv\u003e🧪 \u003cstrong\u003e3rd-Party Lab Tested\u003c\/strong\u003e — \u003ca href=\"\/he\/pages\/quality\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003eQuality \u0026amp; Sourcing →\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🇺🇸 Made in USA · USP Pharma Grade · cGMP \/ FDA-registered\u003c\/div\u003e\n  \u003cdiv\u003e📋 30-Day Money-Back Guarantee — \u003ca href=\"\/he\/pages\/guarantee\" style=\"color:#9a5b3e;text-decoration:underline;\"\u003edetails\u003c\/a\u003e\n\u003c\/div\u003e\n  \u003cdiv\u003e🚚 Free US Shipping over $60\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-how-to\" style=\"margin:32px 0;padding:20px;border:1px solid #e0d5c8;border-radius:8px;\"\u003e\n  \u003ch3 style=\"margin-top:0;\"\u003eHow to take CoQ10 400 mg — quick reference\u003c\/h3\u003e\n  \u003cul style=\"line-height:1.7;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eWhen:\u003c\/strong\u003e with your largest fat-containing meal of the day (lunch or dinner is fine — fat-soluble, absorbs poorly without dietary fat). Move it earlier in the day if you find it slightly stimulating.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 softgel daily for general maintenance and statin support. 2 softgels daily (split with lunch and dinner) for fertility, athletic recovery, or longevity-stack contexts — well within studied range.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eEgg-quality protocol:\u003c\/strong\u003e 200–400 mg per day for 90 days minimum before each conception cycle. Egg maturation cycle ≈ 90 days. Sperm production cycle ≈ 74 days.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eMigraine protocol:\u003c\/strong\u003e 100–400 mg per day, evaluate at 12 weeks (Sándor 2005; Shoeibi 2017). Move dose earlier in the day if sleep is affected.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eCardiovascular \/ statin replacement:\u003c\/strong\u003e 100–300 mg\/day daily, indefinitely; coordinate with your cardiologist.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\" style=\"color:#9a5b3e;\"\u003eGlutathione 500 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\" style=\"color:#9a5b3e;\"\u003eAstaxanthin 12 mg\u003c\/a\u003e for the full \u003ca href=\"\/he\/collections\/fertility\" style=\"color:#9a5b3e;\"\u003eEgg Quality Stack\u003c\/a\u003e.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBest paired with\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\" style=\"color:#9a5b3e;\"\u003ePQQ 20 mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\" style=\"color:#9a5b3e;\"\u003eUrolithin A 500 mg\u003c\/a\u003e for the full \u003ca href=\"\/he\/collections\/mitochondrial-renewal\" style=\"color:#9a5b3e;\"\u003eMitochondrial Renewal stack\u003c\/a\u003e.\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eBright yellow urine?\u003c\/strong\u003e Normal. Means you are absorbing it — fat-soluble surplus passes through.\u003c\/li\u003e\n  \u003c\/ul\u003e\n  \u003cp style=\"margin-bottom:0;\"\u003e→ \u003ca href=\"\/he\/pages\/protocols\" style=\"color:#9a5b3e;font-weight:600;\"\u003eFull protocol guide for the entire stack\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"th-footer-links\" style=\"margin-top:48px;padding-top:24px;border-top:1px solid #e0d5c8;\"\u003e\n  \u003ch3 style=\"margin-bottom:12px;\"\u003eHave a specific question?\u003c\/h3\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/faq\" style=\"color:#9a5b3e;\"\u003eFAQ — most common questions\u003c\/a\u003e covers shipping, drug interactions, refunds, dosing.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/quality\" style=\"color:#9a5b3e;\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e — every batch tested, COAs available on request.\u003c\/p\u003e\n  \u003cp style=\"margin:0 0 16px;\"\u003e→ \u003ca href=\"\/he\/pages\/getting-started\" style=\"color:#9a5b3e;\"\u003eGetting Started — where to begin\u003c\/a\u003e if this is your first supplement from us.\u003c\/p\u003e\n  \u003cp style=\"margin:0;\"\u003e→ Or just \u003ca href=\"mailto:support@truehealthprotocol.health\" style=\"color:#9a5b3e;\"\u003eemail support directly\u003c\/a\u003e. We respond within 24 hours.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47696470409434,"sku":"THP-COQ10-400-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/coq10_03.jpg?v=1774728960"},{"product_id":"liposomal-nad-ultimate-1000mg","title":"Liposomal NAD+ Ultimate 1000mg | 10-Active Phospholipid Formula for NAD+, Sirtuins \u0026 Mitochondria","description":"\u003cp\u003e\u003cstrong\u003eTen clinically-relevant longevity actives in one phospholipid-encapsulated capsule\u003c\/strong\u003e — direct NAD+ alongside two precursor pathways (NMN + NR), a SIRT1 activator (Trans-Resveratrol), two mitochondrial cofactors (CoQ10 + PQQ), a senolytic flavonoid (Quercetin), a universal antioxidant (Alpha-Lipoic Acid), and the methylation\/energy B-vitamins (B3 + B12). The most comprehensive NAD+ formula in our range, designed for adults running a serious longevity protocol who want every leg of the NAD+ machinery covered in a single capsule.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTen actives, one capsule:\u003c\/strong\u003e direct NAD+ + NMN + NR (three precursor pathways) + Trans-Resveratrol + PQQ + CoQ10 + Quercetin + Alpha-Lipoic Acid + Vitamin B3 + Vitamin B12.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal phospholipid encapsulation\u003c\/strong\u003e — small phospholipid vesicles structurally identical to your cell membranes, designed to bypass gastric breakdown and deliver actives at the cellular level rather than relying solely on dissolved-into-blood transport.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy it matters:\u003c\/strong\u003e NAD+ levels drop ~50% between age 40 and 60 (Massudi 2012 PLoS One; Camacho-Pereira 2016 Cell Metabolism), and CD38-driven NAD+ consumption rises with age — single-pathway support often plateaus.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 50+, anyone already on NMN-only who has stalled, and serious longevity stack users who want NAD+ supply, sirtuin activation, mitochondrial support, and antioxidant defense in one daily capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake:\u003c\/strong\u003e 2 capsules daily with breakfast — several actives are fat-soluble.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you want the simplest entry point:\u003c\/strong\u003e see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. If you want the highest-dose single-ingredient NMN: \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat \"liposomal\" actually means — the chemistry, not the marketing\u003c\/h2\u003e\n\u003cp\u003eA liposome is a microscopic vesicle (typically 50–500 nanometers) bounded by a phospholipid bilayer — the same molecular architecture as the cell membranes inside your body. Phosphatidylcholine and related phospholipids are amphipathic: a water-loving head group on one side, two fatty-acid tails on the other. Suspended in water, they self-assemble into closed bilayer spheres with an aqueous core, encapsulating whatever water-soluble cargo is present.\u003c\/p\u003e\n\u003cp\u003eFor NAD+ and the other actives in this formula, liposomal delivery does three concrete things:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtects the molecules from gastric and enzymatic degradation.\u003c\/strong\u003e Free NAD+ is a large, charged, unstable molecule that is partially hydrolyzed in the acid environment of the stomach and further degraded by intestinal enzymes (CD38 and related glycohydrolases). The phospholipid shell shields the cargo until the vesicle reaches the absorptive epithelium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnables direct membrane fusion.\u003c\/strong\u003e The lipid bilayer of the liposome can fuse with enterocyte and target-cell membranes, releasing contents directly into the cell rather than relying entirely on receptor- or transporter-mediated uptake. This bypasses the saturable transporter ceiling that limits, for example, oral Vitamin C absorption above ~200–500 mg per dose (Levine 1996 PNAS).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImproves bioavailability of fragile cargoes.\u003c\/strong\u003e Davis 2016 (Nutr Metab Insights) and Hickey 2008 (J Nutr Environ Med) demonstrated multi-fold AUC improvements for liposomal vs standard Vitamin C at the same oral dose. The principle — phospholipid protection plus direct membrane delivery — extends to other unstable hydrophilic molecules including NAD+ and its precursors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLiposomal is not a substitute for IV NAD+ — intravenous delivery still produces higher peak plasma levels — but for daily oral support of cellular NAD+, phospholipid encapsulation is the most validated way to bypass the limits of standard capsule and tablet delivery.\u003c\/p\u003e\n\n\u003ch2\u003eWhy one capsule covers three NAD+ precursor pathways (and why that hedges your bet)\u003c\/h2\u003e\n\u003cp\u003eNAD+ is built in your cells from three different precursors, each entering the salvage pathway through a different enzyme:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN (nicotinamide mononucleotide)\u003c\/strong\u003e — one step away from NAD+, most extensively studied human-trial precursor (Yoshino 2021 Science; Igarashi 2022 NPJ Aging). Enters via the Slc12a8 transporter (Grozio 2019 Nature Metabolism) or via dephosphorylation to NR before re-entry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR (nicotinamide riboside)\u003c\/strong\u003e — one additional enzymatic step (NRK1\/NRK2 phosphorylation). Trammell 2016 Nature Communications demonstrated 2.7-fold elevation in blood NAD+ at 1000 mg\/day in healthy adults; Martens 2018 Nature Communications, Conze 2019 Sci Reports, and Brakedal 2022 Cell Metab Parkinson's pilot all used NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme itself. Less studied for oral bioavailability, but the inclusion alongside precursors hedges against any individual transporter or conversion bottleneck. If your NRK1 expression is low, the NMN\/NR you take may not convert efficiently — so the formula provides finished coenzyme as a parallel input.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost adults respond to NMN-only or NR-only protocols. A meaningful subset don't — their bloodwork shows minimal NAD+ rise even at 1000 mg\/day. Triple-precursor coverage in one capsule is designed for those people, and for adults 50+ where the salvage pathway as a whole is running below baseline efficiency.\u003c\/p\u003e\n\n\u003ch2\u003eWhy precursors alone aren't enough — the four-pillar NAD+ strategy\u003c\/h2\u003e\n\u003cp\u003eJust raising NAD+ isn't the whole job. NAD+ is a substrate that gets consumed in real time by sirtuins (SIRT1–SIRT7), PARPs (DNA repair), CD38 (the dominant age-related NAD+ consumer; Camacho-Pereira 2016), and SARM1 (axon health). A serious longevity strategy works on four levers:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply\u003c\/strong\u003e — raise the precursor pool. Covered here by NMN + NR + direct NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivation\u003c\/strong\u003e — engage sirtuins so the raised NAD+ actually gets used. Covered by Trans-Resveratrol, the canonical SIRT1 activator (Howitz 2003 Nature; Hubbard 2013 Science crystallography showing 8-fold SIRT1 activation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial output\u003c\/strong\u003e — give the electron transport chain the cofactors and biogenesis signals to actually turn elevated NAD+ into ATP. Covered by CoQ10 (Complex I–III electron carrier; Folkers 1990 PNAS) and PQQ (PGC-1α activator and mitochondrial biogenesis signal; Chowanadisai 2010 J Biol Chem).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDefense\u003c\/strong\u003e — protect the rising NAD+ from accelerated consumption and protect mitochondria from the increased ROS that comes with higher metabolic activity. Covered by Quercetin (CD38 inhibition + senolytic activity; Escande 2013 Diabetes; Yousefzadeh 2018 EBioMedicine) and Alpha-Lipoic Acid (universal antioxidant that recycles Vitamin C, Vitamin E, glutathione, and CoQ10 back to active forms; Packer 1995 Free Radic Biol Med).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe B-vitamins (B3 as niacinamide and B12 as methylcobalamin) close two specific cofactor loops: B3 is the upstream substrate for the entire NAD+ salvage pathway, and B12 supports the methionine\/SAMe methylation cycle that NAD+ precursors burn through (which is why high-dose NMN-only users add TMG — same problem, different solution).\u003c\/p\u003e\n\n\u003ch2\u003eThe 10 actives — mechanism, dose rationale, and the trial that supports each\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDirect NAD+\u003c\/strong\u003e — the finished coenzyme. Bypasses all three precursor conversion steps. Used here as a parallel input for adults whose NMN\/NR conversion efficiency may be impaired.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one-step NAD+ precursor. Yoshino 2021 (Science, 250 mg\/day in postmenopausal women, 10-week trial, improved muscle insulin sensitivity); Igarashi 2022 (NPJ Aging, 250 mg\/day in older adults, walking-speed and grip-strength improvements at 12 weeks); Pencina 2022 (iScience, 900 mg\/day single-dose pharmacokinetic ceiling work).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — alternate precursor pathway. Trammell 2016 (Nat Commun, 1000 mg\/day, blood NAD+ +2.7×); Martens 2018 (Nat Commun, 6-week trial, blood-pressure and arterial-stiffness reduction in middle-aged adults); Conze 2019 (Sci Reports, 8-week dose-response).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol\u003c\/strong\u003e — SIRT1 activator. Howitz 2003 (Nature, original SIRT1 activation work from the Sinclair lab); Hubbard 2013 (Science, crystal structure showing 8-fold direct SIRT1 activation at the allosteric site); Tomé-Carneiro 2013 (Mol Nutr Food Res, Spanish coronary heart disease cohort, 1-year inflammatory marker improvements). Critical pairing: a raised NAD+ pool with no sirtuin activator is a substrate without an enzyme to use it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePQQ (Pyrroloquinoline Quinone)\u003c\/strong\u003e — mitochondrial biogenesis signal via PGC-1α activation. Chowanadisai 2010 (J Biol Chem, mtDNA increase + mitochondrial gene expression); Harris 2013 (J Nutr Biochem, inflammatory marker improvements); Nakano 2009 (FOOD Style 21, cognition trial). PQQ is also a 20,000-cycle redox-stable antioxidant — far more cycles than ascorbate or tocopherol before it's consumed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 (Ubiquinone)\u003c\/strong\u003e — electron transport chain cofactor at Complex I–III. Folkers 1990 (PNAS, mitochondrial energy production); Marcoff 2007 (J Am Coll Cardiol, statin-induced CoQ10 depletion mechanism); Q-SYMBIO trial (Mortensen 2014, JACC Heart Failure, 100 mg 3×\/day, 2-year all-cause mortality reduction in heart failure patients).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuercetin\u003c\/strong\u003e — senolytic flavonoid (clears senescent \"zombie\" cells via BCL-2\/BCL-xL inhibition; Yousefzadeh 2018 EBioMedicine 10-flavonoid screen, ranked second behind Fisetin) AND CD38 inhibitor (Escande 2013 Diabetes — slowing the dominant age-related NAD+ consumer means more of your raised NAD+ stays in circulation) AND mast-cell stabilizer \/ NF-κB inhibitor (Mlcek 2016 Molecules).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlpha-Lipoic Acid (ALA)\u003c\/strong\u003e — universal antioxidant (water- AND fat-soluble, works in all cell compartments including mitochondrial matrix) AND antioxidant recycler (regenerates oxidized Vitamin C, Vitamin E, glutathione, and CoQ10 back to active forms; Packer 1995 Free Radic Biol Med) AND direct mitochondrial cofactor for pyruvate dehydrogenase + α-ketoglutarate dehydrogenase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin B3 (Niacinamide)\u003c\/strong\u003e — the upstream substrate that the NAD+ salvage pathway is built on. Without sufficient B3, NMN and NR conversion both bottleneck.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin B12 (Methylcobalamin)\u003c\/strong\u003e — supports the methionine\/SAMe methylation cycle that high-dose NMN\/NR protocols burn through. The reason TMG is the standard pairing for NMN 1000 mg users is methylation buffering — B12 is the upstream cofactor for the same cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvery active is dose-disclosed on the label. No proprietary blends, no fairy-dusting.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the NAD+ family — choose the right product\u003c\/h2\u003e\n\u003cp\u003eOur NAD+ family covers seven distinct positions. Pick by use case, not by price:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest single-ingredient entry:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e. The standard starting point. One ingredient, one decision.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose single-ingredient NMN:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. For adults 50+ or non-responders at 500 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR with B-vitamin cofactors:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNicotinamide Riboside (NR) Hard Capsules\u003c\/a\u003e. The longest human research track record (65+ trials).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMid-tier daily NAD+ + Resveratrol capsule:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e. Direct NAD+ with the SIRT1 activator built in.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePure NMN\/NR\/Resveratrol\/PQQ drink mix:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000 mg Pure Focus Formula\u003c\/a\u003e. For people who prefer a stick pack to a capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBerry-flavored liquid drink format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e. TSA-friendly, no capsule swallowing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne-bottle longevity baseline:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e. NMN + niacin + CoQ10 + B-complex + Vitamins C\/E + collagen-synthesis cofactors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaximum-comprehensive (this product):\u003c\/strong\u003e 10 actives, liposomal phospholipid delivery, four-pillar NAD+ strategy in one capsule. Top of the range.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the deeper choice between NMN-only and a comprehensive formula, see our \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ guide\u003c\/a\u003e and the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStack pairings — what completes the protocol\u003c\/h2\u003e\n\u003cp\u003eThis formula is engineered for breadth, not depth on any single mechanism. To go deeper on a specific lever, add a single-ingredient product:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — if you sustain this formula long-term or stack it with additional standalone NMN, methylation pool depletion is the most common silent failure mode. TMG (trimethylglycine) is the methyl-donor buffer the David Sinclair \/ Brad Stanfield consensus recommends for any sustained high-dose NAD+ protocol.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — the dedicated CD38 inhibitor (Escande 2013 Diabetes). The Quercetin in this formula provides partial CD38 coverage; Apigenin doubles down on slowing the age-related NAD+ leak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — the AMPK leg of the four-pathway longevity map (sirtuins \/ AMPK \/ autophagy \/ senolytics). Berberine and NAD+ precursors are mechanistically complementary; Yin 2008 head-to-head with metformin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — the autophagy leg. Eisenberg 2016 (Nature Med) cardiovascular mortality data. Different mechanism (autophagy\/mitophagy via EP300 inhibition) than the senolytic Quercetin already in this formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — the universal cofactor underneath everything else. NAMPT (the NMN→NAD+ enzyme) is magnesium-dependent; the SAMe methylation cycle is magnesium-dependent; ATP only circulates as Mg-ATP. Two-thirds of US adults run below the RDA — the most common silent reason a NAD+ stack underperforms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — the mitophagy layer (clears damaged mitochondria via PINK1\/Parkin). PQQ in this formula builds new mitochondria; Urolithin A removes the broken ones to make room.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the full architecture, see the \u003ca href=\"\/he\/pages\/protocols\"\u003eCellular Longevity Protocol\u003c\/a\u003e and the \u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health cornerstone\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdults 50+\u003c\/strong\u003e — NAD+ decline is steeper after 50 (Massudi 2012 PLoS One showed roughly 50% reduction by age 60), CD38 expression rises with age (Camacho-Pereira 2016 Cell Metab), and single-pathway precursor support frequently plateaus.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone running a serious longevity protocol\u003c\/strong\u003e who wants NAD+ supply, sirtuin activation, mitochondrial cofactors, and antioxidant defense in one daily capsule rather than 5–7 separate bottles.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN-only non-responders\u003c\/strong\u003e — people who took 500–1000 mg NMN daily for 2–3 months and didn't notice the energy\/recovery shift the rest of the protocol produced. Triple-precursor coverage hedges against individual conversion bottlenecks; the SIRT1 activator gives the raised NAD+ a job.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAthletes and high-demand adults\u003c\/strong\u003e — periods of heavy training, post-illness recovery, jet lag, and high-stress workloads where mitochondrial demand outruns baseline supply.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who want simplicity\u003c\/strong\u003e — one capsule, one decision. The formula handles the multi-mechanism architecture so you don't have to.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent (within 12 months) cancer treatment\u003c\/strong\u003e — raising NAD+ has theoretical implications for certain cancer types. The evidence is mixed and context-dependent. Discuss with your oncologist before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding\u003c\/strong\u003e — Resveratrol is contraindicated; NMN\/NR have no human pregnancy safety data. Default to caution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople on warfarin or other anticoagulants\u003c\/strong\u003e — Quercetin and Resveratrol both have weak antiplatelet activity; CoQ10 has minor warfarin interactions. Coordinate with your prescriber.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWithin 14 days of scheduled surgery\u003c\/strong\u003e — standard pre-surgical washout for the antioxidant + antiplatelet activity in the formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSevere liver or kidney disease\u003c\/strong\u003e — high-load multi-active formulas should be cleared by your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdults under 30 with no specific reason to supplement\u003c\/strong\u003e — baseline NAD+ in young adults is generally adequate; the cost\/benefit changes substantially after 40–50.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e some users notice subtle morning energy, mental clarity, or reduced afternoon dip within the first week. The direct NAD+ component reaches cells faster than precursor-only formulas; the B12 + niacinamide can also produce a near-term energy lift independent of the NAD+ pathway.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes for most users. Exercise recovery quality starts to shift — this is the timeframe Trammell 2016 (NR PK trial) showed measurable blood NAD+ elevation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably. Sirtuin-driven downstream effects (cardiovascular, metabolic) start to appear — this is the Martens 2018 NR-trial blood-pressure-improvement window and the Yoshino 2021 NMN-trial muscle-insulin-sensitivity window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained NAD+\/sirtuin\/mitochondrial support. Subjective energy plateau stabilizes; objective markers (recovery quality, sleep depth, sustained focus across the day) settle into a new baseline. Trans-Resveratrol cardiovascular markers (Tomé-Carneiro 2012\/2013) typically start showing in this window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6+:\u003c\/strong\u003e the long-term anti-aging mechanisms compound. NAD+ is upstream of so many pathways that the cumulative effect is broader than any single subjective marker captures. Daily consistency matters more than dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eApproximately 10–15% of users notice less than expected at 4 weeks — the highest-yield additions for non-responders are TMG 1000 mg (methylation buffer) and Magnesium Glycinate 400 mg (NAMPT cofactor).\u003c\/p\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 2 capsules daily in the morning with breakfast. Best with a meal that contains some fat — CoQ10, Resveratrol, and several other actives are fat-soluble and absorption is meaningfully better with dietary fat (10–15 g is sufficient). Avoid taking with grapefruit or grapefruit juice (CYP3A4 interaction with Resveratrol metabolism).\u003c\/p\u003e\n\u003cp\u003eIf you experience GI sensitivity in the first week, drop to 1 capsule daily for 7 days, then build to 2. The Quercetin + Resveratrol + B-complex combination can be more activating than people expect — not a problem, just titrate.\u003c\/p\u003e\n\u003cp\u003eAvoid evening dosing — raised NAD+ in the evening can disrupt the natural circadian dip in NAD+\/NADH ratio that supports deep sleep onset. Morning dosing aligns with the body's own NAD+ rhythm.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eDirect NAD+ (Nicotinamide Adenine Dinucleotide)\u003c\/li\u003e\n  \u003cli\u003eNMN (β-Nicotinamide Mononucleotide)\u003c\/li\u003e\n  \u003cli\u003eNR (Nicotinamide Riboside)\u003c\/li\u003e\n  \u003cli\u003eTrans-Resveratrol (from \u003cem\u003ePolygonum cuspidatum\u003c\/em\u003e, ≥98% HPLC)\u003c\/li\u003e\n  \u003cli\u003ePQQ (Pyrroloquinoline Quinone disodium salt)\u003c\/li\u003e\n  \u003cli\u003eCoQ10 (Ubiquinone)\u003c\/li\u003e\n  \u003cli\u003eQuercetin\u003c\/li\u003e\n  \u003cli\u003eAlpha-Lipoic Acid (R\/S form)\u003c\/li\u003e\n  \u003cli\u003eVitamin B3 (as Niacinamide)\u003c\/li\u003e\n  \u003cli\u003eVitamin B12 (as Methylcobalamin)\u003c\/li\u003e\n  \u003cli\u003ePhospholipid encapsulation matrix (sunflower-derived phosphatidylcholine)\u003c\/li\u003e\n  \u003cli\u003eVegetarian HPMC capsule shell\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNo proprietary blends. No artificial colors, no titanium dioxide, no magnesium stearate, no maltodextrin, no soy, no gluten. Third-party tested for purity and potency.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in a cGMP-certified facility under FDA-registered standards. Each batch is third-party tested for identity, potency, heavy metals (lead, cadmium, mercury, arsenic below USP limits), and microbial contamination (total plate count, yeast\/mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e). Trans-Resveratrol is HPLC-verified ≥98% trans-isomer (the cis-isomer is biologically inactive). NMN and NR are pharmaceutical-grade, HPLC-verified. PQQ is the disodium salt form — the only form with published human-trial data. Phospholipid carrier is non-GMO sunflower lecithin (not soy). Bottled in amber HDPE with desiccant for light- and oxygen-sensitivity protection.\u003c\/p\u003e\n\n\u003ch2\u003eSafety \u0026amp; interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants and antiplatelet drugs\u003c\/strong\u003e (warfarin, aspirin, clopidogrel) — Quercetin and Resveratrol have weak antiplatelet activity; coordinate with your prescriber and monitor INR if applicable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStatins\u003c\/strong\u003e — CoQ10 in this formula is supportive (statins deplete CoQ10; Marcoff 2007). No dose adjustment usually needed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCYP3A4 substrates\u003c\/strong\u003e (some statins, immunosuppressants, certain anti-arrhythmics) — Resveratrol has weak CYP3A4 interaction. Avoid grapefruit\/grapefruit juice with this product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer treatment\u003c\/strong\u003e — discuss with your oncologist before starting any NAD+ precursor supplement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding\u003c\/strong\u003e — not recommended (Resveratrol contraindication, no NMN\/NR pregnancy safety data).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery\u003c\/strong\u003e — stop 14 days before any scheduled surgery (standard antioxidant + antiplatelet washout).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNiacin flush\u003c\/strong\u003e — this formula uses Niacinamide (no flush) rather than free Niacin (flush). Flushing is not expected.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiver or kidney disease\u003c\/strong\u003e — clear with your physician before starting any high-load multi-active formula.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eIs liposomal really better, or is it marketing?\u003c\/strong\u003e For unstable or poorly absorbed water-soluble compounds (Vitamin C, NAD+, glutathione, curcumin), the published bioavailability and AUC data favor properly-formulated liposomal delivery (Davis 2016 Nutr Metab Insights for Vitamin C is the cleanest published comparison). It is not marketing — but the quality bar matters. A \"liposomal\" product that is just lecithin powder mixed with the active is not a true liposome and won't perform the same way. We use sunflower-derived phosphatidylcholine in a small-particle phospholipid matrix.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy include direct NAD+ AND NMN AND NR? Isn't one enough?\u003c\/strong\u003e For most adults, one is enough. The reason this formula includes all three is to hedge against individual conversion bottlenecks — a meaningful subset of adults (~10–15%) don't respond well to NMN-only, and triple-precursor coverage gives the cell three different entry points to the salvage pathway. For adults 50+ where the salvage pathway as a whole runs less efficiently, parallel precursor inputs are more reliable than depending on a single conversion step.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eShould I take this with TMG?\u003c\/strong\u003e If you sustain this formula long-term (3+ months) or stack it with additional standalone NMN above 500 mg\/day, yes. The methylation pool gets burned through clearing nicotinamide; TMG (trimethylglycine, 1000 mg\/day) replenishes the methyl donors and is the standard pairing for sustained high-dose NAD+ protocols. See our \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e page for the full mechanism.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with my existing NMN or NR product?\u003c\/strong\u003e Yes — many people stack this with a higher-dose standalone NMN (like our \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e) for the highest-load protocol. The math: this formula contributes precursors plus the activator + cofactor + defense layers; the standalone NMN raises the precursor load further. If you go this route, add TMG.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is this different from your NAD+ 5-in-1 Complete Mitochondrial Formula?\u003c\/strong\u003e The 5-in-1 leans toward the foundational\/baseline end of the range (NMN + Niacin + CoQ10 + B-Complex + Vitamins C\/E + collagen-synthesis cofactor, two capsules daily). This Liposomal Ultimate is the high-end multi-mechanism formula — it doesn't include Vitamin C or HA but adds NR, direct NAD+, Resveratrol, PQQ, Quercetin, and ALA, and uses phospholipid encapsulation. Different jobs: 5-in-1 is the broad baseline; Liposomal Ultimate is the dedicated NAD+\/sirtuin\/mitochondrial formula for serious longevity stacks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is this different from the Liquid NAD+ Anti-Aging Drink?\u003c\/strong\u003e The Liquid Drink is a berry-flavored stick pack format, primarily NAD+ + Resveratrol + supporting actives in liquid form — better for people who don't want to swallow capsules or who travel frequently (TSA-friendly). Liposomal Ultimate is broader (10 actives vs the Drink's smaller active count) and uses phospholipid encapsulation rather than direct liquid. Many people use the Drink for travel and switch to Liposomal Ultimate at home.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy morning dosing? Can I take it at night?\u003c\/strong\u003e The body's natural NAD+\/NADH ratio rises in the morning and falls in the evening — mirroring the circadian clock. Raised NAD+ in the evening can interfere with the natural dip that supports deep sleep onset. Morning dosing aligns with the body's own rhythm and is what every published clinical trial used.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Some users do (the B12 + niacinamide can produce a short-term clarity\/energy lift). Most users notice the cumulative effect at 2–4 weeks. About 10–15% of users see less than expected at 4 weeks — for those people, the highest-yield additions are TMG (methylation buffer) and Magnesium Glycinate (NAMPT cofactor).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e Yes. Caffeine doesn't interfere with NAD+ precursor uptake. Many users take it alongside their morning coffee. If you have caffeine sensitivity, the B12 + niacinamide can amplify the alertness slightly — not a problem, just calibrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle on\/off?\u003c\/strong\u003e No published evidence supports cycling. The clinical trials that ran for 6–12 months showed sustained and accumulating benefit without requiring breaks. Daily consistency is what produces the result.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e The capsule shell is HPMC (vegetable cellulose). The phospholipid carrier is sunflower-derived (not animal). All active ingredients are vegan. Suitable for vegetarians and vegans.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow long does one bottle last?\u003c\/strong\u003e At 2 capsules daily it's a 30-day supply per bottle. Most people use it as a daily long-term foundation rather than a short course.\u003c\/p\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR: which NAD+ precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+: which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN: morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal: clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health: the 7 daily nutrients that run underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eThe True Health Protocol page — full longevity stack architecture\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eReferences cited (selected): Massudi 2012 PLoS One; Camacho-Pereira 2016 Cell Metabolism; Yoshino 2021 Science; Igarashi 2022 NPJ Aging; Trammell 2016 Nature Communications; Martens 2018 Nature Communications; Conze 2019 Scientific Reports; Howitz 2003 Nature; Hubbard 2013 Science; Tomé-Carneiro 2013 Mol Nutr Food Res; Chowanadisai 2010 J Biol Chem; Folkers 1990 PNAS; Marcoff 2007 J Am Coll Cardiol; Mortensen 2014 JACC HF (Q-SYMBIO); Yousefzadeh 2018 EBioMedicine; Escande 2013 Diabetes; Mlcek 2016 Molecules; Packer 1995 Free Radic Biol Med; Davis 2016 Nutr Metab Insights; Hickey 2008 J Nutr Environ Med; Levine 1996 PNAS. These references describe the active ingredients generally and not this specific finished product.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have a medical condition, or are scheduled for surgery.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698100945114,"sku":"THP-NAD-LIPO-1000","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liposomal-nad.jpg?v=1775666045"},{"product_id":"selerb-nad-5-in-1-complete-mitochondrial-formula","title":"NAD+ 5-in-1 Complete Mitochondrial Formula | NMN + CoQ10 + B-Complex + Antioxidants + Skin","description":"\u003cp\u003e\u003cstrong\u003eFive longevity systems in one daily capsule\u003c\/strong\u003e — NAD+ precursors, mitochondrial cofactors, antioxidants, collagen-synthesis cofactors, and skin-hydration support. Built for people who want one bottle that covers most of the longevity-and-beauty bases without managing five separate purchases.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOne capsule, five active systems.\u003c\/strong\u003e NAD+ precursors (NMN + Niacin) + mitochondrial cofactors (CoQ10 + full B-complex) + antioxidant defense (Vitamins C + E) + collagen-synthesis cofactors (Vitamin C-dependent prolyl-4-hydroxylase + lysyl hydroxylase) + skin-hydration support (Hyaluronic Acid precursors).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want a comprehensive baseline and don't want to assemble a multi-bottle stack themselves — or anyone whose previous attempt at a 5-bottle longevity stack ended with three of the bottles sitting unused.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe trade-off, plain:\u003c\/strong\u003e the dose of each individual ingredient is lower than dedicated single-ingredient products. If you want maximum dose of one specific compound (e.g. 1000 mg NMN, 600 mg trans-Resveratrol, 400 mg CoQ10), use the standalone version. This product is engineered for breadth, not depth.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 2 capsules with breakfast\u003c\/strong\u003e, daily. Several ingredients (Vitamin E, CoQ10) absorb materially better with meal fat — eat the capsules with the meal, not on an empty stomach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat \"5-in-1\" actually means — and why we chose these five\u003c\/h2\u003e\n\u003cp\u003eMost \"complete longevity\" formulas are either (a) a single NAD+ precursor with a vitamin or two thrown in for marketing, or (b) a 30-ingredient kitchen-sink blend at homeopathic doses with everything hidden inside a \"proprietary blend\" so you can't see the actual amounts. Neither is honest engineering.\u003c\/p\u003e\n\u003cp\u003eThe five systems in this formula were chosen because they are the five places where biological aging actually starts to fail at the cellular level — and where missing one breaks the others:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ pool (precursors):\u003c\/strong\u003e NAD+ is the coenzyme behind cellular energy, DNA repair, and sirtuin-pathway longevity signaling. It declines roughly 50% by age 50 (Massudi 2012, \u003cem\u003ePLoS One\u003c\/em\u003e; Camacho-Pereira 2016, \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, the rest of the chain has no fuel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactors (CoQ10 + B-complex):\u003c\/strong\u003e NAD+ is necessary but not sufficient. The electron transport chain still needs CoQ10 to shuttle electrons from Complex I\/II to Complex III, and the Krebs cycle still needs B1 (thiamine), B2 (riboflavin → FAD), B3 (niacin → NAD+ pool), B5 (pantothenic acid → coenzyme A), B6 (pyridoxal-5-phosphate), and B12 to actually run. Raising NAD+ without the cofactors is like adding more fuel to a car with a clogged fuel injector.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant defense (Vitamins C + E):\u003c\/strong\u003e mitochondria leak ~1–2% of their electrons as superoxide during normal operation (Murphy 2009, \u003cem\u003eBiochem J\u003c\/em\u003e). Vitamin C (water-soluble, neutralizes radicals in the cytoplasm and plasma) and Vitamin E (fat-soluble, neutralizes lipid peroxidation in the membrane) are the two-front defense. They regenerate each other (Packer 1979, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCollagen-synthesis cofactors:\u003c\/strong\u003e Vitamin C is the rate-limiting cofactor for the prolyl-4-hydroxylase and lysyl-hydroxylase enzymes that crosslink procollagen into the stable triple-helix that gives skin, joints, and connective tissue their structure. Scurvy is what total Vitamin C deficiency looks like — collagen synthesis fails. Even subclinical insufficiency degrades skin recovery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkin hydration (HA precursors):\u003c\/strong\u003e Hyaluronic Acid binds up to 1,000× its weight in water; native production drops sharply after 40 (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Oral HA precursors raise dermal HA over weeks (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvery active is dose-disclosed on the label. \u003cstrong\u003eNo proprietary blends.\u003c\/strong\u003e If a \"complete formula\" hides its individual ingredient amounts inside a single \"proprietary blend\" weight, that's almost always because at least one of the doses is too small to be effective at the price they're charging.\u003c\/p\u003e\n\n\u003ch2\u003ePer-system mechanism deep dive\u003c\/h2\u003e\n\n\u003ch3\u003eSystem 1 — NAD+ precursors (NMN + Niacin)\u003c\/h3\u003e\n\u003cp\u003eTwo precursors, one pool. NMN (nicotinamide mononucleotide) raises NAD+ via the most direct salvage pathway (NMN → NAD+ via NMNAT enzymes). Niacin (nicotinic acid) feeds the Preiss-Handler pathway. Using both gives more consistent intracellular NAD+ in different tissue compartments — the liver tends to favor the niacin route while peripheral tissue favors NMN\/NR (Trammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e; Yoshino 2018, \u003cem\u003eCell Metab\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThe trade-off this formula makes: dose. The NMN dose here is moderate. If the strongest NMN response in the published literature is what you're after — Yoshino's 2021 \u003cem\u003eScience\u003c\/em\u003e trial dosed 250 mg\/day, Igarashi's 2022 \u003cem\u003eNPJ Aging\u003c\/em\u003e dosed 250 mg, and Pencina's 2022 \u003cem\u003eiScience\u003c\/em\u003e dosed up to 900 mg — the dose-response peaks around 600–1000 mg\/day. For that ceiling, see \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. For breadth across five systems with NAD+ included, this 5-in-1 is the design.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 2 — Mitochondrial cofactors (CoQ10 + full B-complex)\u003c\/h3\u003e\n\u003cp\u003eCoQ10 (ubiquinone) is the electron carrier between Complex I\/II and Complex III of the inner mitochondrial membrane. Endogenous synthesis declines from age 30 onward; statin medications block its synthesis directly via the same HMG-CoA-reductase inhibition that lowers cholesterol (Folkers 1990, \u003cem\u003ePNAS\u003c\/em\u003e; Marcoff 2007, \u003cem\u003eJ Am Coll Cardiol\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThe full B-complex matters because the TCA cycle and oxidative phosphorylation are a relay race — if any cofactor is missing, the whole chain stalls at that step:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB1 (Thiamine)\u003c\/strong\u003e — cofactor for pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (α-KGDH). Without B1, glucose can't enter the TCA cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB2 (Riboflavin)\u003c\/strong\u003e — precursor of FAD, the prosthetic group for Complex II of the electron transport chain.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB3 (Niacin)\u003c\/strong\u003e — precursor of NAD+ itself, the coenzyme used at Complex I.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB5 (Pantothenic acid)\u003c\/strong\u003e — precursor of coenzyme A, the carrier that delivers acetyl groups into the TCA cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB6 (Pyridoxal-5-phosphate)\u003c\/strong\u003e — required for amino acid → TCA-cycle entry and heme synthesis.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eB12 (Methylcobalamin)\u003c\/strong\u003e — required for the methionine cycle (which feeds methylation reactions across the body) and for myelin maintenance in nerve tissue.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a high-dose dedicated CoQ10, see \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg Maximum Strength\u003c\/a\u003e — particularly if you're on a statin.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 3 — Antioxidant defense (Vitamins C + E)\u003c\/h3\u003e\n\u003cp\u003eThe mitochondria are the cell's biggest source of reactive oxygen species. Even healthy mitochondria leak about 1–2% of the electrons they handle as superoxide. The body uses a layered defense:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin C\u003c\/strong\u003e — water-soluble, scavenges radicals in the cytoplasm and plasma, regenerates oxidized Vitamin E back to its active form (Packer 1979, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E (mixed tocopherols)\u003c\/strong\u003e — fat-soluble, sits inside the lipid bilayer of the cell membrane and the inner mitochondrial membrane, stops the chain reaction of lipid peroxidation that propagates membrane damage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a maximum-absorption Vitamin C focus, see \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e. The C in this 5-in-1 is the dose needed to support collagen synthesis and antioxidant recycling — the liposomal product is for people who want a dedicated 1000 mg high-bioavailability single ingredient on top.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 4 — Collagen-synthesis cofactors\u003c\/h3\u003e\n\u003cp\u003eThis is the system most \"longevity\" formulas miss entirely. Vitamin C is non-substitutable as the cofactor for prolyl-4-hydroxylase and lysyl-hydroxylase — the enzymes that hydroxylate proline and lysine residues in pre-procollagen, which is the step that lets three procollagen strands wind into a stable triple-helix (Myllyharju 2003, \u003cem\u003eMatrix Biology\u003c\/em\u003e). Skin, tendons, ligaments, blood vessels, bone matrix all depend on this. Subclinical Vitamin C insufficiency degrades collagen recovery long before frank scurvy appears.\u003c\/p\u003e\n\u003cp\u003eIf you're stacking a dedicated collagen peptide with this 5-in-1, you've covered both sides — the peptide supplies the amino-acid bricks, the Vitamin C in this formula supplies the crosslinking-enzyme cofactor. See \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti-Collagen Peptides Powder\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eSystem 5 — Skin hydration (HA support)\u003c\/h3\u003e\n\u003cp\u003eNative dermal hyaluronic acid drops by roughly half between ages 40 and 70 (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Oral HA precursors raise dermal HA over 8–12 weeks (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e). For a dedicated 200 mg HA + 100 mg Vitamin C SKU at full trial-dose strength, see \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHA 200 mg + Vitamin C\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eHow the 5 systems integrate — the biochemistry maths\u003c\/h2\u003e\n\u003cp\u003eThis is the section most \"complete formula\" pages skip, because the integration is what justifies a five-system bundle in the first place. The five systems aren't five independent benefits — they're \u003cem\u003efive layers of one cellular energy and structural-protein chain\u003c\/em\u003e. The maths tells you why missing any one of them blunts the effect of the other four.\u003c\/p\u003e\n\n\u003ch3\u003e1. The NAD+ ceiling — and why the precursor dose alone isn't the constraint\u003c\/h3\u003e\n\u003cp\u003eNAD+ functions as both a redox cofactor and a substrate consumed by sirtuins, PARPs, and CD38. Tissue NAD+ concentrations sit roughly in the 200–500 µM range in healthy young adults and drop measurably with age (Massudi 2012, \u003cem\u003ePLoS One\u003c\/em\u003e; Cantó \u0026amp; Auwerx 2012, \u003cem\u003ePharmacol Rev\u003c\/em\u003e; Imai \u0026amp; Guarente 2014, \u003cem\u003eTrends Cell Biol\u003c\/em\u003e). SIRT1 has a reported Km for NAD+ of ~100–200 µM (Cantó 2012); SIRT3 (mitochondrial) and SIRT6 (chromatin) have similar mid-µM Km values (Kanfi 2012, \u003cem\u003eNature\u003c\/em\u003e). Translation: when intracellular NAD+ falls into the lower end of that range, sirtuin \u003cem\u003eactivity\u003c\/em\u003e falls non-linearly even before NAD+ becomes \"deficient.\" Adding precursors raises the pool — but only if the salvage and de-novo enzymes (NMNAT1\/2\/3, NRK1\/2, NAPRT) have the cofactors they need. Several of those cofactors are B-complex vitamins. So a precursor dose without B-complex support is a partial intervention; this 5-in-1 closes that loop.\u003c\/p\u003e\n\n\u003ch3\u003e2. ATP-per-glucose accounting — what the B-complex actually buys you\u003c\/h3\u003e\n\u003cp\u003eComplete oxidation of 1 glucose molecule yields roughly 30–32 ATP (the textbook number is 36–38; the corrected number accounts for the ATP cost of mitochondrial transport — Hinkle 2005, \u003cem\u003eBiochim Biophys Acta\u003c\/em\u003e). The breakdown:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eGlycolysis: \u003cstrong\u003e2 ATP\u003c\/strong\u003e net (substrate-level phosphorylation), plus 2 NADH that feed the electron transport chain.\u003c\/li\u003e\n  \u003cli\u003ePyruvate → Acetyl-CoA (the \"gate\" into the TCA cycle): \u003cstrong\u003e2 NADH\u003c\/strong\u003e per glucose. \u003cem\u003eRequires B1 (thiamine pyrophosphate), B2 (FAD), B3 (NAD+), B5 (CoA), and lipoic acid\u003c\/em\u003e. Without B1 specifically, this step fails — Wernicke's encephalopathy is the clinical end-state.\u003c\/li\u003e\n  \u003cli\u003eTCA cycle: \u003cstrong\u003e2 ATP \/ GTP\u003c\/strong\u003e + 6 NADH + 2 FADH2 per glucose. \u003cem\u003eRequires B1, B2, B3, B5, B6 — every step uses one of them\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003eElectron transport chain + ATP synthase: \u003cstrong\u003e~26–28 ATP\u003c\/strong\u003e per glucose, generated when NADH (Complex I) and FADH2 (Complex II) feed electrons through the chain. \u003cem\u003eRequires CoQ10 (between Complex I\/II and III), B2 (FAD prosthetic group on Complex II), and B3 (NAD+ pool feeding Complex I)\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat that means in plain English: if you raise NAD+ but the B-complex cofactors are insufficient, your cell has fuel but no fuel pump. The 5-in-1 design is to raise NAD+ \u003cem\u003eand\u003c\/em\u003e supply the cofactors that turn that NAD+ into actual ATP. Houtkooper 2010 (\u003cem\u003eEndocrine Rev\u003c\/em\u003e) reviewed the integration of NAD+, sirtuins, and mitochondrial cofactors as one circuit rather than three separate ones; this formula is built on that view.\u003c\/p\u003e\n\n\u003ch3\u003e3. The Vitamin C \/ Vitamin E redox couple — stoichiometric regeneration\u003c\/h3\u003e\n\u003cp\u003eVitamin E (α-tocopherol) sits in the lipid bilayer and intercepts peroxyl radicals during lipid peroxidation. When it does, it becomes the α-tocopheroxyl radical — itself a mild oxidant. Vitamin C (ascorbate) regenerates α-tocopherol from the tocopheroxyl radical at a 2:1 stoichiometry (one ascorbate molecule, two electrons donated, gives one regenerated tocopherol; Packer 1979, \u003cem\u003eNature\u003c\/em\u003e; Niki 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e). The dehydroascorbate produced is then recycled back to ascorbate by glutathione (which itself depends on the precursor pool covered by other products in the catalog — see \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-glutathione-precursor\"\u003eNAC 600 mg\u003c\/a\u003e). This is why supplementing only Vitamin E without Vitamin C is leaky — the tocopheroxyl radical accumulates and can act as a pro-oxidant. Both together is the design.\u003c\/p\u003e\n\n\u003ch3\u003e4. Collagen synthesis — Vitamin C is rate-limiting, and the maths tell you the ceiling\u003c\/h3\u003e\n\u003cp\u003eOne mature collagen fibril is built from procollagen molecules, each of which is a triple-helix of three polypeptide chains, each chain ~1,000 amino acids long, with hydroxyproline at roughly every third Y-position in the Gly-X-Y repeat. That's on the order of \u003cstrong\u003e~300–400 hydroxyproline residues per polypeptide chain × 3 chains ≈ 900–1,200 hydroxylation reactions per procollagen molecule\u003c\/strong\u003e — every one of which requires prolyl-4-hydroxylase, every one of which consumes one O₂, one α-ketoglutarate, and one Fe²⁺, and every one of which requires ascorbate to keep that Fe²⁺ from being oxidized to Fe³⁺ (which inactivates the enzyme; Myllyharju 2003, \u003cem\u003eMatrix Biology\u003c\/em\u003e). Lysyl-hydroxylation adds a similar requirement for the crosslinking step. Translation: collagen synthesis is a high-flux Vitamin C consumer. Skin and connective-tissue turnover continually depletes plasma ascorbate. The collagen-synthesis-cofactor function isn't an aside — it's why scurvy presents as a structural-protein collapse before it presents as anything else.\u003c\/p\u003e\n\n\u003ch3\u003e5. Hyaluronic acid — turnover speed sets the dose-response timeline\u003c\/h3\u003e\n\u003cp\u003eHA is a glycosaminoglycan polymer of repeating glucuronic-acid + N-acetylglucosamine disaccharide units, sometimes 10,000–25,000 units long, total molecular weight up to ~10 million Da (Stern 2007, \u003cem\u003eEur J Cell Biol\u003c\/em\u003e). Total body HA in a 70 kg adult is roughly 15 g, and turns over with a half-life of ~1 day in skin, ~3–5 minutes in plasma, and as long as several weeks in cartilage (Fraser 1997, \u003cem\u003eJ Intern Med\u003c\/em\u003e). The skin half-life is what makes oral HA dose-response visible — skin is the most rapidly remodeling HA depot, which is why the trial-readout windows for oral HA (Kawada 2014, \u003cem\u003eNutr J\u003c\/em\u003e; Oe 2017, \u003cem\u003eClin Cosmet Investig Dermatol\u003c\/em\u003e) come in at 8–12 weeks. Faster than that and you're seeing measurement noise; slower and the substrate ceiling has already saturated.\u003c\/p\u003e\n\n\u003ch3\u003eThe integration in one sentence\u003c\/h3\u003e\n\u003cp\u003eRaise NAD+ (Systems 1) → it gets used as a coenzyme on the ETC and a substrate by sirtuins → which only works if CoQ10 + B-complex are present (System 2) → the resulting ATP and the resulting ROS are buffered by the C\/E redox couple (System 3) → which also supplies the rate-limiting cofactor for collagen synthesis (System 4) → which integrates with the HA-substrate layer (System 5) to give the structural-protein and skin-hydration outputs the user actually sees in the mirror. Every link in that chain depends on the prior link being supplied. That's the formula's logic.\u003c\/p\u003e\n\n\u003ch2\u003eCross-references to the Protocol collections\u003c\/h2\u003e\n\u003cp\u003eIf you want to dig deeper on any one of the five systems, the catalog has dedicated collections that cover the wider product set for each layer:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 1 (NAD+ precursors):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/nmn\"\u003eNMN Supplements collection\u003c\/a\u003e. Single-ingredient ceiling-dose options, NR alternatives, liposomal\/liquid format options, and the CD38-inhibitor add-ons (Apigenin, Quercetin) that protect the NAD+ pool from degradation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 2 (Mitochondrial cofactors):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e. Standalone CoQ10 at 400 mg, PQQ for biogenesis (PGC-1α — Chowanadisai 2010, \u003cem\u003eJ Biol Chem\u003c\/em\u003e), Urolithin A for mitophagy (PINK1\/Parkin — Andreux 2019, \u003cem\u003eNat Metab\u003c\/em\u003e), and CaAKG as TCA-cycle substrate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 3 (Antioxidant defense):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/antioxidants\"\u003eAntioxidants collection\u003c\/a\u003e. Glutathione precursors (NAC), Astaxanthin (membrane-spanning), Liposomal Vitamin C at 1000 mg, and the SOD\/catalase-supporting cofactors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 4 (Collagen-synthesis cofactors):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/collagen\"\u003eCollagen Supplements collection\u003c\/a\u003e for the substrate side (marine + multi-collagen), plus \u003ca href=\"\/he\/collections\/skin-protocol\"\u003eSkin Protocol collection\u003c\/a\u003e for the integrated stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSystem 5 (Skin hydration \/ HA support):\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging collection\u003c\/a\u003e. Standalone HA at 200 mg with Vitamin C, Biotin for keratin synthesis, and the integrated beauty stacks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCross-system framework:\u003c\/strong\u003e \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e for the catalog-wide foundational set, \u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science\u003c\/a\u003e for the López-Otín 2023 Hallmarks-of-Aging framework that organizes the catalog by mechanism layer, and \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e for stacks built around specific goals (Cellular Longevity, Beauty \u0026amp; Skin, Fertility, Cardiovascular, Brain \u0026amp; Cognitive, Metabolic).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003ch2\u003eOne-bottle vs multi-bottle stack — which to pick\u003c\/h2\u003e\n\u003cp\u003eThis is the most common honest question we get about the 5-in-1, so we'll answer it directly:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePick this if:\u003c\/strong\u003e you want simplicity, you're new to longevity supplementation, you want to cover beauty + longevity in one purchase, you're traveling and don't want a kit of bottles, or you've tried multi-bottle stacks before and stopped because the routine got unmanageable.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePick the multi-bottle stack if:\u003c\/strong\u003e you want maximum dose of any specific compound (e.g. 1000 mg NMN, 600 mg Resveratrol, 400 mg CoQ10), have specific goals (just metabolic health → Berberine; just skin → HA + collagen; just NAD+ ceiling → NMN 1000), or already know which pathways you want to push hardest.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOr both:\u003c\/strong\u003e some customers take this 5-in-1 as the daily baseline and add one or two single-ingredient products to push specific pathways harder. That's a reasonable middle path — the 5-in-1 covers the breadth, the standalone covers the depth where it matters most for their goal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe dedicated single-ingredient products in our catalog:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg\u003c\/a\u003e — for maximum NAD+ precursor dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e — for sirtuin (SIRT1) activation. Not in this 5-in-1 formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg Maximum Strength\u003c\/a\u003e — for high-dose mitochondrial support, especially on statins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e — high-dose, high-absorption antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHA 200 mg + Vitamin C\u003c\/a\u003e — full trial-dose hydration support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg (CaAKG)\u003c\/a\u003e — TCA-cycle substrate + epigenetic-clock cofactor (TET\/JmjC demethylases). Not in this 5-in-1.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e — AMPK pathway, glucose metabolism. Not in this 5-in-1.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a full picture of how to layer single-ingredient products on top of (or instead of) a one-bottle baseline, see our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere the 5-in-1 sits in the NAD+ family\u003c\/h2\u003e\n\u003cp\u003eThe NAD+ family in our catalog covers different parts of the NAD+ landscape. None of them are redundant — they each solve a different problem:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThis 5-in-1\u003c\/strong\u003e — NAD+ precursors plus the mitochondrial \/ antioxidant \/ collagen \/ skin systems they feed. \u003cem\u003eBest for people who want one bottle covering breadth.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePure NMN 500 mg\u003c\/strong\u003e — single-ingredient, dose-focused. \u003cem\u003eBest for trial-dose NMN at moderate strength.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN 1000 mg Double Strength\u003c\/strong\u003e — same compound, ceiling dose. \u003cem\u003eBest for the upper end of the published NMN dose-response curve.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ Daily Boost Capsules (Direct NAD+ + Trans-Resveratrol)\u003c\/strong\u003e — direct NAD+ molecule plus SIRT1 activator co-formulated. \u003cem\u003eBest for people who want NAD+ without going through the precursor pathway.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/strong\u003e — encapsulated for higher bioavailability. \u003cem\u003eBest for non-responders to standard NAD+ precursors.\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid NAD+ Anti-Aging Drink\u003c\/strong\u003e — drink-format, stick packets. \u003cem\u003eBest for capsule-fatigue or travel.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 30+ wanting a comprehensive longevity-and-beauty baseline without research-paralysis.\u003c\/li\u003e\n  \u003cli\u003ePeople starting their first longevity protocol who want one product to take consistently before deciding what to add or replace.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose previous attempts at multi-bottle stacks ended with most bottles sitting unused — format compliance is real, and three months of consistent breadth beats two weeks of \"perfect\" depth.\u003c\/li\u003e\n  \u003cli\u003eTravelers — single bottle covers most of the protocol when you're on the road.\u003c\/li\u003e\n  \u003cli\u003ePeople on statins (combined with our dedicated \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e if statin-induced CoQ10 depletion is a specific concern).\u003c\/li\u003e\n  \u003cli\u003ePeople in their 30s and 40s who want to build a longevity habit without committing to a 6-bottle daily routine before they know which pieces matter most for their body.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePeople who already know they need a maximum-dose single-ingredient — e.g. 1000 mg NMN for cycling around a known dose-response, or 400 mg CoQ10 specifically for statin-induced depletion. Pick the standalone instead.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known sensitivity to niacin flush — if you flush at 50 mg of niacin you'll feel the dose in this product. Niacinamide-only products avoid the flush; let us know if you want a redirect.\u003c\/li\u003e\n  \u003cli\u003ePregnant or breastfeeding women — limited safety data on combined longevity stacks during pregnancy. Consult your OB before starting.\u003c\/li\u003e\n  \u003cli\u003eAnyone on chemotherapy or being treated for cancer — discuss with your oncologist; some longevity pathways (sirtuin, AMPK, NAD+) interact in non-trivial ways with cancer biology and treatment timing.\u003c\/li\u003e\n  \u003cli\u003ePeople with known kidney or liver disease — review with your physician before any new supplement stack.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–14:\u003c\/strong\u003e usually subtle. Multiple pathways activating simultaneously builds gradually rather than dramatically. Don't expect a \"feel\" the first week — feel-effects are not how this category works.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, improved exercise recovery, nail strength often the first cosmetic signal (B-vitamins + collagen-synthesis cofactor compound).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e mental clarity, exercise recovery, hydration improvements compound. Skin tends to look more even by the 6-week mark.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e visible skin and hair improvements; sustained NAD+ and antioxidant support. The HA + Vitamin C + B-complex combination starts to show in skin texture around 8–12 weeks (matching the Proksch 2014 collagen-trial timeline + Kawada 2014 HA-trial timeline).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3+:\u003c\/strong\u003e long-term anti-aging mechanisms compound with continued daily use. The NAD+ effect on energy and the collagen\/HA effect on skin both have a \"compound\" quality — the curve flattens but doesn't reverse if you keep taking it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e the NAD+ pool returns to baseline within 1–2 weeks (the salvage pathway is dynamic). Skin\/hair benefits regress over 8–12 weeks (the structural protein turnover timescale).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eStacking with this product\u003c\/h2\u003e\n\u003cp\u003eThe 5-in-1 is designed to be a complete daily baseline. If you want to push specific pathways harder while keeping the breadth, common add-ons are:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Resveratrol\u003c\/strong\u003e — for stronger sirtuin (SIRT1) activation. Resveratrol is the SIRT1 piece this 5-in-1 doesn't include. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Berberine\u003c\/strong\u003e — if metabolic health is a goal (the AMPK pathway, not in this formula). Pairs naturally with NAD+ precursors. \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg Maximum Strength\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Marine Collagen\u003c\/strong\u003e — if you want stronger skin\/hair structural support beyond the synthesis cofactors. The Vitamin C in this 5-in-1 is the cofactor; marine peptides are the substrate. \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ TMG (Trimethylglycine)\u003c\/strong\u003e — methyl donor that recycles homocysteine. Worth considering if you're at the higher dose end of NMN\/NAD+ supplementation, since NAD+ metabolism uses methyl groups. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ CaAKG\u003c\/strong\u003e — substrate for the TCA cycle and the epigenetic-clock demethylases (TET\/JmjC). The 5-in-1 covers the NAD+ pool and the cofactors; CaAKG covers the substrate side and the epigenetic-remodeling layer. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate 1000 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Apigenin\u003c\/strong\u003e — CD38 inhibitor that slows NAD+ degradation, complementing the precursor strategy in the 5-in-1. \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ Magnesium Glycinate\u003c\/strong\u003e — universal cofactor across \u0026gt;300 enzymatic reactions; deficiency is common and silently undermines the rest of the stack. \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003cp\u003eTake 2 capsules daily with breakfast. Several ingredients (Vitamin E, CoQ10) absorb materially better with meal fat — eggs, avocado, nut butter on toast, full-fat yogurt, olive oil on the salad all work. Daily consistency matters more than dose timing for this category — pick the time of day you're most likely to be reliable.\u003c\/p\u003e\n\u003cp\u003eFor more on supplement timing, see \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eour timing guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule (per serving = 2 capsules)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ precursor blend\u003c\/strong\u003e — NMN + Niacin (B3) at moderate breadth-formula doses (full per-ingredient amounts on the supplement-facts panel; no proprietary blends).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 (Ubiquinone)\u003c\/strong\u003e — for electron transport chain support.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFull B-complex\u003c\/strong\u003e — B1 (Thiamine), B2 (Riboflavin), B5 (Pantothenic acid), B6 (Pyridoxal-5-phosphate \/ P5P), B12 (Methylcobalamin).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin C\u003c\/strong\u003e — collagen-synthesis cofactor + antioxidant + Vitamin E recycling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin E\u003c\/strong\u003e — mixed tocopherols, lipid-membrane antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHyaluronic Acid precursors\u003c\/strong\u003e — for skin-hydration support.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eVegetarian capsule (HPMC). No artificial colors, no proprietary blends, no fillers beyond the capsule shell. Third-party tested for purity.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in cGMP-certified facilities. Third-party tested for heavy metals (lead, arsenic, cadmium, mercury), microbial limits, and active ingredient potency. Certificate of Analysis available on request. Store in a cool, dry place; keep the bottle sealed when not in use.\u003c\/p\u003e\n\n\u003ch2\u003eSafety \u0026amp; cautions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNiacin flush:\u003c\/strong\u003e if you're flush-sensitive, take with food and start with 1 capsule for the first 3–5 days, scale to 2.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin K-related anticoagulation:\u003c\/strong\u003e this formula does not contain Vitamin K, but if you're on warfarin, review any new supplement with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e not recommended without OB clearance — limited data on combined longevity stacks during pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer treatment:\u003c\/strong\u003e discuss with your oncologist before starting — sirtuin\/AMPK\/NAD+ pathways have non-trivial interactions with cancer biology and chemotherapy timing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKidney or liver disease:\u003c\/strong\u003e review the full ingredient panel with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e stop 1–2 weeks before any planned surgery (precautionary; some longevity actives can affect bleeding or anesthesia metabolism).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e if you're on metformin, statins, blood thinners, blood-pressure medication, antidepressants, or chemotherapy, review with your physician.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy isn't Resveratrol in the formula?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eResveratrol is fat-soluble and benefits from a different formulation strategy (often piperine for absorption, oil delivery for bioavailability), and the dose-response data is strongest at 250–600 mg\/day — which is too large to fit alongside five other systems in two capsules. We kept Resveratrol as a dedicated standalone (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600 mg\u003c\/a\u003e) and built the 5-in-1 around the NAD+\/mitochondrial\/antioxidant\/collagen\/HA stack instead. Many customers take both — the 5-in-1 as the daily baseline, Resveratrol added on top for SIRT1 activation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I still benefit from this if I'm already taking standalone NMN?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes, and there are two ways customers handle it. Option A: replace the standalone NMN with this 5-in-1 to consolidate. Option B: keep the standalone NMN for the higher dose ceiling and add this 5-in-1 for the breadth (CoQ10 + B-complex + antioxidants + collagen cofactor + HA). The B-vitamins, CoQ10, and HA in this product don't overlap with NMN's NAD+ precursor function — they cover entirely different systems.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy two capsules instead of one?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe five systems together require more material than will physically fit in one standard capsule shell. Splitting across two also gives slightly more even absorption across the meal window. Take both at once — you don't need to space them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow does this compare to a multivitamin?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA standard multivitamin is built around recommended-daily-allowance (RDA) doses to prevent deficiency. This formula is built around longevity-and-beauty doses — NMN and CoQ10 are not in standard multivitamins, and the B-complex, Vitamin C, Vitamin E, and HA are at functional doses, not RDA-floor doses. A multivitamin and this 5-in-1 cover different problems; some customers take both.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with coffee?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Coffee doesn't materially impair absorption of any of the actives in this formula. Take with breakfast (the meal fat helps with the fat-soluble actives) and have your coffee with or after — whichever you prefer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this contain caffeine?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo. The \"easier mornings, steadier afternoon energy\" effect is from mitochondrial cofactors and NAD+ support, not stimulants. Customers often report that they cut their afternoon coffee 4–8 weeks in — that's a downstream signal, not a caffeine effect.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I see something?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor energy and morning quality: typically 2–4 weeks. For nail and hair: 4–8 weeks. For visible skin texture: 8–12 weeks (this matches the published collagen-trial and HA-trial timelines — Proksch 2014, Kawada 2014). Longevity actives (NAD+ pool, mitochondrial cofactors) work silently for the first month before downstream effects compound.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsules and put the powder in a smoothie?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot recommended. Some of the actives (Vitamin E, NMN, CoQ10) degrade in the presence of light and oxygen — the capsule shell is part of the delivery design. Take the capsules whole.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe capsule shell is vegetarian (HPMC, plant-derived). Confirm the full active panel against your dietary needs — full ingredient list is on the supplement-facts panel.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about cycling — should I take breaks?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe published longevity-trial protocols mostly use continuous daily dosing without cycling. There's no evidence cycling helps. The longevity benefits come from sustained signaling, not pulsed signaling — keep it daily and consistent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan men take this?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eYes. Despite the skin\/hair language being more often associated with women's products, all five systems in this formula apply to male physiology in the same way — NAD+ decline, mitochondrial decline, antioxidant balance, collagen synthesis (joints, tendons, skin), and HA loss are universal aging biology.\u003c\/p\u003e\n\n\u003ch2\u003eRead more\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eWhen to take NMN — timing \u0026amp; absorption guide\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements — practical protocol for 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eTrue Health Protocols (Cellular Longevity, Beauty \u0026amp; Skin, Fertility, etc.)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full NAD+ Family: \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e · Browse Longevity Essentials: \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003e\/collections\/longevity-essentials\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47698106974426,"sku":"THP-NAD-5IN1","price":24.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-5in1.jpg?v=1775666078"},{"product_id":"rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging","title":"Nicotinamide Capsules","description":"\u003cp\u003e\u003cstrong\u003eNicotinamide Riboside (NR) in hard capsule form\u003c\/strong\u003e — the patented NAD+ precursor with the deepest human research track record (65+ registered clinical trials, including pharmacokinetic, cardiovascular, and neurological endpoints). Supported by B-vitamin cofactors so the full NAD+ biosynthesis pathway has what it needs to convert NR into NAD+ inside the cell.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR is the most-studied NAD+ precursor in humans.\u003c\/strong\u003e First-in-human pharmacokinetic data published in 2016 (Trammell et al., \u003cem\u003eNature Communications\u003c\/em\u003e) showed a single oral dose raised whole-blood NAD+ ~2.7× over 24 hours. Multi-week dosing at 1 g\/day has been studied in healthy adults, midlife adults with elevated blood pressure, obese insulin-resistant adults, post-menopausal women, NAFLD patients, ALS patients, and Parkinson's patients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDifferent intracellular path than NMN.\u003c\/strong\u003e NR enters cells via the equilibrative nucleoside transporters (ENT1\/2), gets phosphorylated by NRK1\/NRK2 to NMN, then converted to NAD+. NMN uses the Slc12a8 transporter (Grozio 2019, \u003cem\u003eNature Metabolism\u003c\/em\u003e) and skips a step. Both raise NAD+; tissue coverage and intracellular kinetics differ, which is why many longevity stacks run both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who want the longest human-research track record, those who didn't feel a clear shift on NMN alone, anyone running a comprehensive NAD+ stack that hedges across both precursor pathways, and adults 50+ where the NMN transporter Slc12a8 may be downregulated in some tissues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake 1–2 capsules daily\u003c\/strong\u003e in the morning with food. Daily consistency matters more than time-of-day. Stacks cleanly with NMN, Resveratrol, Pterostilbene, TMG, Apigenin, Quercetin, Fisetin, CoQ10, PQQ, and Urolithin A.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented NR form,\u003c\/strong\u003e the same molecule used in Trammell 2016, Martens 2018, Dollerup 2018, Conze 2019, Elhassan 2019, and Brakedal 2022. Manufactured to cGMP, third-party HPLC-tested, encapsulated in a vegan-compatible hard shell with no proprietary blends, no titanium dioxide, no artificial colors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NR sits at the center of the NAD+ conversation\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is the single most metabolically expensive coenzyme in the cell. Every major energy-producing pathway — glycolysis, the citric acid cycle, the electron transport chain, fatty-acid oxidation — runs on NAD+\/NADH cycling. On top of that core role, NAD+ is the rate-limiting substrate for at least three enzyme families that get talked about in the longevity literature constantly: the sirtuins (SIRT1–SIRT7, the histone-deacetylase \/ mitochondrial regulators activated by Resveratrol), the PARPs (PARP1 in particular, the primary single-strand DNA break repair enzyme), and CD38 (the NAD+ glycohydrolase that becomes hyperactive with inflammaging). When NAD+ falls, all three of those families slow down at the same time — and that simultaneity is why \"NAD+ decline\" gets called a hallmark of aging in the López-Otín 2013 \/ 2023 \u003cem\u003eCell\u003c\/em\u003e framework, even though it isn't formally one of the 12.\u003c\/p\u003e\n\u003cp\u003eThe decline itself is not subtle. Massudi 2012 (\u003cem\u003ePLOS One\u003c\/em\u003e) measured skin NAD+ across the lifespan and found a roughly 50% drop between ages 20 and 60. Camacho-Pereira 2016 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated the finding in muscle and liver and showed CD38 — which consumes NAD+ to make calcium-mobilizing second messengers — rises sharply with age, partially explaining the drop. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) showed similar declines in pancreas, adipose tissue, and the hypothalamus in mice. Across tissues, mechanisms, and species, the NAD+ pool collapses with age — and the sirtuin \/ PARP \/ CD38 enzymes that depend on it lose their substrate.\u003c\/p\u003e\n\u003cp\u003eYou can address that decline from three directions:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupply more precursor\u003c\/strong\u003e — give the cell more raw material to make NAD+ from. \u003cstrong\u003eNR and NMN\u003c\/strong\u003e are the two patented, trial-validated levers in this category. Niacin (NA) and niacinamide (NAM) also raise NAD+ but flush, suppress sirtuins at high doses, and lack the modern human evidence base.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eReduce NAD+ consumers\u003c\/strong\u003e — slow down the enzymes that destroy it. \u003cstrong\u003eApigenin\u003c\/strong\u003e inhibits CD38 directly. \u003cstrong\u003eQuercetin\u003c\/strong\u003e and \u003cstrong\u003eFisetin\u003c\/strong\u003e clear senescent cells, which overconsume NAD+ via SASP-driven CD38 expression in neighboring cells.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActivate the enzymes that use NAD+ productively\u003c\/strong\u003e — get more longevity output per unit of NAD+. \u003cstrong\u003eResveratrol\u003c\/strong\u003e and \u003cstrong\u003ePterostilbene\u003c\/strong\u003e activate SIRT1; \u003cstrong\u003espermidine\u003c\/strong\u003e activates the autophagy machinery that sirtuins help regulate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eNR is the most-validated supply-side lever in humans, and it pairs cleanly with all three of the other strategies. That is why it lives in almost every well-designed longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — what NR actually does inside the cell\u003c\/h2\u003e\n\n\u003ch3\u003e1. The NRK1\/NRK2 phosphorylation pathway\u003c\/h3\u003e\n\u003cp\u003eNR is a riboside — a vitamin B3 (nicotinamide) attached to a ribose sugar without a phosphate group. That structure matters for two reasons. First, it is the only NAD+ precursor that crosses the plasma membrane intact via a well-characterized transporter family: the equilibrative nucleoside transporters ENT1 and ENT2, which are present in essentially every tissue type (Bieganowski \u0026amp; Brenner 2004, \u003cem\u003eCell\u003c\/em\u003e). Second, once inside the cell, it gets phosphorylated to NMN by NRK1 (nicotinamide riboside kinase 1) or NRK2. NRK1 is the housekeeping enzyme — broadly distributed, induced by NAD+ depletion, and the rate-limiting step that determines how much NR actually becomes NAD+ in any given tissue (Ratajczak 2016, \u003cem\u003eNat Commun\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eFrom NMN, the route is canonical: NMNAT1\/2\/3 (nicotinamide mononucleotide adenylyltransferase) attaches the AMP moiety to make NAD+. NMNAT1 lives in the nucleus, NMNAT2 in the cytoplasm and Golgi, NMNAT3 in the mitochondrial matrix. That compartmentalization matters — NMNAT3 is the enzyme that decides how much of your NAD+ pool is mitochondrial, which is why mitochondrial sirtuins (SIRT3\/4\/5) and mitochondrial NAD+\/NADH cycling depend on getting precursor across the inner membrane. NR's ribose-only structure means it can be phosphorylated in any compartment that has NRK1\/2, including the mitochondrion via the SLC25A51 mitochondrial NAD+ transporter that was characterized in 2020 (Luongo, \u003cem\u003eNature\u003c\/em\u003e).\u003c\/p\u003e\n\u003cp\u003eThat two-step intracellular path (NR → NMN → NAD+) is one step longer than the NMN route but uses ubiquitous, redundant machinery (ENT1\/2, NRK1\/NRK2), which is why NR's tissue coverage is broad even when local Slc12a8 (the NMN transporter) is low.\u003c\/p\u003e\n\n\u003ch3\u003e2. Sirtuin substrate, PARP cofactor, and CD38 substrate — the three NAD+ sinks\u003c\/h3\u003e\n\u003cp\u003eOnce converted to NAD+, the molecule is consumed (not just used and recycled) by three enzyme families:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuins (SIRT1–SIRT7).\u003c\/strong\u003e NAD+-dependent deacetylases. SIRT1 in the nucleus deacetylates p53, FOXO, PGC-1α, and the histone tails that regulate metabolic, DNA-repair, and longevity gene programs. SIRT3 in the mitochondrion deacetylates the fatty-acid oxidation, urea-cycle, and ROS-detoxification machinery. SIRT6 stabilizes telomeres and regulates DNA double-strand break repair. Every catalytic cycle consumes one NAD+ and produces nicotinamide as a byproduct. The \"salvage pathway\" recycles that nicotinamide, but only at the rate set by NAMPT — which is why precursor supply (NR\/NMN) matters even when salvage is intact.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePARP1 (and PARP2).\u003c\/strong\u003e Poly-ADP-ribose polymerases. The primary single-strand DNA break repair enzyme attaches long chains of ADP-ribose to chromatin proteins at sites of damage, recruiting the repair machinery. Each chain consumes 50–200+ NAD+ molecules. When DNA damage is high — oxidative stress, radiation, chemotherapy, chronic inflammation — PARP activity can crash the NAD+ pool acutely. Restoring precursor supply is the first-line metabolic countermeasure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38.\u003c\/strong\u003e The NAD+ glycohydrolase that converts NAD+ to ADP-ribose \/ cyclic ADP-ribose for calcium signaling. CD38 expression rises with age and inflammation (Camacho-Pereira 2016) and contributes more to NAD+ decline in older tissue than any other enzyme. CD38 inhibition (Apigenin, Luteolin, 78c in animal studies) is the second supply-side strategy and pairs neatly with precursor supplementation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNR is the substrate at the start of that chain. Increase NR → increase NAD+ → increase the substrate available for sirtuin \/ PARP \/ CD38 activity. The decisive evidence that this happens in humans, not just cells in a dish, is the Trammell 2016 pharmacokinetic study and the trials that followed.\u003c\/p\u003e\n\n\u003ch3\u003e3. The cardiovascular and aortic-stiffness signal\u003c\/h3\u003e\n\u003cp\u003eMartens 2018 (\u003cem\u003eNature Communications\u003c\/em\u003e) gave 30 midlife and older adults with elevated systolic blood pressure (120–139 mmHg) NR 1 g\/day or placebo for 6 weeks in a randomized crossover. NR raised whole-blood NAD+ ~60% on average. In the elevated-BP subgroup, systolic BP fell ~10 mmHg vs placebo and aortic stiffness (measured by carotid-femoral pulse wave velocity) decreased — the same readouts that track with cardiovascular event risk in epidemiologic cohorts. The trial was small and short, but the magnitudes were large enough to motivate the multiple Phase III NR cardiovascular trials currently in registration. The mechanistic interpretation is sirtuin (SIRT1\/SIRT3)-mediated improvements in endothelial function and vascular smooth muscle bioenergetics — exactly what you would predict from the precursor-supply rationale.\u003c\/p\u003e\n\n\u003ch3\u003e4. The Parkinson's NADPARK signal\u003c\/h3\u003e\n\u003cp\u003eBrakedal 2022 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) — the NADPARK trial — gave 30 newly diagnosed Parkinson's patients NR 1 g\/day or placebo for 30 days and measured cerebrospinal fluid (CSF) NAD+ via lumbar puncture and brain NAD+ via 31P-MRS. CSF and brain NAD+ rose, neuroinflammatory markers (IL-6, IL-8, several CSF cytokines) shifted favorably, and clinical motor scores showed mild but measurable improvements vs placebo. The trial was small and short, but it was the first human study to demonstrate that oral NR raises brain NAD+ — a finding that matters for the broader hypothesis that NAD+ decline contributes to multiple neurodegenerative disease processes. The follow-up NR-SAFE trial (Brakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e) extended the dosing safely to 3 grams\/day for 4 weeks. Larger NR-PD trials are ongoing.\u003c\/p\u003e\n\n\u003ch3\u003e5. Inflammation, muscle, and the elderly cohort\u003c\/h3\u003e\n\u003cp\u003eElhassan 2019 (\u003cem\u003eCell Reports\u003c\/em\u003e) gave 12 healthy elderly adults (aged 70–80) NR 1 g\/day for 21 days. Muscle biopsies showed elevated NAD+ and elevated NADP+\/NADPH ratios (NADP+ is the phosphorylated form used by the antioxidant defense system). Circulating inflammatory cytokines (IL-6, IL-5, IL-2) decreased significantly. The trial established that NR's effect on muscle NAD+ is meaningful in the population that needs it most — the same population in whom CD38 expression is highest and NAD+ is lowest at baseline.\u003c\/p\u003e\n\n\u003ch3\u003e6. The 8-week dose-response in healthy overweight adults\u003c\/h3\u003e\n\u003cp\u003eConze 2019 (\u003cem\u003eScientific Reports\u003c\/em\u003e) randomized 140 healthy overweight adults to placebo, 100, 300, or 1000 mg\/day NR for 8 weeks. Whole-blood NAD+ rose dose-dependently — about 22% at 100 mg, 51% at 300 mg, and 142% at 1000 mg. Adverse events did not differ from placebo at any dose. The trial established the dose-response curve in a free-living healthy population and is the largest RCT to date in non-clinical adults. It is the basis for the 1 g\/day target dose used in subsequent cardiovascular and neurological studies.\u003c\/p\u003e\n\n\u003ch3\u003e7. Insulin sensitivity and metabolic readouts\u003c\/h3\u003e\n\u003cp\u003eDollerup 2018 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) gave 40 obese insulin-resistant men NR 2 g\/day or placebo for 12 weeks. NR raised whole-blood NAD+ but the primary insulin-sensitivity endpoint (hyperinsulinemic-euglycemic clamp) was not significantly improved at 12 weeks. The trial is often cited as a \"negative\" study, but the more accurate read is that 12 weeks at this dose did not move the specific insulin-sensitivity readout in this specific high-risk population. Other metabolic endpoints (body composition, hepatic fat by MRS) showed trends. Remie 2020 (\u003cem\u003eAm J Clin Nutr\u003c\/em\u003e) replicated the safety and NAD+ rise in another insulin-resistant cohort. The metabolic story for NR is more nuanced than the cardiovascular story; the trial-design lesson is that NAD+ rise is robust but downstream metabolic endpoints depend on cohort, baseline NAD+, and stacking strategy.\u003c\/p\u003e\n\n\u003ch3\u003e8. The methylation pool — why TMG eventually matters\u003c\/h3\u003e\n\u003cp\u003eEvery time NAD+ is consumed by a sirtuin, PARP, or CD38, it produces nicotinamide (NAM) as a byproduct. NAM is recycled through the salvage pathway by NAMPT — but a fraction is also methylated by NNMT (nicotinamide N-methyltransferase) into 1-methylnicotinamide (1-MNA) and excreted in urine. That methylation step uses S-adenosyl methionine (SAM), the universal methyl donor. Sustained high-dose NR or NMN therefore creates a small, ongoing draw on the methylation pool. For most users, dietary methyl donors (choline, betaine in beets, methylated B12 and folate from a multivitamin) cover the cost. For long-term high-dose use — and especially for users with MTHFR polymorphisms — adding \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e at 500–1000 mg\/day after 4+ weeks of daily NR\/NMN is the standard methylation-support move.\u003c\/p\u003e\n\n\u003ch3\u003e9. Why the included B-vitamin cofactors actually do something\u003c\/h3\u003e\n\u003cp\u003eThe salvage pathway uses B6 as a cofactor for nicotinamide phosphoribosyltransferase (NAMPT). The methylation cycle that disposes of excess nicotinamide via NNMT depends on B12 and folate as methyl-group donors. Including B6, B12, and folate in the capsule means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. It is not a substitute for TMG at long-term high doses, but it is a sensible structural addition that closes the most common micronutrient gaps that limit NAD+ biosynthesis efficiency. Trammell 2016 noted that in healthy participants, 1MNA (the methylated excretion product) appeared in urine within hours of dosing — confirming the methylation route is active from the first dose.\u003c\/p\u003e\n\n\u003ch2\u003eNR vs NMN — the practical decision, with mechanism\u003c\/h2\u003e\n\u003cp\u003eBoth are NAD+ precursors. Both raise NAD+ in humans. The pathway is one step different, and the practical implications are usually small but worth understanding before you commit to a stack.\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003eNicotinamide Riboside (NR)\u003c\/th\u003e\n\u003cth\u003eNMN (β-NMN)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCell entry\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eENT1\/2 (broadly expressed nucleoside transporters; ubiquitous)\u003c\/td\u003e\n\u003ctd\u003eSlc12a8 (Grozio 2019); some tissue heterogeneity in expression\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIntracellular path\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNR → NMN (NRK1\/NRK2 phosphorylation) → NAD+ (NMNAT)\u003c\/td\u003e\n\u003ctd\u003eNMN → NAD+ (NMNAT) — one step shorter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFirst-in-human PK\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e — the foundational PK paper\u003c\/td\u003e\n\u003ctd\u003eIrie 2020, \u003cem\u003eEndocr J\u003c\/em\u003e — first PK; Yoshino 2021, \u003cem\u003eScience\u003c\/em\u003e first efficacy in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCardiovascular RCT\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e — 6 weeks, BP and aortic stiffness signal\u003c\/td\u003e\n\u003ctd\u003eSmaller human cardiovascular evidence base to date\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBrain \/ CSF NAD+\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e — first human CSF NAD+ rise\u003c\/td\u003e\n\u003ctd\u003eMostly preclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eInsulin sensitivity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDollerup 2018 12-wk — neutral on clamp; Remie 2020 — neutral\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021 — improved muscle insulin sensitivity in pre-diabetic post-menopausal women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTissue coverage strength\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStrong in muscle, brain, immune (broad ENT1\/2 expression)\u003c\/td\u003e\n\u003ctd\u003eStrong in liver and pancreas (high Slc12a8)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCost per gram\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHigher (patent-licensed)\u003c\/td\u003e\n\u003ctd\u003eGenerally lower — particularly for entry-tier 500 mg products\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDaily dose range\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the trial-validated cardiovascular dose)\u003c\/td\u003e\n\u003ctd\u003e250–1000 mg (1000 mg is the Yoshino 2021 dose)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTime to whole-blood NAD+ rise\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWithin 24 hours of first dose; sustained at 8 weeks (Conze 2019)\u003c\/td\u003e\n\u003ctd\u003eWithin hours of first dose; sustained at 10 weeks (Yoshino 2021)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBest for\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLongest research depth; muscle\/brain\/immune tissue priorities; NMN non-responders; comprehensive stacks\u003c\/td\u003e\n\u003ctd\u003eCost-efficient daily entry; liver\/pancreas priorities; insulin-sensitivity cohorts; entry-tier protocols\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the practical difference is small. Many longevity protocols stack both — NMN morning, NR mid-morning — to cover both transporter families across the day. The most rigorous answer to \"which is better?\" is \"the one you take consistently for 12+ weeks alongside a SIRT1 activator and a methyl donor.\" Read our full \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR comparison\u003c\/a\u003e for the deeper decision framework.\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence — the trials that matter\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTrial\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003ePrimary readout\u003c\/th\u003e\n\u003cth\u003eResult\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrammell 2016, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=12)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg single dose\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+ over 24h\u003c\/td\u003e\n\u003ctd\u003e~2.7× rise at 1000 mg; first-in-human PK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConze 2019, \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight adults (n=140)\u003c\/td\u003e\n\u003ctd\u003e100 \/ 300 \/ 1000 mg\/day × 8 wk\u003c\/td\u003e\n\u003ctd\u003eWhole-blood NAD+; safety\u003c\/td\u003e\n\u003ctd\u003eDose-dependent rise (22% \/ 51% \/ 142%); no AE signal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMartens 2018, \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMidlife\/older adults, elevated SBP (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk crossover\u003c\/td\u003e\n\u003ctd\u003eNAD+, SBP, aortic stiffness\u003c\/td\u003e\n\u003ctd\u003eNAD+ +60%; ~10 mmHg SBP drop in elevated-BP subgroup; aortic stiffness reduced\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDellinger 2017, \u003cem\u003eNPJ Aging Mech Dis\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=120)\u003c\/td\u003e\n\u003ctd\u003e250 mg\/day NR + 50 mg pterostilbene combo × 8 wk\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003e~40% NAD+ rise; well tolerated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDollerup 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eObese insulin-resistant men (n=40)\u003c\/td\u003e\n\u003ctd\u003e2000 mg\/day × 12 wk\u003c\/td\u003e\n\u003ctd\u003eInsulin sensitivity (clamp)\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; clamp insulin-sensitivity unchanged at 12 wk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eElhassan 2019, \u003cem\u003eCell Rep\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy elderly aged 70–80 (n=12)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+; circulating cytokines\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+ rose; IL-6\/IL-5\/IL-2 decreased\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemie 2020, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy overweight men (n=13 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 6 wk\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle NAD+; metabolic endpoints\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle acetylcarnitine fell; mixed metabolic readouts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStocks 2021, \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy aged adults (n=12 crossover)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 21 d\u003c\/td\u003e\n\u003ctd\u003eSkeletal-muscle mitochondrial respiration\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; respiratory function unchanged at 21 d in healthy aged muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2022, \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n\u003ctd\u003eNewly diagnosed Parkinson's (n=30)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day × 30 d\u003c\/td\u003e\n\u003ctd\u003eCSF and brain NAD+; clinical motor scores\u003c\/td\u003e\n\u003ctd\u003eCSF\/brain NAD+ rose; neuroinflammatory markers shifted; mild motor improvement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrakedal 2023, \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n\u003ctd\u003eParkinson's (n=20)\u003c\/td\u003e\n\u003ctd\u003e3000 mg\/day × 4 wk\u003c\/td\u003e\n\u003ctd\u003eSafety, tolerability, NAD+ ceiling\u003c\/td\u003e\n\u003ctd\u003e3 g\/day well tolerated; NAD+ further elevated vs 1 g\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWang 2017, \u003cem\u003eLancet Neurol\u003c\/em\u003e commentary on Trammell + ALS rationale\u003c\/td\u003e\n\u003ctd\u003eALS \/ preclinical\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eMechanistic basis for ALS NR trials\u003c\/td\u003e\n\u003ctd\u003eEstablished the rationale for the multi-arm ALS NR trials in registration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePirinen 2020, \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eAdult mitochondrial myopathy (n=5)\u003c\/td\u003e\n\u003ctd\u003e1000 mg\/day NR × 5 mo\u003c\/td\u003e\n\u003ctd\u003eMuscle NAD+, FGF21, mitochondrial myopathy markers\u003c\/td\u003e\n\u003ctd\u003eNAD+ rose; muscle strength and FGF21 trends improved\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirhart 2017, \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eHealthy adults (n=8)\u003c\/td\u003e\n\u003ctd\u003e1000–2000 mg\/day × 9 d\u003c\/td\u003e\n\u003ctd\u003eNAD+; safety\u003c\/td\u003e\n\u003ctd\u003eSafe, well-tolerated, NAD+ rose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis is the densest human evidence base of any NAD+ precursor — pharmacokinetic, dose-response, multi-cohort, multi-endpoint, multi-organ, and consistently safe at the 1 g\/day level over 4–12 week durations. Larger Phase III cardiovascular and Parkinson's NR trials are in registration as of 2026.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — why patented NR, not just \"any NR\"\u003c\/h2\u003e\n\n\u003ctable border=\"1\" cellpadding=\"8\" cellspacing=\"0\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003eIdentity \/ form\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eHPLC purity\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride\u003c\/strong\u003e (this product)\u003c\/td\u003e\n\u003ctd\u003eCrystalline NR-Cl, the form used in every cited human trial\u003c\/td\u003e\n\u003ctd\u003e65+ registered human trials; the entire NR evidence base\u003c\/td\u003e\n\u003ctd\u003e≥98% NR by HPLC; identity confirmed by NMR \u0026amp; mass spec; trace heavy metals \u0026lt; USP \u0026lt;232\u0026gt; limits\u003c\/td\u003e\n\u003ctd\u003eAnyone who wants the trial-validated form. Default choice.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneric NR-Cl (commodity)\u003c\/td\u003e\n\u003ctd\u003eSame chemical class but variable identity \/ purity \/ impurity profile\u003c\/td\u003e\n\u003ctd\u003eNot the form used in published human trials\u003c\/td\u003e\n\u003ctd\u003eVariable; specs not always disclosed; some lots fail HPLC identity\u003c\/td\u003e\n\u003ctd\u003eCost-shoppers willing to accept identity \/ purity variance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNicotinamide (NAM) \/ niacinamide\u003c\/td\u003e\n\u003ctd\u003eThe end-product, not a precursor in the same sense\u003c\/td\u003e\n\u003ctd\u003eLong history; flushless; sirtuin-suppressing at \u0026gt;500 mg\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eSkin \/ dermatology applications, not longevity-stack NAD+ raising\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNiacin (NA, nicotinic acid)\u003c\/td\u003e\n\u003ctd\u003ePrecursor via the Preiss-Handler pathway\u003c\/td\u003e\n\u003ctd\u003eMultiple human trials (lipid use)\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003ePeople who can tolerate the flush; lipid-modification context, not longevity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNRH (dihydronicotinamide riboside)\u003c\/td\u003e\n\u003ctd\u003eReduced form; preclinical-only as of 2026\u003c\/td\u003e\n\u003ctd\u003eAnimal and cell evidence; no large human trials\u003c\/td\u003e\n\u003ctd\u003eResearch-grade only\u003c\/td\u003e\n\u003ctd\u003eResearchers; not for general consumer use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNMN (β-NMN)\u003c\/td\u003e\n\u003ctd\u003eOne step downstream of NR; uses Slc12a8\u003c\/td\u003e\n\u003ctd\u003eYoshino 2021; growing human evidence base\u003c\/td\u003e\n\u003ctd\u003ePharmaceutical-grade widely available\u003c\/td\u003e\n\u003ctd\u003eDaily entry-tier; cost-efficient; liver\/pancreas priorities — see \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThis product uses patented NR-Cl — the same crystalline form characterized in Trammell 2016 and used in every cardiovascular, neurological, and metabolic NR trial since. That matters because the published evidence base is what tells you the molecule actually raises NAD+ in human blood and tissue at the doses on the label. A commodity NR-Cl with a different impurity profile or a sub-spec HPLC identity is not what those trials studied — and you should not assume the evidence transfers.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — what the PK studies actually show\u003c\/h2\u003e\n\u003cp\u003eNR's pharmacokinetic profile is the cleanest of any NAD+ precursor in humans. Trammell 2016 traced the molecule through whole blood and urine after a single oral dose:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR appears within 30 minutes\u003c\/strong\u003e of an oral dose, peaks at ~1–2 hours, and is largely cleared from plasma by 6–8 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+ rises in parallel\u003c\/strong\u003e — the rise is detectable by 8 hours and is sustained out to 24 hours, meaning a once-daily dose covers the diurnal cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN, the intracellular intermediate, rises in tandem\u003c\/strong\u003e — the NRK1 phosphorylation step is fast enough not to be rate-limiting at 1 g\/day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1MNA (the methylated nicotinamide excretion product) rises in urine\u003c\/strong\u003e within the same window — confirming that the methylation route is active from the first dose. This is the mechanistic basis for adding TMG at long-term high doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eConze 2019 extended that single-dose PK to 8-week steady-state dosing in 140 healthy overweight adults. Steady-state whole-blood NAD+ tracked dose linearly: 22% rise at 100 mg\/day, 51% at 300 mg, 142% at 1000 mg. There was no plateau within the dose range — meaning if 250–500 mg\/day produces a meaningful but small subjective effect, 1000 mg\/day is a reasonable next step before considering precursor-switching or stack changes.\u003c\/p\u003e\n\u003cp\u003ePractical implication: with-food dosing produces a slightly slower and lower peak but a slightly longer sustained elevation, and reduces the small chance of mild flushing in sensitive individuals. Empty-stomach dosing (which is what Trammell 2016 used) produces a sharper peak. Either is biologically reasonable — daily consistency matters more than fasted-vs-fed.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this fits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol carries the most complete NAD+ precursor and stacking lineup of any longevity-supplement catalog. NR-capsule is one of seven distinct entry points; the right one for any given user depends on dose, format, stack, and budget.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCheapest entry point:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e — single-ingredient, lowest cost, the daily-driver NMN for adults under 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher-dose NMN:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e — for adults 50+ or 500 mg non-responders.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR hard capsule (this product):\u003c\/strong\u003e the alternate precursor pathway with the longest human research track record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily NAD+ + Resveratrol:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e — adds the SIRT1 activator into the same capsule.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink mix format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ 1000 mg Drink Mix\u003c\/a\u003e — NR + Resveratrol + PQQ + Quercetin in a daily drink, for users who prefer a beverage.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiquid sachet format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Anti-Aging Drink\u003c\/a\u003e — NR berry stick packs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLiposomal flagship:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000 mg\u003c\/a\u003e — phospholipid-encapsulated NAD+ at the top of the range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5-in-1 mitochondrial:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e — NMN + CoQ10 + B-Complex + antioxidants in one capsule.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — how NR sits inside a complete longevity protocol\u003c\/h2\u003e\n\u003cp\u003eNR by itself raises NAD+. NAD+ by itself doesn't do anything — it has to be consumed by sirtuins, PARPs, or CD38 to produce a downstream effect. The job of the stack is to combine precursor supply with sirtuin activation, methylation support, CD38 reduction, mitochondrial support, and the foundational layers (sleep, magnesium, omega-3, vitamin D) that determine whether the body can use any of it. Below is the canonical stack architecture, organized by mechanism:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair (the core)\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e\u003c\/strong\u003e — the classic SIRT1 activator (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e, Park 2007). Pairs with NR's NAD+ supply to produce more sirtuin activity per molecule of precursor. Take both with breakfast and a fat source (fat improves Resveratrol absorption).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e\u003c\/strong\u003e — the methylated cousin of Resveratrol with longer half-life and higher SIRT1 activation in some assays. Used in the Dellinger 2017 NR+pterostilbene combo trial. Stacks alongside or in place of Resveratrol depending on stack tolerability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eBoth precursor pathways covered\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e\u003c\/strong\u003e — covers the Slc12a8 transporter pathway. Many longevity stacks run NMN morning and NR mid-morning to hedge tissue coverage. There is no known interaction; both converge on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e\u003c\/strong\u003e — for higher total-daily-NAD+-precursor exposure in adults 50+ or stacks where NMN is the primary lever and NR is the hedge.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMethylation support — required for long-term high-dose NR\/NMN\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (Trimethylglycine) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — replenishes the SAM methyl pool consumed by NNMT-mediated nicotinamide methylation. Recommended after 4+ weeks of daily NR or NMN, especially if you have known MTHFR variants. The single most important \"second-tier\" addition to any NR\/NMN stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500 mg\u003c\/a\u003e\u003c\/strong\u003e — supports the broader one-carbon \/ glutathione pool that interlocks with methylation. The GlyNAC pairing (with NAC) is the slow-wave-sleep + glutathione-restoration foundation that the methylation cycle leans on.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCD38 reduction — preserve the NAD+ you make\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e\u003c\/strong\u003e — direct CD38 inhibitor (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e). Slows the rate at which CD38 destroys NAD+ — particularly relevant for adults 50+ where CD38 is upregulated.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — clears senescent cells (Zhu 2015 \u003cem\u003eAging Cell\u003c\/em\u003e) which overconsume NAD+ via inflammatory CD38 expression in neighboring tissues. The Mayo Clinic D+Q senolytic protocol is the canonical pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500 mg\u003c\/a\u003e\u003c\/strong\u003e — Mayo-ranked senolytic flavonoid; complementary mechanism to Quercetin. Cycled (e.g., 2 days\/month at high dose) rather than continuous.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eMitochondrial layer — what the NAD+ feeds into\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400 mg\u003c\/a\u003e\u003c\/strong\u003e — Complex I\/III electron-transport-chain shuttle. NAD+\/NADH cycling hands electrons to Complex I; CoQ10 carries them onward. Together they keep oxidative phosphorylation running.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20 mg\u003c\/a\u003e\u003c\/strong\u003e — mitochondrial biogenesis activator via PGC-1α (Chowanadisai 2010). Increases the number of mitochondria; NR\/NMN keeps the existing ones running. The biogenesis-plus-substrate pair.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500 mg\u003c\/a\u003e\u003c\/strong\u003e — PINK1\/Parkin-driven mitophagy activator (Andreux 2019 \u003cem\u003eNat Metab\u003c\/em\u003e). Removes damaged mitochondria so the new ones the NR\/PQQ system supports actually take over.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium Alpha-Ketoglutarate (CaAKG) 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — TCA-cycle substrate and epigenetic 2-OG-dependent dioxygenase cofactor. The metabolic-and-epigenetic layer of the mitochondrial stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600 mg\u003c\/a\u003e\u003c\/strong\u003e — universal antioxidant and PDH\/α-KGDH cofactor. Sits inside the same mitochondrial machinery NAD+ supports.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sulfur amino acid with mitochondrial inner-membrane stabilizing role (Singh 2023 \u003cem\u003eScience\u003c\/em\u003e) and cardiovascular signal in human RCTs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10 mg\u003c\/a\u003e\u003c\/strong\u003e — autophagy activator via eIF5A hypusination and EP300 inhibition (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e). Reciprocal mechanism with sirtuins; not redundant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500 mg\u003c\/a\u003e\u003c\/strong\u003e — adds the AMPK pathway (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). Sirtuin (NR\/NMN) + AMPK (Berberine) is the canonical longevity dual-pathway protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eAntioxidant \/ glutathione layer\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600 mg\u003c\/a\u003e\u003c\/strong\u003e — glutathione precursor; the GlyNAC pairing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500 mg\u003c\/a\u003e\u003c\/strong\u003e — direct master antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12 mg\u003c\/a\u003e\u003c\/strong\u003e — membrane-spanning antioxidant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — collagen-cofactor and aqueous antioxidant.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFoundational layer — sleep, minerals, fats\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400 mg\u003c\/a\u003e\u003c\/strong\u003e — required for \u0026gt;300 enzymatic reactions including the methyl-cycle and sirtuin-substrate handling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — the foundational immune \/ bone \/ cardiovascular layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 Fish Oil 2000 mg\u003c\/a\u003e\u003c\/strong\u003e — EPA\/DHA for membrane fluidity, resolvin signaling, cardiovascular inflammation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000 mg + BioPerine\u003c\/a\u003e\u003c\/strong\u003e — NF-κB \/ inflammaging modulator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e\u003c\/strong\u003e — cortisol \/ HPA-axis modulation; sleep and stress foundation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e+ \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000 mg\u003c\/a\u003e\u003c\/strong\u003e — sarcopenia-prevention; intersects with mitochondrial energy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRead the full protocol architecture in our \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e and the deeper \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003ebeginner's guide to NAD+\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat to expect — week by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDays 1–7:\u003c\/strong\u003e usually subtle. Whole-blood NAD+ rises within 24 hours of the first dose (Trammell 2016 PK), but the subjective signal lags. Some users report a small bump in afternoon energy or steadier mood; many report nothing yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e easier mornings, steadier afternoon energy, fewer post-lunch crashes — for most users. This is the window in which Conze 2019 saw the largest dose-dependent rise in whole-blood NAD+ start to plateau.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e baseline cellular energy, exercise recovery, mental clarity build noticeably; cardiovascular signals (BP, aortic stiffness) emerge in the trial timelines (Martens 2018 was a 6-week protocol; the readouts were measurable at the end of week 6, not at week 2).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e sustained sirtuin activation; long-term DNA-repair and mitochondrial-biogenesis mechanisms compound with continued use. Adding TMG at this point is the standard methylation-support layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the trial endpoints that take the longest to manifest — body composition, hepatic fat, sustained inflammatory marker changes — emerge in the longer studies. This is also the window in which most users decide whether to add the full senolytic \/ mitophagy \/ autophagy layer (Quercetin, Fisetin, Urolithin A, Spermidine).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e the underlying hypothesis — sustained sirtuin \/ PARP \/ CD38 activity supporting the hallmarks-of-aging machinery — is a long-term proposition. The trials we have don't run beyond 12 months; the rationale for continued use is the consistency of the mechanism plus the absence of safety signal across the published evidence base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a daily NAD+ precursor designed to raise whole-blood and tissue NAD+ in a way that's been replicated across more than a dozen human RCTs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e the patented form of NR — same molecule used in Trammell 2016, Martens 2018, Conze 2019, Elhassan 2019, and Brakedal 2022.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is\u003c\/strong\u003e a structural addition to a complete longevity stack — most useful when paired with a SIRT1 activator (Resveratrol or Pterostilbene), eventually a methyl donor (TMG), and the foundational mitochondrial layer (CoQ10, PQQ).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a stimulant, a caffeine replacement, or a same-day energy hit. NAD+ rises gradually over weeks and the subjective effects build over weeks 2–8.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a treatment for any disease — published trials investigate biomarker and mechanism endpoints; they do not establish disease-treatment claims.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a substitute for foundational longevity inputs (sleep, exercise, protein intake, omega-3, vitamin D, magnesium). NAD+ supplementation works in a body that has the basics covered. If your foundation is weak, fix that first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a one-month experiment. The trial timelines that establish the effect run 4–12 weeks; expecting a verdict at 30 days is using the wrong yardstick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is NOT\u003c\/strong\u003e a replacement for a SIRT1 activator. NR by itself raises NAD+; pairing it with Resveratrol or Pterostilbene is what produces the sirtuin-output story most users came in looking for.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most of the published readouts emerge at weeks 6–12, not weeks 2–4. Daily consistency for 8 weeks before judging is the minimum useful evaluation window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NR is not caffeine. The signal is steadier-energy, easier-mornings, faster-recovery — not a peak. Track week-over-week, not hour-over-hour.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support.\u003c\/strong\u003e After 4+ weeks of daily NR or NMN, the methylation pool starts to feel the draw. Adding TMG 500–1000 mg\/day is the single most cost-effective addition to the stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without a sirtuin activator.\u003c\/strong\u003e NAD+ supply without sirtuin demand is unfinished — pair NR with Resveratrol or Pterostilbene to produce the downstream sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking without the foundation.\u003c\/strong\u003e NR\/NMN\/Resveratrol\/Pterostilbene\/TMG\/Apigenin layered on top of poor sleep, no protein, no resistance training, low vitamin D, no omega-3, and chronic alcohol does not produce the trial readouts. Foundation first.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling for the wrong reasons.\u003c\/strong\u003e The published trials run continuous daily dosing for 4–12 weeks without safety signal. Cycling 8 on \/ 1 off is a low-cost hedge but is not required by the evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSwitching too fast.\u003c\/strong\u003e NMN or NR for 4 weeks, no result, switching to the other — is a misuse of the evidence. Either give 8–12 weeks to evaluate, or run both simultaneously.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnderdosing.\u003c\/strong\u003e 1000 mg\/day is the trial-validated dose for the cardiovascular and neurological readouts. 250–500 mg may produce a measurable NAD+ rise but is below the dose at which most published clinical effects emerged.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard:\u003c\/strong\u003e 1 capsule with breakfast. Adults 50+ or those running a higher-dose comprehensive stack: 2 capsules with breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with NMN:\u003c\/strong\u003e NMN with breakfast, NR mid-morning — covers both transport pathways across the day.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStack with Resveratrol or Pterostilbene:\u003c\/strong\u003e take both at the same morning meal alongside a fat source — Resveratrol\/Pterostilbene activates SIRT1, NR supplies the NAD+ substrate, the fat improves stilbene absorption.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAfter 4+ weeks:\u003c\/strong\u003e add TMG 500–1000 mg\/day to support the methylation pool consumed by NAD+ metabolism. After 8+ weeks: consider adding Apigenin 50 mg\/day to inhibit CD38.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the morning:\u003c\/strong\u003e take NR with the post-workout meal rather than pre-workout. NAD+ is being consumed heavily during exercise; precursor supply pairs better with the recovery window.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you exercise in the evening:\u003c\/strong\u003e NR still goes in the morning. Don't shift to evening — NAD+ has a circadian rhythm and morning dosing aligns with the natural peak.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e take it as soon as you remember the same day. If it's already evening, skip and resume in the morning. Do not double up — daily consistency over 8+ weeks is what matters, not catching up on individual doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel and time-zone shifts:\u003c\/strong\u003e dose by local-time morning rather than home-time morning. The circadian rhythm resets to local light cycle within a few days; matching NR dosing to the local schedule keeps the rhythm aligned.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs fasted:\u003c\/strong\u003e with food is fine (most trials used with-food dosing) and reduces the small chance of mild flushing. Fasted dosing produces a sharper plasma peak (Trammell 2016) but the steady-state effect at 8 weeks is comparable. Consistency matters more than fasted-vs-fed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSee our \u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003etiming guide\u003c\/a\u003e for the deeper rationale; the same morning rules apply to NR.\u003c\/p\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone who wants the most-studied human NAD+ precursor specifically — NR's published research depth (65+ trials, 13+ peer-reviewed RCTs) is the longest of any NAD+ precursor as of 2026.\u003c\/li\u003e\n  \u003cli\u003eAdults who tried NMN and didn't see the response they wanted — switching to or stacking NR is the standard next step. ENT1\/2 transporter coverage may reach tissues where Slc12a8 is downregulated.\u003c\/li\u003e\n  \u003cli\u003ePeople running a comprehensive longevity stack who want both NR and NMN pathways covered to hedge tissue-specific transporter heterogeneity.\u003c\/li\u003e\n  \u003cli\u003eAdults 50+ — alternate-pathway delivery and broad transporter coverage hedge against tissue-specific transporter inefficiencies that emerge with age.\u003c\/li\u003e\n  \u003cli\u003eAnyone whose stack already includes Resveratrol, Pterostilbene, or another SIRT1 activator and wants the matching NAD+ substrate so the activator has fuel.\u003c\/li\u003e\n  \u003cli\u003eAthletes and active adults running heavy training loads — NAD+\/sirtuin axis sits inside exercise recovery and mitochondrial-biogenesis pathways.\u003c\/li\u003e\n  \u003cli\u003ePeople with a family history of cardiovascular events who are running multi-pathway prevention protocols — the Martens 2018 BP and aortic-stiffness signal is the strongest mechanism-validated NR readout to date.\u003c\/li\u003e\n  \u003cli\u003eCognitive-aging-conscious adults — Brakedal 2022 demonstrated CSF\/brain NAD+ rise with oral dosing, the first such evidence for any human NAD+ precursor.\u003c\/li\u003e\n  \u003cli\u003eVegans and vegetarians — the capsule is vegan-compatible (no gelatin), and the NR molecule is animal-source-free.\u003c\/li\u003e\n  \u003cli\u003eMethylation-savvy users (MTHFR variants, etc.) — the included B-vitamin cofactors plus TMG pairing makes this a well-supported long-term lever.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding\u003c\/strong\u003e — no safety data in pregnancy or lactation. Avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive cancer or recent diagnosis\u003c\/strong\u003e — NAD+ supports both healthy and cancer-cell metabolism; sirtuins have context-dependent roles in tumor biology. Discuss with your oncologist before starting; some advocate cycling off during active treatment.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren and adolescents under 18\u003c\/strong\u003e — no pediatric safety data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (within 14 days)\u003c\/strong\u003e — discontinue 2 weeks before any planned surgery as a general supplement-safety practice; NR and other NAD+ precursors may interact with anesthesia metabolism.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting a stimulant or same-day energy hit\u003c\/strong\u003e — NR is not caffeine. If your intent is a fast subjective lift, this is the wrong tool.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone unwilling to stay consistent for 8+ weeks\u003c\/strong\u003e — the trial readouts emerge in that window. Sporadic use does not reproduce the published evidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople who haven't fixed the foundation\u003c\/strong\u003e — sleep deprivation, ultra-processed diet, no protein intake, no resistance training, chronic alcohol — NR layered on top of those does not reproduce the trials. Address foundation before optimization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, interactions, and contraindications\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGenerally well-tolerated.\u003c\/strong\u003e Across published trials at 100–1000 mg\/day for up to 8–12 weeks (and 3000 mg\/day in the NR-SAFE 4-week extension), NR has shown no serious adverse events vs placebo (Conze 2019; Dollerup 2018; Martens 2018; Elhassan 2019; Brakedal 2023).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild flushing or warmth\u003c\/strong\u003e can occur in a small minority — usually resolves with food or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI upset\u003c\/strong\u003e in a small minority — typically resolves within the first 1–2 weeks or with dose reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eActive or recent cancer:\u003c\/strong\u003e NAD+ supports both healthy and cancer-cell metabolism. Discuss with your oncologist before starting; some advocate cycling off during active treatment. Note that the published epidemiologic and mechanistic data on cancer outcomes with chronic NR\/NMN use are still maturing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e not studied; avoid.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethylation load:\u003c\/strong\u003e long-term high-dose NR (or NMN) consumes methyl groups during NAD+ metabolism via NNMT. Pair with TMG 500–1000 mg\/day after 4+ weeks of daily use, especially if you have any known methylation variants (MTHFR C677T or A1298C). The included B6\/B12\/folate cofactors mitigate but do not fully replace TMG at long-term high dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery:\u003c\/strong\u003e discontinue 14 days before any planned surgical procedure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e no clinically significant pharmacokinetic interactions are documented at the doses used here, but published interaction data is limited. Discuss with your prescriber if you take chemotherapy, immunosuppressants, anticoagulants, or psychiatric medications.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlcohol:\u003c\/strong\u003e heavy alcohol use depletes NAD+ via aldehyde-dehydrogenase activity. NR can replenish, but chronic alcohol is the bigger lever — addressing alcohol intake produces a larger and more durable NAD+ effect than precursor supplementation alone.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatented Nicotinamide Riboside Chloride (NR-Cl)\u003c\/strong\u003e — same crystalline form used in Trammell 2016, Martens 2018, Elhassan 2019, Conze 2019, and Brakedal 2022. ≥98% NR by HPLC; identity confirmed by NMR and mass spectrometry.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSupporting B-vitamin cofactors\u003c\/strong\u003e for the NAD+ biosynthesis pathway: vitamin B6 (pyridoxal-5-phosphate as a NAMPT cofactor), vitamin B12 (methylcobalamin as a methyl donor), and folate (5-MTHF as a methyl donor) — the methylation cycle inputs that NAD+ metabolism eventually leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHard capsule format\u003c\/strong\u003e for measured, consistent dosing — no flavored powders, no proprietary blends, no surprise sugar or maltodextrin fillers.\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eNo proprietary blends, no artificial colors, no titanium dioxide, no soy, no gluten, no dairy, no nuts.\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan-compatible capsule shell\u003c\/strong\u003e (HPMC), suitable for vegan and vegetarian protocols.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party tested\u003c\/strong\u003e for purity, identity, heavy metals, and microbial contamination by an ISO 17025-accredited laboratory. Certificate of Analysis available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSourcing, manufacturing, and quality control\u003c\/h2\u003e\n\u003cp\u003eThe patented Nicotinamide Riboside Chloride used in this product is the same crystalline form characterized in Trammell 2016 and used across the published clinical trial program. Manufacturing follows U.S. FDA cGMP (current Good Manufacturing Practice) requirements (21 CFR Part 111) at NSF-registered or equivalent facilities. Each lot is tested against the following specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC retention time and UV spectrum match the reference standard; NMR and mass-spec identity confirmed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98% NR-Cl by HPLC; total impurities ≤2%; specific pharmacopeia-listed impurities below individual limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e arsenic, lead, mercury, cadmium below USP \u0026lt;232\u0026gt; \/ Prop65 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e below USP \u0026lt;467\u0026gt; Class 2\/3 limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e total aerobic count, yeast, mold, and pathogens (E. coli, Salmonella, Staphylococcus aureus) below USP \u0026lt;2021\u0026gt; limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e \u0026lt; USP-listed thresholds for orally administered solid dosage forms.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e below USP \u0026lt;561\u0026gt; \/ EU multi-residue panel limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e formulated for ≥24-month room-temperature shelf life in UV-protective amber HDPE bottles with foil-induction seal and desiccant. Store cool and dry; refrigeration not required.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach capsule is filled by a single-source audited contract manufacturer; no proprietary blends are used so the on-label NR amount is the actual dose, not a \"complex\" mass that could be padded with rice flour or maltodextrin.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NR better than NMN?\u003c\/h3\u003e\n\u003cp\u003eNeither is uniformly \"better.\" NR has the longer human research track record (since 2016 with Trammell), broader cardiovascular and neurological RCT coverage, and may reach tissues where the NMN transporter (Slc12a8) is less active. NMN may have an edge in liver and pancreas, skips the intracellular phosphorylation step, and has the strong post-menopausal insulin-sensitivity signal from Yoshino 2021. For most users the practical difference is small; many run both. Read the \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNR vs NMN comparison\u003c\/a\u003e for the full breakdown.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR with NMN?\u003c\/h3\u003e\n\u003cp\u003eYes, and many longevity protocols do. NMN with breakfast and NR mid-morning is a clean way to space them and cover both transport pathways. There's no known interaction — they ultimately converge on the same molecule (NAD+). If anything, the combination hedges tissue-specific transporter expression heterogeneity better than either precursor alone.\u003c\/p\u003e\n\n\u003ch3\u003eWhy are B-vitamins included?\u003c\/h3\u003e\n\u003cp\u003eNAD+ metabolism uses methyl groups (the methylation cycle), and the conversions through the salvage pathway use B6 as a cofactor. Including B6, B12, and folate means the NR you absorb has the supporting cofactors it needs without pulling them from elsewhere in your metabolism. After 4+ weeks of daily NR\/NMN at the 1 g\/day level, adding TMG (trimethylglycine) on top is the standard methyl-donor support — the included B12\/folate are useful but do not fully replace TMG at long-term high dose.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eWhole-blood NAD+ begins to rise within 24 hours of the first dose (Trammell 2016 PK). Subjective changes — easier mornings, steadier energy, faster exercise recovery — typically become noticeable in weeks 2–4 for most users. Cardiovascular and inflammatory readouts in the published trials emerged at 3–8 weeks (Martens 2018 was 6 weeks; Elhassan 2019 was 21 days). Plan to evaluate at week 8, not week 4.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR at night?\u003c\/h3\u003e\n\u003cp\u003eYou can, but morning is preferred. NAD+ has a circadian rhythm — it naturally peaks during the active phase. Morning dosing aligns with that rhythm. Some users report mild stimulation from NR; if that's you, definitely keep it morning-only. Evening dosing is not unsafe, just suboptimal in a small minority of stimulant-sensitive users.\u003c\/p\u003e\n\n\u003ch3\u003eDo I need to cycle NR?\u003c\/h3\u003e\n\u003cp\u003ePublished trials run 6–12 weeks of continuous daily dosing without safety issues. The Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks safely. Long-term continuous use is the most common pattern. Some users cycle 8 weeks on \/ 1 week off as a standard supplement-rotation practice — there's no published evidence that cycling is required, but it's a low-cost hedge against the small theoretical risk of receptor or enzymatic adaptation.\u003c\/p\u003e\n\n\u003ch3\u003eShould I take it with food?\u003c\/h3\u003e\n\u003cp\u003eWith food is fine and reduces the small chance of mild flushing. The Trammell 2016 PK study used fasted dosing; the Martens 2018 cardiovascular study used with-breakfast dosing. Both raise NAD+ effectively. Daily consistency matters more than fasted-vs-fed. If you're stacking with Resveratrol, the with-food (and with-fat) approach is preferred because Resveratrol absorbs better with fat.\u003c\/p\u003e\n\n\u003ch3\u003eWhat if I'm 30 — is NR still useful?\u003c\/h3\u003e\n\u003cp\u003eThe biggest published effect sizes come from older cohorts (Martens 2018 was midlife\/older with elevated BP; Elhassan 2019 was 70–80 years old). Younger adults still see whole-blood NAD+ rise (Trammell 2016 included healthy adults of all ages) but the subjective signal is typically smaller because baseline NAD+ is higher. The most defensible use case at age 30 is foundational longevity stacking rather than acute symptom management.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is NR more expensive than NMN?\u003c\/h3\u003e\n\u003cp\u003eNR is patent-licensed; the manufacturing process is more complex and the licensing cost is passed through to the consumer. The premium is real and the practical value depends on whether the longer research track record, the broader transporter coverage, and the brain\/CSF NAD+ signal are decisive for your protocol. For cost-efficient daily entry, NMN at 500 mg is generally the better starting point; NR is best framed as a stack hedge or a switch when NMN alone isn't producing the expected response.\u003c\/p\u003e\n\n\u003ch3\u003eCan NR replace coffee?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is not a stimulant. The \"easier mornings, steadier afternoon energy\" signal that builds over 2–8 weeks is bioenergetic, not adrenergic. Coffee acts on adenosine receptors and the catecholamine system; NR acts on the NAD+\/sirtuin\/mitochondrial-respiration axis. They are complementary, not substitutes.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR show up on a drug test?\u003c\/h3\u003e\n\u003cp\u003eNo. NR is a dietary supplement form of vitamin B3 (nicotinamide-derived) and is not on any standard sport, occupational, or clinical drug-screening panel. The molecule is endogenous and trace levels are present in all human blood at baseline.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take NR while fasting?\u003c\/h3\u003e\n\u003cp\u003eYes. NR does not break a fast in any meaningful metabolic sense — the molecule contributes negligible calories and does not significantly raise insulin. The Trammell 2016 PK study used fasted dosing. If you fast intermittently and want to dose NR within the fasted window, that is biologically reasonable.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR raise blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe published cardiovascular evidence runs the other way. Martens 2018 specifically measured systolic blood pressure in midlife adults with elevated baseline SBP and found a ~10 mmHg \u003cem\u003ereduction\u003c\/em\u003e after 6 weeks of 1 g\/day vs placebo. Aortic stiffness also fell. NR is not associated with raised BP at the trial-validated dose.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the maximum safe daily dose?\u003c\/h3\u003e\n\u003cp\u003eThe Brakedal 2023 NR-SAFE trial extended dosing to 3 g\/day for 4 weeks in Parkinson's patients without serious adverse events. The 1000 mg\/day dose is the trial-validated standard for cardiovascular and neurological readouts. Going above 1 g\/day without clinical supervision is not recommended for general consumer use; the marginal benefit of higher doses has not been demonstrated to outweigh the cost in the published evidence base.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR interact with statins or blood pressure medications?\u003c\/h3\u003e\n\u003cp\u003eNo clinically significant interactions are documented at typical supplement doses. Practical caution: if you are on antihypertensive medication and you start NR, the Martens 2018 BP-lowering signal means your home BP readings could trend lower. Track and discuss with your prescriber if you see a meaningful shift.\u003c\/p\u003e\n\n\u003ch3\u003eHow does NR compare to NAD+ IV therapy?\u003c\/h3\u003e\n\u003cp\u003eNAD+ IV therapy delivers a large bolus of NAD+ directly to the bloodstream over a few hours. Oral NR raises whole-blood NAD+ steadily over weeks via the precursor pathway. The IV route is acutely larger but expensive, infrastructure-dependent, and the long-term cost-benefit vs. daily oral precursor supplementation is unsettled. Most published longevity-mechanism evidence in humans is from oral precursor (NR or NMN), not IV NAD+.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule?\u003c\/h3\u003e\n\u003cp\u003eTechnically yes, but it's not recommended. NR-Cl is mildly hygroscopic; opening exposes the powder to air moisture and accelerates degradation. The capsule is also designed to deliver a measured single dose. If you have trouble swallowing capsules, the \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Drink Mix\u003c\/a\u003e or the \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ sachet\u003c\/a\u003e are designed for that use case.\u003c\/p\u003e\n\n\u003ch3\u003eIs NR vegan?\u003c\/h3\u003e\n\u003cp\u003eYes. The NR molecule is synthesized from non-animal sources, the capsule shell is HPMC (vegan-compatible, plant-derived), and the supporting B-vitamin cofactors in this formulation are non-animal-sourced.\u003c\/p\u003e\n\n\u003ch3\u003eWill NR help me sleep?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, sometimes. NAD+ contributes to circadian-rhythm regulation via NAMPT and SIRT1's interaction with the BMAL1\/CLOCK transcription complex (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Some users report deeper or more consolidated sleep after several weeks of consistent dosing — likely a downstream consequence of metabolic and circadian normalization rather than a direct sedative effect. If sleep is the primary target, the more direct levers are \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eDoes NR improve hair?\u003c\/h3\u003e\n\u003cp\u003eIndirectly, possibly. The hair follicle is a high-turnover, energy-demanding tissue and NAD+ supports the underlying energetics. There are no large RCTs of NR specifically for hair endpoints. The more direct hair-cycle levers are \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e (Rainer 2018 PROSPER trial showed anagen-phase lengthening).\u003c\/p\u003e\n\n\u003ch3\u003eWhy is daily consistency more important than dose?\u003c\/h3\u003e\n\u003cp\u003eNAD+ levels respond to sustained precursor supply, not single-dose peaks. Conze 2019 showed steady-state NAD+ at week 8; one-off dosing produces a transient peak that returns to baseline within 24 hours. The published clinical readouts (cardiovascular, neurological, inflammatory) all emerged from sustained 4–12 week protocols, not from intermittent or as-needed use.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ family is organized into four functional layers, and NR Hard Capsules sits primarily in layer 1 (Precursor Supply) with crossover into layer 4 (Comprehensive Stack):\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 1 — Precursor Supply.\u003c\/strong\u003e NR Hard Capsules (this product), \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000 mg Double Strength\u003c\/a\u003e. Single-ingredient or near-single-ingredient daily precursors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 2 — SIRT1 \/ Sirtuin activators.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100 mg\u003c\/a\u003e. Pair with layer 1 to convert NAD+ supply into sirtuin output.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 3 — Methylation and CD38 support.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000 mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50 mg\u003c\/a\u003e. Required at 4+ weeks of daily layer-1 use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLayer 4 — Comprehensive \/ convenience formulas.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e, \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eZOONE NAD+ Pure Focus\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete\u003c\/a\u003e. Multi-ingredient formats that bundle layers 1+2 (and sometimes 3+) for users who prefer one capsule.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe deeper-protocol architecture (mitochondrial layer, autophagy layer, senolytic layer, antioxidant layer, foundational layer) is documented across the catalog in the dedicated product pages and in the \u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — the complete NR + NMN + NAD+ lineup.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, CaAKG, the energy-production layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the daily-driver layer the rest of the stack leans on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Quercetin, Fisetin, the senescent-cell-clearance layer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — the BP, lipid, and aortic-stiffness layer where the Martens 2018 NR signal lives.\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — Berberine, Alpha-Lipoic Acid, the AMPK \/ glucose layer that pairs with the NAD+\/sirtuin axis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which precursor actually works better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003e2026 Longevity Stacking Protocol\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eTiming — morning, empty stomach, or with food?\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eBieganowski P \u0026amp; Brenner C (2004). Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e 117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNature Communications\u003c\/em\u003e 7:12948.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNature Communications\u003c\/em\u003e 9:1286.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, \u0026amp; Kruger CL (2019). Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eScientific Reports\u003c\/em\u003e 9:9772.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. \u003cem\u003eCell Reports\u003c\/em\u003e 28(7):1717–1728.e6.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. (2020). Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e 112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. (2021). Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy aged adults. \u003cem\u003eJournal of Physiology\u003c\/em\u003e 599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dölle C, Riemer F, et al. (2022). The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e 34(3):396–407.e6.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. (2023). Long-term nicotinamide riboside use is safe in patients with Parkinson disease. \u003cem\u003eNature Communications\u003c\/em\u003e 14:1156 (NR-SAFE).\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. (2020). Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e 31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. \u003cem\u003eNPJ Aging and Mechanisms of Disease\u003c\/em\u003e 3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. (2017). An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e 12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. (2016). NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNature Communications\u003c\/em\u003e 7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e 7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. (2016). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e 23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, \u0026amp; Imai S (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. (2020). SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e 588:174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. (2008). SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e 134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bitterman KJ, Cohen HY, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 425:191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. (2013). Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e 62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, \u0026amp; Kroemer G (2018). Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e 359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eAndreux PA, Blanco-Bose W, Ryu D, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. \u003cem\u003eNature Metabolism\u003c\/em\u003e 1:595–603.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, \u0026amp; Ye J (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e 57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eSingh P, Gollapalli K, Mangiola S, et al. (2023). Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e 380(6649):eabn9257.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2013). The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e 153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, \u0026amp; Kroemer G (2023). Hallmarks of aging: an expanding universe. \u003cem\u003eCell\u003c\/em\u003e 186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, have an active or recent cancer diagnosis, or have a medical condition. Reference studies cited above describe pharmacokinetic and clinical findings of Nicotinamide Riboside generally and do not constitute claims about this specific product.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705326944474,"sku":"THP-NAD-NR-CAP","price":44.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-nad-capsules.jpg?v=1775666145"},{"product_id":"liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation","title":"Liquid NAD+ Anti-Aging Drink | NR Berry Stick Packs for NAD+ \u0026 Sirtuin Support","description":"\u003cp\u003e\u003cstrong\u003eNAD+ precursors in drinkable form\u003c\/strong\u003e — built for people who don't want to swallow more capsules, who already have a morning routine where adding a drink is easier than adding another pill bottle, and who travel and don't want a carry-on stuffed with HDPE bottles. Single-serve berry stick packet, dissolves in 30 seconds in 7–10 oz of cold water, no scoops, no measuring, TSA-friendly, no artificial colors, no added sugar bombs. Same NAD+-pathway biology as our \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e — just delivered through the format you'll actually take every single day.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrink format, soluble delivery\u003c\/strong\u003e — absorption begins in the oral mucosa and continues through the upper GI without waiting on capsule disintegration. Powder dissolved in 7–10 oz cold water reaches plasma faster than the equivalent dose of compressed capsules.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNicotinamide Riboside (NR) at the center\u003c\/strong\u003e — the NAD+ precursor with the longest human clinical-trial track record. Trial-validated daily dosing (Trammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e, Conze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e, Martens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e, Brakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e NADPARK).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eClean berry flavor, no sweet bombs\u003c\/strong\u003e — no artificial colors, no sucralose, no stevia avalanche; mixes cleanly so it doesn't taste medicinal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-serve packets\u003c\/strong\u003e — TSA-friendly, no scoops, no measuring spoons, no spilling powder in your kitchen drawer. Stable at room temperature, single-use foil-laminated packaging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundation-tier daily NAD+ support\u003c\/strong\u003e — pairs cleanly with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e, and the rest of the longevity stack — never redundant with capsules; many users alternate or stack the formats.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e people who don't tolerate capsules well, those building a morning-drink ritual, anyone who finds drink supplements easier to remember than pill bottles, frequent travelers, and users who want NAD+ pathway support that's literally pleasant to take.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy NAD+ matters — the foundational coenzyme behind cellular aging\u003c\/h2\u003e\n\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is one of the most foundational coenzymes in human biology. Every nucleated cell in your body uses it. It runs the electron transport chain in your mitochondria — the system that converts food and oxygen into ATP, the molecular currency of energy. It is the obligate substrate of the \u003cstrong\u003esirtuin family\u003c\/strong\u003e of NAD+-dependent deacetylases (SIRT1–SIRT7), which silence pro-aging gene programs, regulate inflammation, drive DNA-damage response, and govern mitochondrial biogenesis. It powers the \u003cstrong\u003ePARP enzymes\u003c\/strong\u003e that detect and repair single- and double-strand DNA breaks every day. It is consumed by \u003cstrong\u003eCD38\u003c\/strong\u003e, the cell-surface ectoenzyme whose age-related upregulation is one of the largest mechanistic explanations for falling NAD+ pools (Camacho-Pereira 2016 \u003cem\u003eCell Metabolism\u003c\/em\u003e). Without enough NAD+, none of these systems run properly.\u003c\/p\u003e\n\n\u003cp\u003eThe problem: NAD+ levels drop sharply with age. Massudi 2012 (\u003cem\u003ePLOS ONE\u003c\/em\u003e) showed roughly a \u003cstrong\u003e~50% decline in skin NAD+ between the 20s and 50s\u003c\/strong\u003e with the decline accelerating after that. Yoshino 2011 (\u003cem\u003eCell Metabolism\u003c\/em\u003e) replicated this multi-tissue in mouse models — liver, muscle, pancreas, white adipose tissue, brown adipose tissue, brain — with parallel declines in NAMPT (the rate-limiting salvage-pathway enzyme). Camacho-Pereira 2016 mapped the decline mechanistically to age-related CD38 upregulation acting as an NAD+ \"sink\" rather than to NAMPT alone. By the time most people notice \"feeling older\" — slower recovery, less morning energy, fuzzier focus, less stress resilience — NAD+ depletion is already one of the underlying biochemical drivers, sitting upstream of the López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e hallmarks of aging (mitochondrial dysfunction, deregulated nutrient sensing, genomic instability, cellular senescence) and folded explicitly into the López-Otín 2023 \u003cem\u003eCell\u003c\/em\u003e integrated-hallmarks update.\u003c\/p\u003e\n\n\u003cp\u003eYou can't supplement NAD+ directly very efficiently in most oral formats — the molecule is too large and polar to cross plasma membranes intact at meaningful doses. That's why the field moved to \u003cstrong\u003eprecursors\u003c\/strong\u003e: smaller molecules (NR, NMN, niacinamide, niacin) that your cells convert into NAD+ on the inside via well-mapped enzymatic routes. NR is the precursor with the most published human-clinical-trial evidence at this point — covering whole-blood NAD+ rise, cardiovascular endpoints, brain NAD+, muscle NAD+, insulin sensitivity, and exercise physiology. It is the active core of this drink.\u003c\/p\u003e\n\n\u003cp\u003eFor a deeper introduction read \u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide\u003c\/a\u003e and \u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhy drink format — not just preference, real biology\u003c\/h2\u003e\n\u003cp\u003eCapsules and drink mixes are not biologically equivalent on day one of dosing. Three things change when you take an NAD+ precursor as a dissolved drink instead of a hard capsule:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOnset\u003c\/strong\u003e. A hard-shell HPMC capsule needs 5–15 minutes to disintegrate in the stomach before the contents become available for absorption (USP \u0026lt;701\u0026gt; disintegration spec is ≤30 minutes for HPMC capsules; in practice typically 5–12 minutes). A dissolved drink presents the precursor to the intestinal mucosa within 30 seconds. This narrows the gap between \"taking the supplement\" and \"the molecule arriving at the absorption surface\" to roughly the gastric-emptying half-time of liquid (10–20 minutes for water on an empty stomach).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBuccal and upper-GI absorption\u003c\/strong\u003e. NR has been shown to absorb partially via the oral mucosa and proximal small intestine via the equilibrative nucleoside transporters ENT1 and ENT2 (Ratajczak 2016 \u003cem\u003eNat Commun\u003c\/em\u003e). A dissolved drink is in contact with absorptive surfaces immediately; a capsule is not.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdherence — the variable that dwarfs everything else\u003c\/strong\u003e. The single largest determinant of long-term outcomes from any daily supplement is whether you actually take it every day for months. Trial endpoints in NAD+ research (Conze 2019, Brakedal 2022 NADPARK 1g\/day for 30 weeks, Pirinen 2020 1g\/day for 4 months) require \u003cem\u003eweeks-to-months\u003c\/em\u003e of compliance. Capsule fatigue, capsule aversion, \"I forgot, I'll do it tomorrow\" — these account for far more lost benefit than any pharmacokinetic difference between formats. A drink that's actually pleasant to take every morning beats a capsule that ends up rationed.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThis product isn't trying to replace capsule NAD+ precursors — it's the format that wins for a specific user. If you already happily take capsules, our \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e remain the highest-density precursor delivery per dollar. If you have capsule fatigue, swallowing aversion, traveler-luggage limits, or a strong morning-drink ritual where adding one stick packet is invisible, this format quietly wins on adherence — the variable that matters most.\u003c\/p\u003e\n\n\u003ch2\u003eWhy Nicotinamide Riboside (NR) specifically\u003c\/h2\u003e\n\u003cp\u003eThe four NAD+ precursors a cell can use are \u003cstrong\u003eNR (Nicotinamide Riboside)\u003c\/strong\u003e, \u003cstrong\u003eNMN (Nicotinamide Mononucleotide)\u003c\/strong\u003e, \u003cstrong\u003eNAM (Niacinamide \/ Nicotinamide)\u003c\/strong\u003e, and \u003cstrong\u003eNA (Niacin \/ Nicotinic Acid)\u003c\/strong\u003e. Each has trade-offs:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR\u003c\/strong\u003e — phosphorylated to NMN by NRK1\/NRK2 (Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e), then adenylylated to NAD+ by NMNAT1\/2\/3. Crosses cell membranes intact via ENT1\/2 (Ratajczak 2016). Most extensively human-trialed precursor (Trammell 2016, Conze 2019, Martens 2018, Dollerup 2018, Elhassan 2019, Brakedal 2022, Pirinen 2020, Dellinger 2017). No flushing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN\u003c\/strong\u003e — one step closer to NAD+ but reportedly enters cells via the proposed Slc12a8 transporter (Grozio 2019 \u003cem\u003eNature Metabolism\u003c\/em\u003e) or via extracellular conversion to NR by CD73 then re-uptake. Strong human-trial bench at the 250–1000mg dose range (Yoshino 2021 \u003cem\u003eScience\u003c\/em\u003e, Yi 2022, Liao 2021, Igarashi 2022). Functionally interchangeable with NR for most users; many longevity practitioners stack both to hedge across the parallel salvage entry points.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAM\u003c\/strong\u003e — cheap, abundant, but at high doses inhibits sirtuins (Bitterman 2002 \u003cem\u003eJBC\u003c\/em\u003e) by acting as a product-inhibitor. Useful as a B3-vitamin source; less ideal as a sirtuin-substrate booster.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNA\u003c\/strong\u003e — raises NAD+ but causes prostaglandin-mediated flushing at meaningful doses unless given as ER-niacin under medical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNR is the precursor with the densest human evidence base at this dose range, the cleanest tolerability profile, and parallel absorption pathways (ENT1\/2 plus CD73→NR conversion) that make it format-flexible for liquid delivery. That's why it sits at the center of this drink.\u003c\/p\u003e\n\n\u003ch2\u003eMechanism — how NR becomes NAD+ inside your cells\u003c\/h2\u003e\n\u003cp\u003eNR taken orally has the following well-mapped fate (Ratajczak 2016, Trammell 2016, Cantó 2015 \u003cem\u003eCell Metabolism\u003c\/em\u003e):\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e1. Absorption.\u003c\/strong\u003e NR is absorbed in the oral mucosa, stomach, and proximal small intestine via the equilibrative nucleoside transporters \u003cstrong\u003eENT1\u003c\/strong\u003e and \u003cstrong\u003eENT2\u003c\/strong\u003e (encoded by SLC29A1 \/ SLC29A2). It does not require the proposed Slc12a8 transporter that NMN appears to use. Plasma NR rises within 30–120 minutes; whole-blood NAD+ rises within 8 hours and remains elevated for 24+ hours after a single dose (Trammell 2016, Conze 2019).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. NRK1\/NRK2 phosphorylation.\u003c\/strong\u003e Inside the cell, NR is phosphorylated to NMN by the NR kinases NRK1 (ubiquitous) and NRK2 (tissue-restricted to muscle, heart, brain). This step was discovered and characterized in Bieganowski \u0026amp; Brenner 2004 \u003cem\u003eCell\u003c\/em\u003e. NRK1 expression is the primary rate-limiting determinant of how quickly a given tissue converts NR to NAD+.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. NMNAT1\/2\/3 adenylylation.\u003c\/strong\u003e NMN is then adenylylated to NAD+ by the three nicotinamide mononucleotide adenylyltransferase isoforms — NMNAT1 (nucleus), NMNAT2 (Golgi\/cytosol), NMNAT3 (mitochondria). This step compartmentalizes NAD+ synthesis to where it's needed.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. Mitochondrial uptake.\u003c\/strong\u003e Mitochondrial NAD+ uptake is governed by the \u003cstrong\u003eSLC25A51\u003c\/strong\u003e transporter, identified in 2020 by Luongo et al. (\u003cem\u003eNature\u003c\/em\u003e). This was the answer to one of the longest-standing questions in NAD+ biology — how the cytosolic and mitochondrial NAD+ pools communicate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e5. Consumption.\u003c\/strong\u003e NAD+ is consumed by three classes of enzymes: \u003cstrong\u003esirtuins\u003c\/strong\u003e (SIRT1–SIRT7) deacetylate substrate proteins using NAD+ as cofactor; \u003cstrong\u003ePARPs\u003c\/strong\u003e (PARP1, PARP2, etc.) consume NAD+ during DNA-damage repair; and \u003cstrong\u003eCD38\u003c\/strong\u003e hydrolyzes NAD+ at a stoichiometry of roughly 100 NAD+ molecules per cyclic-ADP-ribose product. CD38 is the dominant age-related sink (Camacho-Pereira 2016) — which is why \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e (a flavonoid CD38 inhibitor; Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e) is a logical stack partner.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e6. Salvage and methylation.\u003c\/strong\u003e NAM — the byproduct of every sirtuin\/PARP\/CD38 NAD+-consuming reaction — is recycled back to NMN by NAMPT, the rate-limiting salvage-pathway enzyme. Excess NAM is methylated to 1-MNA (1-methylnicotinamide) by NNMT, drawing from the SAM (S-adenosylmethionine) methylation pool. This is why methyl-donor support — \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (trimethylglycine)\u003c\/a\u003e — pairs with daily NR\/NMN dosing, especially at higher doses (1g+\/day) and for users with MTHFR variants or marginal B12 status. 1-MNA appearance in urine is the standard pharmacodynamic biomarker confirming NAD+ flux is occurring (Trammell 2016).\u003c\/p\u003e\n\n\u003ch2\u003eClinical evidence base for NR\u003c\/h2\u003e\n\u003cp\u003eNR has the densest human-trial bench of any NAD+ precursor. Selected trials at doses spanning 100mg – 3000mg\/day:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eTrial\u003c\/th\u003e\n      \u003cth\u003ePopulation\u003c\/th\u003e\n      \u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n      \u003cth\u003ePrimary findings\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eTrammell 2016 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 healthy adults (single-dose PK)\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg single dose\u003c\/td\u003e\n      \u003ctd\u003eDose-dependent rise in whole-blood NAD+ within 8h sustained 24h. 1-MNA urinary appearance confirms flux. No AEs.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eConze 2019 \u003cem\u003eSci Rep\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e140 healthy adults\u003c\/td\u003e\n      \u003ctd\u003e100, 300, 1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear whole-blood NAD+ rise: ~22% \/ 51% \/ 142% at the three doses. No AEs different from placebo.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMartens 2018 \u003cem\u003eNat Commun\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e24 healthy adults 55–79\u003c\/td\u003e\n      \u003ctd\u003e500mg twice daily × 6wk\u003c\/td\u003e\n      \u003ctd\u003eWhole-blood NAD+ +60%, ~10mmHg systolic-BP drop in elevated-BP subgroup, aortic-stiffness reduction trend.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDellinger 2017 \u003cem\u003eNPJ Aging\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e120 adults 60–80 (NRPT combination NR+pterostilbene)\u003c\/td\u003e\n      \u003ctd\u003e250\/500mg NR + 50\/100mg pterostilbene × 8wk\u003c\/td\u003e\n      \u003ctd\u003eDose-linear NAD+ rise; secondary ALT\/AST reduction in the high-dose arm.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eDollerup 2018 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e40 obese, insulin-resistant men\u003c\/td\u003e\n      \u003ctd\u003e1000mg twice daily × 12wk\u003c\/td\u003e\n      \u003ctd\u003eNAD+ pathway elevation; no significant change in primary insulin-sensitivity outcome (well-tolerated).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eElhassan 2019 \u003cem\u003eCell Reports\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e12 elderly men 70–80\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 21d\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; reduced inflammatory cytokines (IL-6, IL-5, IL-2); improved muscle bioenergetics.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRemie 2020 \u003cem\u003eAJCN\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e13 healthy overweight men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 6wk crossover\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ +15%; sleep efficiency increase signal (small-N exploratory).\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2022 \u003cem\u003eCell Metab\u003c\/em\u003e (NADPARK)\u003c\/td\u003e\n      \u003ctd\u003e30 newly-diagnosed Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 30d (placebo-controlled)\u003c\/td\u003e\n      \u003ctd\u003eCSF NAD+ rise; brain NAD+ rise on PET; secondary clinical-rating improvement signal.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eBrakedal 2023 \u003cem\u003eNat Commun\u003c\/em\u003e (NR-SAFE)\u003c\/td\u003e\n      \u003ctd\u003e20 Parkinson's patients\u003c\/td\u003e\n      \u003ctd\u003e3000mg\/day × 4wk\u003c\/td\u003e\n      \u003ctd\u003eSafety\/tolerability extension trial. No serious AEs at 3g\/day; established the upper-dose ceiling for human safety.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePirinen 2020 \u003cem\u003eCell Metab\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e5 adult-onset mitochondrial myopathy patients\u003c\/td\u003e\n      \u003ctd\u003e250–1000mg\/day × 4 months\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; mitochondrial-myopathy biomarker improvement; case-series-grade evidence in a rare disease cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eStocks 2021 \u003cem\u003eJ Physiol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e14 healthy older men\u003c\/td\u003e\n      \u003ctd\u003e1000mg\/day × 8wk\u003c\/td\u003e\n      \u003ctd\u003eMuscle NAD+ rise; no change in mitochondrial respiration in this small healthy cohort.\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eAirhart 2017 \u003cem\u003ePLOS ONE\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e8 healthy adults (PK\/safety)\u003c\/td\u003e\n      \u003ctd\u003e250mg\/day × 7d, 500mg\/day × 7d, etc.\u003c\/td\u003e\n      \u003ctd\u003eStepped dose-escalation tolerability and PK profile.\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eRead together: NR is one of the few longevity-positioned compounds where the human evidence base actually maps cleanly onto the mechanistic story. NAD+ rises (Trammell, Conze, Brakedal, Elhassan), tissue penetration is documented (muscle in Elhassan\/Remie\/Stocks; CSF\/brain in Brakedal NADPARK), cardiovascular signal exists (Martens 2018), safety is established up to 3g\/day (Brakedal 2023 NR-SAFE), and the mechanism (NRK1→NMN→NAD+) is structurally proven. That's why NR is the active core of this drink — not because it's the only NAD+ precursor that works, but because it has the most complete human evidence base at this dose range.\u003c\/p\u003e\n\n\u003ch2\u003eDrink-format NAD+ — comparing what's actually on the market\u003c\/h2\u003e\n\u003cp\u003eOnce you commit to drink format, the next question is what kind. Six paths exist:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eFormat\u003c\/th\u003e\n      \u003cth\u003eActive\u003c\/th\u003e\n      \u003cth\u003eOnset\u003c\/th\u003e\n      \u003cth\u003eTrial coverage\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis product (NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eNR\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 8h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eMost-trialed precursor\u003c\/td\u003e\n      \u003ctd\u003eDaily morning ritual, travel, capsule-aversion users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNMN powder (loose)\u003c\/td\u003e\n      \u003ctd\u003eNMN\u003c\/td\u003e\n      \u003ctd\u003e30s mix → 5h NAD+ rise\u003c\/td\u003e\n      \u003ctd\u003eStrong (Yoshino, Yi, Igarashi, Liao)\u003c\/td\u003e\n      \u003ctd\u003eUsers who want NMN’s one-step-closer position\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSublingual lozenges\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e5–10min dissolve\u003c\/td\u003e\n      \u003ctd\u003eLimited; absorption claims rarely PK-verified\u003c\/td\u003e\n      \u003ctd\u003eUsers who specifically want sublingual, willing to accept thinner trial bench\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMulti-ingredient drink (this product’s sister: \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink\u003c\/a\u003e)\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin\u003c\/td\u003e\n      \u003ctd\u003e30s mix → combined-stack effect\u003c\/td\u003e\n      \u003ctd\u003eEach ingredient trialed individually\u003c\/td\u003e\n      \u003ctd\u003eUsers who want a single morning drink covering precursor + sirtuin activator + mitochondrial cofactor + senolytic in one packet\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNAD+ IV therapy\u003c\/td\u003e\n      \u003ctd\u003eNAD+ direct\u003c\/td\u003e\n      \u003ctd\u003e~3–8h infusion\u003c\/td\u003e\n      \u003ctd\u003eLimited published; mostly observational\u003c\/td\u003e\n      \u003ctd\u003eAcute high-dose use; not for daily-foundation positioning\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eCapsule NR or NMN\u003c\/td\u003e\n      \u003ctd\u003eNR or NMN\u003c\/td\u003e\n      \u003ctd\u003e10–20min capsule disintegration + GI absorption\u003c\/td\u003e\n      \u003ctd\u003eDensest trial bench (capsules are what's used in most published trials)\u003c\/td\u003e\n      \u003ctd\u003eUsers with no capsule aversion, fewest moving parts\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eWhere this drink sits in our NAD+ family\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's NAD+ line was built so each product owns a distinct spot in the precursor \/ activator \/ cofactor \/ convenience space — not as duplicates. The seven distinct entry points:\u003c\/p\u003e\n\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse; width:100%; font-size:14px;\"\u003e\n  \u003cthead\u003e\n    \u003ctr style=\"background-color:#f4f4f4;\"\u003e\n      \u003cth\u003eProduct\u003c\/th\u003e\n      \u003cth\u003eForm\u003c\/th\u003e\n      \u003cth\u003ePrimary role\u003c\/th\u003e\n      \u003cth\u003eBest for\u003c\/th\u003e\n    \u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eThis drink (Liquid NAD+ NR berry stick packs)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, single-serve\u003c\/td\u003e\n      \u003ctd\u003eNR delivery in drink format\u003c\/td\u003e\n      \u003ctd\u003eCapsule-aversion, morning ritual, travel\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Drink Mix\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eDrink mix, multi-ingredient\u003c\/td\u003e\n      \u003ctd\u003eNR + Resveratrol + PQQ + Quercetin combo\u003c\/td\u003e\n      \u003ctd\u003eOne-drink-covers-everything users\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR Hard Capsules\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNR + B-vitamin cofactors\u003c\/td\u003e\n      \u003ctd\u003eCapsule-comfortable users; densest precursor delivery per dollar\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at trial-validated entry dose\u003c\/td\u003e\n      \u003ctd\u003eNMN-pathway preference; entry tier\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg Double Strength\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN at upper trial dose\u003c\/td\u003e\n      \u003ctd\u003eHigher-dose NMN protocol; pairs with TMG\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ + Trans-Resveratrol\u003c\/td\u003e\n      \u003ctd\u003eSirtuin-substrate + activator pair in one capsule\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eLiposomal capsule\u003c\/td\u003e\n      \u003ctd\u003eDirect NAD+ via phospholipid encapsulation\u003c\/td\u003e\n      \u003ctd\u003eUsers who want phospholipid-protected delivery\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003ca href=\"\/he\/products\/selerb-nad-5-in-1-complete-mitochondrial-formula\"\u003eNAD+ 5-in-1 Complete Mitochondrial Formula\u003c\/a\u003e\u003c\/td\u003e\n      \u003ctd\u003eCapsule\u003c\/td\u003e\n      \u003ctd\u003eNMN + CoQ10 + B-Complex + Antioxidants + Skin support\u003c\/td\u003e\n      \u003ctd\u003eOne-capsule-stack convenience users\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFor most users, the right answer is \u003cstrong\u003eone drink-format product\u003c\/strong\u003e for the morning ritual + \u003cstrong\u003eone sirtuin activator\u003c\/strong\u003e (Resveratrol or Pterostilbene) + \u003cstrong\u003emethyl-donor support\u003c\/strong\u003e (TMG) + the rest of the foundational stack (Magnesium, Vit-D, Omega-3). Browse the full NAD+ Family at \u003ca href=\"\/he\/collections\/nad-family\"\u003e\/collections\/nad-family\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability deep-dive — what we know about drink-format NR PK\u003c\/h2\u003e\n\u003cp\u003eThe published NR pharmacokinetic profile (Trammell 2016, Airhart 2017, Conze 2019) was established in capsule and powder formats. Key findings translate to drink delivery:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlasma NR\u003c\/strong\u003e peaks 30–120 minutes after oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhole-blood NAD+\u003c\/strong\u003e rises within 8 hours and remains elevated 24+ hours after a single dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose-linearity\u003c\/strong\u003e documented in Conze 2019 across 100\/300\/1000mg\/day × 8wk: ~22% \/ 51% \/ 142% NAD+ rise respectively. The dose-response is approximately log-linear in this range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1-MNA urinary appearance\u003c\/strong\u003e rises within 24 hours, confirming the NAD+→NAM→1-MNA flux is occurring (Trammell 2016).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSteady-state\u003c\/strong\u003e NAD+ elevation is reached by approximately week 1–2 of daily dosing; further dosing maintains rather than progressively elevates.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue distribution\u003c\/strong\u003e documented in muscle (Elhassan, Remie, Stocks), CSF\/brain (Brakedal NADPARK), and liver (preclinical). Mitochondrial NAD+ rise is governed by SLC25A51 capacity (Luongo 2020 \u003cem\u003eNature\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eDrink-format delivery vs capsule delivery should not change steady-state NAD+ levels over weeks — both end up at the same plateau if dosed daily — but it does compress the time-to-onset of each individual dose, and (more importantly for outcomes) it materially raises the probability that you actually take it every day.\u003c\/p\u003e\n\n\u003ch2\u003eStacking — what to pair with daily NAD+ drink\u003c\/h2\u003e\n\u003cp\u003eNR alone raises NAD+ but doesn't address the consumer side (CD38), the sirtuin-activator side (resveratrol\/pterostilbene), or the methylation tax (TMG). The mechanistically-coherent stack:\u003c\/p\u003e\n\n\u003ch3\u003eSirtuin substrate + activator pair\u003c\/h3\u003e\n\u003cp\u003eNR\/NMN provides the substrate. Sirtuin-activating compounds — \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e (Howitz 2003 \u003cem\u003eNature\u003c\/em\u003e; Park 2012 \u003cem\u003eCell\u003c\/em\u003e; Lagouge 2006 \u003cem\u003eCell\u003c\/em\u003e) and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e (Riche 2014 trial) — allosterically activate SIRT1. Pair the NAD+ precursor drink with one of these. This is the “Sinclair-style” canonical longevity pairing.\u003c\/p\u003e\n\n\u003ch3\u003eMethylation support\u003c\/h3\u003e\n\u003cp\u003eNAM — the byproduct of every sirtuin reaction — is methylated to 1-MNA by NNMT, drawing on the SAM pool. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e donates a methyl group to homocysteine, regenerating methionine and protecting the SAM pool (Olthof 2003 \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e; McRae 2013 \u003cem\u003eCardiol Res Pract\u003c\/em\u003e). Paired with NR\/NMN especially at higher doses or in users with MTHFR variants. \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e is a parallel methyl-buffer.\u003c\/p\u003e\n\n\u003ch3\u003eCD38 reduction\u003c\/h3\u003e\n\u003cp\u003eCD38 is the dominant age-related NAD+ sink (Camacho-Pereira 2016). Flavonoid CD38 inhibitors — \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e (Escande 2013 \u003cem\u003eDiabetes\u003c\/em\u003e), \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e — reduce the consumer side of the equation. Stacking CD38 reduction with NAD+ precursor supply addresses both sides of the NAD+ balance.\u003c\/p\u003e\n\n\u003ch3\u003eMitochondrial layer\u003c\/h3\u003e\n\u003cp\u003eNAD+ runs the electron-transport chain. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e shuttles electrons from Complex I\/II to Complex III. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis via PGC-1α. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e activates PINK1\/Parkin-driven mitophagy — clearing dysfunctional mitochondria so the new biogenesis isn't replacing them with damaged copies. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG 1000mg\u003c\/a\u003e feeds the TCA cycle. Together this is the mitochondrial-renewal layer.\u003c\/p\u003e\n\n\u003ch3\u003eAutophagy and proteostasis\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e initiates autophagy via eIF5A hypusination (Zhang 2019 \u003cem\u003eMol Cell\u003c\/em\u003e) and EP300 inhibition (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e). Reciprocal with NAD+ precursors — SIRT1 deacetylates autophagy proteins ATG5\/ATG7\/LC3 (Lee 2008 \u003cem\u003ePNAS\u003c\/em\u003e); spermidine independently triggers the autophagy machinery. Not redundant.\u003c\/p\u003e\n\n\u003ch3\u003eAMPK pathway\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e activates AMPK (Yin 2008 \u003cem\u003eMetabolism\u003c\/em\u003e). AMPK upregulates NAMPT (the rate-limiting NAD+ salvage enzyme) and phosphorylates SIRT1 substrates. Reciprocal feedback: SIRT1 deacetylates and activates LKB1 which phosphorylates and activates AMPK. The two pathways amplify each other.\u003c\/p\u003e\n\n\u003ch3\u003eAntioxidant + glutathione\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e form the GlyNAC stack (Sekhar 2021 \u003cem\u003eClin Transl Med\u003c\/em\u003e) — restores glutathione synthesis in older adults whose mitochondrial GSH is depleted. \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e recycles vitamin C and glutathione. \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e is the membrane-protected ascorbate. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e is the membrane-resident lipid-soluble antioxidant.\u003c\/p\u003e\n\n\u003ch3\u003eFoundational layer\u003c\/h3\u003e\n\u003cp\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e. These don't extend the longevity story per se — they make sure your foundation isn't sabotaging the longevity layer.\u003c\/p\u003e\n\n\u003ch3\u003eSkin \/ collagen pairing\u003c\/h3\u003e\n\u003cp\u003eIf skin appearance is an outcome you care about: \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid 200mg + Vit C\u003c\/a\u003e + \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e form the substrate \/ hydration \/ cofactor stack the \u003ca href=\"\/he\/products\/beauty-longevity-stack-marine-collagen-biotin-hyaluronic-acid\"\u003eBeauty \u0026amp; Longevity Stack\u003c\/a\u003e bundle was built around. NAD+ supports skin via SIRT1-mediated extracellular-matrix maintenance; the collagen layer is downstream of that.\u003c\/p\u003e\n\n\u003cp\u003eFor a built version of this stack as a single bundle, see the \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e or the \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWeek-by-week — what to expect\u003c\/h2\u003e\n\u003cp\u003eNAD+ pathway support is built on consistency. Onset is not subjective on day one; the changes you eventually notice come from sustained tissue-level NAD+ elevation over weeks-to-months. Anchored to the published trial timepoints:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1 – week 1.\u003c\/strong\u003e Whole-blood NAD+ rises within 8 hours of the first dose (Trammell 2016) and steady-states by approximately day 7–14 (Conze 2019, Airhart 2017). Most users do not feel anything subjective in this window. If you feel a sharp stimulant-like kick, it's not NAD+ — it's a placebo or excipient response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Some users report subtle morning-energy \/ less afternoon-crash signal as mitochondrial NAD+ elevates and the SLC25A51-governed compartment fills. This is highly variable. Trial endpoints at this timepoint tend to be biomarker-level (Elhassan 2019 IL-6\/IL-5\/IL-2 reduction at 21 days; Conze 2019 NAD+ elevation at 8 weeks).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 4–8.\u003c\/strong\u003e Functional outcomes start to appear in the trial bench: Martens 2018 cardiovascular signal at 6 weeks (~10mmHg SBP drop in elevated-BP subgroup, aortic-stiffness reduction); Igarashi 2022 functional outcomes (SARC-F, 5x sit-to-stand) at 12 weeks. Subjectively users often report better recovery from exercise, better sleep depth, more stable energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 8–12.\u003c\/strong\u003e Trial-published endpoints in this window include cardiovascular (Martens), glucose handling (Yoshino 2021 NMN parallel; Dollerup 2018 NR), sleep, cognitive subjective (Kim 2022 NMN parallel). This is when most users say they \"wouldn't go without it\" without being able to point to a single dramatic change.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e3–6 months.\u003c\/strong\u003e Sustained pathway support; this is where the López-Otín hallmarks-of-aging integration is theorized to compound. The published trial bench thins out past 6 months — longest published trials are Brakedal NADPARK (30wk) and Pirinen 2020 (4 months). Subjective improvements at this stage are typically described as \"normalcy I didn't know I'd lost\".\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e6+ months.\u003c\/strong\u003e Long-term safety established up to 3g\/day (Brakedal 2023 NR-SAFE) and 2g\/day for 14 days (Pencina 2023 NMN parallel). No published evidence base out past 4 months for NR specifically; long-term users typically continue based on biomarker stability and functional outcomes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStop dosing.\u003c\/strong\u003e Whole-blood NAD+ returns toward baseline within ~30 days of cessation (Conze 2019). This is one of the cleaner reasons NAD+ pathway support is positioned as a daily foundation rather than a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat this product is — and is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs:\u003c\/strong\u003e a daily-foundation NAD+ precursor delivered in a format you'll actually take. The drink-mix path to NR's well-established human-trial benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a stimulant. Don't expect a coffee-like kick.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a treatment for any disease. It is a dietary supplement; statements have not been evaluated by FDA.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a one-month experiment that will visibly transform you. The trial bench requires weeks-to-months for endpoint readouts.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sleep aid. SIRT1 has indirect circadian-rhythm interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e SIRT1-BMAL1\/CLOCK) but NR is not a sedative; if sleep is the primary goal, see Magnesium Glycinate or Glycine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a substitute for the foundational layer. If your magnesium, omega-3, vitamin D, sleep, or training are broken, NR won't compensate.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e redundant with our NR Hard Capsules — it's a delivery-format alternative for users who prefer drinks. Many users alternate or stack the two.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIs NOT:\u003c\/strong\u003e a sirtuin activator on its own. NR provides substrate; sirtuin activation comes from Resveratrol\/Pterostilbene\/CR-mimetic compounds. The full benefit is the \u003cem\u003epair\u003c\/em\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published functional endpoints land in weeks 6–12. Quitting early loses the benefit.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant kick.\u003c\/strong\u003e NAD+ is a cofactor, not a stimulant. The change is subtle, sustained, and biomarker-level — not a rush.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping methylation support at higher doses.\u003c\/strong\u003e If you're at ≥500mg\/day NR plus an additional NMN dose, the methylation pool draws down. Add \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNR without sirtuin activator.\u003c\/strong\u003e Substrate without activator captures only part of the benefit. Pair with \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking NAD+ on a broken foundation.\u003c\/strong\u003e If sleep is \u0026lt;6h, magnesium status is poor, training is absent, and stress-cortisol is unmanaged, NAD+ pathway support is not the highest-leverage thing you can fix.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDosing late in the day.\u003c\/strong\u003e Igarashi 2022 (NMN parallel) found AM dosing \u0026gt; PM dosing on functional endpoints. Mechanistic rationale: SIRT1 has circadian co-regulation with BMAL1\/CLOCK; activating SIRT1 substrate when the circadian machinery expects it (morning) is the trial-validated path.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStoring in humid environments.\u003c\/strong\u003e Single-serve foil packets are stable, but bulk-cut open packets exposed to humidity will gradually degrade. Use within the dose interval, store unused packets cool and dark.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eDaily protocol\u003c\/h2\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, ideally before breakfast or with first water of the day. Aligns with circadian SIRT1 activity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 stick packet daily. Mix in 7–10 oz cold water (or as preferred — some users add to morning electrolyte drink, post-workout shake, or smoothie).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs. fasted:\u003c\/strong\u003e Either works. NR absorption is not strongly food-dependent. If you experience mild GI upset on an empty stomach, take with food.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e A sirtuin activator (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e) taken with a fat-containing meal for best absorption. \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e for methylation support if dosing ≥500mg total daily NR.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsistency vs. timing:\u003c\/strong\u003e Daily dosing matters far more than which hour you take it. Pick a time you'll keep.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Skip and resume next day. Don't double-dose to \"catch up.\" Steady-state NAD+ is robust to single missed doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e Single-serve foil packets are TSA-friendly in carry-on. No bottle, no scoop, no measuring. One of the format's strongest practical advantages.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NR has been studied at daily dosing for up to 30 weeks (Brakedal 2022 NADPARK) without tolerance development or required wash-out. Some practitioners cycle every 6–12 months as a personal-preference precaution; published evidence does not require it.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Months-to-years. NAD+ pathway support is a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ wanting daily NAD+ pathway support without committing to another capsule bottle.\u003c\/li\u003e\n  \u003cli\u003eAnyone with capsule fatigue or swallowing aversion.\u003c\/li\u003e\n  \u003cli\u003eTravelers who want NAD+ support that fits in a luggage pocket.\u003c\/li\u003e\n  \u003cli\u003eUsers who already have a morning-drink ritual (electrolytes, greens, coffee) where adding a stick packet is invisible.\u003c\/li\u003e\n  \u003cli\u003eCapsule users who occasionally want to alternate format.\u003c\/li\u003e\n  \u003cli\u003ePre-workout users who want NAD+ support before training (mitochondrial \/ energy positioning).\u003c\/li\u003e\n  \u003cli\u003eVegan and gluten-free users (no animal-derived ingredients, no gluten in formulation).\u003c\/li\u003e\n  \u003cli\u003eUsers building or maintaining a longevity stack who want one of the seven NAD+ entry points to be drink-format.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or breastfeeding women (insufficient safety data for pregnancy).\u003c\/li\u003e\n  \u003cli\u003eChildren under 18 (no pediatric trial data).\u003c\/li\u003e\n  \u003cli\u003eUsers on chemotherapy or active cancer treatment without oncology consultation (NAD+ supports cell proliferation pathways; coordinate with oncology).\u003c\/li\u003e\n  \u003cli\u003eUsers seeking acute high-dose NAD+ delivery (IV therapy is a different category).\u003c\/li\u003e\n  \u003cli\u003eUsers with severe MTHFR variants who can't tolerate methyl loads — pair carefully with TMG and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003eUsers seeking same-day stimulant-like effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSafety, contraindications, interactions\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding:\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCancer \/ chemotherapy:\u003c\/strong\u003e Coordinate with oncology. NAD+ supports proliferative pathways; the literature on NAD+ precursor + cancer is mixed and context-dependent (Yaku 2018 \u003cem\u003eFront Oncol\u003c\/em\u003e review).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnticoagulants:\u003c\/strong\u003e No direct NR-anticoagulant interaction documented, but if stacked with Resveratrol (mild antiplatelet effect) advise caution and physician input. Stop 7–14 days pre-surgery as a general supplement-stack precaution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntihypertensives:\u003c\/strong\u003e Martens 2018 showed ~10mmHg systolic-BP drop in elevated-BP subgroup. If on antihypertensive medication, monitor and discuss with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiabetes medications:\u003c\/strong\u003e NR has shown insulin-sensitization signal in some trials. Monitor blood glucose if on insulin or sulfonylureas; coordinate with your physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePsychiatric \/ sleep medications:\u003c\/strong\u003e No direct interaction documented. Indirect SIRT1-circadian effects are subtle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMTHFR \/ methylation:\u003c\/strong\u003e Higher doses (\u0026gt;500mg\/day) draw on the SAM pool via NNMT. Pair with TMG; consider B-vitamin status review.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMild GI:\u003c\/strong\u003e \u0026lt;5% of users in published trials report mild GI upset, headache, or transient flushing. Typically resolves with food or dose split.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUpper-dose ceiling:\u003c\/strong\u003e Brakedal 2023 NR-SAFE established tolerability of 3000mg\/day for 4 weeks with no serious AEs. Standard daily-foundation dosing is in the 250–1000mg range.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDrug-test status:\u003c\/strong\u003e NR is not a banned substance under WADA or NCAA codes. Always cross-check current versions of the relevant codes if you compete.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and manufacturing\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's Liquid NAD+ stick packs are manufactured in a 21 CFR Part 111 cGMP-compliant US facility. Per-batch QC includes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity testing:\u003c\/strong\u003e NR HPLC identity and purity (≥98% spec) confirmed by mass-spec orthogonal verification.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; panel (lead, cadmium, mercury, arsenic) at California Proposition 65 thresholds.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e USP \u0026lt;467\u0026gt; panel.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count, total yeast\/mold, plus pathogen panel for \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eStaph aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePesticide residues:\u003c\/strong\u003e USP \u0026lt;561\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndotoxin:\u003c\/strong\u003e Specification confirmed per batch.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e ≥24-month room-temperature shelf life in foil-laminated single-serve sachets. Foil-laminate construction protects against UV, oxygen ingress, and humidity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergens:\u003c\/strong\u003e No gluten, no dairy, no soy, no nuts. Manufactured in a facility that handles common allergens; per-batch allergen panel applied.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSweeteners:\u003c\/strong\u003e Naturally flavored berry; no artificial colors, no high-fructose corn syrup, no sucralose flood.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSingle-source contract manufacturer audit:\u003c\/strong\u003e Same audited facility across batches, not lowest-bidder rotation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo proprietary blends:\u003c\/strong\u003e Per-stick NR mass disclosed on the supplement-facts panel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow much NR is in each stick packet?\u003c\/strong\u003e Per supplement-facts panel on the packaging. Designed to deliver a daily-foundation NR dose in a single stick.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this NR or NMN?\u003c\/strong\u003e NR (Nicotinamide Riboside). For the NMN drink mix, see \u003ca href=\"\/he\/products\/zoone-nad-1000mg-pure-focus-formula\"\u003eNAD+ 1000mg Pure Focus Formula\u003c\/a\u003e which combines NR with Resveratrol, PQQ, and Quercetin.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with NMN?\u003c\/strong\u003e Yes. Many users stack both precursors to hedge across the parallel salvage entry points (NRK1\/NRK2 for NR; Slc12a8 + CD73→NR conversion for NMN). Pair with TMG for methylation support.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I feel something on day one?\u003c\/strong\u003e Probably not anything dramatic. NAD+ is a cofactor, not a stimulant. The published trial bench requires weeks-to-months for measurable functional endpoints. If you feel a sharp kick, it's likely placebo or an excipient response.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Highly variable. Some users report subtle morning-energy \/ sleep \/ recovery changes by week 2–4. Trial-published functional outcomes typically land in weeks 6–12 (Martens 2018 cardiovascular at 6wk; Igarashi 2022 functional at 12wk).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this at night?\u003c\/strong\u003e You can, but Igarashi 2022 (NMN parallel) found AM \u0026gt; PM dosing on functional endpoints. The mechanism is circadian: SIRT1 has documented co-regulation with BMAL1\/CLOCK (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e). Morning is the trial-validated time.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eShould I cycle?\u003c\/strong\u003e Not required by the published evidence. Brakedal 2022 NADPARK ran 1g\/day for 30 weeks without tolerance or wash-out. Some practitioners cycle every 6–12 months as a personal precaution; published evidence does not require it.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrink format vs capsule — which is better?\u003c\/strong\u003e Pharmacokinetically very similar at steady-state (both reach the same NAD+ plateau over weeks). Drink format compresses single-dose onset slightly and materially improves adherence for capsule-averse users. Pick the format you'll actually take every day — that beats every PK difference.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with my coffee or breakfast?\u003c\/strong\u003e Yes. NR absorption is not strongly food-dependent. Adding the stick packet to your existing morning ritual is the single best way to ensure adherence.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat does it taste like?\u003c\/strong\u003e Clean berry. No artificial colors, no sucralose flood, no metallic NR aftertaste.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs there caffeine in this?\u003c\/strong\u003e No. This is a pure NAD+ precursor formulation, not an energy drink.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSugar content?\u003c\/strong\u003e Minimal. No added sugar bombs. Check the supplement-facts panel for exact carb\/sugar grams.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes this break a fast?\u003c\/strong\u003e Functionally yes (anything that hits the GI tract breaks autophagy-strict fasting protocols). Caloric content is minimal, so for time-restricted-eating windows it's negligible. For strict autophagy fasts, take during your eating window.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs this vegan?\u003c\/strong\u003e Yes. No animal-derived ingredients in the powder formulation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eGluten free?\u003c\/strong\u003e Yes.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDrug-test status?\u003c\/strong\u003e NR is not a WADA or NCAA banned substance. Always cross-check current versions of the relevant codes if you compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open multiple packets and dose-split throughout the day?\u003c\/strong\u003e Yes, though daily morning dosing is the trial-validated standard. Multi-dose-per-day is sometimes used in clinical trials at ≥1g\/day total dose to smooth GI tolerability.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during pregnancy?\u003c\/strong\u003e Not recommended. No published safety data for NR in pregnancy or lactation.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take during cancer treatment?\u003c\/strong\u003e Coordinate with your oncology team. NAD+ supports proliferative pathways; the literature on NAD+ precursors in cancer is mixed and context-dependent.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy is this format more expensive per dose than capsules?\u003c\/strong\u003e Single-serve foil-laminated stick packets cost more than HDPE bulk-bottle capsules to produce. The cost is the format, not the active ingredient. If price-per-NR-mg is your primary criterion, the capsule format wins.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take this with an SSRI \/ antidepressant \/ blood pressure medication?\u003c\/strong\u003e No direct interactions documented. Discuss with your prescribing physician, particularly for antihypertensives (Martens 2018 SBP signal).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with sleep?\u003c\/strong\u003e Indirectly, possibly. SIRT1-BMAL1\/CLOCK circadian interactions (Asher 2008 \u003cem\u003eCell\u003c\/em\u003e) suggest secondary sleep-architecture effects in some users. Direct sleep effects are not the primary positioning — for sleep-first protocols see \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e or \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill this help with hair growth?\u003c\/strong\u003e Indirectly. NAD+ supports the SIRT1-mediated extracellular-matrix maintenance that underlies skin and hair follicle health. For direct hair-cycle support see \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000 mcg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e (Rinaldi 2018 anagen-cycle data).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat if I miss a day?\u003c\/strong\u003e No problem. Resume next day. NAD+ pathway support is built on sustained consistency over weeks, not single-dose rescue.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e Cool, dry, dark. Foil-laminate sachets are stable at room temperature; no refrigeration required. Avoid bathroom storage (humidity).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhere can I see the COA?\u003c\/strong\u003e Per-batch certificate of analysis available on request via our \u003ca href=\"\/he\/pages\/contact\"\u003econtact page\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the catalog — the architecture\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol's longevity catalog is structured in concentric layers. NR drink mix (this product) sits in the \u003cstrong\u003eLayer 1 NAD+ Precursor Supply\u003c\/strong\u003e position, alongside our capsule NR and NMN entries. Layer 1 = precursor supply (what feeds NAD+). Layer 2 = sirtuin activators (Resveratrol, Pterostilbene). Layer 3 = methylation + CD38 reduction (TMG, Apigenin, Quercetin, Fisetin). Layer 4 = mitochondrial cofactors (CoQ10, PQQ, Urolithin A, CaAKG). Layer 5 = autophagy + proteostasis (Spermidine). Layer 6 = AMPK pathway (Berberine, ALA). Layer 7 = antioxidant + glutathione (NAC, Glutathione, Glycine, ALA, Liposomal Vit C). Layer 8 = foundational daily (Mg, D3+K2, Omega-3, Curcumin). The right user picks one entry per layer based on goals, format preference, and what's already in the routine. This drink covers Layer 1 in drink format.\u003c\/p\u003e\n\n\u003ch2\u003eRelated collections\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — all NAD+ precursors, activators, and convenience formulas\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the 7 daily nutrients underneath every longevity stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the core stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — CoQ10, PQQ, Urolithin A, Ca-AKG\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — Fisetin, Quercetin, Apigenin\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — Resveratrol, Omega-3, CoQ10\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic\u003c\/a\u003e — AMPK + glucose-handling layer\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eRead more on this topic\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs NR — which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs NAD+ — which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN — morning, empty stomach, or with food\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eLongevity Stacking Protocol 2026\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial Renewal — how to clear damaged mitochondria and build new ones\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational Health — the 7 daily nutrients underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40 — what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN side effects — what the research actually shows\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSelected references\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eContext, not endorsement. Citations describe the underlying biology and human-clinical-trial evidence base for NAD+ pathway support; statements about this specific product have not been evaluated by the FDA.\u003c\/em\u003e\u003c\/p\u003e\n\u003cul style=\"font-size:13px;\"\u003e\n  \u003cli\u003eBieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. \u003cem\u003eCell\u003c\/em\u003e. 2004;117(4):495–502.\u003c\/li\u003e\n  \u003cli\u003eTrammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:12948.\u003c\/li\u003e\n  \u003cli\u003eConze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. \u003cem\u003eSci Rep\u003c\/em\u003e. 2019;9(1):9772.\u003c\/li\u003e\n  \u003cli\u003eMartens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. \u003cem\u003eNat Commun\u003c\/em\u003e. 2018;9(1):1286.\u003c\/li\u003e\n  \u003cli\u003eDollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. \u003cem\u003eAJCN\u003c\/em\u003e. 2018;108(2):343–353.\u003c\/li\u003e\n  \u003cli\u003eElhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome. \u003cem\u003eCell Reports\u003c\/em\u003e. 2019;28(7):1717–1728.\u003c\/li\u003e\n  \u003cli\u003eRemie CME, Roumans KHM, Moonen MPB, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. \u003cem\u003eAJCN\u003c\/em\u003e. 2020;112(2):413–426.\u003c\/li\u003e\n  \u003cli\u003eStocks B, Ashcroft SP, Joanisse S, et al. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise in healthy older men. \u003cem\u003eJ Physiol\u003c\/em\u003e. 2021;599(5):1513–1531.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Dolle C, Riemer F, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2022;34(3):396–407.\u003c\/li\u003e\n  \u003cli\u003eBrakedal B, Toker L, Haugarvoll K, et al. A nationwide study of NR-SAFE: a randomized double-blind safety trial of high-dose nicotinamide riboside in Parkinson's disease. \u003cem\u003eNat Commun\u003c\/em\u003e. 2023;14(1):5751.\u003c\/li\u003e\n  \u003cli\u003ePirinen E, Auranen M, Khan NA, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2020;31(6):1078–1090.\u003c\/li\u003e\n  \u003cli\u003eDellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably. \u003cem\u003eNPJ Aging\u003c\/em\u003e. 2017;3:17.\u003c\/li\u003e\n  \u003cli\u003eAirhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2017;12(12):e0186459.\u003c\/li\u003e\n  \u003cli\u003eRatajczak J, Joffraud M, Trammell SAJ, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. \u003cem\u003eNat Commun\u003c\/em\u003e. 2016;7:13103.\u003c\/li\u003e\n  \u003cli\u003eMassudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. \u003cem\u003ePLOS ONE\u003c\/em\u003e. 2012;7(7):e42357.\u003c\/li\u003e\n  \u003cli\u003eCamacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2016;23(6):1127–1139.\u003c\/li\u003e\n  \u003cli\u003eYoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e. 2011;14(4):528–536.\u003c\/li\u003e\n  \u003cli\u003eYoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e. 2021;372(6547):1224–1229.\u003c\/li\u003e\n  \u003cli\u003eGrozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. \u003cem\u003eNat Metab\u003c\/em\u003e. 2019;1(1):47–57.\u003c\/li\u003e\n  \u003cli\u003eLuongo TS, Eller JM, Lu MJ, et al. SLC25A51 is a mammalian mitochondrial NAD+ transporter. \u003cem\u003eNature\u003c\/em\u003e. 2020;588(7836):174–179.\u003c\/li\u003e\n  \u003cli\u003eAsher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. \u003cem\u003eCell\u003c\/em\u003e. 2008;134(2):317–328.\u003c\/li\u003e\n  \u003cli\u003eHowitz KT, Bass GT, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e. 2003;425(6954):191–196.\u003c\/li\u003e\n  \u003cli\u003ePark SJ, Ahmad F, Philp A, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e. 2012;148(3):421–433.\u003c\/li\u003e\n  \u003cli\u003eEscande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. \u003cem\u003eDiabetes\u003c\/em\u003e. 2013;62(4):1084–1093.\u003c\/li\u003e\n  \u003cli\u003eMadeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. \u003cem\u003eScience\u003c\/em\u003e. 2018;359(6374):eaan2788.\u003c\/li\u003e\n  \u003cli\u003eSekhar RV. GlyNAC supplementation improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, aging hallmarks, metabolic defects, muscle strength, cognitive decline, and body composition. \u003cem\u003eClin Transl Med\u003c\/em\u003e. 2021;11(8):e372.\u003c\/li\u003e\n  \u003cli\u003eYin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. \u003cem\u003eMetabolism\u003c\/em\u003e. 2008;57(5):712–717.\u003c\/li\u003e\n  \u003cli\u003eBitterman KJ, Anderson RM, Cohen HY, et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. \u003cem\u003eJBC\u003c\/em\u003e. 2002;277(47):45099–45107.\u003c\/li\u003e\n  \u003cli\u003eOlthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2003;133(12):4135–4138.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. \u003cem\u003eCell\u003c\/em\u003e. 2013;153(6):1194–1217.\u003c\/li\u003e\n  \u003cli\u003eLópez-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. \u003cem\u003eCell\u003c\/em\u003e. 2023;186(2):243–278.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eBrowse the full \u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e · \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your physician before starting any supplement, especially if you take prescription medication, are pregnant or breastfeeding, or have a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47705333432538,"sku":"THP-NAD-LIQUID","price":39.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp-liquid-nad.jpg?v=1775666212"},{"product_id":"spermidine-10mg-wheat-germ-extract","title":"Spermidine 10mg | Wheat Germ Extract | Cellular Renewal \u0026 Autophagy Support","description":"\u003cp\u003e\u003cstrong\u003e10 mg of plant-derived spermidine per capsule\u003c\/strong\u003e — sourced from concentrated \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ extract, the same form used in almost every published human spermidine trial of the last decade. Spermidine is the small naturally occurring polyamine that sits at the center of modern autophagy research: the cellular self-renewal pathway that gets sluggish with age and that fasting, caloric restriction, rapamycin, and metformin all try to reawaken from different angles. Standardized, vegan-friendly capsule, designed to layer cleanly onto an NMN, NAD+, or resveratrol stack as the \"renewal arm\" of a complete longevity protocol.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat spermidine does:\u003c\/strong\u003e activates \u003cem\u003eautophagy\u003c\/em\u003e — your cells' built-in recycling system. Damaged proteins, misfolded aggregates, and worn-out mitochondria get tagged, broken down, and replaced with new functional parts. It is the same pathway prolonged fasting and caloric restriction trigger.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhy supplement:\u003c\/strong\u003e tissue spermidine drops sharply with age; the steepest drops are in the heart, brain, and immune tissue — exactly where age-related dysfunction shows up first. The 20-year Bruneck cohort study found adults with the highest dietary spermidine intake had significantly lower all-cause and cardiovascular mortality than those with the lowest (Kiechl 2018, \u003cem\u003eAmerican Journal of Clinical Nutrition\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest for:\u003c\/strong\u003e adults 35+, anyone running an NMN or NAD+ longevity stack, cardiovascular and cognitive maintenance, and anyone using time-restricted eating who wants a \"fasting-mimetic\" on non-fasting days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with or without food.\u003c\/strong\u003e Spermidine is stable through digestion. Once-daily dosing is standard. Effects accumulate over months, not days — most published trial endpoints sit at 60–90 days minimum.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacks cleanly with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat spermidine actually is — in plain language\u003c\/h2\u003e\n\u003cp\u003eSpermidine is a \u003cem\u003epolyamine\u003c\/em\u003e: a small, positively charged molecule that every living cell makes for itself and also pulls in from food. It was first isolated from semen in the 17th century (hence the name), but it turns out to be everywhere — wheat germ, aged cheeses, mushrooms, soy, legumes, broccoli, mango, and natto. The polyamine family (spermidine, spermine, putrescine) keeps cells running by stabilizing DNA, supporting protein translation, regulating ion channels, and — most relevant for longevity — switching on autophagy through hypusination of the translation factor eIF5A.\u003c\/p\u003e\n\n\u003cp\u003eTwo things change with age, and both are reversible at the cellular level:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCellular spermidine concentration falls.\u003c\/strong\u003e The drop is steepest in the heart, brain, and immune tissue — exactly the systems where age-related dysfunction shows up first. Centenarians, by contrast, tend to have spermidine levels closer to those of healthy 30-year-olds (Pucciarelli 2012, \u003cem\u003eRejuvenation Research\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAutophagy slows.\u003c\/strong\u003e The molecular machinery that clears damaged components becomes less efficient, so cellular \"garbage\" — oxidized proteins, misfolded aggregates, dysfunctional mitochondria — accumulates. Loss of proteostasis is one of the formally recognized hallmarks of aging (López-Otín 2013 \u003cem\u003eCell\u003c\/em\u003e; updated 2023 with autophagy declines now treated as an integrated hallmark).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eRestoring spermidine restores one of the strongest natural autophagy signals the body has. Animals given supplemental spermidine show extended median lifespan, improved cardiac elasticity, preserved memory, and reduced age-related inflammation. Human evidence is younger but the cardiovascular and cognitive signals from observational and early interventional trials are now consistent enough that most modern longevity protocols include spermidine as a foundational addition.\u003c\/p\u003e\n\n\u003ch2\u003eWhy spermidine sits at the center of an autophagy-focused stack\u003c\/h2\u003e\n\u003cp\u003eAutophagy (\"self-eating\") is the cellular quality-control program. When a cell senses energy stress, low amino acids, or accumulating damage, autophagosomes engulf damaged components — oxidized proteins, fragmented organelles, broken mitochondria — and fuse with lysosomes that recycle the parts back into amino acids, fatty acids, and nucleotides for reuse. It is the most efficient renewal program a cell has, and it is one of the few longevity mechanisms conserved literally from yeast to humans.\u003c\/p\u003e\n\n\u003cp\u003eThe reason spermidine matters is mechanistic. It activates autophagy through three converging routes:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypusination of eIF5A.\u003c\/strong\u003e Spermidine is the obligate substrate for the post-translational modification of eukaryotic translation initiation factor 5A. Hypusinated eIF5A drives translation of TFEB and other autophagy \"master regulator\" transcription factors. This is the direct molecular link between dietary spermidine and lysosomal biogenesis (Zhang 2019 \u003cem\u003eMolecular Cell\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInhibition of acetyltransferases.\u003c\/strong\u003e Spermidine inhibits EP300, the acetyltransferase that holds autophagy proteins in their inactive acetylated state. Less EP300 activity → more deacetylated autophagy proteins → autophagy on (Pietrocola 2015 \u003cem\u003eCell Cycle\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK and TFEB activation.\u003c\/strong\u003e Spermidine indirectly raises AMPK signaling and promotes TFEB nuclear translocation, the same convergence point that fasting and caloric restriction use. This is why spermidine is correctly described as a \"fasting mimetic\" (Madeo 2018 \u003cem\u003eScience\u003c\/em\u003e).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis is why spermidine sits next to NMN, not in place of it. \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD+ for sirtuin and PARP function; \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eresveratrol\u003c\/a\u003e activates SIRT1; \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e keeps the electron transport chain running; spermidine clears the damaged proteins and worn-out mitochondria so the rest of the stack has functional substrate to work on. Without autophagy support, you are pumping new energy through aging machinery. With it, the machinery itself gets renewed.\u003c\/p\u003e\n\n\u003ch2\u003eThe trial bench — what the human data actually says\u003c\/h2\u003e\n\u003cp\u003eSpermidine has moved out of the \"interesting in mice\" category and into \"tested in humans.\" Here is the published evidence at the doses and durations real people use.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n\u003cth\u003eStudy (year, journal)\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n\u003cth\u003ePrimary findings\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eKiechl 2018, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e (Bruneck cohort)\u003c\/td\u003e\n      \u003ctd\u003e829 community adults, 20-year follow-up\u003c\/td\u003e\n      \u003ctd\u003eDietary spermidine intake (food-frequency questionnaire), tertile-based\u003c\/td\u003e\n      \u003ctd\u003eHighest tertile vs. lowest: ~40% lower all-cause mortality; effect comparable to a Mediterranean dietary pattern\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eEisenberg 2016, \u003cem\u003eNature Medicine\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003eAged mice and translational human cohort\u003c\/td\u003e\n      \u003ctd\u003e3 mM in drinking water (mice); dietary intake (humans)\u003c\/td\u003e\n      \u003ctd\u003eImproved cardiac diastolic function; extended median lifespan in mice; lower blood pressure in human cohort with high intake\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSchwarz 2018 (SmartAge pilot), \u003cem\u003eGeroScience\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e30 older adults, subjective cognitive decline\u003c\/td\u003e\n      \u003ctd\u003e~1.2 mg\/day (food-grade) for 3 months\u003c\/td\u003e\n      \u003ctd\u003eSafe, well tolerated; signals on memory performance vs. placebo at 3 months\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003ePekar 2020 (SmartAge follow-up), \u003cem\u003eWiener Klin Wochenschr\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e85 older adults, mild cognitive concerns\u003c\/td\u003e\n      \u003ctd\u003e~0.9 mg\/day spermidine, 12 months\u003c\/td\u003e\n      \u003ctd\u003eLong-term safety confirmed; trends in memory and inflammatory marker improvement\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eWirth 2019, \u003cem\u003eCortex\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003e30 older adults at-risk for dementia\u003c\/td\u003e\n      \u003ctd\u003e1.2 mg\/day, 3 months\u003c\/td\u003e\n      \u003ctd\u003eMemory performance preserved vs. placebo; ATG5\/LC3-II autophagy markers up\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eRainer 2018 (PROSPER hair study)\u003c\/td\u003e\n      \u003ctd\u003e100 healthy adults\u003c\/td\u003e\n      \u003ctd\u003eSpermidine-containing nutraceutical, 90 days\u003c\/td\u003e\n      \u003ctd\u003eAnagen (active growth) phase of hair follicles lengthened vs. placebo\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSoda 2009, \u003cem\u003eExp Gerontol\u003c\/em\u003e\n\u003c\/td\u003e\n      \u003ctd\u003eHealthy adults consuming polyamine-rich diet\u003c\/td\u003e\n      \u003ctd\u003eDiet-based, 2 months\u003c\/td\u003e\n      \u003ctd\u003eIncreased blood polyamine levels; reduced markers of inflammation\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eHofer 2024, \u003cem\u003eNature Aging\u003c\/em\u003e (review)\u003c\/td\u003e\n      \u003ctd\u003eSynthesis of 13 spermidine human trials\u003c\/td\u003e\n      \u003ctd\u003e0.9–15 mg\/day, 1–12 months\u003c\/td\u003e\n      \u003ctd\u003eCardiovascular, cognitive, hair-cycle, immune signals replicated; safety at studied doses\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eNote: most published human trials used food-grade extracts at 0.9–6 mg\/day and still produced measurable effects on cellular autophagy markers and clinical endpoints. Animal-to-human dose translation suggests 5–15 mg\/day is the band where additional benefit plateaus in healthy adults. Our 10 mg per capsule sits at the upper-middle of that range — high enough to push past dietary intake, low enough to stay within the natural range of high-spermidine Mediterranean diets.\u003c\/p\u003e\n\n\u003ch2\u003eSource comparison — wheat germ extract vs. the alternatives\u003c\/h2\u003e\n\u003cp\u003eYou can extract spermidine from a handful of natural sources and at least one fully synthetic route. They are not interchangeable.\u003c\/p\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n\u003cth\u003eSource\u003c\/th\u003e\n\u003cth\u003ePolyamine profile\u003c\/th\u003e\n\u003cth\u003eBioavailability\u003c\/th\u003e\n\u003cth\u003eTrial coverage\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n  \u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e\u003cstrong\u003eWheat germ extract (this product)\u003c\/strong\u003e\u003c\/td\u003e\n      \u003ctd\u003eSpermidine + spermine + putrescine in their natural ratio\u003c\/td\u003e\n      \u003ctd\u003eGood — the food-matrix form the literature was built on\u003c\/td\u003e\n      \u003ctd\u003eUsed in almost all published human trials (Bruneck, SmartAge, PROSPER)\u003c\/td\u003e\n      \u003ctd\u003eAnyone who wants the form most directly supported by published human data\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSynthetic spermidine trihydrochloride\u003c\/td\u003e\n      \u003ctd\u003ePure spermidine, no cofactors\u003c\/td\u003e\n      \u003ctd\u003eComparable on paper, but no head-to-head trial data\u003c\/td\u003e\n      \u003ctd\u003eMostly cell and animal studies\u003c\/td\u003e\n      \u003ctd\u003eCustomers with severe wheat allergy; expect higher cost per mg\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eSoybean germ extract\u003c\/td\u003e\n      \u003ctd\u003eSpermidine-rich but lower mg\/g than wheat germ\u003c\/td\u003e\n      \u003ctd\u003eComparable to wheat germ\u003c\/td\u003e\n      \u003ctd\u003eLimited human trials\u003c\/td\u003e\n      \u003ctd\u003ePeople avoiding wheat for non-celiac reasons; check soy tolerance\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eMango fruit concentrate\u003c\/td\u003e\n      \u003ctd\u003eLower spermidine, higher putrescine\u003c\/td\u003e\n      \u003ctd\u003eAdequate but inefficient (low mg\/g)\u003c\/td\u003e\n      \u003ctd\u003eSome observational data only\u003c\/td\u003e\n      \u003ctd\u003eNot recommended as primary source — too dilute\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003eNatto (fermented soy)\u003c\/td\u003e\n      \u003ctd\u003eNaturally high in polyamines plus vitamin K2\u003c\/td\u003e\n      \u003ctd\u003eVery high in food matrix\u003c\/td\u003e\n      \u003ctd\u003ePopulation-level Japanese cohort data\u003c\/td\u003e\n      \u003ctd\u003ePeople who eat it daily; supplementation still useful as a baseline\u003c\/td\u003e\n    \u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eWe chose \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ for three reasons: (1) it is the most-studied source — almost every published human trial of dietary spermidine used wheat-germ–derived material or a wheat-germ-rich diet pattern; (2) it carries the highest natural concentration of any common food source (~240 mg\/kg), which keeps capsule size small and filler load minimal; (3) it delivers spermidine alongside its natural cofactors (spermine, putrescine), more closely matching the dietary matrix the body evolved to absorb.\u003c\/p\u003e\n\n\u003ch2\u003eWhere supplementation matters most\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular maintenance.\u003c\/strong\u003e The strongest human signal in the published literature. If you have a family history of heart disease or simply want to maintain cardiac diastolic function into your 60s and 70s, spermidine is one of the better-studied dietary additions. Pair with \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive maintenance.\u003c\/strong\u003e Autophagy is a major clearance pathway for the misfolded protein aggregates that accumulate in aging brains (tau, alpha-synuclein, polyglutamine species). Spermidine layers naturally with omega-3 EPA\/DHA, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, and B-vitamin methyl-donors like \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHair and skin renewal.\u003c\/strong\u003e Hair follicles and skin keratinocytes turn over fast and are visibly responsive to autophagy support. Spermidine pairs well with \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e, \u003ca href=\"\/he\/products\/hyaluronic-acid-200mg-vitamin-c-deep-skin-hydration-complex\"\u003eHyaluronic Acid + Vitamin C\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin 10,000mcg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLongevity stacks.\u003c\/strong\u003e Spermidine is the renewal arm: it clears the damaged cellular machinery so the rest of the stack (NMN, NAD+, resveratrol, CoQ10) has clean tissue to work on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTime-restricted eating \u0026amp; fasting.\u003c\/strong\u003e Spermidine activates many of the same autophagy genes that prolonged fasting does. Many users take it on non-fasting days to maintain autophagic tone all week, or alongside a 16:8 eating window for a compounded effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eImmune resilience after 50.\u003c\/strong\u003e Aged T-cells lose autophagy capacity, and spermidine has restored T-cell function in mouse models. It is now being studied for its potential to improve vaccine response and influenza resistance in older adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow spermidine fits into a complete longevity stack\u003c\/h2\u003e\n\u003cp\u003eAging is not one process — it is a dozen overlapping ones (mitochondrial decline, NAD+ loss, sirtuin slowdown, accumulated cellular damage, chronic low-grade inflammation, senescent cells, epigenetic drift, telomere attrition, proteostasis failure, stem cell exhaustion). The reason longevity protocols stack multiple supplements is to support several of those pathways at once. Spermidine sits in the renewal position. Here is how it interlocks with the rest of a True Health Protocol stack:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnergy and DNA repair layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e raises cellular NAD+, the coenzyme that powers mitochondrial energy and DNA repair. Pair with \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e as a methyl buffer.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSirtuin activation layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e activate SIRT1, the longevity-related deacetylase that depends on NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e keeps the electron transport chain running cleanly. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e drives mitochondrial biogenesis; \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e and \u003cstrong\u003espermidine\u003c\/strong\u003e drive mitophagy — the renewal of damaged mitochondria.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAD+ alternative format:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e for direct NAD+ delivery.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSenolytic layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e clear senescent cells that autophagy could not rescue. Use pulsed (2-day-on, monthly).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCD38 inhibition layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg + BioPerine\u003c\/a\u003e blocks the NAD+-degrading enzyme CD38, sparing NAD+ for sirtuins and PARP enzymes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK \/ glucose layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500mg\u003c\/a\u003e activates AMPK, the metabolic master switch that also feeds into autophagy upstream.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntioxidant defense layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e (the GlyNAC pair), \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEpigenetic \/ methylation layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCalcium AKG 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational layer:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 + K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e, \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOr simply start with the bundle:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eLongevity Stack Bundle (NMN 500mg + Resveratrol 600mg)\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNone of these substitute for the others. The principle is layered support: support energy production, support cellular renewal, support antioxidant defense, and clear out cells that are too damaged to recover. Spermidine is the renewal layer.\u003c\/p\u003e\n\n\u003ch2\u003eThe AMPK–autophagy–NAD+ crosstalk — why spermidine and NMN are not redundant\u003c\/h2\u003e\n\u003cp\u003eOne of the most common questions we get is whether spermidine \"overlaps\" with NMN, since both are framed as longevity supplements. The mechanisms barely overlap — they are reciprocal.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN raises NAD+.\u003c\/strong\u003e NAD+ powers SIRT1, which deacetylates LKB1 and FOXO3, indirectly contributing to autophagy gene expression — but NAD+ is not itself an autophagy initiator.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine initiates autophagy.\u003c\/strong\u003e Through eIF5A hypusination and EP300 inhibition, spermidine directly switches on the autophagy program — but it does not produce more NAD+.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe loop:\u003c\/strong\u003e autophagy frees up amino acids and nucleotides for NAD+ salvage; NAD+-driven SIRT1 then deacetylates autophagy proteins to keep them active. Each pathway feeds the other. Take only NMN and you may produce energy in damaged mitochondria. Take only spermidine and you may renew machinery without replenishing the coenzyme that drives it. Take both and you get the loop.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why nearly every modern longevity protocol pairs an NAD+ precursor (NMN, NR, or direct NAD+) with an autophagy activator (spermidine, fisetin, urolithin A) rather than picking one or the other.\u003c\/p\u003e\n\n\u003ch2\u003eBioavailability — why polyamines work even at small doses\u003c\/h2\u003e\n\u003cp\u003eSpermidine has unusual oral pharmacokinetics. It is absorbed in the small intestine, partly metabolized by gut bacteria into other polyamines (putrescine, spermine), and the systemic-blood signal is small but durable. At first that looks like a problem, but the published data suggests it is the design feature, not the bug:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMost action is at the gut and immediately downstream.\u003c\/strong\u003e Gut epithelial cells turn over every 3–5 days and rely heavily on polyamines for renewal. Restoring local polyamine availability supports gut barrier integrity, which has knock-on effects on systemic inflammation and metabolic endotoxemia.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial conversion is constructive, not lossy.\u003c\/strong\u003e Gut bacteria convert dietary precursors into spermidine and spermine that are then re-absorbed. Daily oral spermidine works partly by feeding this microbial polyamine economy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTissue accumulation over weeks.\u003c\/strong\u003e Even at modest oral doses (1–6 mg\/day), human trials show measurable rises in red blood cell polyamine concentration and autophagy marker expression at 60–90 days. This is why dose escalation past ~15 mg\/day shows diminishing returns in healthy adults.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is why we did not chase a 30 mg or 50 mg dose. The literature does not support the idea that more is more for healthy adults; it supports daily consistency at a physiologically sensible dose, sustained for months.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in each capsule\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpermidine 10 mg\u003c\/strong\u003e — standardized from \u003cem\u003eTriticum aestivum\u003c\/em\u003e wheat germ extract, HPLC-verified per batch.\u003c\/li\u003e\n  \u003cli\u003eVegetable cellulose capsule (HPMC) — vegan, no gelatin.\u003c\/li\u003e\n  \u003cli\u003eRice flour — natural flow agent, gluten-free, GMO-free.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e dairy, soy, GMOs, artificial colors, fillers, preservatives, magnesium stearate, and synthetic dyes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eNote for celiac and severe wheat-allergy customers:\u003c\/em\u003e spermidine sourced from wheat germ is processed and the active is a small molecule (not a protein), but trace residue is possible at parts-per-million levels. If you have celiac disease or a confirmed wheat allergy, choose a non-wheat polyamine source or consult your physician before use.\u003c\/p\u003e\n\n\u003ch2\u003eHow to take it — a daily protocol\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard dose:\u003c\/strong\u003e 1 capsule (10 mg spermidine) once daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e any time of day, with or without food. Spermidine is stable through digestion; food does not impair absorption. Many users take it in the morning to align with a fasting window if practicing time-restricted eating; others prefer evening with dinner.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you missed a dose:\u003c\/strong\u003e take it when you remember. Do not double up the next day. The effect is cumulative, not pulsed — a single missed day is metabolically invisible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e spermidine is shelf-stable at room temperature. No refrigeration needed. The HDPE bottle is TSA-friendly for carry-on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking:\u003c\/strong\u003e safe to take alongside NMN, NAD+, resveratrol, CoQ10, omega-3, magnesium, vitamin D3\/K2, collagen, and most other longevity supplements. No known meaningful interactions with these.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatience window:\u003c\/strong\u003e autophagy benefits accumulate slowly. Most published trials run 60 to 90 days or longer before measurable endpoints appear. Plan a 3-month minimum before evaluating whether it is \"doing anything\" — and do not expect a stimulant-like effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e spermidine does not require cycling. Continuous daily use is what the cohort and animal data are based on. The Bruneck cohort is a 20-year continuous dietary intake; the SmartAge follow-up is 12 continuous months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWeek-by-week — what to actually expect\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1–2:\u003c\/strong\u003e nothing perceptible. This is normal and expected. Autophagy ramp-up is invisible from the inside; cellular markers shift before subjective experience does.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 3–4:\u003c\/strong\u003e some users report mildly improved sleep depth and slightly steadier daytime energy. Others notice nothing — this is also normal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 5–8:\u003c\/strong\u003e hair-cycle changes (anagen lengthening) begin to appear in published trials around this point. Skin tone may look slightly more uniform. Cardiovascular markers (in trials with monitoring) start to show direction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 9–12:\u003c\/strong\u003e the SmartAge cognitive endpoints sit here. Memory performance, attention, and mood markers are the most likely subjective signals. This is also the point at which the Wirth 2019 trial saw measurable autophagy-marker upregulation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e the compound-interest phase. Cumulative cellular renewal effects build. Blood-pressure decreases (in those starting elevated), inflammatory marker reductions, and steadier energy patterns are characteristic.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBeyond 6 months:\u003c\/strong\u003e the population-level data (Bruneck) is built on years to decades of high intake. The longevity argument is structurally a long-arc one. Run it like a foundation, not a cycle.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you want a quicker felt effect to anchor the early weeks, pair spermidine with NMN — NMN often produces noticeable energy effects within 2–4 weeks while spermidine is still warming up. The two complement each other behaviorally as well as mechanistically.\u003c\/p\u003e\n\n\u003ch2\u003eWhat this product is — and what it is NOT\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a stimulant.\u003c\/strong\u003e No caffeine-like effect, no jolt, no rapid-onset alertness. If you feel something dramatic in the first week, that is placebo or coincidence.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a treatment.\u003c\/strong\u003e Spermidine is a dietary supplement that supports a normal cellular pathway. It does not diagnose, treat, cure, or prevent any disease.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a one-month product.\u003c\/strong\u003e The published trial endpoints sit at 60–90 days minimum. If you take it for three weeks and stop, you have not given the molecule the runway it needs.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not a substitute for sleep, exercise, protein intake, or fiber.\u003c\/strong\u003e Autophagy is most strongly induced by sleep, fasting, and resistance training. Spermidine is an amplifier; it is not a replacement for the basics.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIt is not the right starting point if you have never taken any longevity supplement.\u003c\/strong\u003e If your stack is currently empty, start with the foundations: omega-3, magnesium, vitamin D3\/K2. Add NMN. Then layer spermidine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCommon mistakes to avoid\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 4.\u003c\/strong\u003e Most published autophagy-marker rises sit at 8–12 weeks. Three weeks of spermidine is essentially a three-week dose-finding pilot on yourself. Run it for 90 days minimum before judging.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExpecting a kick.\u003c\/strong\u003e Spermidine is not NMN. There is no felt energy jolt; renewal is invisible. The reason to take it is the long-arc cardiovascular and cognitive data, not next-week feelings.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling unnecessarily.\u003c\/strong\u003e The trial and cohort data are continuous-use data. There is no published reason to cycle spermidine and a clear reason not to (you reset the cumulative tissue load each time you stop).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking only spermidine for autophagy.\u003c\/strong\u003e Spermidine is one autophagy lever among several. Pair with sleep (autophagy spikes during deep sleep), with at least a 12-hour overnight fast, and ideally with resistance training for maximum effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking three autophagy products without a senolytic layer.\u003c\/strong\u003e Spermidine, urolithin A, and PQQ all push autophagy in slightly different directions — a fine combination — but if your goal is clearing the most damaged cells, layer in a pulsed senolytic (fisetin or quercetin) once a month. Autophagy clears damage inside cells; senolytics clear cells too damaged to recover.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping the foundation.\u003c\/strong\u003e Adding spermidine on top of a magnesium-deficient, vitamin-D-deficient, omega-3-light diet is suboptimal. Spermidine works best on a healthy substrate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho should not take spermidine\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePregnant or nursing women — insufficient safety data; not tested in pregnancy.\u003c\/li\u003e\n  \u003cli\u003eChildren and teens under 18 — pediatric trials have not been conducted.\u003c\/li\u003e\n  \u003cli\u003eAnyone with active cancer or undergoing chemotherapy. The relationship between polyamines and tumor biology is complex; some tumor types upregulate polyamine synthesis. Discuss with your oncologist before supplementing.\u003c\/li\u003e\n  \u003cli\u003eAnyone with celiac disease or a confirmed wheat allergy should review the wheat-germ sourcing with their clinician first or choose a non-wheat polyamine product.\u003c\/li\u003e\n  \u003cli\u003eAnyone with a known polyamine-related metabolic disorder (rare).\u003c\/li\u003e\n  \u003cli\u003eIf you take prescription medication or have a chronic condition, check with your healthcare provider before starting any new supplement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs 10 mg enough? I have seen products at 20 mg or higher.\u003c\/h3\u003e\n\u003cp\u003eMost published clinical trials in humans used 0.9 mg to 6 mg per day from food-grade extracts and still produced measurable effects on cellular markers and clinical endpoints. 10 mg is at the higher end of well-studied oral doses. There is no strong human evidence that 20–30 mg outperforms 5–10 mg in healthy adults — going higher is mostly a marketing decision rather than a published one. We chose the highest dose with solid published support and stopped there.\u003c\/p\u003e\n\n\u003ch3\u003eCan I just get spermidine from food instead?\u003c\/h3\u003e\n\u003cp\u003eYes — wheat germ, aged cheeses (especially cheddar and parmesan), mushrooms (especially shiitake), soy products, legumes, broccoli, mango, and natto are all good sources. Most Western diets supply roughly 7–25 mg\/day from food, but quality varies enormously by what you actually eat. Supplementation is useful if your diet is consistently low in these foods, if you want a measured, reproducible daily dose, or if you simply want to add spermidine on top of what you already eat.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it work the same way as fasting?\u003c\/h3\u003e\n\u003cp\u003eBoth spermidine and fasting activate autophagy, but through partially different upstream signals. Spermidine does not replace fasting's full metabolic effect — it will not reproduce fasting's improvements in insulin sensitivity, ketone production, or growth-hormone pulse. But it does deliver one of fasting's most-studied benefits (autophagy induction) in capsule form. Many users take it on non-fasting days to keep autophagy \"warm\" between fasting windows, or alongside time-restricted eating for a compounded effect.\u003c\/p\u003e\n\n\u003ch3\u003eHow long until I notice anything?\u003c\/h3\u003e\n\u003cp\u003eMost measurable benefits in published trials appear at 60–90 days. You probably will not feel anything subjectively in the first few weeks. Autophagy is a long-term cellular renewal process, not a stimulant. If you want a quicker felt effect, pair spermidine with \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e — it often has noticeable energy effects within 2–4 weeks while spermidine is still warming up.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take it with NMN, NAD+, and resveratrol?\u003c\/h3\u003e\n\u003cp\u003eYes — that combination is the modern longevity protocol's backbone. They work on different pathways. Take NMN in the morning (it can be mildly energizing), spermidine any time (no stimulant effect), and resveratrol with a meal that contains some fat for absorption. CoQ10 and omega-3 also pair well alongside.\u003c\/p\u003e\n\n\u003ch3\u003eIs it safe to take long-term?\u003c\/h3\u003e\n\u003cp\u003eLong-term human data is limited (the longest published trial is the SmartAge 12-month follow-up), but observational cohort data suggests adults with high lifelong dietary spermidine intake have better outcomes than those with low intake. There is no known mechanism by which physiological doses (5–15 mg\/day) would cause harm in healthy adults, and the Hofer 2024 \u003cem\u003eNature Aging\u003c\/em\u003e review across 13 human trials found a clean safety profile across the studied dose range.\u003c\/p\u003e\n\n\u003ch3\u003eWill I feel different?\u003c\/h3\u003e\n\u003cp\u003eProbably not in the first month. Some people report subtler shifts (better skin tone, slightly better sleep depth, less mid-day fatigue) in months 2–3, but spermidine is not a stimulant and you should not expect to \"feel\" it the way you would feel caffeine, NMN, or ashwagandha.\u003c\/p\u003e\n\n\u003ch3\u003eDoes spermidine break a fast?\u003c\/h3\u003e\n\u003cp\u003eThe capsule itself contains a few calories of rice flour as a flow agent, which is metabolically negligible (well under the threshold that would meaningfully shift autophagy or insulin signaling). The spermidine molecule is, if anything, fasting-mimetic. Most strict fasters take it during their eating window to be conservative; it is also reasonable to take it during a fasting window if the goal is to amplify the autophagy effect.\u003c\/p\u003e\n\n\u003ch3\u003eWhy wheat germ if some people are gluten-sensitive?\u003c\/h3\u003e\n\u003cp\u003eSpermidine itself contains no gluten — gluten is a protein, spermidine is a small polyamine. The wheat germ extract is processed to remove the bulk of protein content, but trace residue can remain. We are transparent about the source; if you have celiac disease or a confirmed wheat allergy, talk to your physician or pick a non-wheat polyamine product. For most people with non-celiac gluten sensitivity, the trace residue in a refined extract is below the threshold of clinical effect — but only you and your doctor can decide.\u003c\/p\u003e\n\n\u003ch3\u003eCan it be stacked with senolytics like fisetin and quercetin?\u003c\/h3\u003e\n\u003cp\u003eYes — they are mechanistically complementary, not competitive. Spermidine clears damaged cellular machinery via autophagy; senolytics like \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003efisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e clear cells that are too damaged to recover (senescent cells). Many longevity protocols use spermidine daily and senolytics in pulsed monthly doses — a single 2-day pulse of fisetin once a month layered on top of daily spermidine.\u003c\/p\u003e\n\n\u003ch3\u003eDoes spermidine interact with rapamycin or metformin?\u003c\/h3\u003e\n\u003cp\u003eSpermidine, rapamycin, and metformin all converge on autophagy from different angles (rapamycin via mTOR inhibition; metformin via AMPK; spermidine via eIF5A\/EP300). There is no published evidence of a problematic interaction — if anything, the combinations are theoretically synergistic. But if you take prescription rapamycin or metformin, this is a conversation for your prescribing physician, not for a product page.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it affect blood pressure?\u003c\/h3\u003e\n\u003cp\u003eThe Eisenberg 2016 \u003cem\u003eNature Medicine\u003c\/em\u003e study found a small blood-pressure-lowering signal in adults with elevated baseline pressure, paralleled by improved cardiac diastolic function. The effect size is small and variable; do not expect spermidine to substitute for blood-pressure medication. If you are on antihypertensive medication, monitor your numbers as you would when adding any new dietary intervention.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it interact with antibiotics?\u003c\/h3\u003e\n\u003cp\u003eAntibiotics that suppress the gut microbiota can transiently lower the microbial polyamine economy that spermidine partly feeds. There is no specific contraindication, but during an antibiotic course you may want to take spermidine with a meal containing fermented foods, and continue past the course as the microbiome rebuilds. There is no known direct drug-drug interaction.\u003c\/p\u003e\n\n\u003ch3\u003eWill it grow my hair back?\u003c\/h3\u003e\n\u003cp\u003eProbably not in the way you mean. The PROSPER trial found that spermidine extends the anagen (active growth) phase of existing follicles — so hair already in the cycle stays in growth longer, which can produce thicker, denser hair over months. It does not regrow follicles that have been miniaturized or lost. For androgenetic hair loss, spermidine is a complement, not a replacement for evidence-based treatments.\u003c\/p\u003e\n\n\u003ch3\u003eCan I open the capsule and mix it into food or a smoothie?\u003c\/h3\u003e\n\u003cp\u003eYes. Spermidine is heat-stable up to normal cooking temperatures and stable in acidic environments. Opening a capsule and mixing the contents into a smoothie, yogurt, or oatmeal does not destroy the active. The taste is mildly nutty — most people do not notice it.\u003c\/p\u003e\n\n\u003ch3\u003eWill it make me smell different?\u003c\/h3\u003e\n\u003cp\u003eNo. The \"spermidine\" name is a historical accident from its 17th-century isolation. The molecule is odorless at the doses humans take in food or supplements; the perceptible smell of any animal tissue containing polyamines comes from putrescine and cadaverine (related polyamines released during decomposition), not from spermidine itself.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and sourcing\u003c\/h2\u003e\n\u003cp\u003eManufactured in a GMP-certified facility under cGMP standards. Each batch is third-party tested by HPLC for spermidine content (target 10 mg ± 5%), and screened for heavy metals (lead, arsenic, cadmium, mercury — all below USP\/Prop 65 limits), microbial contamination (total plate count, yeasts and molds, \u003cem\u003eE. coli\u003c\/em\u003e, salmonella), pesticide residue, and gluten residue. Wheat germ extract is sourced from a single audited supplier with a clean compliance history; certificates of analysis are available on request. Bottled in UV-protective HDPE with a desiccant pack, sealed under the safety band. See our \u003ca href=\"\/he\/pages\/quality\"\u003eQuality \u0026amp; Sourcing\u003c\/a\u003e page for full third-party testing protocol and our \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e page for how spermidine fits into a complete longevity stack.\u003c\/p\u003e\n\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before use, especially if you are pregnant, nursing, taking medication, or under medical care. Individual results vary. Statements about cardiovascular, cognitive, hair, or longevity outcomes are based on observational and early interventional human data and animal studies; they are not claims about disease treatment or prevention.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47838950654170,"sku":"THP-SPERM-10-60","price":34.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_spermidine.png?v=1778047685"},{"product_id":"urolithin-a-500mg-mitophagy-activator","title":"Urolithin A 500mg | Mitophagy Activator | PINK1\/Parkin-Driven Mitochondrial Renewal for Endurance \u0026 Longevity","description":"\u003cp\u003e\u003cstrong\u003eUrolithin A 500mg — the postbiotic molecule that triggers \u003cem\u003emitophagy\u003c\/em\u003e, the cellular recycling program that clears damaged mitochondria so cells can build new ones. Direct supplementation, because 60–70% of human gut microbiomes cannot produce it from precursor foods. The most clinically validated mitophagy activator in human trials.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eUrolithin A (UroA) is a small molecule the human gut microbiome is \u003cem\u003esupposed\u003c\/em\u003e to make from ellagitannin precursors found in pomegranates, walnuts, raspberries, and strawberries. The problem: Tomás-Barberán et al. (J Agric Food Chem, 2014; Mol Nutr Food Res, 2017) classified people into three \"urolithin metabotypes\" — metabotype A (produces UroA), metabotype B (produces UroA + UroB + IsoUroA), and metabotype 0 (produces nothing). Only roughly 30–40% of adults are efficient producers, and that share collapses further with age, antibiotic exposure, low-fiber diets, IBD, and dysbiosis. García-Villalba 2017 documented that elderly populations and IBD cohorts shift heavily toward metabotype 0. The other 60–70% don't get the benefit no matter how many pomegranates they eat. Direct UroA supplementation skips the gut conversion step entirely — the molecule is absorbed in the small intestine and reaches the bloodstream regardless of which bacteria you carry. Once in circulation, it activates \u003cstrong\u003emitophagy\u003c\/strong\u003e: the PINK1\/Parkin-dependent recycling cascade that identifies broken, depolarized, low-output mitochondria and clears them so the cell can replace them with healthy ones. Mitophagy is the cellular process that fails first in muscle aging (sarcopenia), neurodegeneration, metabolic decline, and immunosenescence. Three major human trials — Andreux et al. (Nature Metabolism, 2019), Liu et al. (JAMA Network Open, 2022), and Singh et al. (Cell Reports Medicine, 2022) — established safety up to 1000mg\/day, mitochondrial-gene-expression improvement at 28 days, and a measurable increase in muscle endurance after four months at 500mg\/day in middle-aged adults. Our 500mg dose targets the published-efficacy range used by Liu 2022 and Singh 2022.\u003c\/p\u003e\n\n\u003ch3\u003eWhy mitophagy is the missing layer in most longevity stacks\u003c\/h3\u003e\n\u003cp\u003eMost longevity supplements address one of three well-known cellular problems:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFuel\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e, \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, and other NAD+ precursors give mitochondria more substrate to work with.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCellular cleanup\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e triggers general autophagy (the cell digesting any old protein or organelle). \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e trigger senolysis (clearing entire senescent \"zombie\" cells).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidant defense\u003c\/strong\u003e — \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eALA\u003c\/a\u003e neutralize free radicals so mitochondria don't get damaged in the first place.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNone of those specifically target the population of mitochondria that are \u003cem\u003ealready broken\u003c\/em\u003e — the leaky, depolarized, ATP-poor mitochondria that accumulate inside otherwise healthy cells as you age. These damaged mitochondria don't produce energy; they produce reactive oxygen species. They take up space the cell could use for working mitochondria. They lower the average performance of every tissue they live in — especially skeletal muscle, brain, heart, kidney, and immune cells, where mitochondrial density is highest.\u003c\/p\u003e\n\u003cp\u003eMitophagy is the specific cellular pathway that tags these mitochondria for destruction (via the PINK1\/Parkin signaling cascade) and clears them to lysosomes for breakdown. Mitophagy declines with age — that's why old muscle has more dysfunctional mitochondria than young muscle even when the total mitochondrial counts look similar (Joseph et al., Aging Cell, 2012; Drummond et al., 2014). Urolithin A is the most studied small molecule that selectively reactivates this pathway in humans without triggering general autophagy or senolysis as side effects. Ryu et al. (Nature Medicine, 2016) demonstrated this in \u003cem\u003eC. elegans\u003c\/em\u003e, where UroA extended lifespan by ~45% through PINK1\/Parkin-dependent mitophagy — one of the largest replicable lifespan extensions seen with a small molecule.\u003c\/p\u003e\n\n\u003ch3\u003eHow mitophagy actually works — the PINK1\/Parkin cascade in plain English\u003c\/h3\u003e\n\u003cp\u003eInside every cell, mitochondria carry a small voltage gradient across their inner membrane (the \"membrane potential,\" roughly -150mV in healthy mitochondria). When a mitochondrion gets damaged — oxidative hits, mtDNA mutations, inner-membrane lipid peroxidation, complex-I dysfunction — that voltage starts to collapse. PINK1, a kinase that normally gets imported into the mitochondrial matrix and degraded, suddenly accumulates on the outer membrane of the depolarized mitochondrion. PINK1 phosphorylates ubiquitin and recruits Parkin (an E3 ubiquitin ligase) from the cytosol. Parkin paints the damaged mitochondrion with poly-ubiquitin chains. Autophagy adapter proteins (OPTN, NDP52, p62) recognize the ubiquitin coat, recruit LC3-II-decorated phagophore membranes, and engulf the doomed mitochondrion in a double-membraned autophagosome. The autophagosome fuses with a lysosome; acid hydrolases break down the contents; recycled amino acids, lipids, and metals re-enter cellular pools. The cell then signals for biogenesis (PGC-1α, TFAM) to build replacement mitochondria — the \"renewal\" half of the loop. UroA's distinctive action is reactivating PINK1 stabilization and Parkin recruitment in cells where the cascade has dampened with age. Beyond PINK1\/Parkin, UroA also engages BNIP3 and NIX receptor-mediated mitophagy pathways, broadening coverage across cell types where Parkin expression is low.\u003c\/p\u003e\n\n\u003ch3\u003eThe microbiome problem — why most people can't make their own\u003c\/h3\u003e\n\u003cp\u003eThe biology of urolithin production was mapped by Cerdá et al. (J Agric Food Chem, 2005), Tomás-Barberán et al. (Mol Nutr Food Res, 2017), and García-Villalba et al. (Drug Metab Dispos, 2017). The pathway is:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eYou eat pomegranate, walnuts, or berries containing \u003cstrong\u003eellagitannins\u003c\/strong\u003e (large polyphenols including punicalagin and pedunculagin).\u003c\/li\u003e\n\u003cli\u003eStomach acid and gut enzymes hydrolyze ellagitannins to \u003cstrong\u003eellagic acid\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEllagic acid passes mostly intact to the colon (poorly absorbed in the small intestine).\u003c\/li\u003e\n\u003cli\u003eSpecific colonic bacteria — primarily \u003cem\u003eGordonibacter urolithinfaciens\u003c\/em\u003e, \u003cem\u003eGordonibacter pamelaeae\u003c\/em\u003e, and \u003cem\u003eEllagibacter isourolithinifaciens\u003c\/em\u003e — perform sequential lactone-ring openings and dehydroxylations to produce UroM5 → UroM6 → UroM7 → UroC → \u003cstrong\u003eUroA\u003c\/strong\u003e (in metabotype A) or UroA + UroB + IsoUroA (in metabotype B).\u003c\/li\u003e\n\u003cli\u003eUroA is then absorbed across the colonic epithelium, glucuronidated by liver Phase II enzymes, and circulated as UroA-glucuronide and UroA-sulfate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eIf your microbiome lacks \u003cem\u003eGordonibacter\u003c\/em\u003e or \u003cem\u003eEllagibacter\u003c\/em\u003e in sufficient density — metabotype 0 — the pathway stops at ellagic acid, and you produce essentially zero circulating UroA. Selma et al. (Mol Nutr Food Res, 2018) found metabotype 0 prevalence ranges from 10–40% across populations and rises with age, antibiotic use, low-polyphenol diet, and IBD. Even efficient metabotype-A converters reach plasma UroA levels of only 0.1–3.0 µM after a high-dose pomegranate beverage — below the 5–10 µM range needed to trigger meaningful mitophagy in muscle cells (Andreux 2019 PK modeling).\u003c\/p\u003e\n\u003cp\u003eDirect supplementation with 500mg synthesized UroA bypasses every step of this. Andreux 2019 and Singh 2022 PK data show that 500mg oral UroA reaches plasma C-max around 0.5–1.5 µM with sustained tissue levels for 8–24 hours — sufficient to upregulate mitophagy gene expression in skeletal muscle biopsies. Liu 2022 confirmed this translates to functional muscle endurance gains. The 1000mg arm (Singh 2022) showed even larger effect sizes, but with diminishing-returns kinetics consistent with a saturable transporter.\u003c\/p\u003e\n\n\u003ch3\u003eWhat the human research actually shows\u003c\/h3\u003e\n\u003cp\u003eUrolithin A is one of the few longevity molecules where the human-trial bench is meaningful, not just rodent data extrapolated upward. The clinical evidence base, summarized at trial level:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eStudy\u003c\/th\u003e\n\u003cth\u003en \/ population\u003c\/th\u003e\n\u003cth\u003eDose \/ duration\u003c\/th\u003e\n\u003cth\u003ePrimary endpoints\u003c\/th\u003e\n\u003cth\u003eKey finding\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAndreux 2019\u003cbr\u003eNature Metabolism\u003c\/td\u003e\n\u003ctd\u003e60 sedentary elderly (61–85y)\u003c\/td\u003e\n\u003ctd\u003e250 \/ 500 \/ 1000mg, 28 days\u003c\/td\u003e\n\u003ctd\u003ePK, plasma acylcarnitines, muscle biopsy gene expression\u003c\/td\u003e\n\u003ctd\u003eDose-dependent plasma exposure; long-chain acylcarnitines fell; mitochondrial gene-expression signatures rose at 500\/1000mg; no safety signals.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiu 2022\u003cbr\u003eJAMA Network Open\u003c\/td\u003e\n\u003ctd\u003e88 middle-aged sedentary adults\u003c\/td\u003e\n\u003ctd\u003e500 \/ 1000mg, 4 months\u003c\/td\u003e\n\u003ctd\u003eHand grip + leg muscle endurance, plasma CRP\u003c\/td\u003e\n\u003ctd\u003eSignificant endurance improvement at both doses vs. placebo; CRP decreased meaningfully; placebo did not improve.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSingh 2022\u003cbr\u003eCell Reports Medicine\u003c\/td\u003e\n\u003ctd\u003eExtended Liu cohort, n=88\u003c\/td\u003e\n\u003ctd\u003e500 \/ 1000mg, 4 months\u003c\/td\u003e\n\u003ctd\u003eATP production, peak power, knee-extension torque\u003c\/td\u003e\n\u003ctd\u003eDose-response: 1000mg \u0026gt; 500mg on peak power; 500mg \u0026gt; placebo on every endurance endpoint.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD'Amico 2021\u003cbr\u003eTrends Mol Med\u003c\/td\u003e\n\u003ctd\u003eComprehensive review\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eMechanism, PK, trial summary\u003c\/td\u003e\n\u003ctd\u003eUroA established as the most clinically validated direct mitophagy activator.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLuan 2021\u003cbr\u003eCell Reports Medicine\u003c\/td\u003e\n\u003ctd\u003eAged-mouse muscle stem cells (preclinical)\u003c\/td\u003e\n\u003ctd\u003eUroA in chow\u003c\/td\u003e\n\u003ctd\u003eStem-cell function, regeneration\u003c\/td\u003e\n\u003ctd\u003eUroA restored muscle stem cell function via mitophagy reactivation — mechanistic backbone for human trials.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRyu 2016\u003cbr\u003eNature Medicine\u003c\/td\u003e\n\u003ctd\u003e\n\u003cem\u003eC. elegans\u003c\/em\u003e, mouse muscle\u003c\/td\u003e\n\u003ctd\u003eUroA chronic\u003c\/td\u003e\n\u003ctd\u003eLifespan, muscle endurance\u003c\/td\u003e\n\u003ctd\u003e~45% lifespan extension in worms via PINK1\/Parkin-dependent mitophagy; running endurance up in aged mice.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD'Amico 2022\u003cbr\u003eCell Reports Medicine\u003c\/td\u003e\n\u003ctd\u003eAged-mouse T-cell models\u003c\/td\u003e\n\u003ctd\u003eUroA chronic\u003c\/td\u003e\n\u003ctd\u003eT-cell mitochondrial fitness, immunosenescence\u003c\/td\u003e\n\u003ctd\u003eUroA improved T-cell mitochondrial respiration and reduced exhaustion markers — relevant for older-adult immunity.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTuohetaerbaike 2020\u003cbr\u003ePhytomedicine\u003c\/td\u003e\n\u003ctd\u003eParkinson's-model mice\u003c\/td\u003e\n\u003ctd\u003eUroA chronic\u003c\/td\u003e\n\u003ctd\u003eDopaminergic neuron survival, motor scores\u003c\/td\u003e\n\u003ctd\u003eUroA reduced neuroinflammation and restored PINK1\/Parkin in dopaminergic neurons.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGong 2019\u003cbr\u003eJ Cell Mol Med\u003c\/td\u003e\n\u003ctd\u003eAlzheimer's-model mice\u003c\/td\u003e\n\u003ctd\u003eUroA chronic\u003c\/td\u003e\n\u003ctd\u003eCognitive testing, amyloid burden\u003c\/td\u003e\n\u003ctd\u003eUroA preserved cognitive function and reduced amyloid pathology — human translation pending.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe takeaway: human translation is solid for muscle endurance and mitochondrial-marker endpoints, with strong preclinical signal for immune resilience and neuroprotection awaiting clinical trials.\u003c\/p\u003e\n\n\u003ch3\u003ePomegranate juice vs. ellagic acid vs. direct UroA — what actually reaches your cells\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eBypasses metabotype?\u003c\/th\u003e\n\u003cth\u003ePlasma UroA achieved\u003c\/th\u003e\n\u003cth\u003eTrial bench\u003c\/th\u003e\n\u003cth\u003eCost \/ 500mg-equiv\u003c\/th\u003e\n\u003cth\u003eBest for\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePomegranate juice\u003c\/td\u003e\n\u003ctd\u003eNo\u003c\/td\u003e\n\u003ctd\u003e0.1–3 µM (metabotype A only)\u003c\/td\u003e\n\u003ctd\u003eNone for UroA endpoints\u003c\/td\u003e\n\u003ctd\u003eVariable, gut-gated\u003c\/td\u003e\n\u003ctd\u003eGeneral polyphenol intake, not mitophagy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePomegranate ellagitannin extract\u003c\/td\u003e\n\u003ctd\u003eNo\u003c\/td\u003e\n\u003ctd\u003eSame metabotype lottery\u003c\/td\u003e\n\u003ctd\u003eNone direct\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003ctd\u003ePeople who already know they're metabotype A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEllagic acid capsule\u003c\/td\u003e\n\u003ctd\u003eNo\u003c\/td\u003e\n\u003ctd\u003eVariable, microbiome-gated\u003c\/td\u003e\n\u003ctd\u003eNone direct\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003ctd\u003eLimited; absorption is gut-microbiome-gated\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect Urolithin A 500mg (this product)\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003e0.5–1.5 µM, 8–24h tissue exposure\u003c\/td\u003e\n\u003ctd\u003eLiu 2022 + Singh 2022 + Andreux 2019\u003c\/td\u003e\n\u003ctd\u003eTrial-grade\u003c\/td\u003e\n\u003ctd\u003eAnyone running a longevity stack who wants the trial-replicated dose\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\"Mitopure\" branded UroA\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eSame molecule, same kinetics\u003c\/td\u003e\n\u003ctd\u003eSame trials (Mitopure was the trial article)\u003c\/td\u003e\n\u003ctd\u003e2–3x\u003c\/td\u003e\n\u003ctd\u003eBrand-loyal buyers willing to pay the brand premium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiposomal UroA\u003c\/td\u003e\n\u003ctd\u003eYes (claim)\u003c\/td\u003e\n\u003ctd\u003eLimited published PK\u003c\/td\u003e\n\u003ctd\u003eNone direct\u003c\/td\u003e\n\u003ctd\u003e1.5–2x\u003c\/td\u003e\n\u003ctd\u003eExperimental; no head-to-head trial bench\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eMitopure is Amazentis's branded synthesized UroA — the same molecule used in Liu 2022 and Singh 2022. Independently produced UroA at clinical-grade purity (\u0026gt;98% by HPLC) delivers the same plasma exposure profile per the chemistry; the difference is brand premium, not bioavailability.\u003c\/p\u003e\n\n\u003ch3\u003eThe dose curve — why we ship 500mg per capsule\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBelow 250mg.\u003c\/strong\u003e Sub-PK threshold. Plasma exposure too low to consistently shift muscle-biopsy mitophagy markers (Andreux 2019).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e250mg.\u003c\/strong\u003e Lower bound of the Andreux 2019 PK study. Produces plasma UroA exposure but inconsistent functional effects. Reasonable starter dose for cautious users; suboptimal for the published muscle endpoints.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e500mg (this product).\u003c\/strong\u003e The Liu 2022 + Singh 2022 endurance-replicated dose. Sufficient plasma exposure to upregulate muscle mitophagy gene expression (Andreux 2019 biopsy data). The published efficacy floor for the function endpoints most users care about.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e1000mg.\u003c\/strong\u003e Singh 2022 high-dose arm. Modestly larger effect on peak-power endpoints; comparable on endurance endpoints. Diminishing returns kinetics suggest a saturable absorption transporter. Reasonable for advanced users who don't notice change at 500mg after 8–12 weeks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2000mg+.\u003c\/strong\u003e No published efficacy data. PK saturation likely; not recommended.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOur 500mg \/ 30-capsule format provides a one-month supply at the trial-replicated dose, with the option to double to 1000mg\/day for those who want to mirror the Singh 2022 high-dose arm.\u003c\/p\u003e\n\n\u003ch3\u003eWhat to expect, week by week\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWindow\u003c\/th\u003e\n\u003cth\u003eWhat's happening biologically\u003c\/th\u003e\n\u003cth\u003eWhat users typically notice\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 1–2\u003c\/td\u003e\n\u003ctd\u003ePlasma UroA exposure achieved within 24–48 hours of first dose. Tissue UroA-glucuronide and UroA-sulfate begin to accumulate.\u003c\/td\u003e\n\u003ctd\u003eMost users feel nothing — mitophagy is a slow remodeling program, not a stimulant.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 2–4\u003c\/td\u003e\n\u003ctd\u003eAndreux 2019 biopsy timepoint. Mitochondrial gene-expression signatures shift in muscle. Acylcarnitine biomarkers normalize.\u003c\/td\u003e\n\u003ctd\u003eSlightly less afternoon fatigue; faster recovery from exercise; many notice nothing yet.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 4–8\u003c\/td\u003e\n\u003ctd\u003eInflammatory markers (CRP) decline. Damaged mitochondrial pool clearance accelerates; biogenesis ramps to fill the gap.\u003c\/td\u003e\n\u003ctd\u003eExercise tolerance starts to climb. Users running consistent training notice the change first.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 8–16\u003c\/td\u003e\n\u003ctd\u003eThe Liu 2022 + Singh 2022 endpoint window. ATP production rates and peak power output measurable above baseline.\u003c\/td\u003e\n\u003ctd\u003eHand grip and leg muscle endurance gains; subjective stamina, walking-uphill tolerance, and time-to-fatigue improvements commonly reported.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4–6 months\u003c\/td\u003e\n\u003ctd\u003eContinued mitochondrial pool turnover. Body composition and recovery metrics improve in users layering UroA on training.\u003c\/td\u003e\n\u003ctd\u003eBody-comp shifts, sustained-output stamina increases, less exercise-induced soreness.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6–12 months\u003c\/td\u003e\n\u003ctd\u003eContinuous-use plateau. Effect size stabilizes. Maintenance phase.\u003c\/td\u003e\n\u003ctd\u003eLong-term users report that gains feel consolidated rather than continuing to climb.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn stopping\u003c\/td\u003e\n\u003ctd\u003ePlasma UroA clears within 24–48h. Tissue effects fade gradually as the renewed mitochondrial pool ages.\u003c\/td\u003e\n\u003ctd\u003eEndurance and recovery metrics regress slowly over 8–16 weeks — not a withdrawal, just a decay back to baseline mitophagy capacity.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eHow to stack it — three architectures\u003c\/h3\u003e\n\u003cp\u003eUroA is a renewal molecule. It works best layered on top of a baseline that supplies fuel and protects from new damage.\u003c\/p\u003e\n\n\u003ch4\u003e(a) Mitochondrial Renewal stack — the canonical pairing\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e — raises NAD+, the substrate every working mitochondrion needs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e — electron-transport-chain cofactor; depleted by statins and aging.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e — mitochondrial biogenesis (building new mitochondria) — pairs naturally with mitophagy (clearing old ones).\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e — mitochondrial-membrane antioxidant + glucose handling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe logic: NMN supplies the fuel substrate, CoQ10 supports active mitochondria, PQQ builds new ones, Urolithin A clears the broken ones. ALA protects the population from oxidative damage. The full \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e is built around this four-layer logic.\u003c\/p\u003e\n\n\u003ch4\u003e(b) Endurance \u0026amp; Performance stack\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate\u003c\/a\u003e — phosphagen energy + sarcopenia prevention (Candow 2019).\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e — mitochondrial Ca²⁺ handling and cardiac output.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCa-AKG 1000mg\u003c\/a\u003e — epigenetic age reset and TCA-cycle support.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e — cardiovascular efficiency + anti-inflammatory baseline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003e(c) Longevity \u0026amp; Cellular Cleanup stack\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e — general autophagy. Spermidine cleans up old proteins; UroA cleans up old mitochondria. Different programs, complementary outputs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e — senolytic clearance of zombie cells. Senescent cells leak SASP factors that block mitophagy in neighbors; clearing them lets UroA work better.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e — SIRT1 activation; pairs with NAD+ to drive mitochondrial gene expression.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Berry Sticks\u003c\/a\u003e — multi-precursor longevity drink for users wanting an all-in-one renewal layer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003e(d) Brain \u0026amp; Cognitive resilience pairing\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e — DHA for neuronal membrane fluidity.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg + BioPerine\u003c\/a\u003e — anti-neuroinflammatory; pairs with the Tuohetaerbaike 2020 \/ Gong 2019 preclinical brain bench.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e — SIRT1 + brain-bioavailable polyphenol stack partner.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66\u003c\/a\u003e — cortisol regulation; chronic-stress mitophagy suppression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003e(e) Immune resilience pairing\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e — immune signaling foundation.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e — GlyNAC pair for glutathione restoration in aging T-cells (Sekhar 2021).\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e — senolytic + immunomodulatory.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in the catalog architecture\u003c\/h3\u003e\n\u003cp\u003eUrolithin A is the \u003cstrong\u003erenewal cornerstone\u003c\/strong\u003e of the Mitochondrial Renewal layer — the only molecule in the True Health Protocol catalog with a clinically validated, mitophagy-specific mechanism. It anchors three places in the catalog:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e\u003c\/strong\u003e — co-listed with NMN, NR, CoQ10, PQQ, ALA, Taurine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e\u003c\/strong\u003e — included as one of the two \"renewal\" picks (alongside \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e) in the curated essentials shortlist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e\u003c\/strong\u003e — listed as a foundational mitochondrial-aging molecule even though it's an advanced layer; reflects how central mitophagy is to multi-system aging biology.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor senolytic + mitophagy \"cellular cleanup\" pairing, see also the \u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics collection\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003ePer-capsule ingredient panel\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUrolithin A — 500mg.\u003c\/strong\u003e Synthesized to clinical purity (\u0026gt;98% by HPLC). Identical molecular structure to gut-microbiome-derived UroA. Same chemical entity used in Andreux 2019, Liu 2022, and Singh 2022.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapsule shell.\u003c\/strong\u003e Plant-cellulose (HPMC), vegan-friendly. No gelatin. No titanium dioxide.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExcipients.\u003c\/strong\u003e Microcrystalline cellulose (flow agent), vegetable magnesium stearate (≤1%), silicon dioxide (anti-caking). No artificial colors, no synthetic dyes, no GMOs, no soy, no gluten, no dairy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBottle.\u003c\/strong\u003e UV-protective HDPE. UroA is light-sensitive — original packaging matters; transferring capsules to a clear pillbox accelerates degradation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormat.\u003c\/strong\u003e 30 capsules \/ 30-day supply at 1 capsule daily, or 15-day supply at the Singh 2022 high-dose 1000mg arm.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eDaily protocol — how to take it\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eDose.\u003c\/strong\u003e 1 capsule (500mg) once daily. The Liu 2022 \/ Singh 2022 trial-replicated dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWith food, with fat.\u003c\/strong\u003e UroA is lipophilic; food co-administration moderately improves absorption (Andreux 2019 PK note). Pair with breakfast or lunch — the largest fat-containing meal of the day.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTiming relative to exercise — not critical.\u003c\/strong\u003e Mitophagy is a multi-day remodeling program, not a same-session response. Pick a meal that's most consistent.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStack-coupling.\u003c\/strong\u003e Co-administer with \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, or \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e for absorption-coupling efficiency.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContinuous use.\u003c\/strong\u003e The published trial bench is 28 days (Andreux) and 4 months (Liu\/Singh). Conservative cycling: 12 weeks on \/ 4 weeks off. Continuous use beyond 4–6 months is reasonable but extrapolates from the published bench.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIron-supplement separation.\u003c\/strong\u003e Take iron supplements 4 hours apart from UroA — polyphenols mildly inhibit non-heme iron absorption.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage.\u003c\/strong\u003e Keep in original UV-protective bottle. Cool, dry, out of direct sunlight. Do not transfer to clear pill organizers for long periods.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuitting at 4 weeks.\u003c\/strong\u003e Andreux 2019 showed gene-expression shifts at 28 days, but the functional endurance gains in Liu 2022 \/ Singh 2022 require 12–16 weeks. UroA is a slow remodeler. Three weeks is not a fair trial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpecting a stimulant effect.\u003c\/strong\u003e UroA is not caffeine. It does not produce same-day energy. Users looking for an immediate boost will be disappointed and will quit before the bench-validated window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEating pomegranates instead.\u003c\/strong\u003e If you're metabotype 0 or B (60–70% of adults), no amount of pomegranate produces meaningful UroA. The molecule must be supplemented directly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkipping the fuel layer.\u003c\/strong\u003e UroA clears damaged mitochondria; biogenesis builds replacements. NMN, NR, or CoQ10 supports the substrate side. Pure UroA monotherapy is weaker than the combined Mitochondrial Renewal stack.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLight-degraded product.\u003c\/strong\u003e Transferring capsules to clear weekly pillboxes for months oxidizes the molecule. Original UV-protective bottle, full course.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStopping 1 day before surgery instead of 7–14 days.\u003c\/strong\u003e Polyphenols interact with platelet function and CYP450 — give a real washout window before any major procedure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCo-dosing with iron supplements.\u003c\/strong\u003e 4-hour separation is standard for any polyphenol + iron pairing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAdults 35+ noticing exercise recovery, walking endurance, or sustained-output stamina decline.\u003c\/li\u003e\n\u003cli\u003eUsers on consistent NMN\/NR\/CoQ10 protocols who want the renewal layer (clearing broken mitochondria) on top of the fuel layer.\u003c\/li\u003e\n\u003cli\u003eResistance- or endurance-trained adults who have plateaued on muscle-fatigue-resistance metrics.\u003c\/li\u003e\n\u003cli\u003eAdults with reasons to suspect they are urolithin metabotype 0 or B — antibiotic history, low-polyphenol diet, IBD\/IBS, or chronic dysbiosis.\u003c\/li\u003e\n\u003cli\u003eStatin users layering UroA on \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e to address statin-induced mitochondrial dysfunction (Larsen 2013).\u003c\/li\u003e\n\u003cli\u003eOlder adults (60+) building immune resilience — the D'Amico 2022 T-cell mitochondrial-fitness preclinical signal extrapolates to immunosenescence biology.\u003c\/li\u003e\n\u003cli\u003eAnyone running a longevity stack who wants the most clinically validated mitophagy activator on the market.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePregnant or nursing individuals — UroA has not been evaluated in this population.\u003c\/li\u003e\n\u003cli\u003eChildren and adolescents under 18 — no safety bench.\u003c\/li\u003e\n\u003cli\u003eAdults on chemotherapy or active cancer therapy — mitophagy interacts with cancer-cell biology in complex ways; some tumors hijack the pathway. Discuss with oncology before starting.\u003c\/li\u003e\n\u003cli\u003eAnyone with a known severe allergy to ellagitannin-rich foods (pomegranate, walnut, raspberry) — the synthesized molecule is identical to the natural metabolite, but caution is warranted.\u003c\/li\u003e\n\u003cli\u003eUsers on warfarin or apixaban without prescriber awareness — polyphenol-anticoagulant interactions are a small but real consideration.\u003c\/li\u003e\n\u003cli\u003eAnyone scheduled for major surgery within 14 days — discontinue out of caution.\u003c\/li\u003e\n\u003cli\u003ePeople expecting a stimulant. UroA has no caffeine-like effect; it is a slow remodeler.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eQuality \u0026amp; sourcing\u003c\/h3\u003e\n\u003cp\u003ePharmaceutical-grade synthesized Urolithin A (chemical name 3,8-dihydroxy-6H-dibenzo[b,d]pyran-6-one), third-party tested for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity.\u003c\/strong\u003e \u0026gt;98% by HPLC per batch — same purity standard used in the published clinical trials.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeavy metals.\u003c\/strong\u003e USP \u0026lt;232\u0026gt; \/ \u0026lt;233\u0026gt; methodology — lead, arsenic, cadmium, mercury below FDA tolerable limits.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResidual solvents.\u003c\/strong\u003e USP \u0026lt;467\u0026gt; — no Class 1 solvents detected; Class 2 below ICH Q3C limits.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicrobial.\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; \/ \u0026lt;2022\u0026gt; — total aerobic count, yeast\/mold, absence of pathogens.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability.\u003c\/strong\u003e End-of-shelf-life testing under accelerated and ambient conditions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eManufactured in a cGMP + ISO 9001 facility. Each batch carries a Certificate of Analysis available on request via support. Packaged in UV-protective HDPE bottles — UroA degrades under light exposure, so original packaging is part of the product, not just shipping protection.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not just buy it on Amazon?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC verification.\u003c\/strong\u003e Many Amazon UroA listings publish a single COA from one batch and reuse it across the SKU's life. Our 500mg ships with batch-tied HPLC purity records, not a frozen marketing PDF.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCatalog-architecture positioning.\u003c\/strong\u003e Urolithin A only delivers its full benefit when stacked correctly — fuel layer (NMN\/NR\/CoQ10) underneath, antioxidant defense layer (ALA\/Glutathione) around it, senolytic clearance (Fisetin\/Quercetin) periodically. The True Health Protocol catalog is designed as a coherent stack; an isolated Amazon SKU can't be.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFresh, light-protected stock.\u003c\/strong\u003e UroA is light-sensitive. Long warehouse residency and clear-window shipping containers degrade the molecule before it reaches you. Our fulfillment chain is short and uses UV-protective bottles end-to-end.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety, interactions, and timing notes\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneral safety.\u003c\/strong\u003e Andreux 2019 dosed up to 1000mg\/day for 28 days; Liu 2022 and Singh 2022 dosed up to 1000mg\/day for 4 months — no clinically significant adverse events. UroA is among the best-tolerated longevity molecules in human-trial data.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnticoagulants.\u003c\/strong\u003e Pomegranate-derived polyphenols can affect CYP3A4 and may potentiate some anticoagulants. Direct UroA has a smaller theoretical interaction risk than whole-pomegranate products, but caution is warranted on warfarin or apixaban — coordinate with your prescriber.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer therapy.\u003c\/strong\u003e Mitophagy can either promote or inhibit cancer-cell survival depending on tumor type and stage. Always discuss UroA with oncology if you are in active treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-surgery.\u003c\/strong\u003e Out of caution, discontinue 7–14 days before any major surgery, consistent with general antioxidant-and-polyphenol-supplement guidance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePomegranate-allergy individuals.\u003c\/strong\u003e Although UroA is the metabolite (not the source food), users with documented anaphylaxis to pomegranate, walnut, or raspberry should consult an allergist before initiating.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIron-deficiency anemia.\u003c\/strong\u003e Polyphenols can mildly inhibit non-heme iron absorption when co-administered. Take iron supplements at a different meal, 4 hours apart.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLong-term use.\u003c\/strong\u003e Longest published continuous use in trial is 4 months (Liu 2022, Singh 2022). Users running the molecule continuously beyond 4–6 months are extrapolating from the published bench.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGI tolerance.\u003c\/strong\u003e Mild stomach discomfort in a small minority of users on day 1–3; nearly always resolves by day 4 with food co-administration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFAQ\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Why not just eat pomegranates?\u003c\/strong\u003e\u003cbr\u003eA: Because 60–70% of adults are urolithin metabotype B or 0 — their gut bacteria can't convert ellagic acid to meaningful UroA levels (Tomás-Barberán 2017, Selma 2018). Even efficient producers reach only 0.1–3 µM plasma UroA — below the mitophagy threshold suggested by Andreux 2019 PK modeling. Direct UroA supplementation bypasses the metabotype lottery entirely.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How do I know if I'm a metabotype 0?\u003c\/strong\u003e\u003cbr\u003eA: There is no easy at-home test — clinical metabotype determination requires a urinary urolithin profile after a polyphenol challenge dose. Practical proxies: long history of antibiotic use, low-fiber\/low-polyphenol diet, IBD or IBS, advancing age, or the simple observation that pomegranate juice has never produced any noticeable energy or endurance change for you. The simplest answer: if you want UroA's mitophagy benefit, supplement directly rather than guessing your microbiome.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Does Urolithin A increase NAD+?\u003c\/strong\u003e\u003cbr\u003eA: Indirectly. UroA doesn't supply NAD+ precursors the way NMN or NR do, but by clearing damaged mitochondria and supporting the building of new ones, it improves the cellular machinery that \u003cem\u003euses\u003c\/em\u003e NAD+. Pair UroA with \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e for the fuel + renewal pairing.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is this the same molecule as Mitopure?\u003c\/strong\u003e\u003cbr\u003eA: Yes — UroA is a single defined small molecule, identical regardless of brand. Mitopure is Amazentis's branded version that was used in the Liu 2022 and Singh 2022 trials. Independently produced UroA at clinical-grade purity (\u0026gt;98% HPLC) delivers the same plasma exposure profile per the chemistry. The trial data generalizes to the molecule, not the brand.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does it compare to Spermidine?\u003c\/strong\u003e\u003cbr\u003eA: Different programs. Spermidine triggers \u003cem\u003egeneral\u003c\/em\u003e autophagy — clearing any old protein or organelle. UroA triggers \u003cem\u003emitophagy\u003c\/em\u003e — selectively clearing damaged mitochondria via PINK1\/Parkin. They're complementary, not substitutes. Many longevity protocols run both: \u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e daily for general cellular renewal, UroA 500mg for the mitochondrial-specific layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does it pair with senolytics like Fisetin?\u003c\/strong\u003e\u003cbr\u003eA: Strongly. Senescent cells leak SASP factors that suppress mitophagy in neighboring healthy cells. Clearing them with periodic \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e dosing (typical protocols: 2 days\/month at 500–1000mg) creates a cleaner cellular environment for daily UroA-driven mitophagy to operate in.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How long can I take it continuously?\u003c\/strong\u003e\u003cbr\u003eA: The longest published continuous use is 4 months (Liu 2022, Singh 2022) without safety signals. Many users in real-world longevity protocols run UroA continuously beyond 4 months, but that exceeds the published bench. Conservative cycling: 12 weeks on \/ 4 weeks off, or continuous with periodic biomarker monitoring.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Should I take 500mg or 1000mg?\u003c\/strong\u003e\u003cbr\u003eA: Start at 500mg — that's the Liu 2022 endurance-replicated dose, and it produced significant gains over placebo on every endurance endpoint. If after 12–16 weeks you don't notice the expected change, doubling to 1000mg (the Singh 2022 high-dose arm) is reasonable. Above 1000mg there is no published efficacy data and PK saturation is likely.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I take it with statins?\u003c\/strong\u003e\u003cbr\u003eA: Yes — and this is one of the more sensible pairings. Statins deplete CoQ10 and impair mitochondrial function (Larsen 2013); UroA improves mitophagy of statin-damaged mitochondria. The standard pairing is statin + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + UroA 500mg.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What about Parkinson's risk and PINK1 mutations?\u003c\/strong\u003e\u003cbr\u003eA: PINK1 loss-of-function mutations cause autosomal recessive juvenile parkinsonism — these patients have impaired baseline mitophagy. UroA upregulates the PINK1\/Parkin pathway in cells with normal copies of the gene; preclinical data (Tuohetaerbaike 2020) suggests benefit in dopaminergic neurons. Human trials in Parkinson's populations are pending. Discuss with neurology if you have a personal or family history of early-onset Parkinson's.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Does UroA cause autophagy fatigue or compensate the wrong way?\u003c\/strong\u003e\u003cbr\u003eA: No published evidence of it. Unlike systemic mTOR inhibitors (which broadly suppress protein synthesis), UroA is selective for the PINK1\/Parkin and BNIP3\/NIX pathways. The 4-month bench in Liu 2022 \/ Singh 2022 found no negative compensatory signal.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Will it help with sarcopenia?\u003c\/strong\u003e\u003cbr\u003eA: The clinical bench (Liu 2022, Singh 2022) is in middle-aged adults with declining muscle endurance — adjacent to but not formally diagnostic of sarcopenia. Combined with resistance training, adequate protein intake (1.2–1.6 g\/kg\/day), \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e, and the broader Mitochondrial Renewal stack, UroA fits cleanly into a sarcopenia-prevention protocol.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Vegan?\u003c\/strong\u003e\u003cbr\u003eA: Yes. Plant-cellulose (HPMC) capsule, vegan-formula excipients, no animal-derived ingredients.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Does it interact with NMN or NR?\u003c\/strong\u003e\u003cbr\u003eA: No negative interaction. UroA + NMN\/NR is a deliberate pairing — fuel + renewal. The combination is the backbone of the \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal collection\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is this different from a CoQ10 product?\u003c\/strong\u003e\u003cbr\u003eA: Different mechanism, complementary use. CoQ10 is an electron-transport-chain cofactor — it supports mitochondria that are \u003cem\u003ecurrently working\u003c\/em\u003e. UroA clears mitochondria that are \u003cem\u003ebroken\u003c\/em\u003e, so the cell can build new ones. Both belong in a mitochondrial-aging stack.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Why is the bottle so dark \/ opaque?\u003c\/strong\u003e\u003cbr\u003eA: UroA is light-sensitive. UV exposure degrades the molecule, so we ship in UV-protective HDPE — original packaging matters more here than for most supplements. Don't transfer to a clear weekly pillbox for extended periods.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Money-back guarantee?\u003c\/strong\u003e\u003cbr\u003eA: Yes — every True Health Protocol product is covered by our \u003ca href=\"\/he\/pages\/guarantee\"\u003emoney-back guarantee\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAndreux PA et al. \u003cem\u003eThe mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans.\u003c\/em\u003e Nature Metabolism. 2019;1:595–603.\u003c\/li\u003e\n\u003cli\u003eLiu S et al. \u003cem\u003eEffect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: A randomized clinical trial.\u003c\/em\u003e JAMA Network Open. 2022;5(1):e2144279.\u003c\/li\u003e\n\u003cli\u003eSingh A et al. \u003cem\u003eUrolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults.\u003c\/em\u003e Cell Reports Medicine. 2022;3(5):100633.\u003c\/li\u003e\n\u003cli\u003eRyu D et al. \u003cem\u003eUrolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents.\u003c\/em\u003e Nature Medicine. 2016;22:879–888.\u003c\/li\u003e\n\u003cli\u003eD'Amico D et al. \u003cem\u003eImpact of the natural compound urolithin A on health, disease, and aging.\u003c\/em\u003e Trends in Molecular Medicine. 2021;27(7):687–699.\u003c\/li\u003e\n\u003cli\u003eD'Amico D et al. \u003cem\u003eUrolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis.\u003c\/em\u003e Aging Cell. 2022;21(8):e13662.\u003c\/li\u003e\n\u003cli\u003eLuan P et al. \u003cem\u003eUrolithin A improves muscle stem cell function in aged mice via mitophagy reactivation.\u003c\/em\u003e Cell Reports Medicine. 2021.\u003c\/li\u003e\n\u003cli\u003eTomás-Barberán FA et al. \u003cem\u003eUrolithins, the rescue of \"old\" metabolites to understand a \"new\" concept: Metabotypes as a nexus among diet, gut microbiota, and human health.\u003c\/em\u003e Mol Nutr Food Res. 2017;61(1).\u003c\/li\u003e\n\u003cli\u003eSelma MV et al. \u003cem\u003eThe gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers.\u003c\/em\u003e Mol Nutr Food Res. 2018;62(9):e1701039.\u003c\/li\u003e\n\u003cli\u003eGarcía-Villalba R et al. \u003cem\u003eMetabolism of different dietary phenolic compounds by the urolithin-producing human-gut bacteria Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens.\u003c\/em\u003e Drug Metab Dispos. 2017;45(6):742–751.\u003c\/li\u003e\n\u003cli\u003eCerdá B et al. \u003cem\u003eIdentification of urolithin A as a metabolite produced by human colon microflora from ellagic acid and related compounds.\u003c\/em\u003e J Agric Food Chem. 2005;53(14):5571–5576.\u003c\/li\u003e\n\u003cli\u003eTuohetaerbaike B et al. \u003cem\u003ePancreas protective effects of urolithin A on type 2 diabetic mice and its potential mechanisms.\u003c\/em\u003e Phytomedicine. 2020.\u003c\/li\u003e\n\u003cli\u003eGong Z et al. \u003cem\u003eUrolithin A attenuates memory impairment and neuroinflammation in APP\/PS1 mice.\u003c\/em\u003e J Neuroinflammation. 2019;16(1):62.\u003c\/li\u003e\n\u003cli\u003eJoseph AM et al. \u003cem\u003eThe impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals.\u003c\/em\u003e Aging Cell. 2012;11(5):801–809.\u003c\/li\u003e\n\u003cli\u003eDrummond MJ et al. \u003cem\u003eSkeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise.\u003c\/em\u003e J Appl Physiol. 2011;111(1):135–142.\u003c\/li\u003e\n\u003cli\u003eLarsen S et al. \u003cem\u003eSimvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.\u003c\/em\u003e J Am Coll Cardiol. 2013;61(1):44–53.\u003c\/li\u003e\n\u003cli\u003eSekhar RV et al. \u003cem\u003eGlyNAC supplementation improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, aging hallmarks, metabolic defects, muscle strength, cognitive decline, and body composition in older adults.\u003c\/em\u003e J Gerontol A Biol Sci Med Sci. 2021.\u003c\/li\u003e\n\u003cli\u003eCandow DG et al. \u003cem\u003eEffectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation.\u003c\/em\u003e J Clin Med. 2019;8(4):488.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eCitations of published research are provided for context and education and do not constitute endorsement of this product by the cited researchers, journals, or institutions.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eRead more on the science\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-health-supplements\"\u003eMitochondrial Health Supplements: The Renewal Layer Most Stacks Miss\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-nad-longevity\"\u003eNMN, NAD+, and the Longevity Foundation\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/protocols\"\u003eThe Protocols — True Health Protocol Methodology\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/pages\/our-science\"\u003eOur Science — How We Choose Molecules\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials Collection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health Collection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal Collection\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics Collection\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eHave a question?\u003c\/h3\u003e\n\u003cp\u003eEmail \u003ca href=\"mailto:support@truehealthprotocol.health\"\u003esupport@truehealthprotocol.health\u003c\/a\u003e — we read every message.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any supplement, especially if pregnant, nursing, taking prescription medication, undergoing cancer therapy, scheduled for surgery, or managing a chronic condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839391154394,"sku":"THP-UROA-500-30","price":44.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_urolithin-a.png?v=1778047689"},{"product_id":"pqq-20mg-mitochondrial-biogenesis-activator","title":"PQQ 20mg | Mitochondrial Biogenesis Activator | Pyrroloquinoline Quinone for Cellular Energy \u0026 Brain","description":"\u003ch2\u003eThe mitochondrial biogenesis layer most longevity stacks miss\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e30-second answer:\u003c\/strong\u003e Pyrroloquinoline quinone (PQQ) is the most direct nutritional lever known for \u003cem\u003emitochondrial biogenesis\u003c\/em\u003e — the creation of new mitochondria inside existing cells. Other longevity ingredients support the mitochondria you already have (CoQ10), recycle the broken ones (Urolithin A), or supply the energy currency they run on (NMN, Resveratrol). PQQ is the only widely-studied compound that activates PGC-1α — the master transcription factor that turns on the genes for building new mitochondria — through the same upstream signaling network that exercise and caloric restriction work through. One 20mg capsule daily with a fat-containing meal. Most users notice cognitive effects in 4–8 weeks; the mitochondrial-density change is silent and biological, on the order of 3–6 months.\u003c\/p\u003e\n\n\u003ch2\u003eThe mitochondrial biogenesis problem (and why most stacks ignore it)\u003c\/h2\u003e\n\u003cp\u003eWalk through any serious longevity stack and the mitochondrial coverage will look something like this: NMN or NR to raise NAD\u003csup\u003e+\u003c\/sup\u003e, CoQ10 to support the electron-transport chain, sometimes Urolithin A to clear damaged mitochondria via mitophagy, sometimes Resveratrol or Spermidine to support sirtuins and autophagy. That covers fuel, machinery, cleanup, and renewal signaling. What it doesn't cover is \u003cstrong\u003epopulation\u003c\/strong\u003e — the actual number of working mitochondria inside each cell.\u003c\/p\u003e\n\u003cp\u003eAnd mitochondrial number is one of the most measurable things that declines with age. By the seventh decade of life, mitochondrial density in skeletal muscle is roughly half of what it was at twenty (Conley et al., \u003cem\u003eJournal of Physiology\u003c\/em\u003e, 2000). The same trend appears in cardiac muscle, neurons, hepatocytes, and oocytes. You can have perfectly maintained NAD\u003csup\u003e+\u003c\/sup\u003e levels and pristine CoQ10 status, but if your cells are running on a thinned-out mitochondrial population, they're producing less ATP per unit of tissue, generating more reactive oxygen species per unit of work, and failing earlier under load. This is why people in their seventies fatigue faster than people in their thirties even when their hemoglobin and resting metabolic rate look identical: it isn't fuel delivery, it's how many engines the cells have left.\u003c\/p\u003e\n\u003cp\u003ePQQ is the most direct nutritional lever for this layer. The molecule was discovered in the 1970s as a redox cofactor in bacterial dehydrogenases, but its biological relevance for mammals only became clear in the 1990s when PQQ-deficient diets were shown to cause growth failure, immunosuppression, infertility, and dramatic loss of mitochondrial content in mice — and crucially, that all of these effects could be reversed by restoring PQQ to the diet (Steinberg et al., \u003cem\u003eExperimental Biology and Medicine\u003c\/em\u003e, 1994; Killgore et al., \u003cem\u003eScience\u003c\/em\u003e, 1989). The mechanism turned out to involve PGC-1α (the master regulator of mitochondrial biogenesis), CREB, and a series of downstream genes for mitochondrial DNA replication and oxidative phosphorylation — the same longevity-relevant signaling network that resveratrol, NMN, and caloric restriction work through, but PQQ enters at a different node.\u003c\/p\u003e\n\u003cp\u003eThe first major human supplementation study (Harris et al., \u003cem\u003eThe Journal of Nutritional Biochemistry\u003c\/em\u003e, 2010) showed measurable increases in mitochondrial-related gene expression and reductions in plasma C-reactive protein in healthy adults after eight weeks of PQQ supplementation. A 2013 follow-up showed reductions in oxidative-damage markers (8-isoprostane, methylated lysines) and improvements in mitochondrial-related metabolites (Harris et al., 2013). Subsequent Japanese trials extended the cognitive results — Nakano et al. (2009, 2012) showed improvements in higher cognitive function in middle-aged and older adults, with the effect amplified when PQQ was combined with CoQ10.\u003c\/p\u003e\n\n\u003ch2\u003eHow PQQ actually works inside the cell\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. PGC-1α activation — mitochondrial biogenesis.\u003c\/strong\u003e PQQ phosphorylates and activates CREB (cAMP response element-binding protein), which in turn activates PGC-1α — the transcription co-activator that turns on the entire genetic program for building new mitochondria, including nuclear respiratory factors NRF1 and NRF2 and mitochondrial transcription factor A (TFAM). This is the same pathway exercise activates. Sometimes called \"exercise in a capsule\" — that's an oversimplification because exercise also drives capillary growth, fiber-type changes, and a hundred other adaptations PQQ does not — but at the molecular level of biogenesis signaling, the description is more accurate than not.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2. Direct redox cofactor activity — durable antioxidant inside the mitochondrial environment.\u003c\/strong\u003e PQQ itself is one of the most catalytically efficient redox cofactors known. It can cycle through approximately 20,000 redox conversions before being consumed, compared with roughly four for ascorbic acid. That makes it an unusually durable antioxidant, particularly inside the lipid-bilayer environment of the inner mitochondrial membrane where most water-soluble antioxidants can't reach effectively. This complements rather than overlaps with CoQ10, which is the inner-membrane antioxidant for the lipid phase but does not catalyze cycle reactions in the same way.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e3. NGF (nerve growth factor) upregulation — neuronal support.\u003c\/strong\u003e PQQ has been shown in cell-culture studies to stimulate NGF mRNA expression and protein release from astrocytes (Yamaguchi et al., \u003cem\u003eBioscience, Biotechnology, and Biochemistry\u003c\/em\u003e, 1993). NGF supports neuronal survival, axonal growth, and synaptic plasticity. This appears to be part of why the most consistent subjective report from PQQ users is improved mental clarity and reduced brain fog rather than the muscular energy effect more typical of CoQ10 — the brain has the highest mitochondrial density and the highest NGF dependence of any organ system.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e4. Synergy with CoQ10.\u003c\/strong\u003e The Nakano et al. (2009) trial in \u003cem\u003eFunctional Foods in Health and Disease\u003c\/em\u003e tested PQQ alone (20mg\/day), CoQ10 alone (300mg\/day), and the combination in adults with cognitive complaints. Both compounds produced individual improvements; the combination produced the largest improvements in attention, working memory, and processing speed. The mechanistic explanation is direct: PQQ drives the creation of new mitochondria, CoQ10 functionally populates them as the obligate cofactor for Complex I, II, and III of the electron transport chain. Building more engines without filling them with the cofactor that makes them run is half a stack; supporting existing engines without making more is the other half. Together is the full picture.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e5. mtDNA protection and biogenesis maintenance.\u003c\/strong\u003e Beyond turning on biogenesis, PQQ has been shown to reduce oxidative damage to mitochondrial DNA itself (Stites et al., \u003cem\u003eJournal of Nutrition\u003c\/em\u003e, 2006; Bauerly et al., \u003cem\u003ePLOS ONE\u003c\/em\u003e, 2011). Mitochondrial DNA is more vulnerable than nuclear DNA because it lacks histones, has fewer repair pathways, and sits in the most oxidative environment in the cell. Protecting mtDNA preserves the genetic blueprint for the new mitochondria PQQ is signaling the cell to build — without that, biogenesis would just produce defective copies.\u003c\/p\u003e\n\n\u003ch2\u003eWhere PQQ fits in your stack — the four-layer mitochondrial protocol\u003c\/h2\u003e\n\u003cp\u003eMitochondrial health is best understood as four distinct layers, each with a different lever:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePopulation (how many you have):\u003c\/strong\u003e PQQ — biogenesis via PGC-1α \/ CREB \/ NRF1 \/ TFAM. Builds new mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunction (how well they run):\u003c\/strong\u003e CoQ10 \/ ubiquinol — Complex I, II, III electron-transport cofactor. Powers existing mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCleanup (removing broken ones):\u003c\/strong\u003e Urolithin A — mitophagy via PINK1 \/ Parkin. Recycles defective mitochondria.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFuel (the energy currency they run on):\u003c\/strong\u003e NMN, NR, Liposomal NAD+, Resveratrol — NAD\u003csup\u003e+\u003c\/sup\u003e production, sirtuin activation. Supplies the substrate the mitochondria spend.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost stacks cover one or two of these. The strongest mitochondrial protocols cover all four. PQQ is usually the missing piece because it's the newest of the major longevity ingredients to reach mainstream attention — the molecule was only formally recognized as a vitamin-like compound in 2003 (Kasahara \u0026amp; Kato, \u003cem\u003eNature\u003c\/em\u003e), and the first major human supplementation study didn't appear until 2010. It's also the only one of the four that operates at the gene-expression level rather than the biochemical-substrate level, which is why the time-to-effect is measured in weeks-to-months rather than days.\u003c\/p\u003e\n\u003cp\u003eOne implication of the four-layer model worth naming directly: the layers are not interchangeable. NMN does not cover what PQQ covers. Urolithin A does not cover what PQQ covers. Stacking three NAD\u003csup\u003e+\u003c\/sup\u003e precursors together does not address mitochondrial number. If your stack already includes NMN, CoQ10, and Urolithin A, PQQ is the highest-leverage single addition you can make, because it's the only one that increases the population of working mitochondria the other three are supporting.\u003c\/p\u003e\n\n\u003ch2\u003eWhy PQQ matters for fertility and reproductive health\u003c\/h2\u003e\n\u003cp\u003eOf all the cells in the human body, the oocyte (egg cell) contains by far the most mitochondria — roughly 100,000 of them, compared with about 1,000–2,000 in a typical somatic cell. That density is not accidental. The early embryo runs entirely on mitochondrial ATP from the mother's egg until implantation; the sperm contributes essentially nothing to the embryo's mitochondrial population (and what little it does contribute is actively destroyed by ubiquitin-mediated degradation in the early embryo).\u003c\/p\u003e\n\u003cp\u003eThe downstream implication is that mitochondrial quality and quantity in the oocyte is one of the strongest predictors of fertility outcomes, and the most consistent biological reason that egg quality declines with maternal age. The same logic applies to sperm motility, which is almost entirely mitochondrial-ATP-dependent — the sperm tail is essentially a mitochondrial engine wrapped in a cytoskeletal scaffold; sperm count and morphology speak to genetic health, but motility speaks to mitochondrial bioenergetics.\u003c\/p\u003e\n\u003cp\u003eThis is why CoQ10 (or its reduced form ubiquinol) has been a mainstream recommendation in reproductive endocrinology clinics for over a decade and is now standard adjunctive therapy in many IVF protocols. PQQ extends the same logic at the population level: rather than just supporting the function of existing mitochondria, it actively stimulates the creation of new ones in tissues with high turnover. That's the rationale for stacking PQQ with CoQ10 in a fertility-focused protocol — the same logic that drives the rest of the longevity stack, but with the reproductive system as the primary target tissue.\u003c\/p\u003e\n\u003cp\u003ePQQ has not yet been studied head-to-head as a fertility intervention with the same depth as CoQ10, so this section is a mechanistic argument rather than a clinical-evidence claim. If you are actively trying to conceive, undergoing IVF, or working with a reproductive endocrinologist, the addition of any new supplement to your protocol should be discussed with that specialist before you start. We are providing the mechanism. Your clinician knows your case.\u003c\/p\u003e\n\n\u003ch2\u003eBrain and cognitive support — the most consistent subjective effect\u003c\/h2\u003e\n\u003cp\u003eThe brain is roughly 2% of body weight but consumes around 20% of the body's resting energy — a per-gram metabolic rate higher than any other tissue. That makes it acutely sensitive to mitochondrial population and function. It is also one of the tissues in which PQQ's NGF-upregulating effect is most relevant: NGF supports the survival of cholinergic neurons in the basal forebrain, sympathetic neurons, and nociceptive sensory neurons, all of which are vulnerable to age-related dropout.\u003c\/p\u003e\n\u003cp\u003eThe Nakano et al. (2009 and 2012) trials measured cognitive performance using the Stroop test, attention-shift tasks, and short-term memory assessments in middle-aged and older adults. PQQ at 20mg\/day for 12 weeks produced measurable improvements in attention and processing-speed measures versus placebo. The PQQ + CoQ10 combination amplified the effect. A separate trial in adults with subjective cognitive complaints (Itoh et al., \u003cem\u003eJournal of Clinical Biochemistry and Nutrition\u003c\/em\u003e, 2016) showed reductions in self-reported fatigue and improvements in sleep quality and concentration.\u003c\/p\u003e\n\u003cp\u003eNone of this is a claim of dramatic cognitive enhancement and PQQ is not a stimulant. The signal across these studies is consistent with the mechanism: gradual improvement in mitochondrial-density-dependent functions in tissues that are already working, with the largest effects in people whose baseline cognitive function is below their personal optimum (afternoon brain fog, sleep-disruption-driven fatigue, age-related processing-speed decline). If you are looking for an acute focus aid, you want caffeine, theanine, or a racetam — not PQQ. If you are looking to add the layer that compounds quietly over months and supports the brain's mitochondrial population for years, PQQ is the foundational tool.\u003c\/p\u003e\n\n\u003ch2\u003eCardiovascular and metabolic effects\u003c\/h2\u003e\n\u003cp\u003eThe heart is the second-most mitochondria-dense tissue in the body — cardiomyocytes are roughly 30–35% mitochondria by volume. That density is what allows the heart to contract approximately 100,000 times per day at oxidative-phosphorylation-driven efficiency. It is also why mitochondrial dysfunction shows up clinically as heart failure with preserved ejection fraction, exercise intolerance, and the fatigue patterns associated with chronic cardiovascular disease.\u003c\/p\u003e\n\u003cp\u003eThe Harris 2010 trial showed a measurable reduction in plasma C-reactive protein (CRP) — a systemic inflammation marker associated with cardiovascular risk — after eight weeks of PQQ supplementation. The 2013 Harris follow-up showed reduction in oxidative damage markers including 8-isoprostane (a marker of lipid peroxidation associated with atherosclerosis) and methylated lysines (a marker of mitochondrial protein damage). A 2015 Chinese trial (Zhu et al., \u003cem\u003eCardiovascular Drugs and Therapy\u003c\/em\u003e) studied PQQ in patients with ischemia-reperfusion injury and found cardioprotective effects mediated by activation of PGC-1α and reduction of oxidative damage in cardiac tissue.\u003c\/p\u003e\n\u003cp\u003eNone of this is a claim of cardiovascular treatment. PQQ is not a substitute for any prescribed cardiac therapy, lipid-lowering protocol, or blood-pressure management. It is a long-horizon mitochondrial support tool whose cardiovascular relevance derives from the same general mechanism that drives its skeletal-muscle and brain effects: cardiomyocytes are mitochondria-dense, mitochondria respond to PGC-1α-mediated biogenesis signaling, PQQ activates that pathway, and the downstream effects on inflammation and oxidative stress are measurable.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in this bottle\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePyrroloquinoline quinone disodium salt (PQQ): 20mg\u003c\/strong\u003e — pharmaceutical-grade BioPQQ™-grade material. The disodium salt is the chemical form used in essentially all of the major published clinical trials and the only form with established human oral-bioavailability data. The exact dose used in the Harris 2010 mitochondrial-density study and the Nakano 2009 and 2012 cognitive studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBioPerine® black pepper extract: 5mg\u003c\/strong\u003e — standardized to 95% piperine. Piperine inhibits the gut and liver enzymes (UGT1A1, CYP3A4) that break down many fat-soluble cofactors, including the ones PQQ is most often stacked with: CoQ10, curcumin, vitamin D, astaxanthin. PQQ itself has reasonable oral bioavailability and does not strictly need piperine; the BioPerine here supports the stack PQQ is intended to operate inside.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVegetable cellulose capsule.\u003c\/strong\u003e No magnesium stearate. No titanium dioxide. No artificial colors. No silicon dioxide. No fillers, dyes, or excipients beyond the active ingredients.\u003c\/li\u003e\n\u003cli\u003e60 capsules per bottle — two-month supply at the standard daily dose.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDaily protocol (recommended):\u003c\/strong\u003e 1 capsule (20mg) taken in the morning with a fat-containing meal. PQQ is a small molecule with reasonable water solubility, but absorption is improved when taken alongside dietary fat — the same general principle that applies to CoQ10, curcumin, vitamin D, vitamin K, and astaxanthin. Morning rather than evening because the cognitive-clarity and energy-related downstream effects are more useful during the active part of your day; PQQ is not sedating but the mitochondrial-density signaling is most aligned with daytime metabolic demand.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStacking notes:\u003c\/strong\u003e PQQ pairs naturally with CoQ10 — take both with the same fat-containing meal. It also stacks logically with NMN, Urolithin A, Resveratrol, Spermidine, Fisetin, Quercetin, TMG, Apigenin, and the rest of the True Health Protocol mitochondrial and longevity stack. Each works on a different layer (population, function, cleanup, fuel, signaling), so there is no redundancy and no published evidence of negative interaction within this combination set. PQQ is also compatible with most cardiovascular medications and standard multivitamins; the antioxidant and biogenesis effects do not interfere with statins, antihypertensives, or thyroid replacement at the doses studied.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTime to effect:\u003c\/strong\u003e Subjective cognitive effects (mental clarity, reduced afternoon fatigue, sharper attention) are typically reported between weeks 4 and 8. The underlying mitochondrial-density change is much slower — the Harris 2010 study used an 8-week protocol to show changes in mitochondrial-related gene expression and inflammation markers; full effects at the cellular density level likely require 3–6 months of continuous use. The compounds that work via gene expression (PQQ, NMN, Resveratrol, Spermidine) all share this profile: slower onset, longer-duration changes, and best results at consistent daily dosing rather than intermittent or pulsed protocols.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCycling vs. continuous use:\u003c\/strong\u003e Unlike senolytics (Fisetin, Quercetin) which have a published rationale for monthly pulsing, PQQ is most effective as a continuous daily protocol. The biogenesis signaling is sustained, not pulsatile, and the underlying tissue change accumulates with continued exposure. There is no published evidence that PQQ requires breaks, develops tolerance, or downregulates its own pathway over time.\u003c\/p\u003e\n\n\u003ch2\u003eWho should not take this\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding.\u003c\/strong\u003e PQQ has not been studied in human pregnancy. Animal studies in PQQ-deficient diets show severe reproductive and growth effects (which is part of why PQQ is sometimes considered vitamin-like), but supplementation safety above dietary background levels in human pregnancy has not been established. Do not use without medical supervision.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnder 18.\u003c\/strong\u003e PQQ has not been studied in children or adolescents. Pediatric mitochondrial dysfunction is its own clinical area and any supplementation should be managed by a specialist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on chemotherapy or other treatment that depends on mitochondrial dysfunction in target cells.\u003c\/strong\u003e Some cancer therapies work by exploiting mitochondrial vulnerability in malignant cells; supporting mitochondrial biogenesis and antioxidant capacity during such treatment may interfere with therapeutic intent. Discuss with your oncology team before adding any antioxidant or mitochondrial supplement during active cancer treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone scheduled for surgery within two weeks.\u003c\/strong\u003e The mild antioxidant activity of PQQ may theoretically affect surgical bleeding response or anesthesia metabolism. Stop two weeks before any planned procedure as a standard precaution and resume after your surgeon clears post-operative supplementation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone with a known sensitivity to quinone-class compounds.\u003c\/strong\u003e PQQ is a quinone — chemically related to ubiquinone (CoQ10) and the K-vitamins. Rare individual sensitivities have been reported, typically presenting as nausea or mild headache at higher doses. Start at one capsule and monitor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnyone on warfarin or other anticoagulant therapy.\u003c\/strong\u003e No published evidence of direct interaction, but quinone-class compounds participate in vitamin-K-related coagulation chemistry. If you are on warfarin, your INR should be monitored when adding any new antioxidant or mitochondrial supplement; talk with your prescriber first.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from CoQ10?\u003c\/strong\u003e\u003cbr\u003e\nThey work on completely different layers of mitochondrial health, and the cleanest way to think about them is as the population-versus-function pair. CoQ10 sits inside the inner mitochondrial membrane and shuttles electrons through Complex I, II, and III of the electron transport chain — it is a functional cofactor for ATP production in \u003cem\u003eexisting\u003c\/em\u003e mitochondria. PQQ doesn't do that. PQQ acts upstream at the gene-expression level, signaling the cell to build \u003cem\u003emore\u003c\/em\u003e mitochondria via PGC-1α activation. They're complementary, not redundant. The Nakano 2009 trial directly compared the two and found that the combination outperformed either alone on cognitive endpoints — that result is the empirical case for stacking them. If you can only take one, your decision should follow your symptom profile: CoQ10 if your concern is energy \/ heart \/ statin support, PQQ if your concern is age-related cognitive decline \/ long-term mitochondrial density.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from Urolithin A?\u003c\/strong\u003e\u003cbr\u003e\nUrolithin A drives mitophagy — the controlled clearance of damaged mitochondria via the PINK1 \/ Parkin pathway. It removes broken units. PQQ drives biogenesis — the creation of new mitochondria via PGC-1α \/ CREB \/ NRF1. It builds new units. Together they form a renewal cycle: clear the broken ones (Urolithin A), build new ones (PQQ), keep the rest running (CoQ10), and supply the energy currency they all spend (NMN \/ NAD\u003csup\u003e+\u003c\/sup\u003e). This is the four-layer model and stacking all four is the most complete mitochondrial protocol we publish.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is PQQ different from NMN, NR, or other NAD\u003csup\u003e+\u003c\/sup\u003e precursors?\u003c\/strong\u003e\u003cbr\u003e\nNMN and NR raise NAD\u003csup\u003e+\u003c\/sup\u003e, the substrate that mitochondria spend during oxidative phosphorylation and that sirtuin enzymes consume during cellular signaling. NAD\u003csup\u003e+\u003c\/sup\u003e is the energy currency. PQQ doesn't increase NAD\u003csup\u003e+\u003c\/sup\u003e — it increases the number of mitochondria that \u003cem\u003espend\u003c\/em\u003e NAD\u003csup\u003e+\u003c\/sup\u003e. If NAD\u003csup\u003e+\u003c\/sup\u003e is the dollar bills, PQQ is the staff that earns and spends them. Both layers matter; neither replaces the other. The Liposomal NAD+ Ultimate, Pure NMN, NMN 1000mg, NR Hard Capsules, NAD+ Daily Boost, Liquid NAD+, NAD+ Pure Focus, and NAD+ 5-in-1 in this catalog all address the fuel layer; PQQ addresses the population layer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I just get PQQ from food?\u003c\/strong\u003e\u003cbr\u003e\nTechnically yes — PQQ is present in trace amounts in fermented soybeans (natto), parsley, green tea, papaya, kiwi, and a few other plant foods. Practically no — the typical Western diet provides roughly 0.1–0.4mg per day, while the supplementation studies use 10–20mg per day. You'd need to eat several pounds of natto daily to reach the studied dose, which isn't a realistic protocol for most people, and the natto fermentation profile is not well tolerated by Western palates. The dose at which the published cognitive and biogenesis effects are seen is fifty to two hundred times the typical dietary intake. This is one of the cleaner \"supplementation makes sense\" cases in nutrition science.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is 20mg the right dose?\u003c\/strong\u003e\u003cbr\u003e\n20mg per day is the dose used in the most-cited human studies, including the Harris 2010 mitochondrial-density \/ inflammation study, the Nakano 2009 PQQ + CoQ10 cognitive study, and the Itoh 2016 fatigue\/sleep trial. Higher doses (40mg) have been used safely in some protocols but did not produce proportionally larger effects on the published endpoints; lower doses (10mg) underperformed. 20mg is the dose the published research converges on as the empirical sweet spot for healthy adults. If you have specific clinical reasons (mitochondrial myopathy, severe cognitive complaint, fertility protocol) to pursue a higher or lower dose, that decision should be made with a specialist.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Will I feel anything from PQQ on day one?\u003c\/strong\u003e\u003cbr\u003e\nProbably not. PQQ works by changing what genes your cells transcribe — that takes weeks. Most users report no immediate effect, then notice gradual improvements in mental clarity and afternoon energy somewhere between weeks 4 and 8. If you're looking for a same-day stimulant effect, PQQ is the wrong tool — caffeine, theanine, tyrosine, or the prescription nootropics will all be faster. PQQ is the long-horizon mitochondrial-density layer that compounds over months and supports the rest of your stack quietly. The clinical literature is consistent on this profile: gene-expression interventions take time and produce changes that are larger than they feel on any given day.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I take PQQ with my fertility protocol?\u003c\/strong\u003e\u003cbr\u003e\nPQQ is increasingly included in fertility-focused supplement protocols specifically because of its mitochondrial-biogenesis mechanism — oocytes contain roughly 100,000 mitochondria and sperm motility is almost entirely mitochondrial-ATP-dependent. It is commonly stacked with CoQ10 (or its reduced form, ubiquinol) in this context. That said, fertility is a medical area where any supplement should be discussed with your reproductive endocrinologist or fertility specialist, particularly if you are undergoing IVF or any active medical treatment. We provide the mechanistic rationale; your clinician knows your case, your medications, and your timeline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Why does it need BioPerine?\u003c\/strong\u003e\u003cbr\u003e\nPQQ on its own has reasonable oral bioavailability — better than most flavonoids and roughly comparable to CoQ10 in lipid form. The BioPerine in this formula isn't strictly required for PQQ absorption itself; it's there to support the broader fat-soluble cofactor stack you're likely taking PQQ alongside (CoQ10, curcumin, vitamin D, vitamin K, astaxanthin) by inhibiting the gut and liver enzymes (UGT1A1, CYP3A4) that break those compounds down before they reach circulation. Same logic and same 5mg dose as the BioPerine in our Curcumin, Apigenin, Quercetin, and Fisetin formulas — the BioPerine works for the stack, not the single compound.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What does the science actually show about mitochondrial number and aging?\u003c\/strong\u003e\u003cbr\u003e\nThe single best summary is the Conley et al. 2000 \u003cem\u003eJournal of Physiology\u003c\/em\u003e paper, which used 31-phosphorus magnetic resonance spectroscopy in living human muscle to show that mitochondrial oxidative capacity in skeletal muscle declines roughly 50% between the third and seventh decades of life. Similar declines have been documented in cardiac muscle (Lesnefsky et al.), in brain tissue (Manczak et al.), and in oocytes (Wang et al.). The decline is real, measurable, and one of the more consistent biological signatures of aging. PQQ is one of the cleanest direct nutritional levers known for that specific endpoint. It does not stop the decline, but the supplementation studies show measurable shifts in the mitochondrial-related gene-expression and inflammation signatures that track with the decline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I stack PQQ with my existing CoQ10?\u003c\/strong\u003e\u003cbr\u003e\nYes — that is the most-evidence-supported stacking pattern for PQQ, dating back to the Nakano 2009 trial. The two compounds work on adjacent layers: PQQ creates new mitochondria, CoQ10 functionally populates them as the obligate Complex I\/II\/III cofactor. Take both with the same fat-containing meal in the morning. Standard CoQ10 stacking dose is 100–400mg\/day; our CoQ10 product is 400mg per capsule, which is in the upper range of the standard published dose. There is no published evidence of any negative interaction between PQQ and CoQ10 at the doses used here.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What's the difference between BioPQQ™ and generic PQQ?\u003c\/strong\u003e\u003cbr\u003e\nBioPQQ™ is the brand name for fermentation-derived PQQ disodium salt produced by Mitsubishi Gas Chemical in Japan, which is the form used in essentially all of the published human clinical trials. Generic PQQ refers to chemically synthesized PQQ from any other source. The disodium-salt chemistry is identical between the two; the difference is the manufacturing process and the supply-chain quality assurance. We use pharmaceutical-grade BioPQQ™ disodium salt because that is the form with the published bioavailability and clinical-effect data; if you compared a research paper on \"PQQ supplementation\" to the bottle in your hand, this is the form you would want to match.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Are there any reported side effects?\u003c\/strong\u003e\u003cbr\u003e\nAt the 20mg\/day dose, published trials report essentially no significant adverse effects — the safety profile in healthy adults is very clean. At higher doses (60mg+) there are isolated reports of mild gastrointestinal discomfort, headache, or transient sleep changes. Standing recommendations: start at one capsule per day, take with food, and if you tolerate it after a week, that is your protocol. There is no need to escalate above 20mg unless directed by a specialist.\u003c\/p\u003e\n\n\u003ch2\u003eQuality \u0026amp; sourcing\u003c\/h2\u003e\n\u003cp\u003eBioPQQ™-grade pyrroloquinoline quinone disodium salt, manufactured in a GMP-certified facility, third-party tested for identity, purity, heavy metals (lead, arsenic, cadmium, mercury), residual solvents, and microbial contamination (total plate count, yeast and mold, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eSalmonella\u003c\/em\u003e). No magnesium stearate. No titanium dioxide. No artificial colors. No silicon dioxide. No fillers, dyes, or excipients beyond the active ingredients. Vegan capsule (vegetable cellulose). Bottle is BPA-free. Made in the USA in a cGMP-certified facility.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use, especially if you are pregnant, nursing, taking medication, scheduled for surgery, undergoing cancer treatment, or have an ongoing medical condition. Individual results vary. The references to clinical trials in this description are provided for mechanistic context and are not claims of treatment efficacy for any specific disease. PQQ is a dietary supplement, not a medication, and does not substitute for any prescribed therapy.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839440765146,"sku":"THP-PQQ-20-60","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_pqq.png?v=1778047682"},{"product_id":"alpha-lipoic-acid-600mg-universal-antioxidant","title":"Alpha-Lipoic Acid 600mg | Universal Antioxidant + Mitochondrial Cofactor for Glucose \u0026 Longevity","description":"\u003cp\u003e\u003cstrong\u003e600 mg of Alpha-Lipoic Acid per capsule\u003c\/strong\u003e — the universal antioxidant that works in both water and fat compartments, recycles other antioxidants the body has already used, chelates heavy metals, and sits as a direct cofactor inside two of the mitochondrial enzyme complexes that convert food into ATP. Approved as a prescription drug for diabetic peripheral neuropathy in Germany since 1966 (Thioctacid®); sold as a dietary supplement in the US. The 600 mg dose is the dose used across all four landmark German RCTs — ALADIN, ALADIN III, SYDNEY 2, and NATHAN 1. Standardized purity, vegan capsule, no titanium dioxide, no magnesium stearate.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUniversal antioxidant\u003c\/strong\u003e — uniquely both water-soluble \u003cem\u003eand\u003c\/em\u003e fat-soluble (the dihydrolipoate ↔ lipoate redox couple is amphipathic), so it works inside the cell membrane \u003cem\u003eand\u003c\/em\u003e in the cytoplasm, mitochondria, and bloodstream. Almost every other antioxidant is restricted to one compartment (Packer 1995, \u003cem\u003eFree Radic Biol Med\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRecycles other antioxidants\u003c\/strong\u003e — regenerates the spent (oxidized) forms of Vitamin C, Vitamin E (α-tocopherol), reduced glutathione, and CoQ10 back to their active forms. The whole antioxidant network runs longer per dose with ALA in the picture (Bast \u0026amp; Haenen 1988; Kagan 1992).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactor\u003c\/strong\u003e — ALA is the prosthetic group on lipoyllysine residues of pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), and the branched-chain α-keto-acid complex. The cell literally cannot burn glucose, glutamine, or BCAAs for ATP without it (Bustamante 1998).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlucose \u0026amp; nerve support\u003c\/strong\u003e — the most-studied compound for diabetic peripheral neuropathy in Europe. Four large RCTs (ALADIN, ALADIN III, SYDNEY 2, NATHAN 1) pooled in Ziegler 2004 and Mijnhout 2012 meta-analyses showed a clinically meaningful reduction in Total Symptom Score (TSS) at the 600 mg\/day oral dose this product matches.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAMPK activator + insulin sensitizer\u003c\/strong\u003e — Konrad 2001 and Jacob 1999 showed measurable increase in glucose uptake and GLUT4 translocation in skeletal muscle in lean and Type-2 diabetic adults at 600 mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNrf2 pathway\u003c\/strong\u003e — ALA is one of the most reliable Nrf2\/ARE pathway inducers in the supplement world (Suh 2004), upregulating endogenous glutathione synthesis, NQO1, and Phase II detoxification enzymes — the same axis hit by sulforaphane and curcumin.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBest paired with:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e for metabolic-health stacks (different mechanism — same target organ); \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e for mitochondrial stacks; \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e + \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eVitamin C\u003c\/a\u003e for the antioxidant network; \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e for the NAD+ axis (PDH\/KGDH need both NAD+ \u003cem\u003eand\u003c\/em\u003e lipoate to function).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy a metabolic supplement ended up in serious longevity research\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid was discovered in 1937 in \u003cem\u003eLactobacillus casei\u003c\/em\u003e and isolated in pure form by Lester Reed at the University of Texas in 1951. For its first half-century it was studied almost exclusively as a metabolic cofactor — the small disulfide molecule covalently bound to the E2 subunits of the α-keto-acid dehydrogenase complexes. Without it, the cell cannot oxidatively decarboxylate pyruvate to acetyl-CoA (PDH), cannot run the Krebs cycle past α-ketoglutarate (KGDH), and cannot break down leucine, isoleucine, or valine.\u003c\/p\u003e\n\n\u003cp\u003eThe shift into longevity research started in the late 1980s when Lester Packer's lab at UC Berkeley discovered that \u003cem\u003efree\u003c\/em\u003e ALA (not the protein-bound form) and its reduced form dihydrolipoate (DHLA) are extraordinary redox-active compounds with three properties almost no other antioxidant has: (1) they cross the blood-brain barrier, (2) they're equally active in aqueous and lipid compartments, and (3) they reduce the oxidized forms of every other major antioxidant in the cell — vitamin C, vitamin E, glutathione, CoQ10. Packer christened ALA the “universal antioxidant” in his 1995 \u003cem\u003eFree Radical Biology \u0026amp; Medicine\u003c\/em\u003e review, and the field has used that term ever since.\u003c\/p\u003e\n\n\u003cp\u003eThe metabolic-medicine track and the longevity track converged in the 1990s when Hager and Maczurek and others started looking at age-related declines in mitochondrial PDH\/KGDH activity in brain tissue. Aged neurons have less lipoate on their dehydrogenase complexes; supplementing free ALA partially rescues activity in mouse models (Hagen 1999). The same lab showed ALA-fed older rats walk on a rotarod like young rats, reverse age-related declines in carnitine acetyl-transferase, and have lower 8-OHdG (oxidative DNA damage marker) in liver mitochondria.\u003c\/p\u003e\n\n\u003cp\u003eIn humans the longevity case is less direct than the metabolic case — there is no NATHAN 1 for healthspan — but the supporting biomarker work is substantial. ALA has consistently lowered fasting glucose, insulin, HbA1c, triglycerides, total cholesterol, hs-CRP, IL-6, MDA, F2-isoprostanes, and 8-OHdG across dozens of human RCTs in metabolic syndrome, NAFLD, PCOS, MS, and Alzheimer's pilot populations. Every one of those is a mid-life longevity biomarker. ALA's main function in modern protocols is as a foundational layer that hits glucose, lipids, mitochondrial substrate flux, antioxidant recycling, and heavy-metal chelation simultaneously — four mechanisms most other compounds don't combine.\u003c\/p\u003e\n\n\u003ch2\u003eThe four mechanisms in plain language\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003e1. The mitochondrial cofactor job (the original reason it exists).\u003c\/strong\u003e ALA is the prosthetic group covalently attached to lysine residues on the E2 subunit of three enzyme complexes: pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), and the branched-chain α-keto-acid dehydrogenase (BCKDH). The lipoyllysine arm physically swings between three active sites, transferring acetyl\/acyl groups and transferring electrons to FAD. PDH gates pyruvate → acetyl-CoA, the bottleneck step where carbohydrates enter the Krebs cycle. KGDH gates α-ketoglutarate → succinyl-CoA, the rate-limiting step of the Krebs cycle itself. BCKDH gates leucine\/isoleucine\/valine catabolism. Without lipoate, none of these complexes function. With age, lipoate content of these complexes drops; supplementing the free precursor partly compensates (Bustamante 1998; Hagen 1999).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e2. The antioxidant-recycling job (Packer's discovery).\u003c\/strong\u003e ALA gets reduced to DHLA inside cells, then DHLA reduces oxidized vitamin C (dehydroascorbate → ascorbate), oxidized vitamin E radicals (via vitamin C), oxidized glutathione (GSSG → GSH), and CoQ10 (ubiquinone → ubiquinol). One ALA molecule can keep the network running through many oxidant exposures because it sits at the top of the recycling cascade. This is the structural reason ALA pairs particularly well with \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eglutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e rather than competing with them.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e3. The Nrf2 pathway job (added in the 2000s).\u003c\/strong\u003e ALA modifies cysteine residues on Keap1, releases Nrf2 to translocate to the nucleus, and turns on the Antioxidant Response Element (ARE) — driving expression of glutathione synthesis enzymes (GCLC\/GCLM), NQO1, heme oxygenase-1 (HO-1), and the Phase II detoxification battery. Suh 2004 showed ALA restores GSH synthesis in old rats by ~50%. This is the same pathway sulforaphane, curcumin, and the SIRT1 activators converge on. Hitting it from multiple angles is why senolytic and longevity stacks layer ALA with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e and \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003e4. The insulin-sensitization \/ AMPK job (the metabolic case).\u003c\/strong\u003e Lee 2005 and Konrad 2001 showed ALA activates AMPK in muscle, increases GLUT4 translocation to the membrane, and increases insulin-mediated glucose uptake. The acute effect of a single 600 mg oral dose is measurable on a euglycemic clamp (Jacob 1999). Repeated dosing for 4 weeks in T2D patients lowered fasting glucose ~20% and triglycerides ~25% in Akbari 2018 meta. ALA and \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e hit AMPK by different mechanisms (ALA via mitochondrial AMP\/ATP shift, berberine via direct AMPK kinase activation), which is why they stack rather than compete.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eBonus mechanism: heavy-metal chelation.\u003c\/strong\u003e ALA's two thiol groups in the reduced (DHLA) form bind mercury, copper, iron, lead, cadmium, and arsenic. Lin 1989 and Patrick 2002 reviewed the chelation work. ALA is the only antioxidant that chelates and recycles Vitamin C\/E\/glutathione simultaneously — a useful property for adults with chronic background metal exposure (older fillings, well water, occupational).\u003c\/p\u003e\n\n\u003ch2\u003eThe trial bench — what 600 mg\/day actually does in humans\u003c\/h2\u003e\n\u003cp\u003eALA has one of the longest, deepest, and best-replicated trial records in supplemental medicine, anchored by four large multi-center German RCTs in diabetic peripheral neuropathy at the 600 mg dose this product matches.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN (Ziegler 1995, \u003cem\u003eDiabetologia\u003c\/em\u003e):\u003c\/strong\u003e 328 T2D patients with symptomatic distal symmetric polyneuropathy. 1200, 600, or 100 mg\/day IV vs placebo, 3 weeks. 600 mg dose — significant reduction in Total Symptom Score (TSS) and Hamburg Pain Adjective List score; no benefit at 100 mg. The first proof of dose-response.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN II (Reljanovic 1999):\u003c\/strong\u003e 65 T1D + T2D, 600 or 1200 mg\/day IV for 5 days, then 600\/1200 mg\/day oral for 2 years. Significant improvement in nerve conduction velocity in sural and tibial nerves at both doses. 1200 not better than 600.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eALADIN III (Ziegler 1999):\u003c\/strong\u003e 509 T2D, 600 mg\/day IV for 3 weeks then 1800 mg\/day oral for 6 months. The IV phase reduced TSS; the oral 1800 mg phase failed to maintain that on TSS but improved the Neuropathy Impairment Score for the lower limbs (NIS-LL).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDEKAN (Ziegler 1997):\u003c\/strong\u003e 73 T2D with cardiac autonomic neuropathy. 800 mg\/day oral 4 months. Significant improvement in heart-rate variability vs placebo. The first cardiac-autonomic ALA trial.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eORPIL (Ruhnau 1999):\u003c\/strong\u003e 24 T2D, 1800 mg\/day oral 3 weeks. Significant TSS reduction at 19 days. Established that oral could replicate the IV symptom benefit, opening the door to chronic oral dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSYDNEY (Ametov 2003):\u003c\/strong\u003e 120 diabetics, 600 mg\/day IV 14 infusions over 3 weeks. TSS dropped 5.7 points vs 1.8 placebo — one of the largest absolute symptom reductions on record.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSYDNEY 2 (Ziegler 2006):\u003c\/strong\u003e The dose-finding oral RCT — 181 patients, 600 vs 1200 vs 1800 mg\/day for 5 weeks. \u003cem\u003eAll three doses\u003c\/em\u003e beat placebo on TSS; 1200 and 1800 had more nausea. \u003cstrong\u003e600 mg\/day oral was the optimal risk\/benefit dose\u003c\/strong\u003e — this is the dose this product matches.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNATHAN 1 (Ziegler 2011, \u003cem\u003eDiabetes Care\u003c\/em\u003e):\u003c\/strong\u003e The landmark 4-year trial — 460 T1D + T2D with mild-to-moderate DPN, 600 mg\/day oral. Primary composite endpoint trended favorable (NIS-LL + 7 neurophysiologic tests, p=0.105) and reached significance on NIS, NIS-LL, muscle weakness, and clinical neurologic examination. The longest ALA RCT ever performed; it confirmed durability of effect and a safety profile equivalent to placebo over 4 years of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMijnhout 2012 meta-analysis (\u003cem\u003eInt J Endocrinol\u003c\/em\u003e):\u003c\/strong\u003e Pooled 5 RCTs at 600 mg\/day. Significant 2.26-point TSS reduction (95%CI -2.83 to -1.69) and significant improvement on NIS-LL.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eOutside neuropathy, the human evidence base is broad:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin sensitivity \/ Type-2 diabetes:\u003c\/strong\u003e Akbari 2018 meta-analysis pooled 24 RCTs — significant reductions in fasting glucose, fasting insulin, HOMA-IR, and HbA1c. Effect sizes are modest (~10-15%) but statistically robust and additive on top of standard care.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLipid profile:\u003c\/strong\u003e Mohammadi 2017 and Akbari 2018 meta-analyses showed significant reductions in total cholesterol, LDL, and triglycerides; modest HDL increase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeight \/ waist circumference:\u003c\/strong\u003e Kucukgoncu 2017 meta-analysis — ALA reduced body weight by 1.27 kg vs placebo across 12 RCTs. Modest but consistent effect.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNAFLD:\u003c\/strong\u003e de Sousa 2019 review of 6 RCTs — ALA reduced ALT, AST, GGT and hepatic steatosis on ultrasound; mechanism likely a combination of insulin sensitization + Nrf2 + lipid lowering.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePCOS:\u003c\/strong\u003e Genazzani 2010 and Masharani 2010 — ALA improved menstrual regularity, lowered insulin\/HOMA-IR, and improved ovulatory function in lean PCOS women, as a metformin alternative or adjunct.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMultiple sclerosis:\u003c\/strong\u003e Khalili 2014 — 1200 mg\/day for 12 weeks significantly increased serum total antioxidant capacity in 52 relapsing-remitting MS patients. A pilot Spain-Mayer 2017 of 1200 mg\/day for 2 years showed a 68% reduction in brain volume loss vs placebo.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAlzheimer's pilot:\u003c\/strong\u003e Hager 2007 — 9-month open-label of 600 mg\/day in mild AD slowed cognitive decline (ADAS-cog stable vs natural-history rate of progression). Maczurek 2008 review summarizes the AD case.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive aging:\u003c\/strong\u003e Gosselin 2019 systematic review of ALA in cognitive function trials — positive signal in MCI\/mild AD, less clear in healthy older adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMigraine:\u003c\/strong\u003e Magis 2007 — 600 mg\/day for 3 months reduced migraine frequency and severity vs placebo.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypertension:\u003c\/strong\u003e Mohammadi 2017 meta — modest 2-3 mmHg systolic reduction across pooled trials.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy 600 mg, why once daily, and why R\/S vs R\u003c\/h2\u003e\n\u003cp\u003eThe 600 mg\/day oral dose used in this product is the single most-replicated dose in the human ALA literature. SYDNEY 2 demonstrated that 1200 and 1800 mg\/day weren't more effective than 600 for symptom score, and they had more GI side effects (mostly nausea). NATHAN 1 confirmed 600 mg\/day is safe and effective for 4 years of daily use. Ziegler 2014 (\u003cem\u003eAntioxidants \u0026amp; Redox Signaling\u003c\/em\u003e) summarized: \u003cem\u003e“The therapeutic dose of oral ALA in diabetic neuropathy is 600 mg\/day. Higher doses do not produce additional benefit and are associated with more adverse events.”\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003eALA exists in two enantiomers — the natural \u003cstrong\u003eR-isomer\u003c\/strong\u003e (R-ALA) and the synthetic \u003cstrong\u003eS-isomer\u003c\/strong\u003e. Most consumer products (and all of the German DPN trials including NATHAN 1) used \u003cstrong\u003eracemic R\/S-ALA\u003c\/strong\u003e — a 50\/50 mix. R-ALA is the form your mitochondria make and use; S-ALA is metabolically inert as a cofactor but is still redox-active and contributes to the antioxidant pool. Some \"stabilized R-ALA\" products claim better absorption per mg, but the trial database that established efficacy was built on racemic ALA. We use racemic R\/S-ALA at 600 mg precisely because that's the molecule and dose the trials validated. (If you specifically want R-ALA, it's available; you'd typically take 200-300 mg of R-ALA to roughly equate to 600 mg of racemic.)\u003c\/p\u003e\n\n\u003cp\u003eThe half-life of oral ALA is short — ~30 minutes plasma, with the antioxidant effect on the GSH\/Nrf2 axis lasting 6-12 hours. Once-daily dosing is what the trials used; some clinicians split into 300 mg twice daily on an empty stomach for steadier exposure. Both schedules are evidence-supported.\u003c\/p\u003e\n\n\u003ch2\u003eWhere ALA fits vs. the other compounds in this catalog\u003c\/h2\u003e\n\u003cp\u003eTrue Health Protocol stacks tend to layer ALA at the foundational antioxidant layer, alongside the GlyNAC pair, vitamin C, and CoQ10. Here's how ALA differs from the closest neighbors:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e:\u003c\/strong\u003e Glutathione\/NAC give the cell the substrate and precursor for the body's master antioxidant. ALA \u003cem\u003erecycles\u003c\/em\u003e oxidized glutathione back to active form and turns on the Nrf2 axis that drives glutathione \u003cem\u003esynthesis\u003c\/em\u003e. The three are designed to layer — substrate (NAC), product (GSH), and recycler\/upregulator (ALA).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e:\u003c\/strong\u003e CoQ10 and PQQ live inside the mitochondrial inner membrane — CoQ10 as the mobile electron carrier of complex I→III, PQQ as a redox cofactor and biogenesis activator. ALA sits in the matrix on PDH\/KGDH and recycles ubiquinone ↔ ubiquinol. The three together cover the substrate-flux + electron-transport + redox-recycling axes of mitochondrial energy.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine\u003c\/a\u003e:\u003c\/strong\u003e Both lower fasting glucose and improve insulin sensitivity by AMPK activation, but by different upstream mechanisms (ALA via mitochondrial AMP\/ATP ratio; berberine by direct AMPK kinase activation and gut-microbiome shifts). Stacking is additive (Bertuglia 2008 in animals, several human pilot studies). Berberine has the broader metabolic profile (lipids+glucose+gut); ALA has the broader antioxidant + neuropathy profile.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e:\u003c\/strong\u003e Both activate Nrf2 and inhibit NF-κB. Curcumin is more potent on inflammation; ALA is more potent on glucose. Stacking covers both axes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e:\u003c\/strong\u003e Both are membrane-active antioxidants but astaxanthin lives in the lipid bilayer fixed at right-angles to the membrane; ALA spans aqueous + lipid. They're complementary, not redundant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. NAD+ axis (\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e, \u003ca href=\"\/he\/products\/new-nad-hard-capsules-daily-nad-boost-for-energy-longevity\"\u003eNAD+ Daily Boost\u003c\/a\u003e):\u003c\/strong\u003e PDH and KGDH need \u003cem\u003eboth\u003c\/em\u003e lipoate and NAD+ to function. NAD+ precursors raise the pool of the electron acceptor; ALA provides the cofactor that loads that pool. They're substrate-and-cofactor partners, not competitors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e:\u003c\/strong\u003e Urolithin A activates mitophagy — clears damaged mitochondria. ALA helps the surviving mitochondria run cleaner. Sequential, not redundant.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003evs. \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e:\u003c\/strong\u003e CaAKG provides α-ketoglutarate as a Krebs-cycle intermediate. KGDH then uses lipoate (from ALA) to convert it to succinyl-CoA. They literally work on the same enzyme.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat's in this product\u003c\/h2\u003e\n\u003cp\u003eEach capsule delivers \u003cstrong\u003e600 mg of pharmaceutical-grade racemic R\/S Alpha-Lipoic Acid\u003c\/strong\u003e — the exact molecule and dose used in the SYDNEY 2 and NATHAN 1 trials. We chose racemic over R-only stabilized forms because the entire human evidence base was built on the racemic mixture; switching to R-only changes the dose-response curve and we have no equivalent four-year trial on R-only at this dose.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e60 vegetarian capsules\u003c\/strong\u003e per bottle — 60-day supply at the standard 600 mg\/day or 30-day supply at split 300 mg twice-daily.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHPMC vegan capsule shell\u003c\/strong\u003e — no gelatin, no animal sourcing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo titanium dioxide\u003c\/strong\u003e (banned in EU food in 2022, still common in US supplements). No magnesium stearate, no silicon dioxide, no PEG, no dyes.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExcipient-minimal formulation\u003c\/strong\u003e — only the active and rice flour as a flow agent. We don't include any “stabilizers” that mask oxidized ALA in old-batch product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUV-protective amber HDPE bottle\u003c\/strong\u003e with a foil induction seal — ALA is photosensitive and oxidatively self-degrading; clear bottles and over-large headspace are common ways product loses potency on the shelf.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured in a US FDA-registered facility.\u003c\/strong\u003e Per-batch Certificate of Analysis covers ALA assay (HPLC), residual solvents (EU Pharmacopoeia method), heavy metals (USP \u0026lt;232\u0026gt; \/ ICP-MS), microbial limits (USP \u0026lt;2021\u0026gt;), and absence of pesticides.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmed by HPLC.\u003c\/strong\u003e Many ALA products are sold by total-disulfide assay rather than chromatographic identity; we run HPLC against a reference standard so the labeled mg matches the actual mg.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAllergen-free formulation\u003c\/strong\u003e — no gluten, soy, dairy, peanut, tree-nut, egg, fish, or shellfish.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStandard protocol:\u003c\/strong\u003e 1 capsule (600 mg) once daily on an empty stomach — either 30 min before breakfast or 2-3 hr after dinner. Empty stomach matters: food (especially dairy and high-mineral meals) reduces ALA absorption ~30-40% (Gleiter 1996). The German DPN trials specified empty-stomach dosing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTwice-daily option:\u003c\/strong\u003e Some clinicians split into 300 mg morning + 300 mg afternoon, both empty-stomach. Same total exposure with steadier plasma levels. Either schedule is supported.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake with the rest of the antioxidant-network stack at the same time:\u003c\/strong\u003e \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eglutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e. Network compounds work better dosed together.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDon't take it within 2 hours of \u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003emulti-collagen\u003c\/a\u003e, iron, or thyroid medication (levothyroxine).\u003c\/strong\u003e ALA chelates metals; that's a mechanism feature, but it can blunt absorption of those products. Separate by ~2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin \/ sulfonylurea users:\u003c\/strong\u003e ALA can additively lower glucose. Talk to your prescriber and start with closer glucose self-monitoring during the first 2-4 weeks of use. The 600 mg dose is typically not problematic alone but stacks with insulin\/sulfonylureas on a same-target.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Take when you remember if it's still on an empty stomach; otherwise skip and resume the next day. Don't double-dose — ALA's symptom benefits build over weeks; missing a single day is not consequential.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e Not required. NATHAN 1 ran 4 years of continuous daily use without dose-related toxicity. Long-term use is the use case the trials validated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with — the longevity\/metabolic stack\u003c\/h2\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePair with\u003c\/th\u003e\n\u003cth\u003eWhy\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine HCL 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eDifferent upstream activator of the same AMPK target. Lipid + glucose + gut additive. Take berberine with meals; ALA empty-stomach — the schedules don't conflict.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eThe GlyNAC + ALA network: substrate + product + recycler. Sechi 2009 GlyNAC + ALA showed measurable GSH:GSSG ratio improvement in older adults.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eCloses the GlyNAC loop — glycine is the third amino acid in glutathione. Kumar 2023 GlyNAC trial showed body-composition + glucose benefit in older adults at 24 weeks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eALA recycles oxidized vitamin C back to ascorbate. Liposomal form delivers steady plasma vs ascorbic acid; the recycling loop runs longer.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eMitochondrial energy triad — ALA loads PDH\/KGDH, CoQ10 carries the electrons, PQQ activates biogenesis. Energy + cognition stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eBoth activate Nrf2 by different mechanisms; both inhibit NF-κB. Inflammation + metabolic stack.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin 12mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMembrane-fixed antioxidant + amphipathic ALA = full-membrane oxidant defense across both compartments.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSenolytic flavonoids drop senescent-cell burden; ALA improves the metabolic environment surrounding the surviving cells.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eNAD+ axis substrate. PDH\/KGDH need both NAD+ \u003cem\u003eand\u003c\/em\u003e lipoate. ALA + NMN literally co-fuel the same enzyme step.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eCaAKG supplies α-ketoglutarate; KGDH uses ALA's lipoyllysine to process it. Substrate + cofactor pair on a single enzyme.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMitophagy + cleaner-mitochondria pair — UA clears damaged units, ALA helps the surviving units run cleaner.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational. Mg is a Krebs-cycle cofactor (isocitrate dehydrogenase, α-KG dehydrogenase, ATP synthesis). ALA + Mg covers cofactor + substrate at the same Krebs step.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational membrane substrate; ALA recycles α-tocopherol that protects PUFA from peroxidation. The membrane and the substrate together.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eFoundational longevity layer. D3 governs ~2,000 genes; ALA governs the antioxidant network. Different axes, both essential.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eMitochondrial sulfur amino acid; cardiovascular + insulin pair with ALA.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene 100mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eSIRT1 activators on the longevity axis; ALA on the antioxidant + metabolic axis. Layer both for foundational longevity stacks.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eRealistic timeline — what to expect by week\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1-2:\u003c\/strong\u003e A few people notice steadier post-meal glucose (especially diabetics on monitors). Most feel nothing — that's expected. ALA's effect is biochemical, not stimulatory; this product does \u003cem\u003enot\u003c\/em\u003e give a noticeable kick like caffeine or B-vitamins.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 3-6:\u003c\/strong\u003e Fasting glucose usually 5-15 mg\/dL lower if elevated at baseline (Akbari 2018 effect size). Triglycerides start dropping. Diabetic neuropathy patients begin reporting early TSS reductions in published trials around week 3.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 8-12:\u003c\/strong\u003e The Nrf2\/glutathione-axis turn-on shows up as lower hs-CRP and MDA on labs. HbA1c shifts ~0.2-0.4 points if elevated at baseline. Neuropathy symptom score drops typically peak around week 5-12 (SYDNEY 2 timeline).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3-6:\u003c\/strong\u003e Lipid normalization stabilizes. NAFLD patients show ALT\/AST drops and ultrasound steatosis reduction. Cognitive aging trials see effect emerge here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYear 1+:\u003c\/strong\u003e NATHAN 1 timeline — durable nerve-conduction improvement; safety profile equivalent to placebo across 4 years of daily use.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect:\u003c\/strong\u003e A stimulant kick. Sudden weight loss. A cure for diabetes. ALA is a foundational metabolic + antioxidant tool; the value compounds over months and years.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003eAdults 35+ building a foundational longevity stack (alongside \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMg-Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e).\u003c\/li\u003e\n  \u003cli\u003ePeople with metabolic syndrome, prediabetes, or T2D wanting an evidence-based adjunct (alongside, not instead of, prescribed care).\u003c\/li\u003e\n  \u003cli\u003ePeople with elevated triglycerides, fatty liver markers, or PCOS.\u003c\/li\u003e\n  \u003cli\u003eDiabetic peripheral neuropathy — the indication ALA is approved for in Germany.\u003c\/li\u003e\n  \u003cli\u003eHeavy-metal-exposure populations (older amalgam fillings, well water, occupational) who want a low-key chelating co-factor.\u003c\/li\u003e\n  \u003cli\u003eAnyone running an NAD+ stack — ALA loads the PDH\/KGDH enzymes that consume that NAD+.\u003c\/li\u003e\n  \u003cli\u003eMitochondrial-energy stack builders pairing ALA with \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e.\u003c\/li\u003e\n  \u003cli\u003ePeople interested in the Nrf2\/antioxidant network as a whole and stacking with \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003ecurcumin\u003c\/a\u003e + \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003equercetin\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnant or breastfeeding women\u003c\/strong\u003e — insufficient safety data; talk to your OB.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType-1 diabetics on insulin\u003c\/strong\u003e — potential additive hypoglycemia; don't start ALA without your endocrinologist and closer self-monitoring during the first 4 weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eType-2 diabetics on sulfonylureas (glyburide, glipizide, glimepiride)\u003c\/strong\u003e — same hypoglycemia caution.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHypothyroid patients on levothyroxine\u003c\/strong\u003e — ALA can chelate metals and reduce levothyroxine absorption; separate dosing by 2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIron-deficient patients on iron supplements\u003c\/strong\u003e — ALA chelates iron; separate by 2-3 hours.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThiamine-deficient populations\u003c\/strong\u003e — rare reports of insulin autoimmune syndrome (Hirata's disease) in thiamine-deficient subjects on ALA, almost exclusively Japanese reports. Adequate thiamine intake (B-complex or food) eliminates the concern.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eChildren\u003c\/strong\u003e — the trial database is in adults.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnyone with a known sensitivity\u003c\/strong\u003e to ALA. Talk to your physician if you have any doubt.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eQuality, sourcing, and oxidation control\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid is photosensitive, thermosensitive, and oxidatively self-degrading — bulk ALA powder loses several percent of activity per month if exposed to sunlight, oxygen, or temperatures above ~25°C. Manufacturing and packaging matter more than for almost any other supplement we sell. Our specifications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSynthesis:\u003c\/strong\u003e Pharmaceutical-grade racemic R\/S ALA, the same molecule used in the German Thioctacid drug product.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity:\u003c\/strong\u003e HPLC against a USP-grade reference standard. Total-disulfide assay alone is not sufficient because it can be confused by oxidized impurities.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeavy metals:\u003c\/strong\u003e USP \u0026lt;232\u0026gt; \/ ICP-MS panel below all USP elemental impurity limits (Pb \u0026lt;0.5 ppm, As \u0026lt;1.5 ppm, Cd \u0026lt;0.5 ppm, Hg \u0026lt;1.5 ppm).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMicrobial:\u003c\/strong\u003e USP \u0026lt;2021\u0026gt; total aerobic count \u0026lt;1000 CFU\/g; absence of \u003cem\u003eSalmonella\u003c\/em\u003e, \u003cem\u003eE. coli\u003c\/em\u003e, \u003cem\u003eS. aureus\u003c\/em\u003e.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvents:\u003c\/strong\u003e EU Pharmacopoeia 2.4.24 (gas chromatography). Class 2 and Class 3 solvents below ICH Q3C limits.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e Amber UV-protective HDPE bottle; nitrogen-flushed at fill; foil induction seal; oxygen scavenger desiccant. The packaging is doing real work.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Cool, dry, dark place. Do not refrigerate (condensation on opening accelerates oxidation). Keep the cap tight.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ecGMP-manufactured\u003c\/strong\u003e in an FDA-registered, NSF-audited facility.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch CoA\u003c\/strong\u003e available on request.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFAQ\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eR\/S vs R-ALA — which is “better”?\u003c\/strong\u003e\u003cbr\u003e\nThe honest answer: \u003cem\u003ethe trial database that established ALA as effective was built on R\/S racemic.\u003c\/em\u003e ALADIN, ALADIN II, ALADIN III, DEKAN, ORPIL, SYDNEY, SYDNEY 2, and NATHAN 1 all used racemic. R-only is more bioavailable per mg, but you don't have a NATHAN 1-equivalent four-year trial on R-only at any dose. We chose to match the trial database. If you want pure R-ALA, expect to dose around 200-300 mg to roughly equate to 600 mg of racemic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs ALA the same as Lipoic Acid? Thioctic acid?\u003c\/strong\u003e\u003cbr\u003e\nYes. “Alpha-lipoic acid,” “lipoic acid,” and “thioctic acid” are three names for the same molecule (1,2-dithiolane-3-pentanoic acid). Thioctic acid is the older name and the name used in EU pharmacopoeial monographs.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy empty stomach?\u003c\/strong\u003e\u003cbr\u003e\nGleiter 1996 and Brufani 2014 showed food (especially mineral- and protein-rich meals) drops ALA absorption ~30-40%. Empty stomach is what the trials specified. 30 minutes before food or 2-3 hours after.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it lower my glucose if it's already normal?\u003c\/strong\u003e\u003cbr\u003e\nGenerally not in any way you'd notice. ALA is an insulin sensitizer; it doesn't drop glucose in non-insulin-resistant adults the way insulin or sulfonylureas do. The hypoglycemia risk is on people stacking ALA with insulin, sulfonylureas, or rarely meglitinides.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy does my pee smell weird after taking ALA?\u003c\/strong\u003e\u003cbr\u003e\nA common harmless side effect — ALA's two thiol groups produce a sulfur-smelling metabolite that excretes in urine for some people. Like asparagus pee. Doesn't indicate anything wrong.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHeartburn?\u003c\/strong\u003e\u003cbr\u003e\nTake with a small fat-only buffer (a few almonds, a teaspoon of olive oil) if empty-stomach is uncomfortable; or split to 300 mg twice daily. The 1200 and 1800 mg arms in SYDNEY 2 had more nausea, which is one reason 600 mg ended up the standard.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it with metformin?\u003c\/strong\u003e\u003cbr\u003e\nYes, and it's a common stack. Two different upstream mechanisms (metformin via complex I + AMPK; ALA via mitochondrial AMP\/ATP + Nrf2). Han 2020 meta and others showed additive HbA1c benefit. Keep prescribed metformin under your physician's direction; ALA is an adjunct, not a replacement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about with \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e?\u003c\/strong\u003e\u003cbr\u003e\nCommon stack. ALA empty-stomach in the morning, berberine with meals; the schedules don't conflict. Both hit AMPK by different upstream paths. Glucose + lipid + gut layered profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about with my \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e stack?\u003c\/strong\u003e\u003cbr\u003e\nExcellent layering. ALA loads PDH and KGDH; those enzymes consume the NAD+ that NMN raises. ALA + NMN are substrate and cofactor for the same Krebs-cycle entry steps.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take it long term?\u003c\/strong\u003e\u003cbr\u003e\nNATHAN 1 ran 600 mg\/day for 4 years with safety equivalent to placebo. Long-term daily use is the use case the trials validated.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I take more than 600 mg?\u003c\/strong\u003e\u003cbr\u003e\nYou can — SYDNEY 2 ran 1800 mg\/day for 5 weeks with no efficacy gain over 600 and more nausea. There's no clinical reason to exceed 600 mg\/day for the long-term use case.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my levothyroxine \/ thyroid hormone?\u003c\/strong\u003e\u003cbr\u003e\nPossibly. ALA's chelation can blunt levothyroxine absorption if taken at the same time. Standard practice: take levothyroxine first thing on waking, ALA at least 2-3 hours later. Tell your endocrinologist you're starting ALA.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eI'm B12-deficient or a long-term metformin user. Does that matter?\u003c\/strong\u003e\u003cbr\u003e\nALA does not deplete B12, but adults on long-term metformin should monitor B12 anyway (Aroda 2016). Adequate thiamine (B1) is also important for ALA users in case-report contexts (rare Japanese insulin autoimmune syndrome reports were mostly in thiamine-deficient subjects). A daily B-complex covers this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do I see \"300 mg\" doses elsewhere when the trials used 600 mg?\u003c\/strong\u003e\u003cbr\u003e\nMost consumer products dose lower because (a) ALA is relatively expensive per gram and (b) the marketing emphasis is general antioxidant support, where lower doses are still meaningful. The 600 mg dose is what the human metabolic and neuropathy evidence base was built on. Splitting one 600 mg capsule into two 300 mg doses across the day is a reasonable variant — same total intake.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes ALA help with weight loss?\u003c\/strong\u003e\u003cbr\u003e\nA modest effect — Kucukgoncu 2017 meta showed ~1.27 kg average weight loss vs placebo across 12 RCTs. Don't buy ALA for weight loss alone; do consider it as part of a broader metabolic stack where weight is one of several endpoints.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes it help with brain fog or cognition?\u003c\/strong\u003e\u003cbr\u003e\nThe Hager 2007 Alzheimer's pilot and Khalili 2014 MS trial are the strongest signals. The Gosselin 2019 review found a positive effect in MCI\/mild AD and a less clear effect in healthy older adults. Realistic expectation: it's part of a cognitive-aging stack, not a standalone nootropic.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy do I see this product compared to \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e a lot?\u003c\/strong\u003e\u003cbr\u003e\nThey're often discussed in the same metabolic-supplement category, which is why we cross-link them. They're not substitutes — the German clinical literature on ALA is a separate body of evidence from the metformin-comparison literature on berberine. If your goal is comprehensive metabolic support, both belong in the protocol; if you're starting from zero and have to pick one, berberine has the broader profile (lipids + glucose + gut microbiome) and ALA has the more specific neuropathy + antioxidant-recycling profile.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs ALA the same as omega-3?\u003c\/strong\u003e\u003cbr\u003e\nNo. Omega-3 fish oil delivers EPA and DHA — long-chain polyunsaturated fatty acids that build cell membranes. Alpha-\u003cem\u003elipoic\u003c\/em\u003e acid is a small disulfide cofactor of mitochondrial enzymes — a completely different molecule despite the similar name. Some people also confuse ALA-the-cofactor with ALA-the-omega-3 (alpha-\u003cem\u003elinolenic\u003c\/em\u003e acid, found in flax). Three different molecules.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage?\u003c\/strong\u003e\u003cbr\u003e\nCool, dry, dark. Do not refrigerate (condensation on opening accelerates oxidation). Keep the cap tight; the bottle is amber and nitrogen-flushed for a reason.\u003c\/p\u003e\n\n\u003ch2\u003eWhere this sits in the True Health Protocol catalog\u003c\/h2\u003e\n\u003cp\u003eAlpha-lipoic acid is one of our four pillars of the \u003cstrong\u003eantioxidant-network layer\u003c\/strong\u003e: \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e (the master antioxidant itself), \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e (its precursor), \u003cstrong\u003eALA\u003c\/strong\u003e (the recycler + Nrf2 inducer), and \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003evitamin C\u003c\/a\u003e (the network's water-phase partner). Most adults building a serious protocol layer all four. The ALA-specific role — the universal-antioxidant + mitochondrial-cofactor + Nrf2-inducer combination — is not duplicated by any other compound in the catalog.\u003c\/p\u003e\n\n\u003cp\u003eIt's also a core member of the \u003cstrong\u003emetabolic foundation layer\u003c\/strong\u003e alongside \u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eberberine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eomega-3\u003c\/a\u003e. And of the \u003cstrong\u003emitochondrial-energy layer\u003c\/strong\u003e alongside \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e. ALA is the connective tissue between three otherwise distinct layers of the protocol — one of the few compounds that earns its place in nearly every adult's longevity stack regardless of starting point.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003ePacker L, Witt EH, Tritschler HJ. \u003cem\u003eAlpha-Lipoic acid as a biological antioxidant.\u003c\/em\u003e Free Radic Biol Med. 1995;19(2):227-50.\u003c\/li\u003e\n  \u003cli\u003eBustamante J et al. \u003cem\u003eAlpha-lipoic acid in liver metabolism and disease.\u003c\/em\u003e Free Radic Biol Med. 1998;24(6):1023-39.\u003c\/li\u003e\n  \u003cli\u003eHagen TM et al. \u003cem\u003e(R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function.\u003c\/em\u003e FASEB J. 1999;13(2):411-8.\u003c\/li\u003e\n  \u003cli\u003eSuh JH et al. \u003cem\u003e(R)-alpha-lipoic acid restores glutathione homeostasis in old rats.\u003c\/em\u003e Proc Natl Acad Sci USA. 2004;101(10):3381-6.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eTreatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid (ALADIN study).\u003c\/em\u003e Diabetologia. 1995;38(12):1425-33.\u003c\/li\u003e\n  \u003cli\u003eReljanovic M et al. \u003cem\u003eTreatment of diabetic polyneuropathy with the antioxidant thioctic acid (ALADIN II).\u003c\/em\u003e Free Radic Res. 1999;31(3):171-9.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eTreatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III).\u003c\/em\u003e Diabetes Care. 1999;22(8):1296-301.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eEffects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients (DEKAN study).\u003c\/em\u003e Diabetes Care. 1997;20(3):369-73.\u003c\/li\u003e\n  \u003cli\u003eRuhnau KJ et al. \u003cem\u003eEffects of 3-week oral treatment with the antioxidant thioctic acid (ORPIL study).\u003c\/em\u003e Diabet Med. 1999;16(12):1040-3.\u003c\/li\u003e\n  \u003cli\u003eAmetov AS et al. \u003cem\u003eThe sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: SYDNEY trial.\u003c\/em\u003e Diabetes Care. 2003;26(3):770-6.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eOral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: SYDNEY 2 trial.\u003c\/em\u003e Diabetes Care. 2006;29(11):2365-70.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eEfficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy (NATHAN 1).\u003c\/em\u003e Diabetes Care. 2011;34(9):2054-60.\u003c\/li\u003e\n  \u003cli\u003eMijnhout GS et al. \u003cem\u003eAlpha-lipoic acid for symptomatic peripheral neuropathy: a meta-analysis.\u003c\/em\u003e Int J Endocrinol. 2012;2012:456279.\u003c\/li\u003e\n  \u003cli\u003eZiegler D et al. \u003cem\u003eAntioxidants and diabetic neuropathy.\u003c\/em\u003e Antioxid Redox Signal. 2014;21(8):1291-321.\u003c\/li\u003e\n  \u003cli\u003eKonrad D et al. \u003cem\u003eThe antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via PI3K and AMPK.\u003c\/em\u003e Diabetes. 2001;50(7):1464-71.\u003c\/li\u003e\n  \u003cli\u003eJacob S et al. \u003cem\u003eOral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with T2DM.\u003c\/em\u003e Free Radic Biol Med. 1999;27(3-4):309-14.\u003c\/li\u003e\n  \u003cli\u003eAkbari M et al. \u003cem\u003eThe effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of RCTs.\u003c\/em\u003e Metabolism. 2018;87:56-69.\u003c\/li\u003e\n  \u003cli\u003eMohammadi V et al. \u003cem\u003eThe effect of alpha-lipoic acid (ALA) supplementation on cardiovascular risk factors in metabolic syndrome.\u003c\/em\u003e Adv Pharm Bull. 2017;7(2):185-194.\u003c\/li\u003e\n  \u003cli\u003eKucukgoncu S et al. \u003cem\u003eAlpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of RCTs.\u003c\/em\u003e Obes Rev. 2017;18(5):594-601.\u003c\/li\u003e\n  \u003cli\u003ede Sousa CV et al. \u003cem\u003eAlpha-lipoic acid in NAFLD: a systematic review.\u003c\/em\u003e 2019.\u003c\/li\u003e\n  \u003cli\u003eGenazzani AD et al. \u003cem\u003eAlpha-lipoic acid as a new treatment option for PCOS.\u003c\/em\u003e Gynecol Endocrinol. 2010.\u003c\/li\u003e\n  \u003cli\u003eKhalili M et al. \u003cem\u003eEffect of lipoic acid consumption on oxidative stress in MS.\u003c\/em\u003e Nutr Neurosci. 2014;17(1):16-20.\u003c\/li\u003e\n  \u003cli\u003eHager K et al. \u003cem\u003eAlpha-lipoic acid as a new treatment option for Alzheimer's disease.\u003c\/em\u003e Arch Gerontol Geriatr. 2007;45(1):S6-S10.\u003c\/li\u003e\n  \u003cli\u003eMaczurek A et al. \u003cem\u003eLipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.\u003c\/em\u003e Adv Drug Deliv Rev. 2008;60(13-14):1463-70.\u003c\/li\u003e\n  \u003cli\u003eGosselin LE et al. \u003cem\u003eEffect of acute lipoic acid intake on cognitive function: a systematic review.\u003c\/em\u003e Nutr Rev. 2019.\u003c\/li\u003e\n  \u003cli\u003eMagis D et al. \u003cem\u003eA randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.\u003c\/em\u003e Headache. 2007;47(1):52-7.\u003c\/li\u003e\n  \u003cli\u003eSalehi B et al. \u003cem\u003eInsights on the use of alpha-lipoic acid for therapeutic purposes.\u003c\/em\u003e Biomolecules. 2019;9(8):356.\u003c\/li\u003e\n  \u003cli\u003ePatrick L. \u003cem\u003eMercury toxicity and antioxidants: Part I — role of glutathione and alpha-lipoic acid.\u003c\/em\u003e Altern Med Rev. 2002;7(6):456-71.\u003c\/li\u003e\n  \u003cli\u003eGleiter CH et al. \u003cem\u003eInfluence of food intake on the bioavailability of thioctic acid enantiomers.\u003c\/em\u003e Eur J Clin Pharmacol. 1996;50(6):513-4.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThis product is not intended to diagnose, treat, cure, or prevent any disease. Alpha-lipoic acid is sold in the US as a dietary supplement and is not FDA-approved for any medical condition. These statements have not been evaluated by the FDA. Talk to your doctor before starting any supplement, especially if you are pregnant, breastfeeding, take prescription medication (particularly insulin, sulfonylureas, levothyroxine, or iron), or have any existing medical condition.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839563940058,"sku":"THP-ALA-600-60","price":26.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_ala.png?v=1778049793"},{"product_id":"taurine-1000mg-cardiovascular-mitochondrial-longevity","title":"Taurine 1000mg | Foundational Sulfur Amino Acid for Cardiovascular, Mitochondrial \u0026 Longevity","description":"\u003ch2\u003eTaurine 1000mg — Foundational Sulfur Amino Acid for Cardiovascular, Mitochondrial \u0026amp; Longevity Support\u003c\/h2\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eTaurine is a sulfur-containing amino acid that the body uses to regulate blood pressure, build bile acids, stabilize cardiac and skeletal-muscle membranes, conjugate the toxic byproducts of methionine metabolism, and assemble the mitochondrial-encoded subunits of the electron transport chain (the tRNA-modifying step that mtDNA-encoded enzymes need to translate correctly). It's not a \"lever\" the way NMN or Spermidine is — it's a baseline raw material the cell expects to find in supply. In June 2023, a research team led by Singh, Yadav, and colleagues published a paper in \u003cem\u003eScience\u003c\/em\u003e titled \u003cem\u003e\"Taurine deficiency as a driver of aging\"\u003c\/em\u003e showing that taurine concentrations in human blood drop roughly 80% from age 5 to age 60, that supplementation extended lifespan in mice (~10–12%) and worms, and that the deficiency tracks with several hallmarks of aging — cellular senescence, mitochondrial dysfunction, DNA damage, and inflammation. We added Taurine 1000mg as the fourth foundational nutrient layer underneath the longevity stack, alongside \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e, and the omega-3 \/ membrane-composition layer.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFive-second summary:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e1000mg pharmaceutical-grade L-taurine per capsule, microbial-fermented (vegan, no animal bile)\u003c\/li\u003e\n  \u003cli\u003eTrial-validated dose band: 1000–3000mg\/day across cardiovascular and metabolic RCTs\u003c\/li\u003e\n  \u003cli\u003eAnchor compound for the foundational sulfur layer alongside Glycine, NAC, TMG\u003c\/li\u003e\n  \u003cli\u003eSingh\/Yadav \u003cem\u003eScience\u003c\/em\u003e 2023, Sun \u003cem\u003eHypertension\u003c\/em\u003e 2016, Suzuki \u003cem\u003eEMBO J\u003c\/em\u003e 2002, Beyranvand \u003cem\u003eJ Cardiol\u003c\/em\u003e 2011\u003c\/li\u003e\n  \u003cli\u003eStack-anchor handles: \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e, \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e, \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhy a humble amino acid ended up in serious longevity research\u003c\/h3\u003e\n\u003cp\u003eTaurine has been in pediatric infant formula and ICU parenteral nutrition for decades — it was classified as \"conditionally essential\" because newborns can't synthesize enough on their own. What's new is the discovery of how steeply tissue concentrations decline with normal aging, and how reliably restoring those concentrations reverses age-associated dysfunction in animal models. The Singh\/Yadav \u003cem\u003eScience\u003c\/em\u003e 2023 paper (Singh et al., \u003cem\u003eScience\u003c\/em\u003e 380:eabn9257) measured taurine in monkeys, mice, and humans across the lifespan and found the same trajectory in all three species: roughly 80% of the youthful blood concentration is gone by middle age. When the team supplemented middle-aged mice with taurine for the rest of their lives, the mice lived 10–12% longer, had better-preserved muscle mass and grip strength, lower rates of bone loss, lower fasting glucose, and reduced markers of cellular senescence. The team also reported that taurine concentrations rose acutely after exercise in human subjects, suggesting one of the mechanisms through which exercise extends lifespan may be partially taurine-mediated.\u003c\/p\u003e\n\n\u003cp\u003eThe earlier mechanistic literature (Schaffer \u0026amp; Kim, \u003cem\u003eBiomol Ther\u003c\/em\u003e 2018 review; Ito et al., \u003cem\u003eJ Biomed Sci\u003c\/em\u003e 2014; Suzuki et al., \u003cem\u003eEMBO J\u003c\/em\u003e 2002) had already established taurine's structural role in mitochondrial translation, calcium handling, and bile acid conjugation, but those papers stayed inside specialty journals. The Singh\/Yadav paper put the lifespan-extension claim into a top-tier journal with a longitudinal human cohort attached, and it shifted taurine from \"conditionally essential nutrient\" to \"candidate longevity nutrient.\" Whether the human-lifespan claim survives a randomized controlled trial is still open — but the cross-species concentration trajectory and the reversibility of several aging hallmarks in animal models are now reasonably well-established.\u003c\/p\u003e\n\n\u003cp\u003eThis product sits in the same content-bucket as \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e and \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e: amino-acid raw materials that feed the cell's own machinery rather than acting as drug-like agonists. Building blocks rather than levers. The longevity argument is that levers don't work very well when the building blocks are running below youthful concentrations.\u003c\/p\u003e\n\n\u003ch3\u003eThe four mechanisms that make taurine foundational\u003c\/h3\u003e\n\n\u003ch4\u003e1. Cardiovascular regulation — the heart is built on taurine\u003c\/h4\u003e\n\u003cp\u003eTaurine is the most abundant free amino acid in the heart muscle (concentrations 100–400× higher than in plasma) and in skeletal muscle. It modulates calcium handling at the sarcoplasmic reticulum, stabilizes the cardiac action potential by adjusting potassium and chloride flux, and acts as a partial regulator of vascular tone. Several controlled human trials have shown blood pressure reductions of 5–10 mmHg systolic in mild-to-moderate hypertension at doses of 1.5–3g\/day over 6–12 weeks (Sun et al., \u003cem\u003eHypertension\u003c\/em\u003e 67:541–549, 2016; Militante \u0026amp; Lombardini, \u003cem\u003eCardiovasc Drug Rev\u003c\/em\u003e 20:121–134, 2002 review; Fujita et al., \u003cem\u003eCirculation\u003c\/em\u003e 75:525–532, 1987 in Japanese borderline-hypertension cohorts). Taurine has also been studied as an adjunct in heart failure since at least the 1980s — it's an over-the-counter supplement in Japan with a formal heart-failure indication (Beyranvand et al., \u003cem\u003eJ Cardiol\u003c\/em\u003e 57:333–337, 2011 in NYHA II-III patients showed improved exercise time at 500mg three times daily).\u003c\/p\u003e\n\n\u003ch4\u003e2. Mitochondrial protein synthesis — the missing tRNA modifier\u003c\/h4\u003e\n\u003cp\u003eThis is the mechanism most longevity discussions miss. Mitochondria contain their own DNA and their own protein-translation machinery, and that machinery requires taurine to chemically modify two specific mitochondrial tRNAs (tRNA-Leu(UUR) and tRNA-Lys) at the wobble position of the anticodon. Without enough taurine, those tRNAs misread their codons and the mitochondrial-encoded subunits of the electron transport chain (Complex I and Complex IV) get assembled incorrectly. The result is reduced ATP output and increased reactive oxygen species — exactly the pattern you see in aged tissue (Suzuki et al., \u003cem\u003eEMBO J\u003c\/em\u003e 21:6581–6589, 2002; Kirino et al., \u003cem\u003ePNAS\u003c\/em\u003e 101:15070–15075, 2004; Asano et al., \u003cem\u003eNucleic Acids Res\u003c\/em\u003e 46:1565–1583, 2018). Two genetic mitochondrial diseases (MELAS and MERRF) are caused by mutations that prevent this taurine modification, and human trials have shown that high-dose taurine (9–12g\/day) reduces the frequency of stroke-like episodes in MELAS patients (Ohsawa et al., \u003cem\u003eJ Neurol Neurosurg Psychiatry\u003c\/em\u003e 90:529–536, 2019). This is structural support for the cell's energy-producing apparatus — taurine doesn't make the mitochondria run; it makes sure the mitochondria are built correctly in the first place. \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e works downstream of this — taurine ensures the chain is built, CoQ10 ensures the electrons transfer efficiently across it.\u003c\/p\u003e\n\n\u003ch4\u003e3. Bile acid conjugation — fat absorption and cholesterol clearance\u003c\/h4\u003e\n\u003cp\u003eThe liver conjugates cholic and chenodeoxycholic acid with either glycine or taurine to make bile salts. Taurine-conjugated bile salts (taurocholate, taurochenodeoxycholate) are more soluble at duodenal pH, absorbed more efficiently from the ileum, and circulate at higher rates through the enterohepatic loop than the glycine-conjugated forms. The practical outcome is better fat-soluble vitamin absorption (D, E, K, A — including the \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e in your stack), better absorption of the lipophilic active ingredients in \u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin + BioPerine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, and the carotenoid family broadly, and modestly improved LDL clearance. Several controlled trials in obese subjects have shown taurine supplementation lowers total cholesterol and LDL by 5–10% at 3g\/day (Zhang et al., \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 526:283–290, 2004; Mizushima et al., \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 403:615–622, 1996 in young women on a controlled diet). It pairs naturally with \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e here — taurine and glycine are the two competing conjugating amino acids, and most people running long-term supplementation benefit from supplying both rather than letting the liver default to whichever is more abundant.\u003c\/p\u003e\n\n\u003ch4\u003e4. GABA-A modulation — the calming side\u003c\/h4\u003e\n\u003cp\u003eTaurine is a partial agonist at the GABA-A receptor and the strychnine-sensitive glycine receptor — both inhibitory (Albrecht \u0026amp; Schousboe, \u003cem\u003eNeurochem Res\u003c\/em\u003e 30:1615–1621, 2005; Jia et al., \u003cem\u003eJ Neurosci\u003c\/em\u003e 28:106–115, 2008). It doesn't put you to sleep the way magnesium glycinate's slow downward shift does, but it takes the edge off cardiovascular reactivity and is sometimes used pre-bedtime by people whose heart rate runs high under stress. The subjective effect is closer to \"settled\" than \"drowsy.\" This is the same neurotransmitter pathway your evening \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e dose works through, and the two stack additively without sedation. The Glycine 1500mg in the catalog hits the glycine-receptor side of the same inhibitory complex — taurine, glycine, and magnesium together cover three different binding sites on essentially one circuit.\u003c\/p\u003e\n\n\u003ch4\u003e5. Antioxidant + osmoregulation — the quiet baseline jobs\u003c\/h4\u003e\n\u003cp\u003eTaurine is a direct scavenger of hypochlorous acid (the oxidant neutrophils generate during inflammation) — it forms taurine chloramine, a far less reactive species, which is part of why taurine concentrations in inflamed tissue rise sharply during the acute-inflammatory response (Marcinkiewicz \u0026amp; Kontny, \u003cem\u003eAmino Acids\u003c\/em\u003e 46:7–20, 2014). It is also one of the cell's primary organic osmolytes, balancing intracellular osmolality without disturbing protein folding the way ionic osmolytes (Na⁺, K⁺) would. This osmoregulatory role is why taurine concentrations are so high in tissues with steep ionic flux: heart, retina, brain, skeletal muscle, leukocytes. Loss of intracellular taurine in aging cells correlates with the brittleness those cells show under metabolic stress.\u003c\/p\u003e\n\n\u003ch3\u003eThe clinical evidence — what the human trials actually report\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStudy\u003c\/th\u003e\n\u003cth\u003ePopulation\u003c\/th\u003e\n\u003cth\u003eDose \u0026amp; duration\u003c\/th\u003e\n\u003cth\u003eEndpoint reported\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSingh, Yadav et al. \u003cem\u003eScience\u003c\/em\u003e 2023\u003c\/td\u003e\n\u003ctd\u003eMice + monkeys + cross-sectional human cohort (n=12k+)\u003c\/td\u003e\n\u003ctd\u003e0.5–1g\/kg\/day mice for life; observational humans\u003c\/td\u003e\n\u003ctd\u003eMouse lifespan +10–12%; preserved grip strength, bone mass, fasting glucose; human plasma taurine drops ~80% from age 5→60\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSun et al. \u003cem\u003eHypertension\u003c\/em\u003e 2016\u003c\/td\u003e\n\u003ctd\u003e120 prehypertensive adults\u003c\/td\u003e\n\u003ctd\u003e1.6g\/day × 12 wk vs placebo\u003c\/td\u003e\n\u003ctd\u003eSBP −7.2 mmHg, DBP −4.7 mmHg vs placebo; FMD improved; plasma H₂S signaling restored\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBeyranvand et al. \u003cem\u003eJ Cardiol\u003c\/em\u003e 2011\u003c\/td\u003e\n\u003ctd\u003e29 NYHA II–III heart-failure patients\u003c\/td\u003e\n\u003ctd\u003e1.5g\/day × 2 wk\u003c\/td\u003e\n\u003ctd\u003e6-min walk distance ↑; LV function preserved at exercise stress test\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOhsawa et al. \u003cem\u003eJ Neurol Neurosurg Psychiatry\u003c\/em\u003e 2019\u003c\/td\u003e\n\u003ctd\u003e10 MELAS patients (mtDNA disease)\u003c\/td\u003e\n\u003ctd\u003e9–12g\/day × 52 wk\u003c\/td\u003e\n\u003ctd\u003eStroke-like episode frequency ↓ 60% vs pre-treatment; safety good\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eZhang et al. \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 2004\u003c\/td\u003e\n\u003ctd\u003e30 obese non-diabetic adults\u003c\/td\u003e\n\u003ctd\u003e3g\/day × 7 wk\u003c\/td\u003e\n\u003ctd\u003eTotal cholesterol −9%, LDL −10%, body weight modest ↓\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMoloney et al. \u003cem\u003eDiabetes Res Clin Pract\u003c\/em\u003e 2010\u003c\/td\u003e\n\u003ctd\u003e20 type-1 diabetic patients with FMD impairment\u003c\/td\u003e\n\u003ctd\u003e1.5g\/day × 2 wk\u003c\/td\u003e\n\u003ctd\u003eBrachial artery FMD restored to non-diabetic levels\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDe Carvalho et al. \u003cem\u003eJ Sports Med Phys Fitness\u003c\/em\u003e 2018 meta-analysis\u003c\/td\u003e\n\u003ctd\u003e9 RCTs \/ 222 participants\u003c\/td\u003e\n\u003ctd\u003e1–6g pre-exercise\u003c\/td\u003e\n\u003ctd\u003ePooled time-to-exhaustion ↑ 13–24%; MAOC ↓ during sub-maximal cycling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaleki et al. \u003cem\u003eClin Nutr\u003c\/em\u003e 2020\u003c\/td\u003e\n\u003ctd\u003e40 cardiomyopathy patients\u003c\/td\u003e\n\u003ctd\u003e500mg × 3\/day × 8 wk\u003c\/td\u003e\n\u003ctd\u003eNT-proBNP ↓; LVEF preserved; exercise capacity ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpasov et al. \u003cem\u003eDiabetes Metab\u003c\/em\u003e 2011\u003c\/td\u003e\n\u003ctd\u003eType-2 diabetic patients with retinopathy\u003c\/td\u003e\n\u003ctd\u003e1g\/day × 12 wk\u003c\/td\u003e\n\u003ctd\u003eHbA1c modest ↓; visual evoked potential improved; not powered for hard endpoints\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFujita \u0026amp; Sato \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 1987\u003c\/td\u003e\n\u003ctd\u003e10 borderline hypertensives\u003c\/td\u003e\n\u003ctd\u003e6g\/day × 7 day\u003c\/td\u003e\n\u003ctd\u003eSBP −9 mmHg, DBP −4 mmHg; norepinephrine ↓\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThree things worth noting about this evidence base. First, the cardiovascular signal is the most replicated and the one with the longest pedigree (40+ years, multiple Japanese, Mexican, Iranian, and US groups). Second, the mitochondrial-disease (MELAS) signal at high dose is biological proof that the tRNA-modification mechanism is correct — when you remove the modification by genetics and restore the substrate by supplementation, the disease softens. Third, the Singh\/Yadav 2023 paper is what brought taurine back into longevity conversation; the human-lifespan claim from that paper is observational rather than RCT — the molecular and animal data are what put it on the longevity-protocol map.\u003c\/p\u003e\n\n\u003ch3\u003eForms of taurine — what's on the market and what we ship\u003c\/h3\u003e\n\u003ctable border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;font-size:14px\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003cth\u003eNotes on bioavailability\u003c\/th\u003e\n\u003cth\u003eBest use case\u003c\/th\u003e\n\u003cth\u003eCatalog status\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree L-taurine (this product)\u003c\/td\u003e\n\u003ctd\u003e~70–80% oral bioavailability; peak plasma at 1.5–2.5 hr; t½ ~1 hr\u003c\/td\u003e\n\u003ctd\u003eDaily foundational dose, cardiovascular protocol, GABA-A pre-bed\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eStocked: 1000mg cap\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine + caffeine combo (energy drinks)\u003c\/td\u003e\n\u003ctd\u003eSame taurine bioavailability; caffeine works against parasympathetic effect\u003c\/td\u003e\n\u003ctd\u003ePre-workout window only — defeats CV protocol\u003c\/td\u003e\n\u003ctd\u003eNot catalog\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eN-acetyl taurine\u003c\/td\u003e\n\u003ctd\u003eMarginally more lipophilic, claims of higher CNS penetration; weak human PK data\u003c\/td\u003e\n\u003ctd\u003eNiche; no proven clinical advantage over free taurine\u003c\/td\u003e\n\u003ctd\u003eNot catalog\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMagnesium taurate\u003c\/td\u003e\n\u003ctd\u003eCombines two BP-active nutrients; ~85mg taurine per 1g salt\u003c\/td\u003e\n\u003ctd\u003eCardiovascular-only protocol; expensive per mg taurine\u003c\/td\u003e\n\u003ctd\u003eNot catalog (we stock magnesium glycinate + taurine separately for dose flexibility)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine in protein powder\u003c\/td\u003e\n\u003ctd\u003eTrace amounts (~50–150mg\/scoop); not a meaningful dose\u003c\/td\u003e\n\u003ctd\u003eBackground dietary intake only\u003c\/td\u003e\n\u003ctd\u003eNot catalog\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnimal-bile-derived taurine\u003c\/td\u003e\n\u003ctd\u003eIdentical chemistry; carries trace heavy metals + prion concerns\u003c\/td\u003e\n\u003ctd\u003eCheaper bulk grades use this; we don't\u003c\/td\u003e\n\u003ctd\u003eNot catalog (we use vegan microbial fermentation)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTaurine in whole-food sources\u003c\/td\u003e\n\u003ctd\u003eBeef ~360mg\/100g; chicken ~170mg; fish ~50–250mg; absent from plants\u003c\/td\u003e\n\u003ctd\u003eBackground diet contribution; vegetarians\/vegans run lowest\u003c\/td\u003e\n\u003ctd\u003eDiet, not supplement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eFree L-taurine in capsule form is the format used in essentially every published RCT (Sun 2016, Beyranvand 2011, Zhang 2004, Singh\/Yadav 2023). Anything else with extra ingredients trades dose flexibility for a marketing claim that doesn't survive a head-to-head trial.\u003c\/p\u003e\n\n\u003ch3\u003eStack pairings — what each pair actually does\u003c\/h3\u003e\n\n\u003ch4\u003eMitochondrial-energy stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e:\u003c\/strong\u003e Electron transport chain support. Taurine ensures the chain is assembled correctly (mtDNA tRNA modification → Complex I + IV subunits); CoQ10 ensures the electrons transfer efficiently between Complexes II and III. Stack used by anyone on a statin or with documented mitochondrial fatigue.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN 500mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e:\u003c\/strong\u003e Mitochondrial pair. NMN raises NAD+ supply for Complex I; taurine ensures Complex I is built correctly to use the NAD+ that arrives. Most longevity protocols stack both.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e:\u003c\/strong\u003e Mitochondrial-quality pair. Urolithin A removes damaged mitochondria via mitophagy; taurine ensures the replacement mitochondria are translated correctly. Pairs particularly well for endurance athletes and people over 60.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e:\u003c\/strong\u003e Biogenesis pair. PQQ stimulates mitochondrial biogenesis via PGC-1α (Chowanadisai 2010); taurine ensures the new mitochondria are correctly translated. Stack for endurance, cognitive load, and post-50 metabolic decline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e:\u003c\/strong\u003e ALA is the mitochondrial-matrix antioxidant; taurine handles the cytosolic \/ chloramine antioxidant layer. Both improve glucose handling at moderate doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eCardiovascular stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e:\u003c\/strong\u003e Both modulate GABA-A and cardiovascular ion handling. Magnesium is the cofactor that lets the GABA-A receptor function at all; taurine is a partial agonist at the same receptor. Together they cover both the cofactor and the ligand layers of inhibitory neurotransmission and blood-pressure control.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 2000mg\u003c\/a\u003e:\u003c\/strong\u003e Both support endothelial function (Sun 2016 FMD restoration; Mozaffarian\/Wu 2013 EPA\/DHA). Taurine modulates vascular tone via H₂S signaling; EPA\/DHA modulate via prostaglandin\/resolvin pathways. Stack for cardiovascular longevity past age 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e:\u003c\/strong\u003e The classic Japanese cardiologist heart-failure adjunct. Mortensen 2014 (Q-SYMBIO) on CoQ10; Beyranvand 2011 on taurine; GISSI-HF 2008 on omega-3. Three-compound base for cardio-mitochondrial support.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eSulfur-and-methylation stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG (Trimethylglycine)\u003c\/a\u003e:\u003c\/strong\u003e Both regulate methionine\/sulfur metabolism. TMG donates a methyl group to recycle homocysteine back to methionine; taurine is the downstream sulfur sink that disposes of excess sulfur from the same pathway. Useful for anyone running NMN long-term, because NMN methylation pulls on the methionine cycle.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e:\u003c\/strong\u003e Both are bile-acid conjugating amino acids, both are inhibitory neurotransmitters at distinct receptors. Stack for anyone running long-term lipophilic supplementation (omega-3, curcumin, fat-soluble vitamins) and anyone with sleep onset issues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e:\u003c\/strong\u003e Sulfur-amino-acid trio. NAC is the cysteine precursor for glutathione; glycine is the second glutathione substrate; taurine is the sulfur-sink downstream. The Kumar 2022 GlyNAC trial demonstrates the value of supplying both glutathione substrates in older adults — taurine completes the sulfur-cycle picture.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e:\u003c\/strong\u003e Antioxidant stack. Glutathione is the master cytosolic antioxidant; taurine handles hypochlorous-acid scavenging and osmoregulation. Pair for inflammaging-bias and post-illness recovery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eSkeletal-muscle and performance stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003eCreatine Monohydrate 1000mg\u003c\/a\u003e:\u003c\/strong\u003e Skeletal-muscle pair. Creatine increases ATP buffer capacity; taurine modulates calcium handling and ion channel stability in the same muscle. Useful for sarcopenia prevention and grip strength preservation past age 50.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine pre-workout (1–2g, 30–60 min before training):\u003c\/strong\u003e Endurance signal in the De Carvalho 2018 meta-analysis (~13–24% time-to-exhaustion improvement). Reasonable solo, also stacks with creatine on training days.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eCalming \/ pre-bed stacks\u003c\/h4\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e + \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e 60 min pre-bed:\u003c\/strong\u003e Three-compound inhibitory-tone stack. Magnesium = GABA-A cofactor, taurine = GABA-A partial agonist, glycine = glycine-receptor agonist. No daytime sedation, helps sleep-onset for people with high resting sympathetic tone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine + \u003ca href=\"\/he\/products\/ashwagandha-ksm-66-600mg\"\u003eAshwagandha KSM-66 600mg\u003c\/a\u003e:\u003c\/strong\u003e Stress \/ HPA-axis stack. Ashwagandha lowers cortisol; taurine reduces cardiovascular reactivity to whatever sympathetic surge is left.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in the catalog architecture\u003c\/h3\u003e\n\u003cp\u003eThe True Health Protocol catalog is organized into discrete-mechanism levers (NAD+ family, senolytics, methylation pairings, polyphenol antioxidants) layered on top of foundational raw-material nutrients. The four foundational layers are:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/strong\u003e — mineral cofactor for ~300 enzymes including the NAD+ salvage pathway and ATP hydrolysis\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7\u003c\/a\u003e\u003c\/strong\u003e — fat-soluble vitamin, calcium direction (bone vs. arterial wall)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e\u003c\/strong\u003e — sulfur cycle \/ collagen substrate \/ glutathione precursor \/ inhibitory neurotransmitter\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine 1000mg\u003c\/strong\u003e (this product) — sulfur amino acid, cardiovascular ion handling, mitochondrial tRNA modification, bile conjugation, GABA-A partial agonist\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFoundational means \"the chemistry the headline molecules run on\" — they don't compete with NMN, Spermidine, Fisetin, or Urolithin A; they make those mechanism levers more reliable. If a foundational layer is missing or running low, the discrete-mechanism products work less well than they otherwise would. Taurine specifically rescues the part of the mitochondrial story that NMN and PQQ can't reach: NMN raises NAD+ supply, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e stimulates mitochondrial biogenesis, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e drives mitophagy of damaged mitochondria — but if mtDNA-encoded Complex I and Complex IV subunits are translating with the wrong amino acids, those upstream and downstream interventions are working against a defective base. Taurine fills the structural gap.\u003c\/p\u003e\n\n\u003cp\u003eTaurine is in the \u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e, \u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e, and \u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e smart collections, and is named in the \u003ca href=\"\/he\/blogs\/longevity-essentials\/foundational-health-the-7-daily-nutrients-that-anchor-your-longevity-protocol\"\u003e7 Daily Nutrients\u003c\/a\u003e cornerstone article and the \u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e page as the fourth foundational layer.\u003c\/p\u003e\n\n\u003ch3\u003eWhy 1000mg specifically — the dose-curve argument\u003c\/h3\u003e\n\u003cp\u003eTaurine doses in the published literature range from 500mg\/day (Beyranvand 2011 thrice-daily 500mg HF protocol) up to 12g\/day (Ohsawa 2019 MELAS protocol). What that range hides is a clear shape:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBelow 500mg\/day:\u003c\/strong\u003e Sub-clinical for measured cardiovascular endpoints. The Sun 2016 BP trial used 1.6g\/day; doses below that haven't reliably moved BP.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1000–2000mg\/day (this product's target band):\u003c\/strong\u003e The cardiovascular and metabolic trials cluster here. 1000mg is the foundational daily dose; doubling to 2000mg covers the mid-range Sun\/Beyranvand cardiovascular trial doses.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e3000–6000mg\/day:\u003c\/strong\u003e Endurance, athletic, and aggressive cardiovascular protocols. De Carvalho 2018 endurance meta-analysis pulls average dose around 2.5g pre-exercise. Zhang 2004 cholesterol trial used 3g. Fujita 1987 used 6g.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e9000–12000mg\/day:\u003c\/strong\u003e MELAS and severe-mitochondrial-disease territory. Not appropriate for general longevity protocols; clinically supervised use only.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 1000mg capsule lets you start at 1×\/day for the foundational longevity dose, step to 2×\/day for the cardiovascular protocol, and step further for endurance\/athletic windows without changing product. Most longevity protocols stay in the 1000–2000mg\/day range.\u003c\/p\u003e\n\n\u003ch3\u003eDaily protocol\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational daily (longevity baseline):\u003c\/strong\u003e 1 capsule (1000mg) with breakfast.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCardiovascular \/ blood pressure protocol:\u003c\/strong\u003e 1 capsule with breakfast and 1 with dinner (2000mg total), per the Sun 2016 hypertension trial dose. Re-check blood pressure at week 4 and week 8.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEndurance \/ mitochondrial protocol:\u003c\/strong\u003e 2 capsules pre-workout (2000mg) on training days; 1 capsule with breakfast on rest days. Stacks with Urolithin A for mitochondrial renewal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-bed calming layer (optional):\u003c\/strong\u003e 1 capsule 60 minutes before bed alongside Magnesium Glycinate — most useful if you notice high resting heart rate at sleep onset.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWith food vs. fasting:\u003c\/strong\u003e Taurine is well-absorbed in either state. The bile-conjugation argument suggests \"with the meal that has the most fat\" gets you slightly more downstream benefit per dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eContinuous use:\u003c\/strong\u003e No cycling needed. Taurine is a foundational nutrient, not a receptor agonist with desensitization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWeek-by-week timeline — what the trial literature says you should see\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDay 1–7:\u003c\/strong\u003e Plasma taurine concentration rises; urinary taurine output rises (the body is filling depleted tissue stores first). Subjective: settling effect at the pre-bed dose; nothing felt at the morning dose. Mitochondrial and bile-conjugation effects are silent.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 2–4:\u003c\/strong\u003e First measurable blood pressure shift at the 2000mg\/day cardiovascular dose (Sun 2016: ~5 mmHg systolic by week 4, full effect at week 12). FMD (flow-mediated dilation) begins to improve in subjects with endothelial impairment (Moloney 2010).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 4–8:\u003c\/strong\u003e 6-minute walk distance improves in subjects with cardiomyopathy (Maleki 2020). NT-proBNP trends downward in heart-failure populations (Beyranvand 2011 saw signal at 2 weeks, formal effect at longer trials).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 6–12:\u003c\/strong\u003e Cholesterol panel may show 5–10% LDL reduction at the 3000mg\/day dose (Zhang 2004); fat-soluble vitamin status (D, E, K) shifts upward at the next blood draw. SBP −7.2 \/ DBP −4.7 mmHg in the Sun 2016 prehypertension cohort by week 12.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 3–6:\u003c\/strong\u003e Mitochondrial-translation and tRNA-wobble effects accumulate silently. Endurance signal (time-to-exhaustion) measurable in athletes (De Carvalho 2018 average effect by ~3-4 weeks of consistent supplementation).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonth 6+:\u003c\/strong\u003e Grip strength preservation past 6 months in mouse data (Singh\/Yadav 2023); human grip strength data on this specific endpoint is not yet available, so we frame this as a candidate-mechanism rather than a proven endpoint. Long-run cardiovascular benefit remains the most reliable signal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOn stopping:\u003c\/strong\u003e Plasma taurine drops back toward baseline within 1–2 weeks; cardiovascular and FMD benefits regress over 4–8 weeks based on the trial-stopping data (Sun 2016 follow-up). Mitochondrial-tRNA effects are slowest to revert.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSubstituting an energy drink:\u003c\/strong\u003e 1000mg of taurine is the same dose, but the 27g of sugar and the caffeine load defeat the cardiovascular-protocol point. Capsule, not drink.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuitting at week 2:\u003c\/strong\u003e Subjective effects at 1000mg\/day are often silent. Cardiovascular endpoints take 4–12 weeks. Don't quit during the silent phase.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaking it only pre-workout:\u003c\/strong\u003e Pre-workout dosing is fine for the endurance signal but misses the foundational role. Daily dosing is the correct framing for the longevity literature.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStopping cold before scheduled surgery:\u003c\/strong\u003e Discontinue 14 days before surgery — but tell your surgeon you've stopped, not just \"I take taurine\" without context. The GABA-A modulation matters for anesthesia planning.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStacking with high-dose caffeine for \"energy\":\u003c\/strong\u003e Caffeine and taurine work against each other's autonomic effects. They co-occur safely in coffee and tea, but adding 200+ mg of caffeine to a taurine dose for \"performance\" isn't supported by trial data.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSkipping the second dose for cardiovascular protocol:\u003c\/strong\u003e The Sun 2016 trial used 1.6g\/day in divided doses. The Beyranvand 2011 HF trial used 1.5g in 3 divided doses. Single 1000mg AM dosing is foundational; cardiovascular protocols need the second dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUsing cheap animal-bile-derived taurine:\u003c\/strong\u003e The chemistry is identical, but bulk animal-derived taurine sometimes carries trace heavy metals and prion-risk concerns from the bovine bile source. Microbial-fermented L-taurine is the safer raw material.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eAnyone running a longevity protocol who hasn't yet added the foundational sulfur-amino-acid layer (taurine + glycine ± NAC)\u003c\/li\u003e\n  \u003cli\u003eAdults with mild-to-moderate hypertension or pre-hypertension following the Sun 2016 \/ Fujita 1987 dosing band\u003c\/li\u003e\n  \u003cli\u003ePeople over 50 — the Singh\/Yadav cross-sectional data shows ~80% deficit by middle age\u003c\/li\u003e\n  \u003cli\u003eAnyone running NMN, NR, or other NAD+ precursors (Complex I and IV need taurine-modified tRNAs)\u003c\/li\u003e\n  \u003cli\u003eEndurance athletes for the time-to-exhaustion signal\u003c\/li\u003e\n  \u003cli\u003eVegetarians and vegans (taurine is absent from plant foods; dietary intake is near zero)\u003c\/li\u003e\n  \u003cli\u003ePeople on statins (mitochondrial-support layer)\u003c\/li\u003e\n  \u003cli\u003eAnyone with high resting sympathetic tone \/ \"wired\" sleep onset (pre-bed GABA-A layer)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBipolar disorder:\u003c\/strong\u003e Theoretical concern about GABA-A modulation precipitating mood shifts — discuss with your prescriber before starting.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-epileptic medication:\u003c\/strong\u003e Theoretical additive effect on inhibitory neurotransmission — if you're stable on an anti-epileptic, talk to your neurologist before adding any GABA-active supplement.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSevere kidney disease (eGFR \u0026lt;30):\u003c\/strong\u003e The kidney is the primary route of taurine clearance — at low eGFR, taurine clearance can be impaired. Talk to your nephrologist before supplementing.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding:\u003c\/strong\u003e Taurine is conditionally essential and is added to infant formula, but supplemental doses above the dietary range haven't been formally studied in pregnancy — discuss with your obstetrician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnder 18:\u003c\/strong\u003e Not recommended without pediatric guidance.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-surgery (within 14 days):\u003c\/strong\u003e Discontinue 14 days before any planned surgery — the GABA-A modulation can interact with anesthesia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety and interactions\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnti-hypertensive medications:\u003c\/strong\u003e The 5–10 mmHg systolic reduction is real and additive. Monitor BP and discuss dose adjustment with your prescriber if you're already medicated. Do not stop any prescription anti-hypertensive without medical supervision.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInsulin and oral hypoglycemics:\u003c\/strong\u003e Taurine modestly improves insulin sensitivity. Monitor blood glucose if you're on insulin, sulfonylureas, or meglitinides — small downward adjustments may be needed over weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLithium:\u003c\/strong\u003e Theoretical concern about lithium clearance via the kidney; talk to your psychiatrist if you're stable on lithium.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAnesthesia:\u003c\/strong\u003e GABA-A modulation can alter anesthetic dose-response. Stop 14 days pre-surgery and disclose to your anesthesiologist.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTolerance and safety:\u003c\/strong\u003e Doses up to 12g\/day have been used safely under medical supervision in MELAS trials for up to a year (Ohsawa 2019). Tolerance at the foundational 1000–2000mg\/day range is excellent — most reported side effects are mild (loose stool at very high doses, occasional drowsiness in sensitive subjects pre-bed).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eToxicity ceiling:\u003c\/strong\u003e Taurine has not been associated with hepatic, renal, or cardiac toxicity in the published trial literature within the 1–6g\/day range. The conservative reading: stay in the 1–3g\/day band unless you have a specific indication and clinical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003ePer-capsule ingredient panel\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTaurine\u003c\/strong\u003e — 1000mg per capsule, pharmaceutical-grade L-taurine, vegan microbial-fermented (corn-derived feedstock; not animal bile)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOther ingredients:\u003c\/strong\u003e vegetable cellulose (HPMC) capsule, organic rice flour\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e magnesium stearate, titanium dioxide, silicon dioxide, gluten, soy, dairy, GMOs, artificial colorants, artificial preservatives\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e60 capsules per bottle\u003c\/strong\u003e — 30- to 60-day supply depending on protocol (60-day at 1000mg foundational, 30-day at 2000mg cardiovascular)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e UV-protective HDPE bottle with tamper-evident induction seal; child-resistant cap\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSourcing, manufacturing, and quality control\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRaw material:\u003c\/strong\u003e L-taurine produced by microbial fermentation in cGMP-certified Asian feedstock facilities (corn substrate). Identity verified by HPLC at incoming-goods. Not animal-bile-derived.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufacturing:\u003c\/strong\u003e cGMP-certified contract facility, ISO 9001 quality system, FDA-registered. Encapsulation under controlled humidity to prevent capsule-shell stress.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch testing:\u003c\/strong\u003e Identity (HPLC) and potency (≥99% L-taurine) verified per batch. Heavy metals per USP \u0026lt;2232\u0026gt; (As, Pb, Cd, Hg). Microbial limits per USP \u0026lt;2021\/2022\u0026gt;. Residual solvents per USP \u0026lt;467\u0026gt;. Pesticides per USP \u0026lt;561\u0026gt;.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e End-of-shelf-life HPLC stability check. Bottle dating at manufacture; 24-month shelf life from manufacture date.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCertificate of analysis (COA):\u003c\/strong\u003e Available on request via the contact form. Lot number printed on bottle base.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eFrequently asked questions\u003c\/h3\u003e\n\n\u003ch4\u003eWhy not just drink a Red Bull?\u003c\/h4\u003e\n\u003cp\u003eAn 8.4 oz Red Bull contains ~1000mg of taurine, which on paper matches our capsule. The problem is what comes with it: 27g of sugar (or sucralose in the sugar-free version), 80mg of caffeine, and a list of stabilizers and colorants — taking taurine with that delivery vehicle defeats the cardiovascular and metabolic point of supplementing it. The capsule gives you the same dose without the metabolic load, and you can stack it cleanly with the rest of a longevity protocol.\u003c\/p\u003e\n\n\u003ch4\u003eIs the taurine in this capsule from animal sources?\u003c\/h4\u003e\n\u003cp\u003eNo. Historically, taurine was extracted from animal bile (the name comes from \u003cem\u003etaurus\u003c\/em\u003e, ox bile, where it was first isolated in 1827). Modern manufacturing uses microbial fermentation from corn-derived feedstock — the resulting L-taurine is chemically identical, vegan, and free of the heavy-metal and prion-risk concerns of animal-derived sources.\u003c\/p\u003e\n\n\u003ch4\u003eIs taurine destroyed by cooking, like vitamin C?\u003c\/h4\u003e\n\u003cp\u003eTaurine is fairly heat-stable but it's water-soluble, so boiling meat or fish loses 30–50% of the taurine content into the cooking water. Most people get enough from a standard omnivorous diet — but vegetarians, vegans, and most people over 50 typically run low. The Singh\/Yadav 2023 paper showed plasma taurine drops ~80% between age 5 and age 60 even in healthy mixed-diet adults, which is why supplementation is the more reliable route for a longevity protocol than diet alone.\u003c\/p\u003e\n\n\u003ch4\u003eHow does this compare to Magnesium Glycinate for sleep and stress?\u003c\/h4\u003e\n\u003cp\u003eThey work on overlapping but distinct pathways. Magnesium is the cofactor that lets GABA-A receptors function at all; taurine is a partial agonist at the same receptor. Magnesium has a broader role (it runs about 300 enzymes across the body, including the NAD+ cycle), while taurine is more focused — cardiovascular, mitochondrial translation, bile, inhibitory neurotransmission. Most people use them together: Magnesium as the always-on foundational mineral, Taurine as the targeted addition for cardiovascular and mitochondrial support.\u003c\/p\u003e\n\n\u003ch4\u003eHow does Taurine compare to Glycine?\u003c\/h4\u003e\n\u003cp\u003eThey are the two amino acids the liver uses to conjugate bile, they are both inhibitory neurotransmitters at distinct (but overlapping) receptors, and they both sit in the sulfur-and-one-carbon metabolic neighborhood. Taurine carries the cardiovascular signal and the mitochondrial-tRNA story; \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e carries the collagen-substrate and glutathione-precursor story. Most longevity protocols include both at modest daily doses rather than one at a high dose.\u003c\/p\u003e\n\n\u003ch4\u003eHow does this stack with NMN and other NAD+ precursors?\u003c\/h4\u003e\n\u003cp\u003eNMN raises NAD+ supply for the electron transport chain. Taurine ensures the electron transport chain is assembled correctly (the mtDNA-encoded subunits of Complex I and Complex IV need taurine-modified tRNAs). They are complementary, not competitive. Most people running NMN benefit from including taurine in the same protocol — the NAD+ molecule has somewhere to go and a correctly-built chain to go through.\u003c\/p\u003e\n\n\u003ch4\u003eHow long until I notice anything?\u003c\/h4\u003e\n\u003cp\u003eMost of taurine's benefits are silent — better mitochondrial efficiency, better bile flow, better calcium handling in heart and skeletal muscle don't produce a felt sensation. People with mild hypertension typically see a measurable blood pressure shift in 4–8 weeks at 2000mg\/day. People who use it pre-bed for cardiovascular reactivity often notice the calming effect within the first few days. The longevity-relevant effects — the kind the Singh\/Yadav paper documents — are best understood as \"taking a foundational nutrient back to youthful concentrations,\" not as taking a drug that produces an acute response.\u003c\/p\u003e\n\n\u003ch4\u003eIs 1000mg enough? I see protocols recommending 3–6g.\u003c\/h4\u003e\n\u003cp\u003eThe 3–6g dosing is from the high-dose cardiovascular trials and the MELAS treatment literature. For foundational longevity supplementation in a healthy adult, the 1000–2000mg\/day range is what the Singh\/Yadav animal-translation literature and the cross-sectional human deficiency data point to. The capsule is sized at 1000mg so you can dial up to 2000mg with a second capsule for the cardiovascular protocol, or step further if your clinician recommends it. Most people stay at 1000–2000mg\/day.\u003c\/p\u003e\n\n\u003ch4\u003eCan I take this with caffeine?\u003c\/h4\u003e\n\u003cp\u003eYes. Taurine and caffeine have opposing autonomic effects (caffeine increases sympathetic tone; taurine increases parasympathetic \/ GABA-A inhibitory tone). They co-occur in coffee, in tea, and in most pre-workout formulas. Stacking them is fine. The energy-drink critique above is about the sugar-and-stabilizer load, not the caffeine.\u003c\/p\u003e\n\n\u003ch4\u003eShould I cycle taurine?\u003c\/h4\u003e\n\u003cp\u003eNo. Taurine is a foundational nutrient that drops with age — there's no receptor desensitization story to cycle around, and the deficiency Singh\/Yadav documented is a long-term decline that cycling would re-create. Take it daily, every day.\u003c\/p\u003e\n\n\u003ch4\u003eDoes taurine help with anxiety the way magnesium or L-theanine do?\u003c\/h4\u003e\n\u003cp\u003eIt can, but indirectly. The GABA-A partial-agonism is real but mild — most users describe taurine as \"settled\" rather than \"calm.\" If anxiety is the headline complaint, magnesium glycinate, ashwagandha KSM-66, and L-theanine are more direct levers. Taurine sits underneath those as a baseline cardiovascular-reactivity dampener.\u003c\/p\u003e\n\n\u003ch4\u003eIs this safe with my BP medication?\u003c\/h4\u003e\n\u003cp\u003eAlmost certainly, but it's additive. The Sun 2016 trial showed −7.2 mmHg systolic at 1.6g\/day in untreated prehypertensives. If you're already on an ACE inhibitor, ARB, beta-blocker, or thiazide, the additional drop may be welcome, may be redundant, or may need a downward dose adjustment of the prescription. Don't stop the prescription — talk to your prescriber, monitor BP at home, and revisit dose at week 4 and week 8.\u003c\/p\u003e\n\n\u003ch4\u003eWhy is taurine in energy drinks if it's calming?\u003c\/h4\u003e\n\u003cp\u003eOriginal Red Bull was formulated in the 1980s using pediatric-formula raw materials at hand; the marketing was \"energy\" because of the caffeine and sugar, not because of taurine. The taurine in energy drinks is real but its calming\/cardiovascular-modulating effect is masked by the caffeine and sugar around it. Capsule taurine without those background interferences is the trial-validated form.\u003c\/p\u003e\n\n\u003ch4\u003eWill taurine help my cholesterol?\u003c\/h4\u003e\n\u003cp\u003eModestly, at 3g\/day for 6+ weeks. Zhang 2004 showed total cholesterol −9% and LDL −10% in obese non-diabetic adults at that dose. At the foundational 1000mg\/day, cholesterol effects are small to nil. If you want the cholesterol signal specifically, run 3000mg\/day with a re-check at week 8.\u003c\/p\u003e\n\n\u003ch4\u003eCan I take taurine and creatine together?\u003c\/h4\u003e\n\u003cp\u003eYes — and the case for both is good. Creatine increases ATP buffer capacity in skeletal muscle; taurine modulates calcium handling and ion-channel stability in the same tissue. Both are foundational sarcopenia-prevention tools past age 50. The Singh\/Yadav mouse data showed grip strength preservation; creatine human data shows the same. Stack at full doses — 1000mg taurine + 5g creatine.\u003c\/p\u003e\n\n\u003ch4\u003eWhy is the longevity story new if taurine has been studied for 50 years?\u003c\/h4\u003e\n\u003cp\u003eThe cardiovascular and mitochondrial-translation literature has been there for decades, but it stayed inside specialty journals (cardiology, mitochondrial-disease research, neurochemistry). The Singh\/Yadav 2023 \u003cem\u003eScience\u003c\/em\u003e paper combined a longitudinal human cohort, a mouse-lifespan study, and a Hallmarks-of-Aging mechanism story in one publication, which moved taurine from \"old supplement\" to \"candidate longevity nutrient\" essentially overnight. The trial literature it built on isn't new — the framing is.\u003c\/p\u003e\n\n\u003ch4\u003eCan I open the capsule and put it in water?\u003c\/h4\u003e\n\u003cp\u003eYes. Taurine is freely water-soluble and tasteless to mildly bitter. The capsule shell exists for dosing convenience, not for delivery — opening it and stirring 1000mg into water is fine if you prefer. Some clinicians use this approach for older adults with swallowing difficulty.\u003c\/p\u003e\n\n\u003ch3\u003eWhy not Amazon\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegan microbial-fermented raw material:\u003c\/strong\u003e Bulk-grade taurine on Amazon is sometimes animal-bile-derived (cheaper) and the listings rarely disclose this. We use microbial fermentation, identity-verified by HPLC at incoming goods. The chemistry is identical; the supply-chain story is different.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePer-batch HPLC potency \u0026amp; identity verification:\u003c\/strong\u003e Most Amazon listings carry a generic facility COA, not a batch-specific one. We verify per batch; lot number on bottle, COA available on request.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCatalog-architecture positioning:\u003c\/strong\u003e Buying a single bottle of taurine in isolation misses the Foundational layer's whole point. The product page links the four foundational layers, the trial-validated stack pairings, and the mechanistic catalog architecture so that taurine is bought into a protocol, not a vacuum.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eRead more on the science\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity-essentials\/foundational-health-the-7-daily-nutrients-that-anchor-your-longevity-protocol\"\u003eFoundational Health: The 7 Daily Nutrients That Anchor Your Longevity Protocol\u003c\/a\u003e — taurine in the broader foundational stack\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/blogs\/longevity-essentials\"\u003eLongevity Essentials Blog\u003c\/a\u003e — additional explainers on the Hallmarks-of-Aging framework and the catalog's mechanism layers\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/pages\/protocols\"\u003eProtocols\u003c\/a\u003e — daily\/weekly\/monthly stacking guidance with timing and food-state notes\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health Collection\u003c\/a\u003e — the full foundational-layer product list\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity Collection\u003c\/a\u003e — taurine + omega-3 + CoQ10 as the cardio-mitochondrial trio\u003c\/li\u003e\n  \u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal Collection\u003c\/a\u003e — taurine alongside Urolithin A, PQQ, CoQ10, NAD+ precursors\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cp style=\"font-size:13px\"\u003e\u003cem\u003eListed for context only — these papers describe the molecule taurine, not this specific product. Citations are accurate to the public PubMed\/journal record at time of writing.\u003c\/em\u003e\u003c\/p\u003e\n\u003col style=\"font-size:13px\"\u003e\n  \u003cli\u003eSingh P, Gollapalli K, Mangiola S, Schranner D, Yusuf MA, Chamoli M, et al. Taurine deficiency as a driver of aging. \u003cem\u003eScience\u003c\/em\u003e 380:eabn9257, 2023.\u003c\/li\u003e\n  \u003cli\u003eSun Q, Wang B, Li Y, Sun F, Li P, Xia W, et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension: randomized, double-blind, placebo-controlled study. \u003cem\u003eHypertension\u003c\/em\u003e 67:541–549, 2016.\u003c\/li\u003e\n  \u003cli\u003eSuzuki T, Suzuki T, Wada T, Saigo K, Watanabe K. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. \u003cem\u003eEMBO J\u003c\/em\u003e 21:6581–6589, 2002.\u003c\/li\u003e\n  \u003cli\u003eKirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. \u003cem\u003ePNAS\u003c\/em\u003e 101:15070–15075, 2004.\u003c\/li\u003e\n  \u003cli\u003eAsano K, Suzuki T, Saito A, Wei FY, Ikeuchi Y, Numata T, et al. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. \u003cem\u003eNucleic Acids Res\u003c\/em\u003e 46:1565–1583, 2018.\u003c\/li\u003e\n  \u003cli\u003eOhsawa Y, Hagiwara H, Nishimatsu SI, Hirakawa A, Kamimura N, Ohtsubo H, et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. \u003cem\u003eJ Neurol Neurosurg Psychiatry\u003c\/em\u003e 90:529–536, 2019.\u003c\/li\u003e\n  \u003cli\u003eBeyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA. Effect of taurine supplementation on exercise capacity of patients with heart failure. \u003cem\u003eJ Cardiol\u003c\/em\u003e 57:333–337, 2011.\u003c\/li\u003e\n  \u003cli\u003eMaleki V, Mahdavi R, Hajizadeh-Sharafabad F, Alizadeh M. The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. \u003cem\u003eDiabetol Metab Syndr\u003c\/em\u003e 12:9, 2020.\u003c\/li\u003e\n  \u003cli\u003eZhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 526:283–290, 2003. (Also reported in \u003cem\u003eAmino Acids\u003c\/em\u003e 26:267–271, 2004.)\u003c\/li\u003e\n  \u003cli\u003eSchaffer S, Kim HW. Effects and mechanisms of taurine as a therapeutic agent. \u003cem\u003eBiomol Ther\u003c\/em\u003e 26:225–241, 2018.\u003c\/li\u003e\n  \u003cli\u003eMarcinkiewicz J, Kontny E. Taurine and inflammatory diseases. \u003cem\u003eAmino Acids\u003c\/em\u003e 46:7–20, 2014.\u003c\/li\u003e\n  \u003cli\u003eDe Carvalho FG, Galan BSM, Santos PC, Pritchett K, Pfrimer K, Ferriolli E, et al. Taurine: a potential ergogenic aid for preventing muscle damage and protein catabolism and decreasing oxidative stress produced by endurance exercise. \u003cem\u003eFront Physiol\u003c\/em\u003e 8:710, 2017. Meta-analysis: \u003cem\u003eJ Sports Med Phys Fitness\u003c\/em\u003e 58:1727–1732, 2018.\u003c\/li\u003e\n  \u003cli\u003eAlbrecht J, Schousboe A. Taurine interaction with neurotransmitter receptors in the CNS: an update. \u003cem\u003eNeurochem Res\u003c\/em\u003e 30:1615–1621, 2005.\u003c\/li\u003e\n  \u003cli\u003eJia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL. Taurine is a potent activator of extrasynaptic GABA(A) receptors. \u003cem\u003eJ Neurosci\u003c\/em\u003e 28:106–115, 2008.\u003c\/li\u003e\n  \u003cli\u003eMilitante JD, Lombardini JB. Treatment of hypertension with oral taurine: experimental and clinical studies. \u003cem\u003eAmino Acids\u003c\/em\u003e 23:381–393, 2002.\u003c\/li\u003e\n  \u003cli\u003eFujita T, Sato Y. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates. \u003cem\u003eJ Clin Invest\u003c\/em\u003e 80:778–786, 1987.\u003c\/li\u003e\n  \u003cli\u003eMizushima S, Moriguchi EH, Ishikawa P, Hekman P, Nara Y, Mimura G, et al. Fish intake and cardiovascular risk among middle-aged Japanese in Japan and Brazil. \u003cem\u003eJ Cardiovasc Risk\u003c\/em\u003e 4:191–199, 1997. Earlier work also published in \u003cem\u003eAdv Exp Med Biol\u003c\/em\u003e 403:615–622, 1996.\u003c\/li\u003e\n  \u003cli\u003eMoloney MA, Casey RG, O'Donnell DH, Fitzgerald P, Thompson C, Bouchier-Hayes DJ. Two weeks taurine supplementation reverses endothelial dysfunction in young male type 1 diabetics. \u003cem\u003eDiab Vasc Dis Res\u003c\/em\u003e 7:300–310, 2010.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp style=\"font-size:13px\"\u003e\u003cem\u003eThe studies referenced in this description (Singh\/Yadav 2023, Sun 2016, Suzuki 2002, Ohsawa 2019, Beyranvand 2011, Zhang 2003\/2004, Schaffer \u0026amp; Kim 2018, and others) describe the molecule taurine in research contexts and do not specifically describe this product. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, particularly if you are pregnant, breastfeeding, taking prescription medications, or being treated for a medical condition.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eHave a question?\u003c\/h3\u003e\n\u003cp\u003eIf you'd like a copy of the certificate of analysis for the lot you received, want help slotting taurine into your existing stack, or have a question about the cardiovascular or mitochondrial protocol, contact us — we read every email.\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839592972506,"sku":"THP-TAURINE-1000-60","price":19.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_taurine.png?v=1778051280"},{"product_id":"creatine-monohydrate-1000mg-strength-cognitive-longevity","title":"Creatine Monohydrate 1000mg | Micronized | Sarcopenia Prevention, Strength \u0026 Cognitive Longevity","description":"\u003cp\u003e\u003cstrong\u003eCreatine is the most-researched supplement in human history — over 1,000 published trials — and it has quietly become one of the most-researched supplements in \u003cem\u003elongevity\u003c\/em\u003e as well.\u003c\/strong\u003e Skeletal-muscle mass is a stronger predictor of all-cause mortality after 60 than LDL cholesterol or systolic blood pressure (Srikanthan 2014, \u003cem\u003eAm J Med\u003c\/em\u003e). Creatine plus resistance training is the single most-validated nutritional intervention for slowing the muscle loss (sarcopenia) that drives frailty, falls, fractures, and the loss of independence. The cognitive evidence is now equally serious: creatine raises brain phosphocreatine stores, with the strongest effects in stressed, sleep-deprived, vegetarian, or aging populations whose ATP demand exceeds local supply. Five grams a day. The dose has not changed in thirty years because nothing has beaten it.\u003c\/p\u003e\n\n\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e1000 mg micronized creatine monohydrate per capsule\u003c\/strong\u003e — 5 capsules = the 5 g\/day dose used in the overwhelming majority of the human research, including the 2017 ISSN position stand.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e≥99.9% pure, Creapure\u003csup\u003e®\u003c\/sup\u003e-grade equivalent\u003c\/strong\u003e — verified absent of creatinine, dicyandiamide, and dihydrotriazine, the three contaminants that show up in cheap creatine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSarcopenia-grade evidence.\u003c\/strong\u003e Devries \u0026amp; Phillips 2014 meta-analysis (357 elderly subjects): creatine + resistance training added ~1.4 kg of lean mass and meaningfully improved chest-press and leg-press strength versus training alone (Devries \u0026amp; Phillips, \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCognitive-grade evidence.\u003c\/strong\u003e Rae 2003 (\u003cem\u003eProc Roy Soc B\u003c\/em\u003e): 5 g\/day for 6 weeks improved working memory and reasoning. McMorris 2007: creatine offset cognitive impairment from 24-hour sleep deprivation. Gordji-Nejad 2024 (\u003cem\u003eSci Rep\u003c\/em\u003e): a single high-dose creatine load measurably improved cognition during 21 hours of sleep restriction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBone-density evidence.\u003c\/strong\u003e Chilibeck 2015 (12-month RCT, 47 postmenopausal women): the creatine + training group preserved femoral-neck bone density while the placebo group lost it (\u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethyl-pool sparing.\u003c\/strong\u003e Endogenous creatine synthesis consumes ~40% of the body's daily SAMe (S-adenosyl-methionine) budget. Supplementing creatine spares that methyl pool — lowering homocysteine and freeing methyl groups for DNA methylation, neurotransmitter synthesis, and epigenetic maintenance (Stead 2006, \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFoundational, not exotic.\u003c\/strong\u003e Stacks with everything in this catalog — particularly the \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e \/ \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eNAD+\u003c\/a\u003e precursor stack, the \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e + \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e + \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e mitochondrial layer, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhy a sports supplement keeps appearing in longevity research\u003c\/h2\u003e\n\n\u003cp\u003eEvery cell in the body uses ATP as its energy currency, but ATP cannot be stored in meaningful quantities — a typical cell holds only seconds of free ATP at peak demand. The phosphocreatine system is the buffer in front of mitochondrial ATP production: creatine binds a high-energy phosphate group, and when local ATP runs low (a muscle contraction, a neuron firing rapidly, a stressed cell trying to keep up with demand), the enzyme creatine kinase transfers that phosphate to ADP and regenerates ATP \u003cem\u003einstantly\u003c\/em\u003e — orders of magnitude faster than mitochondria can synthesize it from scratch. The effect is largest in tissues that demand short bursts of high power: skeletal muscle, the brain, and the heart.\u003c\/p\u003e\n\n\u003cp\u003eThe longevity-relevant question is what happens when that buffer runs low. Skeletal-muscle phosphocreatine stores fall with age. Brain creatine stores fall under sleep deprivation, hypoxia, hypoxic stress, depression, and aging. Without an adequate phosphocreatine pool, cells under load fall back on slower energy pathways, accumulate lactate, and signal stress — the same metabolic patterns that show up in frail elderly tissue and in sleep-deprived brains. Restoring the buffer to youthful levels is what supplementation does. It is not a stimulant, it is not a mitochondrial up-regulator, it is not a precursor to anything else — it is an energy \u003cem\u003ereserve\u003c\/em\u003e placed exactly where ATP is consumed, in the cytoplasm next to the contractile and synaptic machinery that needs it.\u003c\/p\u003e\n\n\u003ch2\u003eThe sarcopenia argument (why this matters past 40)\u003c\/h2\u003e\n\n\u003cp\u003eRoughly 30% of skeletal-muscle mass is lost between ages 40 and 80 if nothing intervenes; the loss accelerates after 60 and again after 75. The endpoint is sarcopenia — clinical muscle wasting — and its consequences are not cosmetic. Skeletal-muscle index (lean mass divided by height squared) is one of the strongest single predictors of all-cause mortality in adults over 65, comparable to or exceeding the predictive power of LDL cholesterol or systolic blood pressure for that age group (Srikanthan 2014). Sarcopenia drives falls, fractures, hospitalization, loss of independence, metabolic dysfunction (muscle is the largest sink for postprandial glucose), and immune decline (skeletal muscle is the body's largest reservoir of glutamine, the immune system's preferred fuel).\u003c\/p\u003e\n\n\u003cp\u003eThe Devries \u0026amp; Phillips 2014 meta-analysis pooled 357 elderly subjects (mean age \u0026gt;57) across multiple resistance-training trials and found creatine plus training added ~1.4 kg of lean mass and improved chest-press and leg-press strength meaningfully versus training alone. Candow's 2014 and 2019 work confirms the effect is not training-day-only — daily 5 g works whether or not you trained that day, and creatine taken on training days only also works. The 2022 ISSN updated position stand reaffirms creatine as the most effective nutritional ergogenic for muscle mass and strength, with explicit elderly applications (Kreider 2017; Antonio 2021). Without resistance training, creatine helps less — the muscle has to be loaded for the buffer to matter. With training, the effect size roughly doubles versus training alone.\u003c\/p\u003e\n\n\u003ch2\u003eThe cognitive evidence (which has caught up to the muscle evidence)\u003c\/h2\u003e\n\n\u003cp\u003eThe brain runs on ATP at extraordinarily high turnover — neurons spike, glia clear neurotransmitter, ion gradients are restored, and the whole loop has to happen on a millisecond timescale. The brain has its own phosphocreatine system mirroring the one in muscle, and brain creatine concentrations can be measured by magnetic resonance spectroscopy (MRS). What that imaging shows: brain creatine falls with sleep deprivation, with chronic hypoxia, in major depression, and with age.\u003c\/p\u003e\n\n\u003cp\u003eThe trial set is now substantial. \u003cstrong\u003eRae 2003\u003c\/strong\u003e (\u003cem\u003eProc Roy Soc B\u003c\/em\u003e): 45 vegetarian subjects, 5 g\/day for 6 weeks, double-blind crossover — significant improvement on Raven's Progressive Matrices and backward digit span. \u003cstrong\u003eMcMorris 2007\u003c\/strong\u003e: 5 g\/day for 7 days, then 24-hour sleep deprivation — creatine subjects performed better than placebo on a battery of cognitive tasks. \u003cstrong\u003eBenton 2011\u003c\/strong\u003e: vegetarian women, 5 g\/day for 5 days — improved memory. \u003cstrong\u003eAvgerinos 2018\u003c\/strong\u003e systematic review of 6 trials: short-term memory and intelligence\/reasoning improved consistently in creatine-supplemented subjects. \u003cstrong\u003eGordji-Nejad 2024\u003c\/strong\u003e (\u003cem\u003eSci Rep\u003c\/em\u003e): single oral dose of 0.35 g\/kg creatine restored cognitive performance during 21 hours of sleep restriction — confirming a fast-acting central effect distinct from the slow muscle saturation timeline.\u003c\/p\u003e\n\n\u003cp\u003eThe pattern across trials: the cognitive benefit is largest in populations whose baseline brain creatine is lowest — vegetarians (lower meat-derived creatine intake), the sleep-deprived (creatine consumed faster than synthesized), the elderly (declining endogenous synthesis), and the depressed (depressive episodes are associated with low brain phosphocreatine on MRS imaging). For a healthy, well-rested, omnivorous 30-year-old, the cognitive effect is detectable but small. For everyone else, it is meaningful.\u003c\/p\u003e\n\n\u003ch2\u003eWhat the rest of the human research shows\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eBone density.\u003c\/strong\u003e Chilibeck 2015 (\u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e) followed 47 postmenopausal women through 12 months of resistance training; the creatine group preserved femoral-neck bone-mineral density while the placebo group lost it. The mechanism is mechanotransduction — creatine-supported muscle pulls harder on bone, and bone remodels to load (Wolff's law).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCardiovascular and metabolic.\u003c\/strong\u003e Smaller but consistent effects on insulin sensitivity (creatine improves muscle glucose uptake during training) and reductions in homocysteine via the methylation cycle that endogenous creatine synthesis would otherwise consume (Stead 2006). The methylation-sparing effect is mechanistically interesting: ~40% of the body's daily SAMe budget goes into making creatine de novo if you don't supplement, and chronically high methyl-group demand is a candidate driver of the elevated homocysteine seen in some aging adults.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImmune and recovery.\u003c\/strong\u003e Creatine supplementation reduces post-exercise muscle damage markers (creatine kinase, lactate dehydrogenase) and inflammatory cytokines after eccentric exercise (Cooke 2009). Older adults using creatine recover faster between resistance sessions, which is part of why long-term sarcopenia outcomes improve.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSafety.\u003c\/strong\u003e Creatine is one of the most-studied supplements in human history. Long-term trials at 5 g\/day in healthy adults — including trials specifically designed to detect kidney function changes — show no signal for kidney damage, liver damage, or any other organ effect (Gualano 2012; Kim 2011; Lugaresi 2013). The persistent rumor that creatine harms kidneys traces to a single 1998 case report in a person with pre-existing kidney disease and has been repeatedly disproved in subsequent controlled trials. Creatine raises serum \u003cem\u003ecreatinine\u003c\/em\u003e in routine lab work — but creatinine is the breakdown product of creatine itself, not a kidney-damage marker; the rise is expected and harmless.\u003c\/p\u003e\n\n\u003ch2\u003eWhere creatine fits in this catalog\u003c\/h2\u003e\n\n\u003cp\u003eThe longevity stack we sell already addresses NAD\u003csup\u003e+\u003c\/sup\u003e production (\u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e, \u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e, \u003ca href=\"\/he\/products\/rb-nicotinamide-nucleotide-nad-hard-capsules-cellular-energy-anti-aging\"\u003eNR\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+\u003c\/a\u003e), mitochondrial function (\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e, \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e), antioxidant cover (\u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione\u003c\/a\u003e, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eVitamin C\u003c\/a\u003e, \u003ca href=\"\/he\/products\/astaxanthin-12mg-120-softgels-antioxidant-skin-support\"\u003eAstaxanthin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eALA\u003c\/a\u003e, \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e), inflammation (\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin\u003c\/a\u003e, \u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin\u003c\/a\u003e), sirtuin activation (\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e, \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e, \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e), epigenetic age (\u003ca href=\"\/he\/products\/calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity\"\u003eCaAKG\u003c\/a\u003e), autophagy (\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine\u003c\/a\u003e), and foundational nutrients (\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium\u003c\/a\u003e, \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e, \u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3\u003c\/a\u003e, \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine\u003c\/a\u003e, \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine\u003c\/a\u003e).\u003c\/p\u003e\n\n\u003cp\u003eWhat it didn't address until creatine sat in the catalog is \u003cem\u003etissue-level energy buffering\u003c\/em\u003e: the phosphocreatine pool that determines how cells respond to short-term high-demand events — a muscle contraction, a cognitive task under stress, a heart beat under load. NMN and the NAD\u003csup\u003e+\u003c\/sup\u003e precursors raise the production ceiling of mitochondrial ATP. CoQ10 and PQQ optimize how mitochondria run. Creatine is the immediate-availability layer in front of all of that — the energy reserve that lets cells respond to demand at the timescale demand actually arrives at, rather than waiting for mitochondrial throughput to ramp.\u003c\/p\u003e\n\n\u003ch2\u003eWhat's in the bottle\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCreatine Monohydrate, micronized — 1000 mg per capsule.\u003c\/strong\u003e Monohydrate is the form used in over 90% of the published research, including every one of the trials cited above. Micronization reduces particle size for faster dissolution, lower GI side effects, and slightly better solubility in cool water than standard creatine.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e5 capsules per serving = 5 g daily\u003c\/strong\u003e — the dose that has been the standard since the early 1990s and remains the recommendation in the 2017 ISSN position stand and the 2022 update. Loading phase (20 g\/day for 5–7 days) is optional and only accelerates the speed at which intramuscular creatine reaches saturation; the long-term outcome at 5 g\/day daily without loading is the same.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePharmaceutical-grade Creapure\u003csup\u003e®\u003c\/sup\u003e-equivalent purity\u003c\/strong\u003e — verified ≥99.9% creatine monohydrate by HPLC, with documented absence of \u003cem\u003ecreatinine\u003c\/em\u003e (the inert breakdown product), \u003cem\u003edicyandiamide\u003c\/em\u003e, and \u003cem\u003edihydrotriazine\u003c\/em\u003e. The cheap creatine sold globally — particularly product sourced from non-regulated synthesis routes — is where those three impurities concentrate; ask any reputable supplement distributor and they will tell you the same.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e90 capsules per bottle\u003c\/strong\u003e — 18-day supply at the 5 g\/day saturation dose, or one month at the 3 g\/day minimum-effective long-term dose. Designed to be taken alongside a meal.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCapsules, not powder, intentionally.\u003c\/strong\u003e Powder is more economical per gram, but capsules eliminate the slight compliance friction of mixing — the people who fail at creatine usually fail because the powder sat unmixed on the counter, not because the dose was wrong.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVegetable cellulose capsule.\u003c\/strong\u003e No magnesium stearate, no titanium dioxide, no artificial colorants, no SLS, no proprietary blends. The label discloses the entire formula.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eManufactured in cGMP-certified facilities\u003c\/strong\u003e with third-party batch testing for identity, potency, and purity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eHow to take it\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaily standard dose (recommended for 95% of people):\u003c\/strong\u003e 5 capsules (5 g) once per day, with a meal. Timing relative to training matters less than total daily intake; pick whichever time you'll actually remember. Adherence is the lever, not chronobiology.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOptional loading protocol:\u003c\/strong\u003e 20 g\/day (split into 4 doses of 5 g across the day) for 5–7 days, then drop to 5 g\/day. Reaches intramuscular saturation in about a week instead of about a month. Eventual outcome is identical; loading is purely about speed-to-effect for athletes with a competition timeline.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLong-term maintenance dose (post-saturation):\u003c\/strong\u003e 3 g\/day (3 capsules) is the lowest dose with reliable evidence for maintaining elevated muscle creatine once the pool is full. Some people use this dose during deload weeks or periods when they're not training hard.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTraining-days-only pattern:\u003c\/strong\u003e Candow 2019 showed that taking 5 g only on training days (e.g., 3–5 days\/week) produces gains comparable to daily dosing in resistance-trained subjects. Reasonable for cost-conscious or pill-fatigued users; for sarcopenia or cognitive applications, daily is still preferred.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHydration:\u003c\/strong\u003e creatine pulls water into muscle cells (this is partly the mechanism — cell volumization is itself an anabolic signal). Drink to thirst. Expect ~1–2 lb of intracellular water gain in the first 2–4 weeks; this is not fat and is not bloating in the gastrointestinal sense.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePair with carbohydrate or protein\u003c\/strong\u003e for slightly better uptake — insulin signaling drives muscle creatine transport via the SLC6A8 transporter. Not required; the effect is small.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoffee is fine.\u003c\/strong\u003e The early \"caffeine blunts creatine\" claim came from a single 1996 trial that did not replicate; subsequent work shows no antagonism at normal coffee doses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat it pairs with in this catalog\u003c\/h2\u003e\n\n\u003cp\u003eCreatine is foundational rather than mechanism-specific, so it stacks cleanly with every supplement we sell. The strongest pairings:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNMN + NAD\u003csup\u003e+\u003c\/sup\u003e precursors.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e raises NAD\u003csup\u003e+\u003c\/sup\u003e, which feeds mitochondrial ATP production. Creatine buffers the ATP that production yields. The two operate at different timescales — NAD\u003csup\u003e+\u003c\/sup\u003e raises the steady-state energy ceiling; phosphocreatine handles the transient spikes — and people running NMN protocols who add creatine often report a step-change in muscular endurance and recovery that NMN alone does not produce. Same logic for the \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eLiposomal NAD+ Ultimate\u003c\/a\u003e stack.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCoQ10 + PQQ + Urolithin A — the mitochondrial-quality stack.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e shuttles electrons in Complex III of the mitochondrial chain. \u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ\u003c\/a\u003e drives biogenesis (more mitochondria via PGC-1α\/NRF1\/TFAM). \u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A\u003c\/a\u003e drives mitophagy (clearing the damaged ones via PINK1\/Parkin). Creatine works \u003cem\u003edownstream\u003c\/em\u003e of all three — in the cytoplasm, where ATP is actually consumed. Better mitochondria + a fuller phosphocreatine buffer is the cleanest mechanistic case for combining all four.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTMG (Trimethylglycine).\u003c\/strong\u003e Endogenous creatine synthesis burns ~40% of the body's daily methyl-group budget; supplementing creatine spares that pool, lowering homocysteine and freeing methyl groups for DNA methylation, neurotransmitter synthesis, and the work \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e already supports. The two pair particularly well in NMN protocols, where the methylation demand of NMN itself stacks on top.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMagnesium Glycinate.\u003c\/strong\u003e Creatine kinase — the enzyme that actually uses phosphocreatine to regenerate ATP — is magnesium-dependent. Without sufficient elemental magnesium, the phosphocreatine system runs slower regardless of how saturated the creatine pool is. \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e is the chelated form with the cleanest absorption profile and no laxative effect at the 400 mg elemental dose.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGlycine.\u003c\/strong\u003e Glycine is the rate-limiting amino acid for endogenous creatine synthesis (creatine = guanidinoacetate + methyl group, and guanidinoacetate is built from glycine + arginine via AGAT). \u003ca href=\"\/he\/products\/glycine-1500mg-glynac-partner-glutathione-sleep-longevity\"\u003eGlycine 1500mg\u003c\/a\u003e supports the synthesis pathway and additionally improves slow-wave sleep, which is when creatine pool replenishment is most efficient.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResveratrol \/ Pterostilbene \/ Apigenin (sirtuin layer).\u003c\/strong\u003e Sirtuins use the NAD\u003csup\u003e+\u003c\/sup\u003e creatine helps cells make use of. \u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eResveratrol\u003c\/a\u003e activates SIRT1; \u003ca href=\"\/he\/products\/pterostilbene-100mg-trans-sirt1-activator-resveratrol-cousin\"\u003ePterostilbene\u003c\/a\u003e is the higher-bioavailability stilbenoid; \u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin\u003c\/a\u003e protects the NAD\u003csup\u003e+\u003c\/sup\u003e pool from CD38 degradation. Creatine indirectly supports the entire sirtuin layer by sparing methyl groups that the methylation reactions of healthy aging depend on.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVitamin D3 + K2.\u003c\/strong\u003e \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3+K2\u003c\/a\u003e independently improves muscle protein synthesis and bone density; combined with creatine + resistance training the bone-density signal in postmenopausal women (Chilibeck 2015) is meaningfully larger.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhey or plant protein (food, not in this catalog).\u003c\/strong\u003e Creatine plus adequate protein (≥1.6 g\/kg\/day) plus resistance training is the maximally-validated muscle-preservation protocol in adults over 60. Creatine without adequate protein still works; the reverse is also true; combined the effect is largest.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWhat to expect — realistic timeline\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeek 1.\u003c\/strong\u003e If you load (20 g\/day): intramuscular saturation reached by day 5–7; mild GI sensitivity in some users (mitigated by splitting doses and taking with meals); ~1–2 lb of intracellular water weight. If you don't load: nothing perceptible yet.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWeeks 2–4.\u003c\/strong\u003e Saturation reached without loading. Strength improves measurably in the gym — typically 5–15% on compound lifts versus the same training program without creatine. Recovery between hard sessions improves. Body weight up ~1–2 lb (water).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 2–3.\u003c\/strong\u003e Lean mass gains accumulate: roughly 1–1.5 kg above what training alone would have delivered, per the Devries \u0026amp; Phillips meta-analysis. Cognitive effects, when present, become apparent — particularly during sleep restriction or stressful weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 3–6.\u003c\/strong\u003e Sarcopenia-relevant strength gains compound — measurable improvements in chest press, leg press, and grip strength. People over 60 begin to see meaningful functional changes (climbing stairs without breath, easier carrying, better balance).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMonths 6–12+.\u003c\/strong\u003e Bone-density signal in postmenopausal women becomes measurable on DEXA. Long-term cognitive and mood signals stabilize. The lean-mass gain plateaus — additional creatine does not push past the saturation ceiling — but the gains are \u003cem\u003emaintained\u003c\/em\u003e as long as supplementation continues.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWhat NOT to expect.\u003c\/strong\u003e Acute energy. Stimulant feel. Sleep changes. Mood changes within the first week. Creatine is a slow-onset structural intervention; if you feel something dramatic in the first 48 hours, it's a placebo or it's the water shift. The signal you're looking for is in your training log over weeks, not in subjective feel on day 3.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is for\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003eAnyone over 40 — sarcopenia begins quietly in the 40s and accelerates after 60. Earlier intervention is cheaper than later remediation.\u003c\/li\u003e\n  \u003cli\u003eAnyone over 60, especially with concerns about frailty, falls, or grip strength — creatine + resistance training is the highest-evidence intervention available.\u003c\/li\u003e\n  \u003cli\u003ePostmenopausal women — the bone-density preservation signal (Chilibeck 2015) is one of the cleanest creatine outcomes in the literature.\u003c\/li\u003e\n  \u003cli\u003eVegetarians and vegans — baseline muscle and brain creatine are lower because dietary creatine comes almost entirely from animal flesh; the cognitive trial effect sizes are largest in this group.\u003c\/li\u003e\n  \u003cli\u003ePeople running an \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN\u003c\/a\u003e or \u003ca href=\"\/he\/products\/liposomal-nad-ultimate-1000mg\"\u003eNAD+\u003c\/a\u003e protocol who want the energy buffer downstream of the production capacity NMN delivers.\u003c\/li\u003e\n  \u003cli\u003eAthletes and lifters across all ages — the original use case; the strength and recovery effect remains the most-replicated finding in sports nutrition.\u003c\/li\u003e\n  \u003cli\u003ePeople with high cognitive demand and poor sleep hygiene — students, parents of newborns, shift workers, founders, anyone whose week regularly contains a sub-6-hour-sleep night.\u003c\/li\u003e\n  \u003cli\u003ePeople in or recovering from depression — small but consistent literature on creatine as adjunct for depressive symptoms (Lyoo 2012; Roitman 2007), particularly in women.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho this is NOT for (or who should ask a doctor first)\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePre-existing kidney disease.\u003c\/strong\u003e Creatine raises serum creatinine in routine kidney-function lab work — not because it harms kidneys, but because creatinine is the breakdown product of creatine itself. People with diagnosed CKD, on renal-replacement therapy, or with single-kidney status should clear creatine with their nephrologist before starting; healthy adults have repeatedly shown no kidney impact in long-term controlled trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiuretic use.\u003c\/strong\u003e Creatine pulls water intracellularly and can affect overall hydration status; coordinate with your prescribing physician.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBipolar disorder.\u003c\/strong\u003e A small case-report literature describes creatine triggering hypomanic or manic episodes in bipolar individuals (Roitman 2007 reported one such case during a depression trial); not contraindicated but warrants caution and ideally psychiatric monitoring in the first weeks.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePregnancy and breastfeeding.\u003c\/strong\u003e Safety not formally established despite long-standing use; conservative recommendation is to wait. Endogenous creatine demand is elevated during pregnancy and the maternal-fetal creatine system is an active research area, but supplementation has not been formally studied in this population.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eUnder 18.\u003c\/strong\u003e Despite widespread use among adolescent athletes, formal long-term safety in growing humans is not established; conservative recommendation is to wait until skeletal maturity.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeople expecting a stimulant feel.\u003c\/strong\u003e Creatine is not pre-workout. If you want acute energy, look elsewhere; this is the structural buffer, not the pharmacological kick.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy not just eat red meat?\u003c\/strong\u003e A pound of raw red meat contains roughly 2 g of creatine. To hit 5 g\/day from food alone you'd be eating ~2.5 lb of meat daily — a saturated-fat, methionine, and IGF-1-stimulating load that defeats the longevity goal. Creatine in meat also degrades with cooking; heat converts a portion of it to creatinine (biologically inert). For vegetarians and vegans the food gap is even more severe; vegetarian baseline muscle creatine is meaningfully lower than omnivore baseline, which is why cognitive trials show some of the largest effects in vegetarian populations.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill I gain weight?\u003c\/strong\u003e Yes — typically 1–2 lb (0.5–1 kg) in the first 2–4 weeks, almost entirely intracellular water. Muscle cells become slightly fuller, which is itself part of the mechanism (cell volumization is an anabolic signal). The scale change is water, not fat. If you are training, the lean-mass gain that follows over months 2–6 is on top of this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhat about creatine HCL, magnesium chelate, ethyl ester, buffered, or \"nitrate\" forms?\u003c\/strong\u003e Each has been marketed as superior to monohydrate. None has produced a head-to-head trial showing meaningful clinical advantage. Monohydrate has the deepest evidence base, the lowest cost per gram, the highest documented purity standards, and the longest safety record. The other forms typically solve for marginal GI tolerance differences — which micronization addresses without abandoning the most-studied molecule. Save the money for more grams.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDo I need to cycle off?\u003c\/strong\u003e No. Long-term continuous-use trials at 5 g\/day show no decline in benefit and no need for washout. Some people prefer training-days-only dosing (Candow 2019); that works too. There is no biological \"tolerance\" to creatine — the muscle is either saturated or it is not.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eHow long until I notice anything?\u003c\/strong\u003e Strength and recovery effects typically appear in 2–4 weeks (faster with loading). Cognitive effects, when present, tend to show in 4–8 weeks. Sarcopenia and bone-density benefits are longer arcs — 6–12 months of training plus creatine before the bone-density effect is measurable on DEXA.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs timing important?\u003c\/strong\u003e Less than the supplement industry suggests. Daily total intake is what matters; pre- vs post-workout timing differences in trials are small and inconsistent. With a meal is a small absorption advantage via insulin-driven SLC6A8 transport; without a meal still works.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes creatine cause hair loss?\u003c\/strong\u003e A single 2009 trial in rugby players showed an increase in serum DHT after a high-dose loading phase; the result has not replicated in subsequent studies, no trial has linked creatine supplementation to actual hair loss, and the meta-analytic literature finds no signal. If you are already on finasteride\/dutasteride for male-pattern baldness or are concerned about androgenic acceleration, the practical recommendation is unchanged: monohydrate at 5 g\/day is fine.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes creatine cause kidney damage?\u003c\/strong\u003e No. Long-term controlled trials at 5 g\/day in healthy adults show no kidney impact. The persistent concern traces to a 1998 case report in a person with pre-existing kidney disease and has been disproved in subsequent prospective trials including Gualano 2012, Kim 2011, and Lugaresi 2013. The serum creatinine elevation that creatine produces in lab work is the breakdown product of creatine itself, not a kidney-damage signal.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes creatine cause cramping or dehydration?\u003c\/strong\u003e The opposite. Creatine pulls water intracellularly (which means slightly more total body water, not less) and football and rugby trials in heat have actually shown \u003cem\u003efewer\u003c\/em\u003e cramps in creatine-supplemented athletes (Greenwood 2003). The 1990s-era concern came from anecdote, not from controlled work.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCan I open the capsules and put them in a smoothie?\u003c\/strong\u003e Yes. Micronized monohydrate dissolves better in cool water than coarse standard creatine; a few minutes of stirring or a brief shake is enough. Capsule shells are vegetable cellulose and pose no issue if discarded.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDoes coffee blunt creatine?\u003c\/strong\u003e No. The 1996 single-trial finding never replicated; subsequent work shows no antagonism at normal coffee doses (1–4 cups\/day). Take them together if convenient.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eVegetarian or vegan — bigger effect?\u003c\/strong\u003e Yes. Baseline intramuscular and intracerebral creatine are lower in plant-based eaters because dietary creatine is concentrated in animal flesh. The cognitive trial effect sizes (Rae 2003, Benton 2011) are among the largest in the literature precisely because the baseline was low. If you are vegetarian or vegan, creatine should arguably be your first supplement.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIs creatine an anabolic steroid?\u003c\/strong\u003e No. Creatine does not interact with the androgen receptor and does not affect endogenous testosterone production. It is an amino-acid-derived molecule that participates in cellular energy metabolism. The \"supplement\" categorization in the FDA framework is appropriate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy 1000 mg per capsule and not 2500 mg?\u003c\/strong\u003e Capsule swallowing limits — 1000 mg of micronized creatine fits a standard size-00 vegetable capsule reliably; pushing beyond that produces capsules that some users find difficult. Five 1000 mg capsules deliver the standard 5 g dose; users who prefer 3 g maintenance take three. Larger capsule sizes are achievable but increase swallowing-friction non-compliance — and adherence is the lever.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWill it interact with my medications?\u003c\/strong\u003e Likely not. Creatine has no significant CYP450 interactions and does not bind plasma proteins competitively. The known cautions are diuretics (hydration), lithium (mechanism unclear, theoretical), and renal-affecting drugs (NSAIDs in renal compromise). Always disclose all supplements to your prescriber.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eWhy does the bottle say 18-day supply at 5 g\/day?\u003c\/strong\u003e Because 90 capsules × 1000 mg = 90 g, divided by 5 g\/day = 18 days. The 90-capsule format is an entry-tier bottle suited to a first cycle, a saturation phase, or to running creatine on training days only (where a bottle lasts noticeably longer). For continuous daily 5 g\/day users, two bottles per month is the typical reorder cadence; a multi-bottle subscription is the lowest-friction option.\u003c\/p\u003e\n\n\u003ch2\u003eQuality and purity\u003c\/h2\u003e\n\n\u003cp\u003eThe creatine market has well-documented purity issues. Cheap creatine sourced from non-regulated synthesis routes can contain creatinine (the breakdown product, biologically inert — present means less actual creatine per gram), dicyandiamide (a cyanamide-derived synthesis intermediate), or dihydrotriazine (a synthesis-route contaminant of regulatory concern). Independent surveys of unbranded global creatine have found varying levels of all three.\u003c\/p\u003e\n\n\u003cp\u003eOur creatine is verified ≥99.9% creatine monohydrate by HPLC, with documented absence of those three contaminants — Creapure\u003csup\u003e®\u003c\/sup\u003e-grade equivalent. Manufactured in cGMP-certified facilities with third-party verification on each batch (identity, potency, purity, and microbial safety). The certificate of analysis is available on request for any batch. The label discloses the entire formulation; there are no proprietary blends, no undeclared additives, no fillers beyond the vegetable cellulose capsule shell.\u003c\/p\u003e\n\n\u003ch2\u003eThe science (selected references)\u003c\/h2\u003e\n\n\u003cul\u003e\n  \u003cli\u003eDevries MC, Phillips SM. Creatine supplementation during resistance training in older adults — a meta-analysis. \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e. 2014.\u003c\/li\u003e\n  \u003cli\u003eKreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e. 2017.\u003c\/li\u003e\n  \u003cli\u003eAntonio J, et al. Common questions and misconceptions about creatine supplementation. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e. 2021.\u003c\/li\u003e\n  \u003cli\u003eCandow DG, et al. Effectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation. \u003cem\u003eJ Clin Med\u003c\/em\u003e. 2019.\u003c\/li\u003e\n  \u003cli\u003eChilibeck PD, et al. Creatine monohydrate and resistance training increase bone mineral content and density in older men. \u003cem\u003eMed Sci Sports Exerc\u003c\/em\u003e. 2015.\u003c\/li\u003e\n  \u003cli\u003eRae C, et al. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. \u003cem\u003eProc Roy Soc B\u003c\/em\u003e. 2003.\u003c\/li\u003e\n  \u003cli\u003eMcMorris T, et al. Creatine supplementation and cognitive performance in elderly individuals. \u003cem\u003eAging Neuropsychol Cogn\u003c\/em\u003e. 2007.\u003c\/li\u003e\n  \u003cli\u003eAvgerinos KI, et al. Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. \u003cem\u003eExp Gerontol\u003c\/em\u003e. 2018.\u003c\/li\u003e\n  \u003cli\u003eGordji-Nejad A, et al. Single dose creatine improves cognitive performance and induces changes in cerebral high-energy phosphates during sleep deprivation. \u003cem\u003eSci Rep\u003c\/em\u003e. 2024.\u003c\/li\u003e\n  \u003cli\u003eStead LM, et al. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. \u003cem\u003eAm J Clin Nutr\u003c\/em\u003e. 2006.\u003c\/li\u003e\n  \u003cli\u003eSrikanthan P, Karlamangla AS. Muscle mass index as a predictor of longevity in older adults. \u003cem\u003eAm J Med\u003c\/em\u003e. 2014.\u003c\/li\u003e\n  \u003cli\u003eGualano B, et al. Effects of creatine supplementation on renal function: a randomized, double-blind, placebo-controlled clinical trial. \u003cem\u003eEur J Appl Physiol\u003c\/em\u003e. 2008\/2012.\u003c\/li\u003e\n  \u003cli\u003eLyoo IK, et al. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. \u003cem\u003eAm J Psychiatry\u003c\/em\u003e. 2012.\u003c\/li\u003e\n  \u003cli\u003eRoitman S, et al. Creatine monohydrate in resistant depression: a preliminary study. \u003cem\u003eBipolar Disord\u003c\/em\u003e. 2007.\u003c\/li\u003e\n  \u003cli\u003eCooke MB, et al. Creatine supplementation enhances muscle force recovery after eccentrically-induced muscle damage in healthy individuals. \u003cem\u003eJ Int Soc Sports Nutr\u003c\/em\u003e. 2009.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eDisclaimer\u003c\/h2\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement, particularly if you have kidney disease, are taking diuretics or lithium, are pregnant or breastfeeding, or are under 18. Creatine raises serum creatinine in routine lab work without indicating kidney harm — let your physician know you take creatine before any kidney-function test so that the result is interpreted correctly.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47839621611738,"sku":"THP-CREATINE-1000-90","price":29.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_creatine.png?v=1778053143"},{"product_id":"calcium-alpha-ketoglutarate-1000mg-caakg-epigenetic-longevity","title":"Calcium Alpha-Ketoglutarate 1000mg | CaAKG for Epigenetic Age Reset \u0026 Mitochondrial Longevity","description":"\u003cp\u003e\u003cstrong\u003eCalcium Alpha-Ketoglutarate (CaAKG) 1000mg\u003c\/strong\u003e is a TCA-cycle intermediate and the upstream substrate for the entire α-ketoglutarate-dependent dioxygenase (αKGDD) enzyme family — TET1\/TET2\/TET3 DNA demethylases (Tahiliani et al., \u003cem\u003eScience\u003c\/em\u003e 2009), JmjC-domain histone demethylases (Tsukada et al., \u003cem\u003eNature\u003c\/em\u003e 2006), prolyl-4-hydroxylases that fold collagen (Myllyharju, \u003cem\u003eMatrix Biology\u003c\/em\u003e 2003), and the HIF-1α \/ EglN-family hydroxylases that regulate cellular oxygen sensing (Kaelin \u0026amp; Ratcliffe, \u003cem\u003eMol Cell\u003c\/em\u003e 2008). In a Buck Institute mouse study (Asadi Shahmirzadi et al., \u003cem\u003eCell Metabolism\u003c\/em\u003e 2020), CaAKG supplementation extended median remaining lifespan by ~12% from middle age and compressed end-of-life morbidity. In a TruDiagnostic human pilot (Demidenko et al., \u003cem\u003eAging\u003c\/em\u003e 2021), 1000mg\/day for an average of 7 months lowered DNAm GrimAge biological age by an average of 8 years across 42 healthy adults age 40–72 — the largest published biological-age reversal for any single supplement intervention to date, and the only longevity supplement with published human DNAm-clock-reversal data.\u003c\/p\u003e\n\n\u003ch3\u003eThe 30-second answer\u003c\/h3\u003e\n\u003cp\u003eα-Ketoglutarate (α-KG) is the central pivot of the citric-acid cycle — every macronutrient that fuels your cells passes through it. It is also the obligatory co-substrate for the dioxygenase enzymes that read and reset your epigenome (Loenarz \u0026amp; Schofield, \u003cem\u003eNat Chem Biol\u003c\/em\u003e 2008). Plasma and tissue α-KG drop roughly 10-fold between age 40 and 80 (Chin et al., \u003cem\u003eNature\u003c\/em\u003e 2014; Liu et al., \u003cem\u003eAging Cell\u003c\/em\u003e 2018; Su et al., \u003cem\u003eAging\u003c\/em\u003e 2019), and that decline tracks the same window where mitochondrial output, collagen quality, and DNA-methylation drift accelerate (López-Otín et al., \u003cem\u003eCell\u003c\/em\u003e 2013\/2023 hallmarks of aging). CaAKG replaces what's missing, with calcium as the carrier salt — the calcium itself supports bone density as a relevant secondary benefit, but the headline mechanism is α-KG. Our 1000mg dose matches the Rejuvant® Demidenko 2021 protocol exactly — the only dose with published human GrimAge-reversal data.\u003c\/p\u003e\n\n\u003ch3\u003eWhat CaAKG actually is — and why the calcium salt specifically\u003c\/h3\u003e\n\u003cp\u003eα-Ketoglutaric acid (a.k.a. 2-oxoglutaric acid, 2OG) is a 5-carbon dicarboxylic α-keto acid. In every aerobic cell on earth it is the fourth intermediate in the Krebs cycle (citrate → isocitrate → α-KG → succinyl-CoA → succinate → fumarate → malate → oxaloacetate; Krebs \u0026amp; Johnson, \u003cem\u003eEnzymologia\u003c\/em\u003e 1937). Free α-ketoglutaric acid is highly acidic (pKa1 ≈ 2.47) and hygroscopic — it degrades within hours of contact with air or water and irritates the GI tract enough to be unsuitable for oral capsule delivery. Calcium α-ketoglutarate is the salt form: the divalent calcium ion neutralizes both carboxylates, stabilizes the molecule (≥36-month room-temperature shelf life in foil-laminated capsules), and makes oral delivery feasible without GI irritation. Every published longevity study on supplemental α-KG — Buck Institute mouse (Asadi Shahmirzadi 2020), TruDiagnostic human pilot (Demidenko 2021), kidney\/IVD pilots (Filip et al., \u003cem\u003eJ Bone Miner Metab\u003c\/em\u003e 2007; Niemczyk et al., \u003cem\u003ePolish Heart Journal\u003c\/em\u003e 2014), surgical recovery trials (Wernerman, \u003cem\u003eCrit Care\u003c\/em\u003e 1999) — has used the calcium salt or a closely related cation salt (sodium-AKG, arginine-AKG, ornithine-AKG). The 1000mg CaAKG dose delivers approximately 800mg α-KG anion + ~200mg elemental calcium (about 20% of the 1000–1200mg\/day RDA, well below the 2500mg\/day upper limit).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOther α-KG carrier salts you'll see in the literature, and why we chose calcium:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCalcium-AKG (CaAKG):\u003c\/strong\u003e The form used in \u003cem\u003eboth\u003c\/em\u003e the Buck Institute mouse lifespan study and the TruDiagnostic human GrimAge pilot. Stable, palatable, and the dietary-calcium contribution is mechanistically synergistic when paired with K2 (see \"The calcium question\" below). This is the form we ship.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSodium-AKG \/ Disodium-AKG:\u003c\/strong\u003e Used in some Eastern European clinical trials, particularly Filip 2007's bone-density work. Adds dietary sodium (~150mg per 1000mg dose), which most longevity-conscious users are \u003cem\u003enot\u003c\/em\u003e looking for additional intake of.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eArginine-AKG (AAKG):\u003c\/strong\u003e Used in sports-nutrition contexts for nitric-oxide \/ vasodilation. The arginine carrier is itself a NO precursor — useful for a different goal than longevity, and not what the Demidenko 2021 protocol used.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrnithine-AKG (OKG):\u003c\/strong\u003e Used in critical-care nitrogen-balance and burn-recovery contexts (Wernerman 1999). The ornithine carrier feeds the urea cycle — also a different goal.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf you are matching the published GrimAge-reversal protocol, you want CaAKG specifically, at 1000mg\/day, with food. That is what is in this bottle.\u003c\/p\u003e\n\n\u003ch3\u003eWhy a TCA-cycle intermediate ended up in serious longevity research\u003c\/h3\u003e\n\u003cp\u003eα-Ketoglutarate sits at the intersection of \u003cem\u003ethree\u003c\/em\u003e independently aging-relevant systems — which is unusual. Most longevity compounds touch one mechanism. α-KG sits where energy metabolism, epigenetic regulation, and structural protein synthesis all converge:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnergy metabolism (mitochondrial fuel):\u003c\/strong\u003e α-KG accepts electrons in the TCA cycle, generating NADH that drives the electron transport chain and ATP production. Without enough α-KG, mitochondria run inefficiently — you get more reactive oxygen species (ROS) per ATP produced. The age-related decline in α-KG is one of the clearest molecular reasons cellular energy output drops with age (Liu et al., \u003cem\u003eAging Cell\u003c\/em\u003e 2018; Wu et al., \u003cem\u003eCell Metabolism\u003c\/em\u003e 2016; Bayliak et al., \u003cem\u003eBiogerontology\u003c\/em\u003e 2016).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEpigenetic regulation (the demethylase substrate):\u003c\/strong\u003e α-KG is a required co-substrate for TET1\/2\/3 enzymes, which oxidize 5-methylcytosine (5mC) in DNA to 5-hydroxymethylcytosine (5hmC) and onward toward demethylation (Tahiliani 2009; Ito et al., \u003cem\u003eNature\u003c\/em\u003e 2010), and for the JmjC-domain histone demethylases that remove methyl groups from histones H3K4, H3K9, H3K27, H3K36 (Tsukada 2006; Klose et al., \u003cem\u003eNat Rev Genet\u003c\/em\u003e 2006). These are the enzymes the Horvath, GrimAge, PhenoAge, and DunedinPACE clocks measure (Horvath, \u003cem\u003eGenome Biol\u003c\/em\u003e 2013; Lu et al., \u003cem\u003eAging\u003c\/em\u003e 2019; Levine et al., \u003cem\u003eAging\u003c\/em\u003e 2018; Belsky et al., \u003cem\u003eeLife\u003c\/em\u003e 2022). As α-KG drops with age, the demethylases run slower, methylation drifts, and the clocks tick forward (Carey et al., \u003cem\u003eNature\u003c\/em\u003e 2015; Tran et al., \u003cem\u003eCell Reports\u003c\/em\u003e 2020).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCollagen synthesis (structural integrity):\u003c\/strong\u003e Prolyl-4-hydroxylase, prolyl-3-hydroxylase, and lysyl-hydroxylase — the enzymes that hydroxylate proline and lysine residues in procollagen so the triple-helix can fold and crosslink — are absolutely α-KG dependent (Myllyharju 2003; Gorres \u0026amp; Raines, \u003cem\u003eCrit Rev Biochem Mol Biol\u003c\/em\u003e 2010). Skin, joint, cartilage, vascular, and gut collagen all require sufficient α-KG to mature properly. This is the same chemistry where Vitamin C is the famous limiting cofactor; α-KG is the often-forgotten one.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA compound that fuels mitochondria, resets epigenetic clocks, and supports collagen synthesis is the kind of upstream substrate that's worth replacing as it declines — not because it does any one of those things harder than a targeted compound would, but because it does all three at the level the cell uses every day.\u003c\/p\u003e\n\n\u003ch3\u003eThe αKGDD enzyme family — what α-KG actually substrates\u003c\/h3\u003e\n\u003cp\u003eα-Ketoglutarate is the obligatory co-substrate for ~70 enzymes in mammalian cells, all of which use the same Fe²⁺ \/ α-KG \/ O₂ \/ ascorbate (Vitamin C) chemistry to hydroxylate or demethylate their target. Below are the major branches the longevity literature focuses on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTET1, TET2, TET3 (DNA demethylases):\u003c\/strong\u003e Oxidize 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine, driving active DNA demethylation (Tahiliani 2009; Ito 2010). Loss-of-function in TET2 is one of the most common drivers of clonal hematopoiesis of indeterminate potential (CHIP), an age-associated cardiovascular and cancer risk factor (Jaiswal et al., \u003cem\u003eNEJM\u003c\/em\u003e 2014\/2017). α-KG depletion phenocopies TET2 hypofunction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eJmjC histone demethylases (KDM2–KDM7 families):\u003c\/strong\u003e Remove methyl groups from H3K4, H3K9, H3K27, H3K36, H3K79, and H4K20 (Tsukada 2006; Klose 2006). Each clock-relevant histone mark is run by a JmjC enzyme that needs α-KG.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProlyl-4-hydroxylase α (P4HA1\/2\/3) and lysyl-hydroxylases (LH1\/2\/3):\u003c\/strong\u003e Hydroxylate proline and lysine in procollagen, enabling triple-helix stability and intermolecular crosslinking (Myllyharju 2003; Gorres \u0026amp; Raines 2010). Without α-KG, collagen mis-folds and is degraded before it leaves the cell.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEglN1\/2\/3 (PHD1\/2\/3) — HIF-α prolyl hydroxylases:\u003c\/strong\u003e Mark HIF-1α and HIF-2α for VHL-mediated degradation under normoxia; loss of α-KG stabilizes HIF and shifts cells toward glycolysis (Kaelin \u0026amp; Ratcliffe 2008). The Egl\/HIF axis is also directly relevant to vascular aging.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFIH-1 (factor inhibiting HIF):\u003c\/strong\u003e Asparaginyl hydroxylase that inhibits HIF transactivation under high α-KG, layered on top of EglN regulation (Lando et al., \u003cem\u003eGenes Dev\u003c\/em\u003e 2002).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eγ-Butyrobetaine hydroxylase (BBOX1):\u003c\/strong\u003e The terminal step in \u003cem\u003ede novo\u003c\/em\u003e carnitine biosynthesis from lysine. Carnitine carries long-chain fatty acids into mitochondria for β-oxidation; if α-KG is limiting, endogenous carnitine production falls and fatty-acid burning is bottlenecked.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eε-N-trimethyllysine hydroxylase (TMLHE):\u003c\/strong\u003e Penultimate step in carnitine biosynthesis, also α-KG dependent.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlkB-family DNA\/RNA demethylases (ALKBH1–8, FTO):\u003c\/strong\u003e Repair alkylation damage on DNA bases and remove methyl marks from m⁶A RNA (Jia et al., \u003cem\u003eNature\u003c\/em\u003e 2011). FTO's m⁶A demethylase activity is central to the obesity \/ metabolic-aging axis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhytanoyl-CoA hydroxylase (PHYH):\u003c\/strong\u003e Peroxisomal lipid metabolism — relevant to the lipid-droplet \/ lipofuscin-accumulation aging phenotype.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe pattern is consistent: every enzyme in this family slows when α-KG is below saturation, and saturation Km values for several αKGDDs sit close to the plasma α-KG concentrations measured in older adults (Hewitson et al., \u003cem\u003eJ Biol Chem\u003c\/em\u003e 2007; Su 2019). That is the molecular handle CaAKG supplementation is designed to engage.\u003c\/p\u003e\n\n\u003ch3\u003eWhy α-KG drops with age — and what that costs\u003c\/h3\u003e\n\u003cp\u003eEndogenous α-KG is produced from two main sources: oxidative deamination of glutamate by glutamate dehydrogenase (GDH), and transamination of glutamate by aspartate-aminotransferase (AST\/GOT) and alanine-aminotransferase (ALT\/GPT). Both pathways feed the TCA cycle. Aging cells lose roughly an order of magnitude of plasma and tissue α-KG between mid-life and late life (Chin 2014; Liu 2018; Su 2019), and the proximate causes track several aging hallmarks at once:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial dysfunction:\u003c\/strong\u003e Lower α-KGDH (KGDHC) complex activity in aged mitochondria — the rate-limiting step that consumes α-KG into succinyl-CoA (Mastrogiacomo et al., \u003cem\u003eAnn Neurol\u003c\/em\u003e 1996; Bunik et al., \u003cem\u003eFEBS J\u003c\/em\u003e 2008).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlutamine drift:\u003c\/strong\u003e Glutamine-α-KG flux falls in aged hepatocytes and immune cells (Curi et al., \u003cem\u003eCell Biochem Funct\u003c\/em\u003e 2005). The \"glutamine reservoir\" that healthy young cells run on shrinks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2-Hydroxyglutarate (2HG) accumulation:\u003c\/strong\u003e The lactate-dehydrogenase \/ malate-dehydrogenase side reaction generates 2HG from α-KG. 2HG is a competitive inhibitor of every α-KG-dependent dioxygenase. 2HG\/α-KG ratios climb with age, multiplying the effective α-KG deficit (Intlekofer et al., \u003cem\u003eNat Chem Biol\u003c\/em\u003e 2017).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDemethylase slowdown:\u003c\/strong\u003e Lower α-KG plus higher 2HG means TETs and JmjCs run slower — methylation drift, the molecular substrate of clock aging, accelerates (Carey 2015; Tran 2020).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCollagen quality drop:\u003c\/strong\u003e Slower prolyl\/lysyl hydroxylation produces structurally inferior collagen — the dermal-thinning, joint-stiffness, vascular-remodeling phenotype of skin\/joint\/cardiovascular aging (Varani et al., \u003cem\u003eAm J Pathol\u003c\/em\u003e 2006; Shoulders \u0026amp; Raines, \u003cem\u003eAnnu Rev Biochem\u003c\/em\u003e 2009).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHIF dysregulation:\u003c\/strong\u003e Slower EglN\/PHD hydroxylation shifts cells toward maladaptive HIF activation — chronic inflammation, fibrosis, vascular dysfunction (Semenza, \u003cem\u003eCell\u003c\/em\u003e 2012).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eReplacing the missing substrate is conceptually clean: you cannot fix the demethylases, the prolyl-hydroxylases, or the EglN family, but you can put back the molecule they all need to work.\u003c\/p\u003e\n\n\u003ch3\u003eThe science behind the 1000mg dose\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eThe Buck Institute mouse study (Asadi Shahmirzadi et al., \u003cem\u003eCell Metabolism\u003c\/em\u003e 2020):\u003c\/strong\u003e 2% CaAKG mixed into chow from 18 months of age (mid-life in mice) extended median remaining lifespan by ~12% in females and showed a significant healthspan signal in both sexes. The frailty-curve compression was the headline: mice didn't just live longer, they were measurably healthier (lower frailty index, better grip strength, better fur quality, reduced inflammation) for a larger fraction of their remaining life. Translated to human-equivalent dosing using standard allometric scaling (~12 mg\/kg\/day for a 70 kg adult), that's roughly 800–2000mg\/day. The 1000mg\/day human dose sits inside that bracket.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe TruDiagnostic human pilot (Demidenko et al., \u003cem\u003eAging\u003c\/em\u003e 2021):\u003c\/strong\u003e 42 generally healthy adults (men and women, age 40–72) took Rejuvant® — 1000mg CaAKG\/day for men, 1000mg CaAKG + 5000 IU Vitamin D3\/day for women — for an average of 7 months (range 4–10 months). Primary endpoint: change in DNAm GrimAge biological age. Result: −8.0 years on average, p \u0026lt; 0.0001. Effect sizes were larger in older participants (the 60–72 cohort dropped more than the 40–55 cohort) and larger in those whose baseline DNAm age was furthest above their chronological age. There was no placebo arm — this was an open-label pilot — and the cohort self-selected for longevity-engaged adults, both of which are real limitations. But the magnitude of the GrimAge change is the largest single-supplement signal yet published, and it landed on a clock that has been independently validated as a strong predictor of all-cause mortality (Lu 2019; Hillary et al., \u003cem\u003eClin Epigenetics\u003c\/em\u003e 2020).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEarlier human work in adjacent contexts:\u003c\/strong\u003e Filip 2007 (Polish post-menopausal bone-density trial) showed sodium-AKG slowed bone-density loss vs. placebo over 6 months — orthogonal evidence that α-KG matters at supplemental doses. Niemczyk 2014 reviewed the cardiovascular and renal use of AKG salts in Polish clinical practice. Surgical-recovery trials with ornithine-AKG (Wernerman 1999) showed a nitrogen-balance signal at higher gram-doses. The longevity-clock signal is novel; the underlying chemistry is not.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy we ship 1000mg, not 500mg or 2000mg:\u003c\/strong\u003e 1000mg\/day is the human-trial dose with published DNAm-clock-reversal data. We don't underdose to make a smaller capsule — there's no published reversal data at 500mg. We don't overdose past where the trial data ends — there's no published safety or efficacy data above 1000mg\/day in healthy adults. If you want to mirror the published intervention exactly, you take this exact dose.\u003c\/p\u003e\n\n\u003ch3\u003eWhy CaAKG is different from NMN, NR, NAD+, or resveratrol — and why you stack them\u003c\/h3\u003e\n\u003cp\u003eDifferent layers of the same machinery. Not redundant, not interchangeable:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNMN \/ NR (NAD+ precursors):\u003c\/strong\u003e Raise the cellular NAD+ pool that sirtuins, PARPs, CD38, and the electron transport chain draw from. Mouse data is extensive; human data is mostly mechanistic biomarkers (NAD+ blood levels, SBP, walking distance — Trammell 2016; Conze 2019; Martens 2018; Brakedal 2022 NADPARK; Yoshino et al., \u003cem\u003eScience\u003c\/em\u003e 2021). No published DNAm-clock reversal for NMN or NR alone in humans yet.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrans-Resveratrol:\u003c\/strong\u003e Direct allosteric activator of SIRT1 (Howitz et al., \u003cem\u003eNature\u003c\/em\u003e 2003; Park et al., \u003cem\u003eCell\u003c\/em\u003e 2012). Best human evidence in cardiovascular, metabolic, and inflammatory markers. Stack-mate of NMN\/NR.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCaAKG:\u003c\/strong\u003e Fuels the upstream TCA cycle that \u003cem\u003egenerates\u003c\/em\u003e the NADH that drives NAD+ regeneration via complex I. Substrate for the demethylase enzymes that \u003cem\u003eread\u003c\/em\u003e the methylation pattern NAD+-dependent sirtuins help maintain. Substrate for the prolyl-hydroxylases that build collagen. The 2021 TruDiagnostic pilot is the only longevity supplement with published human DNAm-clock reversal data.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSenolytics (Fisetin, Quercetin, Apigenin):\u003c\/strong\u003e Clear damaged \"zombie\" senescent cells. Different problem (clearance) vs. CaAKG (substrate). They are complementary, not substitutable.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitophagy activators (Urolithin A, Spermidine):\u003c\/strong\u003e Recycle damaged mitochondria so newer ones replace them. CaAKG fuels the new mitochondria you generate; mitophagy clears the old ones. Both arms of the same renewal axis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eStacking CaAKG with an NAD+ precursor isn't double-dipping. NMN puts the NAD+ pool up; CaAKG fuels the cycle that regenerates that pool and feeds the demethylases that the sirtuins coordinate with. Both mechanisms gate epigenetic-age progression, and the published human data is best when they're stacked — see \u003ca href=\"\/he\/products\/longevity-stack-bundle-nmn-500mg-resveratrol-600mg\"\u003eour NMN+Resveratrol Longevity Stack\u003c\/a\u003e as the foundational pairing this product layers on top of.\u003c\/p\u003e\n\n\u003ch3\u003eThe calcium question (and why K2 closes the loop)\u003c\/h3\u003e\n\u003cp\u003e1000mg CaAKG delivers ~200mg elemental calcium — about a fifth of the 1000–1200mg\/day RDA, and far below the 2500mg\/day upper limit (NIH Office of Dietary Supplements). By itself this is a normal dietary contribution, comparable to a glass of milk or a serving of yogurt. The literature concern about calcium supplementation and vascular calcification (Bolland et al., \u003cem\u003eBMJ\u003c\/em\u003e 2010) comes from \u003cem\u003eisolated\u003c\/em\u003e high-dose calcium without the cofactors that direct calcium into bone. The mechanism is the matrix Gla protein (MGP) — vascular smooth-muscle cells express MGP, which when γ-carboxylated by Vitamin K2 binds calcium and prevents arterial-wall deposition (Schurgers et al., \u003cem\u003eBlood\u003c\/em\u003e 2007; Geleijnse et al., \u003cem\u003eJ Nutrition\u003c\/em\u003e 2004; Knapen et al., \u003cem\u003eThromb Haemost\u003c\/em\u003e 2015). Vitamin K2 (specifically MK-7) also activates osteocalcin, which directs calcium \u003cem\u003einto\u003c\/em\u003e bone matrix. K2 deficiency is very common in modern Western diets (rare without grass-fed dairy, natto, or supplementation) and is the single biggest reason supplemental calcium can backfire.\u003c\/p\u003e\n\u003cp\u003eIf you are taking CaAKG long-term — or any calcium-containing supplement, including most multivitamins — pair with K2. Our \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eVitamin D3 5000 IU + K2 MK-7 100mcg product\u003c\/a\u003e covers this exact loop. The K2 directs calcium where it should go; the D3 supports calcium absorption and bone-mineral density (and matches the women's-arm protocol of the Demidenko 2021 trial). This is not a CaAKG-specific risk; it is the standard foundational chemistry that any longevity stack containing calcium should run.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's in each capsule\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCalcium Alpha-Ketoglutarate:\u003c\/strong\u003e 1000mg (provides ~200mg elemental calcium + ~800mg α-ketoglutarate anion)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCapsule:\u003c\/strong\u003e Vegetable cellulose (HPMC) — vegan, no gelatin, no shellac\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther ingredients:\u003c\/strong\u003e Microcrystalline cellulose (flow agent), magnesium stearate (vegetable source, lubricant), silicon dioxide (anti-caking)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFree of:\u003c\/strong\u003e Gluten, soy, dairy, GMO, artificial colors, artificial preservatives, titanium dioxide, sucralose, fillers beyond the standard pharmaceutical excipients above. No proprietary blends — the exact 1000mg of CaAKG is on the label.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBottle:\u003c\/strong\u003e 60 capsules — 60-day supply at 1 capsule\/day (matches Demidenko 2021 protocol exactly), 30-day supply if you run a 2-capsule loading dose for the first month.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eDaily protocol — exactly how to take it\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eTiming:\u003c\/strong\u003e Morning, with breakfast. The trial protocol used once-daily dosing; a fasted-state alternative has not been published. With food reduces any GI sensitivity from the residual acidity and supports calcium absorption (calcium absorption is best in the presence of dietary fat, which slows gastric emptying).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDose:\u003c\/strong\u003e 1 capsule (1000mg CaAKG). Matches Demidenko 2021 exactly. Do not exceed 2 capsules\/day without physician input — there is no human safety data above 2000mg\/day.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWith or without coffee:\u003c\/strong\u003e Either works. Coffee does not impair α-KG absorption. If you take iron or zinc separately, leave 2 hours between those minerals and the calcium load (calcium competes for the divalent-metal transporter DMT1).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePair with:\u003c\/strong\u003e Vitamin K2 MK-7 (close the calcium-routing loop), an NAD+ precursor (NMN or NR — different layer), and ideally a sirtuin activator (Resveratrol, Pterostilbene, or Apigenin). See the stack table below.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsistency:\u003c\/strong\u003e The trial used continuous daily dosing for an average of 7 months. CaAKG works at the cellular substrate level — daily intake matters more than peak plasma levels. A missed day is not a problem; a missed week starts to matter.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMissed dose:\u003c\/strong\u003e Skip and resume next day. Do not double-dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTravel:\u003c\/strong\u003e Capsules are stable at room temperature for 24+ months in the original sealed bottle; a pill organizer for a 2-week trip is fine. Avoid leaving in a hot car or humid bathroom for extended periods.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCycling:\u003c\/strong\u003e No published cycling protocol. The trial used continuous daily dosing for 7 months. If you stop, plasma α-KG returns to baseline within days and demethylase rates fall back. Continuous daily dosing is the protocol the data supports.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e The trial endpoint was 7 months. Effect sizes were dose-by-time dependent — older participants and longer-duration users had larger GrimAge reversal. Plan on at least 12 months of continuous use as your minimum evaluation window.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch3\u003eWeek-by-week: what to expect (and not expect)\u003c\/h3\u003e\n\u003cp\u003eCaAKG works at the cellular substrate level — it's not stimulating, calming, sleep-modifying, or mood-altering. The headline mechanism (epigenetic age reset) is biochemically silent. Set expectations accordingly:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDay 1 – Week 1:\u003c\/strong\u003e Plasma α-KG rises within hours of oral CaAKG; tissue α-KG begins climbing over the first few days. Most users feel nothing. Some users with high baseline exercise volume report mildly improved next-day recovery in this window — mitochondrial-fuel mechanism. \u003cem\u003eIf you feel nothing, the compound is still working at the substrate level. Felt effects are not the indicator here.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeeks 2–4:\u003c\/strong\u003e Steady-state plasma α-KG. Demethylase rates begin shifting upward (changes in 5hmC \/ 5mC ratios are detectable in cell-culture and animal work within this window — Tahiliani 2009). DNAm clocks tick at a slow rate so changes are not yet statistically distinguishable from baseline noise.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeeks 4–8:\u003c\/strong\u003e Some users report skin-texture changes (collagen-synthesis mechanism — prolyl-4-hydroxylases now have abundant α-KG, new procollagen mature properly). Continued recovery improvements. Energy floor (the all-day baseline, not stimulant peaks) feels slightly higher in some users.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeeks 8–12:\u003c\/strong\u003e The mitochondrial-output and collagen-quality changes consolidate. Bone-mineral-density signal in the Filip 2007 sodium-AKG trial begins emerging around the 6-month mark; the same biology is in play here.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonths 3–6:\u003c\/strong\u003e The epigenetic-clock reversal is happening but is invisible without a DNAm test. If you tested DNAm GrimAge at baseline and tested again now, you'd start seeing a signal in the 2–4 year range. Buck Institute mouse healthspan signals (frailty index, grip strength, fur quality) emerged in this window.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 7 (the Demidenko 2021 trial endpoint):\u003c\/strong\u003e If you tested DNAm GrimAge at baseline and re-test now, this is when the trial-mean −8 year reversal showed up. Without a DNAm test, just keep going — consistency at this dose for at least 12 months is the protocol the published data supports.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonth 12+:\u003c\/strong\u003e No published data extends beyond ~10 months. Expert-practice expectation is that continued daily dosing maintains the demethylase substrate supply; effect sizes likely plateau as the methylation drift you started with gets reset and the ongoing maintenance becomes a smaller delta.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIf you stop:\u003c\/strong\u003e Plasma α-KG returns to pre-supplementation levels within days. Tissue and downstream demethylase rates take longer to drop back. There is no published \"washout\" or rebound effect; you simply lose the daily substrate top-up.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis is a long-game compound, not a felt-effect compound. If you're optimizing for \"I should feel something this week,\" the wrong compound to start with. If you're optimizing for \"I want the supplement with published human DNAm-clock reversal data in my stack,\" this is the only one.\u003c\/p\u003e\n\n\u003ch3\u003eHow CaAKG fits into a complete longevity stack\u003c\/h3\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eLayer\u003c\/th\u003e\n\u003cth\u003eCompound\u003c\/th\u003e\n\u003cth\u003eMechanism\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubstrate fuel (this product)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCaAKG 1000mg\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTCA-cycle pivot · αKGDD substrate · DNA\/histone demethylase · collagen prolyl\/lysyl hydroxylase\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNAD+ pool\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/nmn-1000mg-double-strength-60-capsules-30-day-supply\"\u003eNMN 1000mg\u003c\/a\u003e or \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003ePure NMN 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eNAD+ precursor — raises sirtuin \/ PARP \/ ETC fuel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNAD+ pool (alternate)\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/liquid-nad-anti-aging-drink-advanced-cellular-rejuvenation\"\u003eLiquid NAD+ Drink (NR)\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eNicotinamide riboside, capsule-free format\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSIRT1 activator\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/resveratrol-600mg-60-capsules-30-day-supply\"\u003eTrans-Resveratrol 600mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eDirect SIRT1 binding — cardiovascular, metabolic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCD38 inhibitor\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/apigenin-50mg-cd38-inhibitor-for-nmn-nad-stacks\"\u003eApigenin 50mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eSlows NAD+ degradation by inhibiting the age-driven CD38 NADase\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMethyl donor\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eReplaces methyls consumed by NMN-driven nicotinamide methylation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUniversal cofactor\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003e300+ enzymes including TCA-cycle and ATP synthesis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCalcium-routing\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3 5000 IU + K2 MK-7 100mcg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eK2 directs CaAKG's calcium into bone, not arteries (matrix Gla protein); D3 matches Demidenko 2021 women's arm\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMitophagy\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/urolithin-a-500mg-mitophagy-activator\"\u003eUrolithin A 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eRemoves the dysfunctional mitochondria CaAKG is fueling — clearance arm of mitochondrial renewal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMitophagy \/ autophagy (alternate)\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/spermidine-10mg-wheat-germ-extract\"\u003eSpermidine 10mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eAutophagy inducer — pairs with mitophagy for full quality-control axis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMitochondrial biogenesis\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/pqq-20mg-mitochondrial-biogenesis-activator\"\u003ePQQ 20mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003ePGC-1α activator — drives new mitochondrial synthesis the αKG fuels\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMitochondrial cofactor\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10 400mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eComplex I \/ II → III electron carrier; depletes with age and statin use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenolytics\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/fisetin-500mg-senolytic-flavonoid-for-cellular-cleanup\"\u003eFisetin 500mg\u003c\/a\u003e · \u003ca href=\"\/he\/products\/quercetin-500mg-senolytic-flavonoid-natural-antihistamine\"\u003eQuercetin 500mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eClear senescent \"zombie\" cells — orthogonal to CaAKG substrate work\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAntioxidant axis\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003eGlutathione 500mg\u003c\/a\u003e · \u003ca href=\"\/he\/products\/alpha-lipoic-acid-600mg-universal-antioxidant\"\u003eAlpha-Lipoic Acid 600mg\u003c\/a\u003e · \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C 1000mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eVitamin C is the second cofactor for every αKGDD enzyme — pairs directly with CaAKG\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCollagen substrate\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen 5000mg\u003c\/a\u003e · \u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti-Collagen Complex\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eProvides the proline\/glycine substrate the α-KG-fueled hydroxylases work on\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardiovascular\u003c\/td\u003e\n\u003ctd\u003e\n\u003ca href=\"\/he\/products\/omega-3-fish-oil-2000mg-epa-dha\"\u003eOmega-3 EPA\/DHA 2000mg\u003c\/a\u003e · \u003ca href=\"\/he\/products\/taurine-1000mg-cardiovascular-mitochondrial-longevity\"\u003eTaurine 1000mg\u003c\/a\u003e\n\u003c\/td\u003e\n\u003ctd\u003eIndependent cardiovascular and mitochondrial axis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetabolic\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/berberine-hcl-500mg-maximum-strength\"\u003eBerberine 500mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eAMPK activator — independent metabolic axis, complementary to αKG fuel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnti-inflammatory\u003c\/td\u003e\n\u003ctd\u003e\u003ca href=\"\/he\/products\/curcumin-1000mg-bioperine-anti-inflammatory-longevity\"\u003eCurcumin 1000mg\u003c\/a\u003e\u003c\/td\u003e\n\u003ctd\u003eInflammaging axis — pairs with senolytics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eVitamin C is the other αKGDD cofactor — and that matters here\u003c\/h3\u003e\n\u003cp\u003eEvery α-KG-dependent dioxygenase requires \u003cem\u003eboth\u003c\/em\u003e α-KG and ascorbate (Vitamin C) to complete its catalytic cycle (Loenarz \u0026amp; Schofield 2008). Ascorbate keeps the active-site iron in the Fe²⁺ state; without it, the enzyme stalls. In young adults, plasma ascorbate is generally sufficient; in older adults and in chronically inflamed states, ascorbate drops below the saturation point of several αKGDDs (Padayatty et al., \u003cem\u003eAnn Intern Med\u003c\/em\u003e 2004). Pairing CaAKG with adequate Vitamin C — ideally a high-bioavailability format like \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e — closes the second cofactor on the same enzymes. This is why the Linus Pauling-era observation that \"Vitamin C builds collagen\" and the modern observation that \"α-KG drives demethylation\" are the same chemistry.\u003c\/p\u003e\n\n\u003ch3\u003eWho this is for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAdults 35+ with a serious longevity practice who want the only supplement with published human DNAm-clock reversal data in their stack.\u003c\/li\u003e\n\u003cli\u003ePeople already running an NMN\/NR + Resveratrol stack and looking for the next non-redundant addition (this is that addition).\u003c\/li\u003e\n\u003cli\u003ePeople who track biological-age clocks (DNAm Horvath, GrimAge, PhenoAge, DunedinPACE) and want a compound with intervention data on those exact clocks.\u003c\/li\u003e\n\u003cli\u003ePeople with collagen-quality concerns (skin elasticity, joint stiffness, vascular flexibility) who want to cover the α-KG cofactor alongside Vitamin C and dietary collagen peptides.\u003c\/li\u003e\n\u003cli\u003eAdults 50+ with bone-density concerns wanting the dual-mechanism (calcium + α-KG) angle, paired with K2 to route the calcium correctly.\u003c\/li\u003e\n\u003cli\u003ePost-menopausal women specifically — the Demidenko 2021 women's-arm protocol (1000mg CaAKG + 5000 IU D3) is the most directly evidenced version of this stack.\u003c\/li\u003e\n\u003cli\u003eVegan \/ gluten-free \/ non-GMO users — HPMC vegetable capsule, no animal-derived excipients, no allergens.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWho this is NOT for\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePeople looking for a felt-effect compound (energy hit, mood lift, sleep aid) — CaAKG works silently at the cellular substrate level.\u003c\/li\u003e\n\u003cli\u003ePeople who will quit at week 4 because \"I don't feel anything yet\" — the trial endpoint was 7 months for a reason.\u003c\/li\u003e\n\u003cli\u003ePeople with kidney disease, hypercalcemia, parathyroid disease, sarcoidosis, or a history of calcium-oxalate stones, without physician guidance — the calcium load matters more for you than for the general population.\u003c\/li\u003e\n\u003cli\u003ePeople already taking a high-dose calcium supplement (1000+ mg\/day) without K2 — adding CaAKG without K2 cofactor is the configuration the Bolland 2010 BMJ concern actually applies to.\u003c\/li\u003e\n\u003cli\u003ePregnant or breastfeeding women, or anyone under 18 — no published safety data in those populations.\u003c\/li\u003e\n\u003cli\u003ePeople with IDH1\/IDH2-mutant cancers or undergoing 2-hydroxyglutarate-targeted oncology therapy — the α-KG \/ 2HG axis is therapeutically modulated in those protocols and supplemental α-KG can interfere.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSafety, interactions, and contraindications\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneral tolerability:\u003c\/strong\u003e CaAKG was well-tolerated in the Demidenko 2021 cohort over 4–10 months at 1000mg\/day, with no serious adverse events reported. Mild GI upset is the most common low-grade side effect at higher (2000mg+) doses; taking with food eliminates this in nearly all cases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCalcium load:\u003c\/strong\u003e ~200mg elemental calcium per capsule. Add to dietary intake to estimate total. Stay below 2500mg\/day combined intake (NIH UL for adults).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKidney disease:\u003c\/strong\u003e If you have CKD stage 3+ or impaired calcium clearance, talk to your physician — the calcium load matters more for you. The α-KG itself is renoprotective in some animal models but the calcium component requires individualized dose adjustment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCalcium channel blockers, thiazide diuretics, hypercalcemia:\u003c\/strong\u003e Consult your physician before supplementing — both can interact with calcium load.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCalcium-oxalate kidney stones:\u003c\/strong\u003e Supplemental calcium taken with oxalate-rich meals actually \u003cem\u003ereduces\u003c\/em\u003e stone risk (calcium binds dietary oxalate in the gut and prevents absorption — Curhan et al., \u003cem\u003eAnn Intern Med\u003c\/em\u003e 1997). But this is patient-specific; talk to your physician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eParathyroid disease, sarcoidosis, granulomatous disease:\u003c\/strong\u003e Calcium handling is altered; consult your physician.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy \/ breastfeeding \/ under 18:\u003c\/strong\u003e Not studied; do not use without physician guidance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIDH1\/IDH2-mutant cancers, 2-HG-targeted oncology:\u003c\/strong\u003e Do not use without your oncologist's explicit approval — the α-KG \/ 2HG axis is therapeutically targeted in those protocols (Dang et al., \u003cem\u003eNature\u003c\/em\u003e 2009).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgery:\u003c\/strong\u003e Stop 2 weeks before scheduled surgery as a general supplement-precaution practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDrug interactions:\u003c\/strong\u003e No clinically significant α-KG drug-drug interactions reported in healthy adults at 1000mg\/day. The calcium component can reduce absorption of tetracycline-class and quinolone-class antibiotics, levothyroxine, and bisphosphonates if taken simultaneously — leave 2 hours between CaAKG and these medications.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Cool, dry place. Keep the desiccant in the bottle. Foil-laminated cap seal under the lid is part of the moisture barrier — do not discard until the bottle is empty.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhat this product is — and is NOT\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS:\u003c\/strong\u003e A pharmaceutical-grade CaAKG capsule at the human-trial dose, designed as the substrate-fuel layer of a serious longevity stack.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS:\u003c\/strong\u003e The only supplement with published human DNAm-GrimAge-clock-reversal data (Demidenko 2021).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS NOT:\u003c\/strong\u003e A stimulant, energy supplement, mood enhancer, or anything you should expect to \"feel.\"\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS NOT:\u003c\/strong\u003e A treatment for any disease. Supplemental, not therapeutic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS NOT:\u003c\/strong\u003e A replacement for foundational diet, sleep, exercise, or NAD+ precursors. CaAKG layers \u003cem\u003eon top of\u003c\/em\u003e the foundational longevity stack — it does not replace any of it.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS NOT:\u003c\/strong\u003e A one-month experiment. The trial endpoint was 7 months. Plan accordingly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS NOT:\u003c\/strong\u003e A bone-density supplement primarily — the calcium is along for the ride. If your goal is bone density, prioritize D3+K2+Magnesium+adequate protein+resistance training, with CaAKG as a substrate-layer add.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIS NOT:\u003c\/strong\u003e A standalone \"longevity in a bottle.\" Stack architecture matters; this is one well-evidenced layer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCommon mistakes to avoid\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuitting at week 4 because \"I don't feel anything.\"\u003c\/strong\u003e The trial endpoint was 7 months. Felt effects are not the indicator. Test DNAm or test patience.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNot pairing with K2.\u003c\/strong\u003e Calcium without K2 is the configuration the Bolland 2010 BMJ concern actually applies to. Add \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e to the stack.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDoubling the dose hoping for faster effect.\u003c\/strong\u003e No published efficacy or safety data above 2000mg\/day in healthy adults. The trial used 1000mg\/day. Match the trial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCycling CaAKG.\u003c\/strong\u003e No published cycling protocol; the trial used continuous daily dosing for 7 months. Cycling is conjecture.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStacking with high-dose isolated calcium supplements without K2.\u003c\/strong\u003e Total calcium load matters; add the K2 cofactor before stacking calcium products.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTaking with iron, zinc, levothyroxine, bisphosphonates, or fluoroquinolones at the same time.\u003c\/strong\u003e Calcium reduces absorption of these. Separate by 2 hours.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkipping foundational chemistry first.\u003c\/strong\u003e If your sleep is broken, your magnesium is depleted, your D3 is below 30 ng\/mL, and your protein intake is under 1g\/kg, fix that \u003cem\u003ebefore\u003c\/em\u003e chasing GrimAge reversal with a substrate-layer compound. The foundations gate the ceiling on every layer above them.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eWhere this sits in catalog architecture\u003c\/h3\u003e\n\u003cp\u003eTrue Health Protocol's catalog is organized as a concentric stack with eight layers, each addressing a distinct hallmark of aging. CaAKG sits in the \u003cem\u003esubstrate-fuel\u003c\/em\u003e layer — the most upstream layer that feeds nearly every layer above it:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eFoundational chemistry\u003c\/strong\u003e (D3+K2, Magnesium, Omega-3, Vitamin C, Collagen) — gates everything above.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSubstrate fuel — TCA + αKGDD enzymes \u003cspan style=\"color:#0a7;\"\u003e(THIS PRODUCT)\u003c\/span\u003e\u003c\/strong\u003e — α-KG for demethylases, prolyl-hydroxylases, EglN, carnitine biosynthesis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ precursor supply\u003c\/strong\u003e (NMN, NR, NAD+ Liquid, NAD+ Hard Caps) — raises the cofactor pool sirtuins\/PARPs\/ETC use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSirtuin activation\u003c\/strong\u003e (Resveratrol, Pterostilbene equivalents) — direct SIRT1 binding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethylation + CD38 management\u003c\/strong\u003e (TMG, Apigenin) — methyl-donor balance and slowing NAD+ degradation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial cofactors + biogenesis\u003c\/strong\u003e (CoQ10, PQQ, Taurine, Creatine).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitophagy + autophagy\u003c\/strong\u003e (Urolithin A, Spermidine).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSenolytics + antioxidant axis\u003c\/strong\u003e (Fisetin, Quercetin, Glutathione, ALA, Astaxanthin).\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe substrate-fuel layer sits second only to foundational chemistry because TCA-cycle output gates the NAD+\/ATP cycle, the demethylase rate, and the collagen-synthesis rate above it. Replacing the missing α-KG is one of the most upstream interventions you can make.\u003c\/p\u003e\n\n\u003ch3\u003eFAQ\u003c\/h3\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How is this different from NMN, NR, or NAD+ supplements?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: NMN\/NR\/NAD+ raise the cellular NAD+ pool. CaAKG fuels the upstream TCA cycle that generates the NADH that drives NAD+ regeneration via the electron transport chain — and feeds the demethylase enzymes that the NAD+-dependent sirtuins coordinate with. Different layer of the same machinery, not redundant. The 2021 TruDiagnostic pilot (Demidenko et al., \u003cem\u003eAging\u003c\/em\u003e) is the only longevity supplement with published human DNAm-GrimAge-clock-reversal data — most NMN\/NR human data is biomarker work (NAD+ blood levels, walking distance, SBP) without DNAm endpoints. Stack them; don't substitute.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why CaAKG and not just α-ketoglutaric acid?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Free α-ketoglutaric acid is unstable (pKa1 ≈ 2.47) and acidic — it degrades within hours of contact with air or water and irritates the GI tract enough to be unsuitable for capsule delivery. The calcium salt is stable, palatable, and what every published longevity study has used (Asadi Shahmirzadi 2020, Demidenko 2021). The calcium is along for the ride and supports bone density as a secondary benefit — not the active mechanism.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why CaAKG specifically, vs. Sodium-AKG, Arginine-AKG, or Ornithine-AKG?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: CaAKG is the form used in \u003cem\u003eboth\u003c\/em\u003e the Buck Institute mouse lifespan study and the TruDiagnostic human GrimAge pilot. Sodium-AKG adds sodium most longevity-conscious users don't want; Arginine-AKG (AAKG) is sports-nutrition for nitric-oxide \/ vasodilation; Ornithine-AKG is critical-care nitrogen-balance. If you're matching the published longevity protocol, you want CaAKG.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will the calcium load cause vascular calcification?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Each capsule provides ~200mg elemental calcium — about a fifth of the RDA, far below the 2500mg\/day upper limit. The Bolland 2010 BMJ concern was about \u003cem\u003eisolated\u003c\/em\u003e high-dose calcium supplementation without K2 cofactor. If you pair Vitamin K2 MK-7 (we recommend our \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2 product\u003c\/a\u003e), the K2 directs calcium into bone matrix and out of arteries via matrix Gla protein activation (Schurgers 2007; Knapen 2015). Standard foundational chemistry, not a CaAKG-specific issue.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How long until I feel something?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: CaAKG works at the cellular substrate level — it's not stimulating, calming, or sleep-modifying. The TruDiagnostic biological-age reversal showed up over 7 months of daily supplementation. This is a long-game compound, not a felt-effect compound. Some users report better recovery from exercise within weeks (mitochondrial-fuel mechanism), and some report skin-texture changes around weeks 4–8 (collagen-synthesis mechanism), but the headline mechanism (epigenetic age reset) is silent. \u003cem\u003eIf you don't feel anything, that doesn't mean it's not working.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Should I get a DNAm clock test before and after?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: If you can afford it, yes — that's how you'll see the headline mechanism. The TruDiagnostic, Elysium Index, and myDNAge clocks are the consumer options. The Demidenko 2021 trial used GrimAge specifically. Test at baseline, then re-test at 7–12 months. If you can't justify the cost, consistency at the trial dose for at least 12 months is the protocol the published data supports — you're matching the intervention even if you can't measure the outcome.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I get α-KG from food?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Trace amounts in meat, eggs, citrus, and leafy greens — but α-KG is a metabolic intermediate, not a stored nutrient. Your body synthesizes its own from glutamine and glutamate via glutamate dehydrogenase and the aminotransferases. The issue is that aging cells make ~10x less of it between age 40 and 80 (Chin 2014; Liu 2018), not that diet is inadequate. Direct supplementation bypasses the age-related decline in endogenous synthesis — no dietary intervention has been shown to do this.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: One capsule or two per day?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: One per day matches the published trial protocol exactly (Demidenko 2021). Some users start with two for the first month before settling at one (a \"loading\" approach), but the 7-month trial used 1000mg\/day — that is the dose with human DNAm-clock-reversal data. There is no published human efficacy or safety data above 1000mg\/day, so we don't recommend going higher.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: AM or PM dosing?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: AM with breakfast is the trial protocol. PM is fine if mornings don't work — there is no documented circadian dependence on α-KG absorption. With food matters more than time of day.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Should I cycle CaAKG?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: No published cycling protocol exists. The trial used continuous daily dosing for 7 months. If you stop, plasma α-KG returns to baseline within days and demethylase rates fall back. Continuous daily dosing is the protocol; cycling is conjecture.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take it with NMN at the same time?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. NMN is typically taken in the morning (some users sublingual, some swallowed); CaAKG with food, also morning. The two compounds work on different layers of the same machinery and there is no documented interaction. If you're running a stack with NMN + Resveratrol + TMG already, CaAKG is the logical next addition.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why does the women's arm of the trial include Vitamin D3?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: The Rejuvant® women's product included 5000 IU D3 because of the bone-density \/ calcium \/ D3 \/ K2 axis — postmenopausal women have a stronger bone-density rationale for stacking the calcium-routing chemistry. Pairing this product with our \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2\u003c\/a\u003e matches that arm of the trial and adds the K2 cofactor that closes the calcification loop the original trial did not include.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take CaAKG with coffee?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. Coffee does not interfere with α-KG absorption. The acid load of coffee is unrelated to the calcium-α-ketoglutarate salt's stability inside the capsule.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take CaAKG fasted, for autophagy stacking?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: There is no published fasted-state CaAKG protocol. The trial protocol was with food. Some users in a fasted-window protocol take CaAKG at the start of the eating window with their first meal — that splits the difference. We don't recommend long-term fully fasted dosing because the residual acidity of the salt can cause low-grade GI sensitivity without buffering.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is CaAKG vegan?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. The α-KG and calcium are minerally synthesized; the HPMC capsule is vegetable cellulose; the excipients are vegetable-source. No animal-derived ingredients.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is CaAKG gluten-free?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. Allergen-tested gluten-free per the certificate of analysis. No wheat, barley, or rye.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Is CaAKG safe with statins?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: No documented interaction. CaAKG does not share the CYP3A4 pathway statins are metabolized by. Statins deplete CoQ10 — if you're on a statin, prioritize \u003ca href=\"\/he\/products\/coq10-400mg-maximum-strength\"\u003eCoQ10\u003c\/a\u003e in your stack alongside CaAKG.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What does the calcium do that's separate from the α-KG?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Each capsule contributes ~200mg elemental calcium toward the 1000–1200mg\/day RDA. Calcium itself supports bone-mineral density (with adequate D3 and K2), neuromuscular function, vascular tone, and intracellular signaling. In the Filip 2007 sodium-AKG bone-density trial, the AKG anion was the active variable; in this product, both the α-KG \u003cem\u003eand\u003c\/em\u003e the calcium contribute mechanistically when paired with K2.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What is GrimAge, and why does it matter?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: GrimAge is a DNA-methylation-based biological-age clock developed by Lu et al. (\u003cem\u003eAging\u003c\/em\u003e 2019) that integrates DNAm signatures of seven plasma proteins and smoking pack-years into a single \"biological age\" estimate. It outperforms earlier clocks (Horvath, Hannum, PhenoAge) in predicting time-to-death, time-to-disease, and healthspan endpoints (Hillary 2020). The Demidenko 2021 CaAKG pilot's −8 year GrimAge change is therefore a clinically meaningful biological-age signal, not just a methylation-pattern artifact.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What's the difference between Horvath, Hannum, PhenoAge, GrimAge, and DunedinPACE clocks?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: All are DNAm-based but differ in the CpG sites and biomarkers they integrate. Horvath (2013) was first, trained on pan-tissue chronological age. Hannum (2013) was blood-only chronological age. PhenoAge (Levine 2018) added phenotypic biomarkers (CRP, glucose, etc.) for healthspan. GrimAge (Lu 2019) added plasma-protein DNAm signatures and is the strongest mortality predictor. DunedinPACE (Belsky 2022) measures pace of aging from a single timepoint. Demidenko 2021 used GrimAge as the primary endpoint.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Will CaAKG show up on a drug test?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: No. α-KG and calcium are normal endogenous metabolites. CaAKG is not on any sport-banned-substance list (WADA, NCAA, USADA).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Why is α-KG sometimes called 2-oxoglutarate or 2OG?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Three names for the same molecule: α-ketoglutaric acid (older biochemistry literature), 2-oxoglutaric acid (current IUPAC name), and 2OG (the abbreviation common in chromatin and oxygen-sensing literature). All refer to the same 5-carbon dicarboxylic α-keto acid that's the 4th TCA-cycle intermediate.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What is the difference between α-KG and 2-hydroxyglutarate (2HG)?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: α-KG has a keto group at the 2-position; 2HG has a hydroxyl. 2HG is generated by side-reactions of malate-dehydrogenase, lactate-dehydrogenase, and (pathologically) IDH1\/2-mutant enzymes (Dang 2009). 2HG competitively inhibits the same αKGDD enzymes α-KG fuels — meaning 2HG accumulation effectively makes α-KG deficiency worse. Aging tissues accumulate 2HG (Intlekofer 2017), compounding the substrate problem. Replacing α-KG with CaAKG raises the α-KG \/ 2HG ratio and re-enables the dioxygenases.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does CaAKG help with hair, skin, or nails?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Indirectly, via collagen synthesis. Prolyl-4-hydroxylase and lysyl-hydroxylase are α-KG-dependent and are the rate-limiting collagen-folding enzymes. CaAKG provides the missing co-substrate; pair with dietary collagen peptides (\u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e or \u003ca href=\"\/he\/products\/multi-collagen-complex-types-i-ii-iii-v-x-240-capsules\"\u003eMulti-Collagen\u003c\/a\u003e), \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eVitamin C\u003c\/a\u003e, and \u003ca href=\"\/he\/products\/biotin-10-000mcg-maximum-strength-hair-skin-nails-formula\"\u003eBiotin\u003c\/a\u003e for the full hair\/skin\/nails protocol.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does CaAKG help with bone density?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Plausibly yes, via two mechanisms: (1) dietary calcium contribution (~200mg per capsule), and (2) Filip 2007 demonstrated that AKG anion at supplemental doses slowed post-menopausal bone-density loss vs. placebo over 6 months in a Polish trial. Pair with D3+K2 for the full bone-mineral protocol (D3 → calcium absorption; K2 → osteocalcin γ-carboxylation → calcium routing into bone matrix; Magnesium → bone-mineral co-substrate).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does CaAKG help with kidney function?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Animal data suggests α-KG is renoprotective in some kidney-injury models (Niemczyk 2014 review). Human data is limited. If you have CKD, the calcium load matters and individualized physician guidance is required.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does CaAKG affect blood pressure?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: No documented BP effect at 1000mg\/day in the Demidenko 2021 cohort. The arginine-AKG (AAKG) form has a documented vasodilation \/ NO-mediated BP effect — that is a different molecule and not what is in this bottle.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Does CaAKG affect blood glucose or insulin sensitivity?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: No documented glycemic effect in healthy adults at 1000mg\/day. Mouse data shows TCA-cycle support can shift hepatic glucose handling, but no clinically significant human glucose signal in the published trial cohort.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I open the capsule and put the powder in a smoothie?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: We don't recommend it. CaAKG is mildly acidic when wet; the capsule shell is part of the GI-protection. Swallow the capsule whole with water, with food.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How does this compare to Rejuvant®?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Rejuvant® was the branded product used in the Demidenko 2021 trial. Our 1000mg CaAKG capsule matches the active ingredient and dose used in the men's-arm protocol of that trial. To match the women's-arm protocol exactly, add our \u003ca href=\"\/he\/products\/vitamin-d3-5000-iu-k2-mk-7-100mcg\"\u003eD3+K2 product\u003c\/a\u003e for the 5000 IU D3 cofactor (and gain the K2 the original trial did not include).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: What are the certificates of analysis for this product?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: HPLC ≥98% purity, USP \u0026lt;232\u0026gt; heavy-metal panel (lead, arsenic, cadmium, mercury) at California Prop 65 thresholds, USP \u0026lt;467\u0026gt; residual solvents, USP \u0026lt;2021\u0026gt; microbial + pathogen panel (E. coli, Salmonella, Staph aureus), USP \u0026lt;561\u0026gt; pesticide panel, allergen panel (gluten\/dairy\/soy\/nuts negative). Available on request.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: How should I store CaAKG?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Cool, dry place, original sealed bottle. Keep the desiccant in the bottle. Avoid humid bathrooms and hot cars. Shelf life ≥36 months from manufacture in the original packaging.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eQ: Can I take CaAKG long-term?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: The Demidenko 2021 cohort took it for an average of 7 months (range 4–10). No published long-term (multi-year) human safety data exists. Mechanistically, α-KG is an endogenous metabolite that your body produces at gram-quantities daily; supplemental 1000mg is well within physiological range. The conservative practice is to re-evaluate annually with your physician.\u003c\/p\u003e\n\n\u003ch3\u003eQuality, sourcing, and manufacturing\u003c\/h3\u003e\n\u003cp\u003ePharmaceutical-grade Calcium Alpha-Ketoglutarate, manufactured under FDA 21 CFR Part 111 cGMP regulations in a third-party-audited facility. Each batch is tested for: identity (HPLC + mass-spec orthogonal verification, ≥98% purity), heavy metals (USP \u0026lt;232\u0026gt; panel — lead, arsenic, cadmium, mercury — at California Prop 65 thresholds, well below FDA limits), residual solvents (USP \u0026lt;467\u0026gt;), microbial + pathogen panel (USP \u0026lt;2021\u0026gt; — total aerobic plate count, yeast\/mold, and absence of E. coli, Salmonella, Staphylococcus aureus), pesticide residues (USP \u0026lt;561\u0026gt;), and allergen panel (gluten, dairy, soy, peanut, tree nut — all negative). Vegan HPMC capsules; no fillers beyond the standard pharmaceutical excipients listed on the label; no proprietary blends — exact 1000mg of CaAKG on the label. No titanium dioxide, no artificial colors, no shellac, no animal-derived gelatin. Foil-laminated cap seal under the lid as a tamper-evidence and moisture barrier. ≥36-month room-temperature shelf life in the original sealed bottle.\u003c\/p\u003e\n\n\u003ch3\u003eRelated collections\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/longevity-essentials\"\u003eLongevity Essentials\u003c\/a\u003e — the foundational chemistry layer of the catalog\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/foundational-health\"\u003eFoundational Health\u003c\/a\u003e — the universal cofactors every longevity stack runs on\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/nad-family\"\u003eNAD+ Family\u003c\/a\u003e — the upstream NAD+ machinery CaAKG fuels\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/mitochondrial-renewal\"\u003eMitochondrial Renewal\u003c\/a\u003e — the energy-renewal axis CaAKG drives\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/beauty-anti-aging\"\u003eBeauty \u0026amp; Anti-Aging\u003c\/a\u003e — the collagen \/ dermal axis CaAKG supports\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/cardiovascular-longevity\"\u003eCardiovascular Longevity\u003c\/a\u003e — the K2 \/ calcium-routing axis\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/metabolic\"\u003eMetabolic Longevity\u003c\/a\u003e — the AMPK \/ glycemic axis\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/senolytics\"\u003eSenolytics\u003c\/a\u003e — the orthogonal cellular-cleanup axis\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/he\/collections\/most-popular\"\u003eMost Popular\u003c\/a\u003e — top-selling foundational stacks\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eRead more\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/longevity-supplements-after-40-what-changes-and-what-to-add\"\u003eLongevity supplements after 40: what changes and what to add\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/how-to-stack-longevity-supplements-a-practical-protocol-for-2026\"\u003eHow to stack longevity supplements: a practical protocol for 2026\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/foundational-health-the-7-daily-nutrients-that-run-underneath-every-longevity-stack\"\u003eFoundational health: the 7 daily nutrients that run underneath every longevity stack\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/mitochondrial-renewal-how-to-clear-damaged-mitochondria-and-build-new-ones\"\u003eMitochondrial renewal: clearing damaged mitochondria and building new ones\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/what-is-nad-a-beginners-guide-to-the-coenzyme-behind-longevity\"\u003eWhat is NAD+? A beginner's guide to the coenzyme behind longevity\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nad-which-should-you-take-in-2026\"\u003eNMN vs. NAD+: which should you take in 2026\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-vs-nr-which-nad-precursor-actually-works-better\"\u003eNMN vs. NR: which NAD+ precursor actually works better\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-time-to-take-nmn-morning-empty-stomach-or-with-food\"\u003eBest time to take NMN: morning, empty stomach, or with food\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/resveratrol-benefits-why-its-the-other-half-of-the-nmn-stack\"\u003eResveratrol benefits: why it's the other half of the NMN stack\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/senolytics-how-to-clear-zombie-cells-with-fisetin-quercetin-and-apigenin\"\u003eSenolytics: clearing zombie cells with Fisetin, Quercetin, and Apigenin\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/best-energy-supplements-that-arent-caffeine\"\u003eBest energy supplements that aren't caffeine\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/he\/blogs\/news\/nmn-side-effects-what-the-research-actually-shows\"\u003eNMN side effects: what the research actually shows\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eSelected references\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAsadi Shahmirzadi A, et al. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice. \u003cem\u003eCell Metabolism\u003c\/em\u003e 32(3):447-456 (2020).\u003c\/li\u003e\n\u003cli\u003eDemidenko O, et al. Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging. \u003cem\u003eAging\u003c\/em\u003e 13(22):24485-24499 (2021).\u003c\/li\u003e\n\u003cli\u003eTahiliani M, et al. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1. \u003cem\u003eScience\u003c\/em\u003e 324(5929):930-935 (2009).\u003c\/li\u003e\n\u003cli\u003eTsukada Y, et al. Histone demethylation by a family of JmjC domain-containing proteins. \u003cem\u003eNature\u003c\/em\u003e 439:811-816 (2006).\u003c\/li\u003e\n\u003cli\u003eIto S, et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. \u003cem\u003eNature\u003c\/em\u003e 466:1129-1133 (2010).\u003c\/li\u003e\n\u003cli\u003eChin RM, et al. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. \u003cem\u003eNature\u003c\/em\u003e 510:397-401 (2014).\u003c\/li\u003e\n\u003cli\u003eLiu PS, et al. α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. \u003cem\u003eNat Immunol\u003c\/em\u003e 18:985-994 (2017); follow-up \u003cem\u003eAging Cell\u003c\/em\u003e 2018.\u003c\/li\u003e\n\u003cli\u003eWu N, et al. Alpha-Ketoglutarate: Physiological Functions and Applications. \u003cem\u003eBiomol Ther\u003c\/em\u003e 24(1):1-8 (2016); \u003cem\u003eCell Metabolism\u003c\/em\u003e 2016 review.\u003c\/li\u003e\n\u003cli\u003eSu Y, et al. Aging-related changes in plasma α-ketoglutarate. \u003cem\u003eAging\u003c\/em\u003e 11(12):4183-4197 (2019).\u003c\/li\u003e\n\u003cli\u003eCarey BW, et al. Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. \u003cem\u003eNature\u003c\/em\u003e 518:413-416 (2015).\u003c\/li\u003e\n\u003cli\u003eTran TQ, et al. α-Ketoglutarate attenuates aging via DNA demethylation. \u003cem\u003eCell Reports\u003c\/em\u003e 33(11):108457 (2020).\u003c\/li\u003e\n\u003cli\u003eKlose RJ, et al. JmjC-domain-containing proteins and histone demethylation. \u003cem\u003eNat Rev Genet\u003c\/em\u003e 7:715-727 (2006).\u003c\/li\u003e\n\u003cli\u003eLoenarz C \u0026amp; Schofield CJ. Expanding chemical biology of 2-oxoglutarate oxygenases. \u003cem\u003eNat Chem Biol\u003c\/em\u003e 4:152-156 (2008).\u003c\/li\u003e\n\u003cli\u003eHewitson KS, et al. Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases. \u003cem\u003eJ Biol Chem\u003c\/em\u003e 282(5):3293-3301 (2007).\u003c\/li\u003e\n\u003cli\u003eKaelin WG \u0026amp; Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. \u003cem\u003eMol Cell\u003c\/em\u003e 30(4):393-402 (2008).\u003c\/li\u003e\n\u003cli\u003eLando D, et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of HIF. \u003cem\u003eGenes Dev\u003c\/em\u003e 16:1466-1471 (2002).\u003c\/li\u003e\n\u003cli\u003eMyllyharju J. Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. \u003cem\u003eMatrix Biology\u003c\/em\u003e 22:15-24 (2003).\u003c\/li\u003e\n\u003cli\u003eGorres KL \u0026amp; Raines RT. Prolyl 4-hydroxylase. \u003cem\u003eCrit Rev Biochem Mol Biol\u003c\/em\u003e 45(2):106-124 (2010).\u003c\/li\u003e\n\u003cli\u003eShoulders MD \u0026amp; Raines RT. Collagen structure and stability. \u003cem\u003eAnnu Rev Biochem\u003c\/em\u003e 78:929-958 (2009).\u003c\/li\u003e\n\u003cli\u003eVarani J, et al. Decreased collagen production in chronologically aged skin. \u003cem\u003eAm J Pathol\u003c\/em\u003e 168:1861-1868 (2006).\u003c\/li\u003e\n\u003cli\u003eHorvath S. DNA methylation age of human tissues and cell types. \u003cem\u003eGenome Biology\u003c\/em\u003e 14:R115 (2013).\u003c\/li\u003e\n\u003cli\u003eHannum G, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. \u003cem\u003eMol Cell\u003c\/em\u003e 49:359-367 (2013).\u003c\/li\u003e\n\u003cli\u003eLevine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. \u003cem\u003eAging\u003c\/em\u003e 10(4):573-591 (2018) — PhenoAge.\u003c\/li\u003e\n\u003cli\u003eLu AT, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. \u003cem\u003eAging\u003c\/em\u003e 11(2):303-327 (2019).\u003c\/li\u003e\n\u003cli\u003eBelsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. \u003cem\u003eeLife\u003c\/em\u003e 11:e73420 (2022).\u003c\/li\u003e\n\u003cli\u003eHillary RF, et al. Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death. \u003cem\u003eClin Epigenetics\u003c\/em\u003e 12:115 (2020).\u003c\/li\u003e\n\u003cli\u003eFilip RS \u0026amp; Pierzynowski SG. The role of α-ketoglutarate in the regulation of bone metabolism. \u003cem\u003eJ Pre-Clin Clin Res\u003c\/em\u003e \/ \u003cem\u003eJ Bone Miner Metab\u003c\/em\u003e (2007).\u003c\/li\u003e\n\u003cli\u003eNiemczyk S, et al. Alpha-ketoglutarate and pulmonary hypertension. \u003cem\u003ePolish Heart Journal\u003c\/em\u003e 72(11):1093-1100 (2014) review.\u003c\/li\u003e\n\u003cli\u003eWernerman J, et al. Alpha-ketoglutarate and post-operative muscle catabolism. \u003cem\u003eCrit Care\u003c\/em\u003e 3(2):R51 (1999).\u003c\/li\u003e\n\u003cli\u003eBolland MJ, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. \u003cem\u003eBMJ\u003c\/em\u003e 341:c3691 (2010).\u003c\/li\u003e\n\u003cli\u003eSchurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. \u003cem\u003eBlood\u003c\/em\u003e 109:3279-3283 (2007).\u003c\/li\u003e\n\u003cli\u003eKnapen MHJ, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. \u003cem\u003eThromb Haemost\u003c\/em\u003e 113:1135-1144 (2015).\u003c\/li\u003e\n\u003cli\u003eGeleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. \u003cem\u003eJ Nutrition\u003c\/em\u003e 134:3100-3105 (2004).\u003c\/li\u003e\n\u003cli\u003eCurhan GC, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. \u003cem\u003eAnn Intern Med\u003c\/em\u003e 126(7):497-504 (1997).\u003c\/li\u003e\n\u003cli\u003ePadayatty SJ, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. \u003cem\u003eAnn Intern Med\u003c\/em\u003e 140:533-537 (2004).\u003c\/li\u003e\n\u003cli\u003eIntlekofer AM, et al. L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. \u003cem\u003eNat Chem Biol\u003c\/em\u003e 13:494-500 (2017).\u003c\/li\u003e\n\u003cli\u003eDang L, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. \u003cem\u003eNature\u003c\/em\u003e 462:739-744 (2009).\u003c\/li\u003e\n\u003cli\u003eJaiswal S, et al. Age-related clonal hematopoiesis associated with adverse outcomes. \u003cem\u003eNEJM\u003c\/em\u003e 371:2488-2498 (2014); CHIP and cardiovascular disease, \u003cem\u003eNEJM\u003c\/em\u003e 377:111-121 (2017).\u003c\/li\u003e\n\u003cli\u003eBayliak MM, et al. Pro-health effects of α-ketoglutarate. \u003cem\u003eBiogerontology\u003c\/em\u003e 17:567-579 (2016).\u003c\/li\u003e\n\u003cli\u003eMastrogiacomo F, et al. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. \u003cem\u003eAnn Neurol\u003c\/em\u003e 39:592-598 (1996).\u003c\/li\u003e\n\u003cli\u003eBunik VI, et al. The 2-oxoglutarate dehydrogenase complex: redox sensor and target. \u003cem\u003eFEBS J\u003c\/em\u003e 275:6234-6253 (2008).\u003c\/li\u003e\n\u003cli\u003eHowitz KT, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. \u003cem\u003eNature\u003c\/em\u003e 425:191-196 (2003).\u003c\/li\u003e\n\u003cli\u003ePark SJ, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. \u003cem\u003eCell\u003c\/em\u003e 148:421-433 (2012).\u003c\/li\u003e\n\u003cli\u003eTrammell SAJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. \u003cem\u003eNat Commun\u003c\/em\u003e 7:12948 (2016).\u003c\/li\u003e\n\u003cli\u003eYoshino J, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. \u003cem\u003eScience\u003c\/em\u003e 372:1224-1229 (2021).\u003c\/li\u003e\n\u003cli\u003eKrebs HA \u0026amp; Johnson WA. The role of citric acid in intermediate metabolism in animal tissues. \u003cem\u003eEnzymologia\u003c\/em\u003e 4:148-156 (1937).\u003c\/li\u003e\n\u003cli\u003eSemenza GL. Hypoxia-inducible factors in physiology and medicine. \u003cem\u003eCell\u003c\/em\u003e 148:399-408 (2012).\u003c\/li\u003e\n\u003cli\u003eLópez-Otín C, et al. The Hallmarks of Aging. \u003cem\u003eCell\u003c\/em\u003e 153:1194-1217 (2013); update \u003cem\u003eCell\u003c\/em\u003e 186(2):243-278 (2023).\u003c\/li\u003e\n\u003cli\u003eJia G, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. \u003cem\u003eNat Chem Biol\u003c\/em\u003e 7:885-887 (2011).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant or nursing, or take prescription medication.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47840283295962,"sku":"THP-CAAKG-1000-60","price":39.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_caakg.png?v=1778080099"},{"product_id":"glycine-1500mg-glynac-partner-glutathione-sleep-longevity","title":"Glycine 1500mg | GlyNAC Partner | Glutathione Precursor, Slow-Wave Sleep \u0026 Healthy-Aging Substrate","description":"\u003ch2\u003eThe 30-second answer\u003c\/h2\u003e\n\u003cp\u003eGlycine is the smallest amino acid in the body and the second substrate the cell uses to build \u003cstrong\u003eglutathione\u003c\/strong\u003e, the body's master endogenous antioxidant. Cysteine is the famous rate-limiter — that's why \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e works — but in older adults glycine becomes a co-bottleneck. Older bodies have a quietly worsening glycine deficit relative to demand, and pairing glycine with NAC (the \u003cstrong\u003eGlyNAC\u003c\/strong\u003e combination) is the precise intervention Baylor College of Medicine's Rajagopal Sekhar group ran through 14-day, 24-week, and 36-week clinical trials in older adults — restoring red-blood-cell glutathione to youthful levels and moving oxidative-stress, mitochondrial-fuel-handling, insulin-sensitivity, body-composition, walking-speed, cognition, and inflammation markers in a single intervention. Glycine also has a second life as the cheapest, safest evidence-based sleep aid in longevity medicine: 3 grams 30–60 minutes before bed lowers core body temperature, deepens slow-wave sleep, and improves next-day subjective alertness in published Japanese trials. Our Glycine 1500mg formula delivers \u003cstrong\u003e500mg of pharma-grade glycine per capsule, 60 vegan HPMC capsules per bottle\u003c\/strong\u003e, with a 1500mg \/ 3-cap serving sized to the GlyNAC clinical literature and a 1000mg \/ 2-cap serving sized to foundational daily use. No fillers, no stearates, no titanium dioxide, no synthetic glycine isomers — just unflavored, unsweetened, third-party-tested glycine.\u003c\/p\u003e\n\n\u003ch2\u003eWhy glycine moved from \"nutrition-class footnote\" to longevity headline\u003c\/h2\u003e\n\u003cp\u003eFor decades glycine was the amino acid you skimmed past in biochemistry textbooks — small, simple, formally \"non-essential\" because the body can technically synthesize it from serine via the SHMT enzyme system. The textbook framing was wrong about the part that matters most for adults over 40. \"Non-essential\" in nutrition has a very specific meaning: an amino acid your body can synthesize \u003cem\u003efrom other amino acids\u003c\/em\u003e, given adequate substrate, energy, and enzymatic capacity. It does not mean \"your body has unlimited supply\" or even \"your body has enough to meet demand.\" Glycine has now been studied carefully enough that two parallel lines of research have flipped its status from nutritional afterthought to one of the most-discussed amino acids in clinical aging biology.\u003c\/p\u003e\n\u003cp\u003eThe first line is the \u003cstrong\u003eglutathione collapse\u003c\/strong\u003e story. Glutathione (GSH) is a tripeptide: γ-glutamyl-cysteinyl-glycine. The enzyme glutamate-cysteine ligase joins glutamate to cysteine, and then glutathione synthetase adds the glycine. Without all three amino acids present in adequate intracellular concentration, the cell cannot manufacture glutathione no matter how much oxidative-stress demand it is facing. Sekhar's group at Baylor was the first to systematically demonstrate, in human older adults, that the cells of aged individuals have markedly reduced glutathione — and that the deficit traces to inadequate glycine and cysteine substrate, not to broken enzymatic machinery. The corollary follow-up was the obvious one: replace the missing substrate, restore the missing glutathione, and see what happens to the rest of the aging picture. Multiple things, it turned out.\u003c\/p\u003e\n\u003cp\u003eThe second line is the \u003cstrong\u003eglycine-deficit-of-aging\u003c\/strong\u003e story, an independent observation that older adults have lower plasma and intracellular glycine relative to demand. The collagen-turnover side of glycine biology consumes a non-trivial fraction of the body's daily production, and age-related changes in collagen turnover combined with reductions in renal recycling and shifts in hepatic one-carbon metabolism appear to compound the gap. Several groups have published on this independently of the GlyNAC literature, and the upshot is the same: older adults consistently show reduced glycine availability relative to physiological need, and supplementation closes the gap dose-dependently with no risk profile of any clinical concern.\u003c\/p\u003e\n\u003cp\u003eIf you have been reading the longevity literature and watching the same precursor names appear in NAD+ posts, glutathione posts, sleep posts, collagen posts, and methylation posts and wondering why one amino acid keeps showing up, this is why. Glycine sits at six different metabolic intersections, and unlike most amino acids where excess is neutral or slightly harmful, the human evidence on supraphysiological oral glycine is unusually clean.\u003c\/p\u003e\n\n\u003ch2\u003eThe Sekhar Baylor trial progression — what GlyNAC actually did in humans\u003c\/h2\u003e\n\u003cp\u003eThe clinical case for glycine supplementation in older adults is anchored in a multi-stage RCT program from Dr. Rajagopal Sekhar's lab at Baylor College of Medicine, run from roughly 2011 onward and culminating in 2021–2022 with the longest-running and most carefully phenotyped trials. The progression matters because each trial extended both duration and outcome panel:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2011 — Sekhar et al., American Journal of Clinical Nutrition.\u003c\/strong\u003e The foundational paper. HIV-positive adults with documented glutathione deficiency received cysteine + glycine supplementation for 14 days. Erythrocyte glutathione concentration was restored, and oxidative-stress and mitochondrial-fuel-handling markers improved alongside it. The proof-of-concept finding was that a substrate-only intervention — no drug, no enzyme — could restore intracellular glutathione in adults with established deficits.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2018 — Sekhar et al., Journals of Gerontology Series A: Biological Sciences and Medical Sciences.\u003c\/strong\u003e The first dedicated older-adult trial. Older adults received GlyNAC (glycine + N-acetylcysteine) for 14 days. The published outcomes included restored erythrocyte glutathione concentrations, decreased oxidative stress, improved mitochondrial fuel oxidation, decreased insulin resistance, decreased endothelial dysfunction, decreased genotoxicity, decreased waist circumference, and improvements in body composition. Two weeks. One amino acid pair.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2021 — Kumar et al., Clinical and Translational Medicine.\u003c\/strong\u003e The 24-week randomized clinical trial. Older adults vs. younger comparator. GlyNAC supplementation for 24 weeks. Outcomes spanned eight aging-relevant domains: oxidative stress, glutathione deficiency, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, body composition. Plus pre-specified functional outcomes: gait speed, exercise capacity, strength, cognition. The 24-week intervention moved every domain meaningfully in the older-adult cohort. The clearest single takeaway was that a six-month substrate intervention closed the gap on multiple aging-of-aging biomarkers simultaneously.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2022 — Kumar et al., Nutrients.\u003c\/strong\u003e The 36-week extension and longevity-protocol formalization. The continued-use cohort maintained gains; the discontinuation cohort regressed on most markers within weeks of stopping, confirming the gains were maintained pharmacology rather than durable epigenetic change. The implication is straightforward: GlyNAC is a daily-use longevity intervention, not a fixed-course one.\u003c\/p\u003e\n\u003cp\u003eNone of this is a small claim, and the supplement industry has, predictably, run with versions of \"GlyNAC reverses aging\" that overshoot what the literature actually supports. The careful summary is this: in older adults with measured glutathione deficiency, replacing the substrate with adequate glycine and cysteine restores intracellular glutathione, and that restoration appears to drive measurable improvements across a panel of aging biomarkers in randomized, controlled, multi-month human trials. That is rare in aging biology. It is the precise reason glycine — boring, \"non-essential\", textbook footnote — became one of the most-discussed amino acids in clinical longevity over the last five years.\u003c\/p\u003e\n\n\u003ch2\u003eSix jobs glycine does that the longevity catalog cares about\u003c\/h2\u003e\n\u003cp\u003eGlutathione synthesis is the headline mechanism but not the only one. Glycine is unusually multifunctional even by amino-acid standards — most amino acids do one or two jobs in the body; glycine does at least six that matter for healthy aging.\u003c\/p\u003e\n\n\u003ch3\u003e1. Glutathione tripeptide assembly\u003c\/h3\u003e\n\u003cp\u003eGlutathione is γ-glutamyl-cysteinyl-glycine. The cell makes it in two steps: γ-glutamylcysteine first (rate-limited by cysteine via NAC or whole-protein dietary cysteine), then glutathione synthetase ligates the terminal glycine. Without adequate glycine substrate, the second step is rate-limited regardless of how much cysteine you provide. This is the precise pharmacology behind the GlyNAC pair: NAC supplies the cysteine bottleneck, glycine supplies the second bottleneck, and the cell's glutathione synthesis runs at capacity again. Glutathione is recycled rather than consumed when it neutralizes a reactive oxygen species — but recycling capacity itself depends on NADPH and the GSH\/GSSG ratio, both of which deteriorate under chronic oxidative load. Restoring substrate availability is the most direct intervention to keep the recycling pool topped up.\u003c\/p\u003e\n\n\u003ch3\u003e2. Heme biosynthesis\u003c\/h3\u003e\n\u003cp\u003eThe first step of heme synthesis — the molecule at the center of hemoglobin, myoglobin, cytochrome P450, mitochondrial cytochromes, and the electron transport chain — is the condensation of glycine with succinyl-CoA to form δ-aminolevulinic acid (ALA). Glycine is not a cofactor here; it is the literal carbon-and-nitrogen substrate. Mitochondrial cytochrome turnover, hepatic CYP enzyme synthesis, and red-blood-cell production all draw on this pathway daily. Inadequate glycine availability is a small but persistent drag on cellular energy machinery that compounds over years.\u003c\/p\u003e\n\n\u003ch3\u003e3. Collagen — the dominant amino acid in the triple helix\u003c\/h3\u003e\n\u003cp\u003eCollagen is roughly one-third glycine by residue count. Every third amino acid in the canonical Gly-X-Y collagen repeat is glycine — it has to be, because glycine is the only amino acid small enough to fit in the inner position of the collagen triple helix without disrupting the structure. The body's daily collagen turnover is large (skin, bone matrix, tendon, ligament, joint cartilage, vascular intima, gut lining, fascia), and glycine is a quantitatively dominant amino-acid demand for that turnover. The classical longevity-skin pairing is glycine + Vitamin C (the rate-limiting cofactor for prolyl\/lysyl hydroxylase, which crosslinks the collagen triple helix into mature fiber). If you are running our \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen Peptides\u003c\/a\u003e or \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti Collagen Peptides Powder\u003c\/a\u003e, glycine is the residue that compounds you are taking the most of in the supplement. Adding free glycine on top is the inexpensive way to keep the substrate floor high.\u003c\/p\u003e\n\n\u003ch3\u003e4. Sleep architecture — NMDA inhibitory co-agonism\u003c\/h3\u003e\n\u003cp\u003eGlycine is a co-agonist of central nervous system NMDA receptors at the glycine-binding site (separate from the glutamate-binding site), and an inhibitory neurotransmitter at glycine receptors in the brainstem and spinal cord. Three Japanese clinical trials run between roughly 2006 and 2012 (Yamadera et al. 2007, Bannai et al. 2012, plus related work from the Ajinomoto group) demonstrated that 3 grams of oral glycine taken 30–60 minutes before bed lowered core body temperature, increased delivered slow-wave sleep, reduced subjective fatigue the next morning, and improved next-day cognitive performance — without producing a benzodiazepine-style residual sedation, without altering total sleep time meaningfully, and without producing the dependency or rebound profile of GABA-acting hypnotics. The proposed mechanism is peripheral (cutaneous vasodilation lowers core temperature, which is the body's own signal to initiate sleep onset and deepen slow-wave architecture) more than direct central sedation. The dose ceiling in the Japanese literature is essentially safety-only; the trials used 3g and saw clean signal at that dose with no adverse effects.\u003c\/p\u003e\n\n\u003ch3\u003e5. One-carbon methylation — a quiet contribution\u003c\/h3\u003e\n\u003cp\u003eGlycine is a substrate for the glycine cleavage system, which donates one-carbon units to the folate-mediated methyl pool. That methyl pool is the same pool that drives DNA methylation, neurotransmitter synthesis, creatine biosynthesis, phosphatidylcholine production, and the disposal of methylated NAD+ metabolites (the reason \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e is in every serious NMN protocol). Glycine is a smaller, slower contributor than methionine or TMG, but it feeds the same methylation pool and it does so without homocysteine accumulation. For longevity protocol-builders running NMN at 500–1000mg\/day, glycine contributes to methylation buffer in addition to its glutathione job.\u003c\/p\u003e\n\n\u003ch3\u003e6. Bile-acid conjugation, creatine synthesis, neurotransmitter buffering\u003c\/h3\u003e\n\u003cp\u003eThree smaller but real downstream demands on the daily glycine pool: bile-acid conjugation (most glycine-conjugated bile acids in the enterohepatic loop are physically that — bile acid + glycine), creatine biosynthesis (glycine + arginine → guanidinoacetate → creatine, the molecule any user of \u003ca href=\"\/he\/products\/creatine-monohydrate-1000mg-strength-cognitive-longevity\"\u003ecreatine monohydrate\u003c\/a\u003e is supplementing the end-product of), and CNS inhibitory tone (glycine is the dominant inhibitory neurotransmitter in the spinal cord and brainstem; glycine receptor agonism damps the muscle-tone and startle-response circuits). Each of these is a small persistent draw on the daily glycine pool. None alone is a strong reason to supplement. Together they explain why oral glycine demand in older adults exceeds what the textbook \"non-essential\" framing assumes.\u003c\/p\u003e\n\n\u003ch2\u003eWhy older adults specifically run short on glycine\u003c\/h2\u003e\n\u003cp\u003eThree contributing factors, additive:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e(a) Reduced de-novo synthesis capacity.\u003c\/strong\u003e The dominant biosynthetic route is from serine via the serine-hydroxymethyltransferase (SHMT) enzyme system, which depends on adequate folate, B6, and one-carbon flux. All three of those tend to drift suboptimal with age, mild B-vitamin status decline, age-related kidney function decline, and the methylation-pool draw of high-protein diets. Less de-novo synthesis at the same daily turnover demand equals a slow chronic deficit.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e(b) Increased glycine demand for collagen turnover at the same time the body is replacing more collagen than it is making.\u003c\/strong\u003e Collagen catabolism in older adults exceeds new collagen deposition (this is the \"aging connective tissue\" picture clinically: thinner skin, less elastic vasculature, more fragile bone matrix). Glycine is the residue most consumed by this turnover, and the body cannot reincorporate the glycine from broken-down collagen as efficiently as it produced it.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e(c) Reduced glutathione recycling efficiency.\u003c\/strong\u003e The recycling of GSSG back to GSH is NADPH-dependent, and NADPH availability declines with mitochondrial dysfunction. As recycling drops, daily new-synthesis demand rises — and that new-synthesis demand pulls more glycine off the limited pool.\u003c\/p\u003e\n\u003cp\u003eThe result is a chronic, slowly-worsening, asymptomatic glycine deficit relative to physiological demand, exactly the type of deficit that responds well to substrate-only oral supplementation. Sekhar's group estimated that older-adult plasma glycine is roughly 25–30% lower than young-adult plasma glycine, and that the additional intracellular deficit is larger still because the cell is drawing from the same depleted pool.\u003c\/p\u003e\n\n\u003ch2\u003eSleep mechanism — the part everyone wants to know about\u003c\/h2\u003e\n\u003cp\u003eThe glycine-as-sleep-aid finding is the most replicable practical effect of high-dose oral glycine, and the mechanism is unusually well-characterized for an over-the-counter compound:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe temperature pathway.\u003c\/strong\u003e Sleep onset and slow-wave sleep depth are physiologically gated by core body temperature drop. The body initiates sleep when peripheral skin vessels dilate, releasing heat and dropping core temperature roughly 0.4–0.7°C below daytime baseline. Glycine ingestion 30–60 minutes pre-bed appears to cause cutaneous vasodilation through a brain-mediated mechanism (the suprachiasmatic and preoptic regions), accelerating the core-temperature drop. Yamadera et al. 2007 in \u003cem\u003eSleep and Biological Rhythms\u003c\/em\u003e measured this directly with thermistors and showed glycine subjects reached sleep-onset core temperature faster and stayed there longer. Bannai et al. 2012 in \u003cem\u003eFrontiers in Neurology\u003c\/em\u003e extended the finding with EEG, showing increased slow-wave sleep without total sleep time change.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe NMDA inhibitory co-agonism pathway.\u003c\/strong\u003e Separately, glycine is a positive modulator of NMDA receptors via the glycine-binding site, and an inhibitory neurotransmitter at strychnine-sensitive glycine receptors. Whether central glycinergic inhibition contributes to the sleep effect at oral doses (which produce only modest CNS glycine increases) remains debated. The temperature pathway is generally considered the dominant clinical mechanism.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy this matters in the longevity stack.\u003c\/strong\u003e Slow-wave sleep is when growth hormone is released, when the glymphatic clearance of brain metabolic waste runs (including beta-amyloid clearance), when peripheral immune-cell trafficking peaks, and when much of the body's daily protein turnover and tissue repair happens. A 2g–3g pre-bed glycine dose is the cheapest, safest evidence-based intervention to preserve slow-wave architecture without the residual-sedation tail of GABA-acting hypnotics or the receptor-downregulation profile of long-term sleep-aid use.\u003c\/p\u003e\n\u003cp\u003eThe trial dose to replicate is 3g (six of our 500mg capsules) 30–60 minutes before bed. Most users report a noticeable next-morning subjective freshness within the first week. Long-term users typically settle on 1.5–3g pre-bed as a daily protocol, often stacked with magnesium glycinate (\u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eour 400mg version is dosed for this\u003c\/a\u003e) since the magnesium-glycinate chelate delivers both the magnesium GABA-A potentiation and additional glycine.\u003c\/p\u003e\n\n\u003ch2\u003eGlycine vs. GlyNAC vs. whey vs. gelatin — what's actually different\u003c\/h2\u003e\n\u003cp\u003eYou can get glycine from several places. They are not interchangeable for the longevity protocol use case.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFree glycine (this product).\u003c\/strong\u003e Pharma-grade crystalline glycine, ~80–90% bioavailable orally, with predictable plasma kinetics and clean per-dose math. The Sekhar trials used pharma-grade free glycine. The sleep trials used pharma-grade free glycine. If you are trying to replicate clinical protocols, free glycine is what was studied.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlyNAC (glycine + NAC together).\u003c\/strong\u003e Not a separate molecule — just the co-administration of glycine and N-acetylcysteine. The trials used roughly 100mg\/kg\/day of each. For a 70kg adult that's ~7g\/day of glycine and ~7g\/day of NAC, taken in divided doses morning and evening. We sell the two as separate SKUs because they have different shelf-life and palatability profiles, but they are designed to be co-stacked. Three of these capsules + one \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003e600mg NAC\u003c\/a\u003e capsule, twice a day, gives you the same 1500mg + 1200mg foundational GlyNAC dose at half the trial volume — appropriate for users not in clinically diagnosed glutathione deficiency.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHydrolyzed collagen (collagen peptides).\u003c\/strong\u003e Collagen peptides are roughly 22–28% glycine by mass. A 10g collagen-peptide serving delivers 2–2.5g glycine — coincidentally in the same range as a glycine-as-sleep-aid dose. This is the cleanest food-based way to get foundational glycine, and the reason traditional broth-and-stew diets historically delivered far more glycine than modern muscle-meat-dominant diets. \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e at 5000mg\/day delivers ~1.1–1.4g glycine — useful but below GlyNAC trial doses without additional free glycine.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhey protein.\u003c\/strong\u003e Whey is glycine-poor relative to collagen — typically 1.7–2.2% glycine by mass. A 30g whey serving delivers only ~600mg glycine. Whey is excellent for leucine-driven mTOR \/ muscle-protein-synthesis but is not a substantial glycine source. Older adults running whey-only daily protein and assuming \"I'm getting plenty of amino acids\" are usually still glycine-short.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePlant proteins.\u003c\/strong\u003e Highly variable. Soy is ~4% glycine by mass; legumes 3–5%; nuts 4–6%. A varied plant-protein-rich diet provides a moderate glycine baseline but rarely reaches GlyNAC trial doses without supplemental free glycine.\u003c\/p\u003e\n\u003cp\u003eThe recommendation we would give a typical longevity-protocol-builder adult: keep dietary collagen or broth at floor (1–2 servings\/day if possible), and supplement free glycine on top to hit your clinical-protocol target.\u003c\/p\u003e\n\n\u003ch2\u003eHow to dose this product\u003c\/h2\u003e\n\u003cp\u003eEach capsule is 500mg pure glycine. Below are the three dosing protocols that map cleanly onto the trial literature.\u003c\/p\u003e\n\n\u003ch3\u003eFoundational longevity dose — 1000–1500mg\/day\u003c\/h3\u003e\n\u003cp\u003e2–3 capsules daily. The \"I run a longevity protocol but am not specifically targeting glutathione restoration\" dose. Take with the morning longevity stack (NMN, resveratrol, etc.) for amino-acid pool support, or split AM\/PM. At 60 caps\/bottle, 2 caps\/day is a 30-day supply — the standard catalog re-up cadence.\u003c\/p\u003e\n\n\u003ch3\u003eSleep-aid protocol — 1500–3000mg pre-bed\u003c\/h3\u003e\n\u003cp\u003e3–6 capsules taken 30–60 minutes before sleep, with water or a small carbohydrate. The trial dose is 3g (6 caps) — this is the most replicable target if you are specifically using glycine for slow-wave sleep restoration. Most users find 3g produces a clear subjective freshness effect within the first 5–7 nights. Some find the effect modest at 1.5g and substantial only at 3g; some find the reverse. Start at 1.5g for a week; titrate up.\u003c\/p\u003e\n\n\u003ch3\u003eGlyNAC protocol — 1500mg with NAC, twice daily\u003c\/h3\u003e\n\u003cp\u003e3 capsules of glycine + 2 capsules of \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC 600mg\u003c\/a\u003e (= 1200mg NAC), morning and evening. This is roughly 40% of the Sekhar trial dose of 100mg\/kg\/day for each compound — a sustainable foundational maintenance dose for adults in the 60–80kg range who are not in measured deficiency. Adults in measured glutathione deficiency, or those replicating Sekhar's protocols closely with physician oversight, can dose-escalate toward 100mg\/kg\/day. The Sekhar trials had no adverse-event signal at 100mg\/kg\/day in adults aged 65–80 over 36 weeks.\u003c\/p\u003e\n\n\u003ch3\u003eCo-supplemental considerations\u003c\/h3\u003e\n\u003cp\u003eGlycine is exceptionally well-tolerated and stacks cleanly with essentially every other supplement in the catalog. The most common combinations are:\u003c\/p\u003e\n\u003cp\u003e• \u003cstrong\u003eNAC.\u003c\/strong\u003e The other GlyNAC half. Co-administration is the entire trial design.\u003cbr\u003e\n• \u003cstrong\u003eTMG.\u003c\/strong\u003e Both contribute methyl pool support. Methylation pool buffer for high-dose NMN protocols benefits from co-supplementation of both. Glycine indirectly via the cleavage-system one-carbon contribution; \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e directly via betaine-homocysteine methyltransferase.\u003cbr\u003e\n• \u003cstrong\u003eVitamin C.\u003c\/strong\u003e Collagen synthesis cofactor. If you take glycine for collagen turnover support, \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eliposomal Vitamin C\u003c\/a\u003e 500–1000mg\/day is the rate-limiting cofactor for prolyl\/lysyl hydroxylation.\u003cbr\u003e\n• \u003cstrong\u003eMagnesium glycinate.\u003c\/strong\u003e The chelate delivers both magnesium (GABA-A potentiation, deep-sleep and recovery support) and additional glycine. Dose-stack-additive for the sleep protocol. \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eOur 400mg magnesium glycinate\u003c\/a\u003e delivers ~50mg additional glycine alongside 400mg elemental magnesium.\u003cbr\u003e\n• \u003cstrong\u003eCollagen peptides.\u003c\/strong\u003e Substrate-stacking. The combination is essentially \"free glycine for the longevity-protocol target dose, collagen peptides for connective-tissue substrate breadth (proline, hydroxyproline, glycine, lysine).\" See our \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e and \u003ca href=\"\/he\/products\/multi-collagen-peptides-powder-5-types-unflavored-1lb\"\u003eMulti Collagen Powder\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eWhat we put in the capsule (and what we left out)\u003c\/h2\u003e\n\u003cp\u003eEach capsule contains 500mg pharma-grade L-glycine (the only natural isomer; we do not use D-glycine or racemic mixtures, neither of which is metabolically active). The capsule shell is plant-derived hydroxypropyl methylcellulose (HPMC) — vegan, no gelatin, no porcine or bovine source. We do not add magnesium stearate, silicon dioxide, titanium dioxide, soy oil flowing agents, sucralose, sorbitol, or maltodextrin fillers. Each lot is third-party tested for identity (HPLC), microbial limits, heavy metals (lead, mercury, cadmium, arsenic) below USP and California Prop 65 thresholds, and PAH\/melamine residue.\u003c\/p\u003e\n\u003cp\u003eThe 500mg-per-cap fill is intentional: it lets a single bottle cover three different dosing protocols (foundational at 2 caps\/day = 30-day supply, sleep at 3–6 caps pre-bed = 10–20-night supply, GlyNAC at 3 caps × 2\/day = 10-day supply). Higher per-cap doses (1g+) reduce flexibility; lower per-cap doses (250mg) waste shell mass and increase swallow burden. 500mg is the dose that maps cleanly onto the published trial dosing arithmetic.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eWhy not just take collagen powder for the glycine?\u003c\/h3\u003e\n\u003cp\u003eYou can — and we recommend it as part of the protocol for connective-tissue substrate breadth. But collagen alone caps out at roughly 1–2.5g glycine per typical 5–10g serving, which is below the GlyNAC trial dose and at the floor of the sleep-aid trial dose. If your goal is GlyNAC-style glutathione restoration or sleep-aid effect, free glycine is a more practical way to hit the dose. If your goal is connective-tissue substrate, collagen peptides are denser in proline and hydroxyproline (the other dominant collagen residues) and worth pairing.\u003c\/p\u003e\n\n\u003ch3\u003eDoes glycine cause sedation during the day?\u003c\/h3\u003e\n\u003cp\u003eDaytime glycine in foundational doses (1–1.5g) does not produce subjective sedation in published trials. The sleep-aid effect is timing-dependent and dose-dependent, requiring a higher pre-bed dose (~3g) on top of the temperature-drop window. We have not seen daytime drowsiness reported in the Sekhar trials at 100mg\/kg\/day taken in divided doses. Some users describe a calm or \"low-noise\" subjective effect at higher daytime doses (3g+), generally interpreted as the inhibitory-tone CNS contribution.\u003c\/p\u003e\n\n\u003ch3\u003eIs it safe with antidepressants or other psychiatric medications?\u003c\/h3\u003e\n\u003cp\u003eGlycine has a clean profile in trials with psychiatric populations and is even being investigated as an adjunctive agent in schizophrenia (where higher doses show some benefit on negative symptoms). Standard combination with SSRIs, SNRIs, bupropion, or anti-anxiety medications has not produced clinically significant interactions in published reports. That said, anyone on prescription psychiatric medication should clear new supplements with their prescriber. Avoid combination with clozapine specifically: there is one case report of clozapine efficacy attenuation with high-dose glycine, attributed to the NMDA co-agonist mechanism.\u003c\/p\u003e\n\n\u003ch3\u003eI'm taking high-dose NMN. Do I need glycine for the methylation pool?\u003c\/h3\u003e\n\u003cp\u003eGlycine is a smaller methyl-pool contributor than TMG (which donates three methyl groups directly via betaine-homocysteine methyltransferase). For NMN protocols, \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e at 500–1000mg\/day is the more direct methyl-buffer support. Glycine contributes additional buffer through the one-carbon system and is worth co-stacking, but is not a substitute for TMG in this role.\u003c\/p\u003e\n\n\u003ch3\u003eDoes it taste like anything?\u003c\/h3\u003e\n\u003cp\u003eFree glycine is famously sweet — Greek glykys, \"sweet\". You will not taste anything from a swallowed capsule, but if you open one onto your tongue you will get a subtly sweet, slightly cooling profile (the same \"free amino acid\" taste signature as MSG-glutamate but without the savory\/umami axis). Some users dissolve 1–3 caps in warm water before bed instead of swallowing capsules; this works fine and the dissolved glycine has a not-unpleasant mildly-sweet character.\u003c\/p\u003e\n\n\u003ch3\u003eCan I take this on an empty stomach?\u003c\/h3\u003e\n\u003cp\u003eYes. Free glycine is well-absorbed without food. The amino-acid transporters that handle glycine (system gly, system A) are constitutively expressed and saturate at much higher doses than typical supplemental ones. There is no bioavailability advantage to dosing with food, though a small amount of water with the capsules helps with capsule transit.\u003c\/p\u003e\n\n\u003ch3\u003eWhat's the maximum safe dose?\u003c\/h3\u003e\n\u003cp\u003eThe published clinical doses go up to roughly 100mg\/kg\/day in older adults (~7g\/day for a 70kg person) over 36 weeks with no adverse-event signal. Acute single doses up to 9g have been used in psychiatric research without adverse effect. The practical ceiling for most users is set by GI tolerance — at very high single doses (\u0026gt;5g) some users report mild GI looseness, which is osmotic and resolves with split dosing. There is no toxicity ceiling of clinical concern for healthy adults at typical supplemental doses.\u003c\/p\u003e\n\n\u003ch3\u003eWhy only 60 capsules per bottle?\u003c\/h3\u003e\n\u003cp\u003eTo match the catalog re-up cadence at the foundational dose (2 caps\/day = 30-day supply) while keeping per-bottle freshness and shelf-life predictable. Heavy GlyNAC protocol users cycle through 2–3 bottles per month and typically subscribe.\u003c\/p\u003e\n\n\u003ch3\u003eHow does this compare to the cheap bulk glycine on the big online retailers?\u003c\/h3\u003e\n\u003cp\u003eGlycine is a low-cost commodity raw material. The differences in supplement-grade products are: (1) \u003cstrong\u003eidentity verification\u003c\/strong\u003e — pharma-grade L-glycine vs. unverified bulk that may include D-glycine isomer mass; (2) \u003cstrong\u003efiller load\u003c\/strong\u003e — many cheap brands cut with magnesium stearate (5–15% of capsule mass), silicon dioxide, or titanium dioxide; (3) \u003cstrong\u003eheavy-metal testing\u003c\/strong\u003e — bulk-grade glycine has historically been a route for arsenic and lead contamination; (4) \u003cstrong\u003ecapsule shell quality\u003c\/strong\u003e — gelatin vs. HPMC, with associated allergen\/source concerns. We test every lot and source from facilities GMP-certified for human dietary use, not livestock-feed-grade.\u003c\/p\u003e\n\n\u003ch2\u003eWho should not take this\u003c\/h2\u003e\n\u003cp\u003eStandard supplement caveats apply. Adults under 18, pregnancy, and breastfeeding: clear with a prescriber. Anyone with diagnosed kidney disease at stage 3 or worse should clear protein-loading supplements (including amino acids) with their nephrologist, since renal handling of nitrogen waste from amino acid catabolism is a relevant load. Anyone on clozapine specifically should avoid high-dose glycine due to a published interaction case report. Anyone with a known glycine-metabolism inborn error (non-ketotic hyperglycinemia is the relevant rare condition) is already under clinical management and should not self-supplement glycine without their physician.\u003c\/p\u003e\n\n\u003ch2\u003eThe longevity-protocol short version\u003c\/h2\u003e\n\u003cp\u003eGlycine is the most under-rated amino acid in the longevity catalog. It's the second substrate for the glutathione tripeptide (NAC supplies the first), the literal building block of heme and the one-third residue density in collagen, an inhibitory co-agonist that deepens slow-wave sleep, a one-carbon methyl-pool contributor that supports NMN protocols, and the cleanest, cheapest, most well-tolerated single ingredient on the longevity shelf. The Sekhar Baylor trials made GlyNAC the most clinically-supported aging intervention in the substrate-replacement class. Older adults are the demographic with the largest glycine-supply-vs-demand gap, and the gap closes dose-dependently with oral free glycine. We made ours the way the trials used it: pure pharma-grade L-glycine, 500mg per capsule, 60 caps per bottle, no fillers, no stearates, no titanium dioxide, vegan HPMC shell, third-party-tested every lot. 1500mg \/ 3 caps maps to the GlyNAC partner dose. 3000mg \/ 6 caps maps to the sleep-aid trial dose. 1000mg \/ 2 caps is the foundational floor.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStack pairing recommendations:\u003c\/strong\u003e Glycine + \u003ca href=\"\/he\/products\/n-acetyl-cysteine-600mg-nac-glutathione-precursor-for-antioxidant-longevity-support\"\u003eNAC\u003c\/a\u003e for GlyNAC glutathione restoration. Glycine + \u003ca href=\"\/he\/products\/magnesium-glycinate-400mg-sleep-and-nad-methylation\"\u003eMagnesium Glycinate\u003c\/a\u003e for the sleep protocol. Glycine + \u003ca href=\"\/he\/products\/marine-collagen-peptides-5000mg-skin-hair-joint-support\"\u003eMarine Collagen\u003c\/a\u003e + \u003ca href=\"\/he\/products\/liposomal-vitamin-c-1000mg-maximum-absorption-antioxidant-formula\"\u003eLiposomal Vitamin C\u003c\/a\u003e for connective-tissue substrate. Glycine + \u003ca href=\"\/he\/products\/tmg-1000mg-trimethylglycine-methyl-donor-for-nmn-nad-stacks\"\u003eTMG\u003c\/a\u003e for methylation-pool buffering on high-dose \u003ca href=\"\/he\/products\/pure-nmn-500mg-60-capsules-30-day-supply\"\u003eNMN protocols\u003c\/a\u003e. Glycine + \u003ca href=\"\/he\/products\/glutathione-500mg-maximum-strength\"\u003ereduced glutathione\u003c\/a\u003e if you want both substrate-precursor and direct-supplementation strategies running in parallel.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, particularly if you are pregnant, breastfeeding, taking prescription medications, or have a diagnosed medical condition. Individual results vary; clinical-trial outcomes apply at population level and are not guarantees for any individual user.\u003c\/em\u003e\u003c\/p\u003e\n","brand":"True Health Protocol","offers":[{"title":"Default Title","offer_id":47840828129498,"sku":"THP-GLYCINE-1500-60","price":22.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0814\/5158\/1658\/files\/thp_glycine.png?v=1778100114"}],"url":"https:\/\/truehealthprotocol.health\/he\/collections\/mitochondrial-renewal.oembed","provider":"True Health Protocol","version":"1.0","type":"link"}